<SEC-DOCUMENT>0001628280-24-018785.txt : 20240429
<SEC-HEADER>0001628280-24-018785.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429080327
ACCESSION NUMBER:		0001628280-24-018785
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20240429
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			C4 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001662579
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				475617627
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39567
		FILM NUMBER:		24886672

	BUSINESS ADDRESS:	
		STREET 1:		490 ARSENAL WAY
		STREET 2:		SUITE 120
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		(617) 231-0700

	MAIL ADDRESS:	
		STREET 1:		490 ARSENAL WAY
		STREET 2:		SUITE 120
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>cccc-20240429.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21890a72-5312-492c-85cd-9bed1985e6ee,g:043d0ee5-1298-4d91-abc8-6300a12bc742,d:41a0551a7b554b0f83839908f7b5cf88-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cccc-20240429</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-2">0001662579</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-3">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-4">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cccc-20240429.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i41a0551a7b554b0f83839908f7b5cf88_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE 14A INFORMATION </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY STATEMENT PURSUANT TO SECTION 14(a) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed by a Party other than the Registrant&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule 14a6(e)(2))</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definitive Proxy Statement</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Material Pursuant to &#167;240.14a12</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">C4 THERAPEUTICS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified in its Charter) </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check boxes that apply): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011.</span></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br/></span><img src="cccc-20240429_g1.jpg" alt="g291624g80a43.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:409px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">490 Arsenal Way, Suite 120 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Watertown, Massachusetts 02472 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To be held June&#160;20, 2024 </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the 2024 Annual Meeting of Stockholders, or Annual Meeting, of C4 Therapeutics, Inc. will be held online on Thursday, June&#160;20, 2024, at 8:30 a.m. Eastern Time. You will be able to attend, vote and submit your questions at </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">www.virtualshareholdermeeting.com/CCCC2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You will need the 16-digit control number included with these proxy materials to attend the Annual Meeting. The purpose of the Annual Meeting is the following: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">To elect three Class&#160;I directors to our Board of Directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier resignation or removal; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">To cast a non-binding, advisory vote to approve the compensation of our named executive officers; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2024; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposal for the election of directors relates solely to the election of Class&#160;I directors nominated by the Board of Directors. Only C4 Therapeutics, Inc., stockholders of record at the close of business on April&#160;23, 2024 will be entitled to vote at the Annual Meeting and any adjournment or postponement thereof. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pleased to take advantage of Securities and Exchange Commission rules that allow companies to furnish their proxy materials over the Internet. We believe that this e-proxy process will not only expedite stockholders&#8217; receipt of proxy materials, but also lower the costs of printing and distributing our proxy materials, as well as reduce the environmental impact of our Annual Meeting. We will mail the Notice of Availability of Proxy Materials, or Notice, instead of a paper copy of our proxy materials and our 2023 Annual Report to Stockholders, or 2023 Annual Report, on or about April 29, 2024. The Notice contains instructions on how to access those documents and to cast your vote via the Internet. The Notice also contains instructions on how to request a paper copy of our proxy materials and our 2023 Annual Report. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your vote is important. Whether or not you are able to attend the meeting in person, it is important that your shares be represented. To ensure that your vote is recorded promptly, please vote as soon as possible, even if you plan to attend the meeting, by submitting your proxy via the Internet at the address listed on the proxy card or by signing, dating and returning the proxy card. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By order of the Board of Directors,</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"><div><img src="cccc-20240429_g2.jpg" alt="g291624g39u12.jpg 1.jpg" style="height:47px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"/></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew J. Hirsch</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Watertown, Massachusetts </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2024</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:93.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_376">E</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_376">xecutive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_376">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_16">Proxy Statement for the 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_16">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_16"> Annual Meeting of Stockholders</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_19">I</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_19">mportant Information About the Annual Meeting and Voting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_22">P</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_22">roposal No. 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_22"> &#8211; E</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_22">lection of the Three Class I</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_22"> Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_22">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_25">C</a>orporate Governance</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_25">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_28">Director Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_28">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_31">E</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_31">xecutive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_31">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_34">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_34">ertain Relationships and Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_34">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_37">Principal Stockholders</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_37">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_40">Section 16(a) Beneficial Ownership Reporting Compliance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_40">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_43">P</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_43">roposal No. 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_43"> &#8211; A</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_43">dvisory Vote to Approve Named Executive Officer Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_43">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">P</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">roposal No. 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46"> &#8211; R</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">atification of the Appointment of KPMG LLP As C4 Therapeutics&#8217;s </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">I</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">ndepe</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">d</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">e</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">Registered Public Accounting Firm for the Fiscal Year Ending December 31, 202</a>4.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_46">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_49">R</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_49">eport of the Audit Committee</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_49">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_55">H</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_55">ouseholding</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_55">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_58">S</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_58">tockholder Proposals</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_58">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_61">O</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_61">ther Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_61">48</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_376"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C4 THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE SUMMARY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 was a transformative year for the Company as we executed across all our key strategic objectives. We delivered on important clinical readouts that enabled us to prioritize our pipeline, executed on business development initiatives that enabled us to improve our financial position and enhanced our corporate governance by adding important expertise to our Board of Directors and Senior Leadership Team. Through these efforts, we saw a meaningful increase in shareholder value at the end of 2023 and continuing into early 2024. We accomplished all of this against the backdrop of one of the most challenging capital markets environments for biotech in recent history. The achievements across key areas of the business are summarized below. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.083%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#40aeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executed Strategic Prioritization of Pipeline</span></td><td colspan="6" style="background-color:#40aeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Improved Financial Position &amp; Extended Cash Runway into 2027</span></td><td colspan="6" style="background-color:#40aeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Enhanced Corporate Governance</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g3.jpg" alt="Picture2.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced clinical development of CFT7455 (IKZF1/3 degrader for multiple myeloma and non-Hodgkin&#8217;s lymphomas) and CFT1946 (BRAF V600X degrader for melanoma, non-small cell lung cancer, and colorectal cancer)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g3.jpg" alt="Picture2.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Entered into license and collaboration agreements with Betta Pharmaceuticals, Co., LTD., Merck Sharp &amp; Dohme, LLC, and Merck KGaA, Darmstadt, Germany, bringing in $46M in upfront payments and the potential for downstream economics</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g3.jpg" alt="Picture2.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Added Owen Hughes to Board of Directors, who brings biopharmaceutical management and capital market experience</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g4.jpg" alt="Picture3.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Focused development efforts for CFT8919 (EGFR L858R degrader for NSCLC) through collaboration with Betta Pharmaceuticals, Co., Ltd.</span></div></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g4.jpg" alt="Picture3.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed $25M equity investment by Betta Investment (Hong Kong) Limited</span></div></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g4.jpg" alt="Picture3.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="background-color:#bfe4ff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadened Senior Leadership Team capabilities through the additions of Len Reyno, M.D., as Chief Medical Officer and Mary Christian, Pharm.D., as Senior Vice President, Regulatory</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g3.jpg" alt="Picture2.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Made data-driven decision to halt development of CFT8634 (BRD9 degrader for synovial sarcoma)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g3.jpg" alt="Picture2.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raised approximately $72M from the sale of common stock through our ATM facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g3.jpg" alt="Picture2.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increased diversity of the nine-member Senior Leadership Team, which now includes five women, one person of color and one person who identifies as LGBTQ+  </span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g4.jpg" alt="Picture3.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Streamlined internal discovery efforts</span></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g4.jpg" alt="Picture3.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executed corporate restructuring and reduced workforce by 30%</span></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div><img src="cccc-20240429_g4.jpg" alt="Picture3.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"/></div></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Environmental, Social and Governance (ESG) Factsheet</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to be held at 8:30 am Eastern Time on June&#160;20, 2024 </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This proxy statement contains information about the 2024 Annual Meeting of Stockholders, or the Annual Meeting, of C4 Therapeutics, Inc., which will be held online on June&#160;20, 2024 at 8:30 a.m. Eastern Time. You may attend the meeting virtually via the Internet at </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">www.virtualshareholdermeeting.com/CCCC2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where you will be able to vote electronically prior to the Annual Meeting and submit questions. The Board of Directors of C4 Therapeutics, Inc. is using this proxy statement to solicit proxies for use at the Annual Meeting. In this proxy statement the use of &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C4 Therapeutics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">us</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; refers to C4 Therapeutics, Inc. and its subsidiary. The mailing address of our principal executive offices is C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies will be voted in accordance with the recommendation of our Board of Directors with respect to each of the matters set forth in the accompanying Notice of Internet Availability of Proxy Materials, or Notice. You may revoke your proxy at any time before it is exercised at the meeting by giving our Corporate Secretary written notice to that effect. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made this proxy statement and our Annual Report to Stockholders for the fiscal year ended December&#160;31, 2023 available to stockholders on or about April 29, 2024. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be Held on June&#160;20, 2024: This proxy statement and our 2023 Annual Report to Stockholders are available for viewing, printing and downloading at </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. A copy of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023, as filed with the Securities and Exchange Commission, or the SEC, except for exhibits, will be furnished without charge to any stockholder upon written request to C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, Attention: Corporate Secretary. This proxy statement and our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 are also available on the SEC&#8217;s website at </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C4 THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL INFORMATION </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Why am I receiving these materials? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors, which is also referred to in this proxy statement as the Board, is providing these proxy materials to you in connection with its solicitation of proxies for use at C4 Therapeutics, Inc.&#8217;s Annual Meeting of Stockholders, which will take place on June&#160;20, 2024 and which is referred to in this proxy statement as the Annual Meeting. Stockholders are invited to attend the Annual Meeting and are requested to vote on the proposals described in this proxy statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stockholders as of the close of business on April&#160;29, 2024 will receive the proxy materials and have the ability to access them via the Internet, including this proxy statement and our Annual Report to Stockholders for the fiscal year ended December&#160;31, 2023, or the Annual Report, at </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">www.virtualshareholdermeeting.com/CCCC2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What proposals will be voted on at the Annual Meeting? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are three proposals scheduled to be voted on at the Annual Meeting: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the election of three Class&#160;I directors to hold office until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a&#160;non-binding,&#160;advisory vote to approve the compensation of our named executive officers; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time this proxy statement was mailed, our management and Board of Directors were not aware of any other matters to be presented at the Annual Meeting other than those set forth in this proxy statement and in the notice accompanying this proxy statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How does our Board of Directors recommend that I vote? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors unanimously recommends that you vote: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.424%"><tr><td style="width:1.0%"/><td style="width:19.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">More Information</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board of Directors Recommendation</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposal 1:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Election of Three Class I Directors</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_22">8</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> each director nominee</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposal 2:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advisory Vote on Executive Compensation</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_43">45</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FOR</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposal 3: </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratification of the Appointment of KPMG LLP as Our Independent Registered Public Accounting Firm for the Year Ending December 31, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_46">46</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FOR</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please cast your vote right away to ensure that your shares are represented at the Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">When are this proxy statement and the accompanying materials scheduled to be sent to stockholders? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to provide access to our proxy materials to our stockholders via the Internet. Accordingly, on or about April&#160;29, 2024, we will begin mailing a Notice of Internet Availability of Proxy Materials, or Notice. Our proxy materials, including the Notice of 2024 Annual Meeting of Stockholders, this proxy statement and the accompanying proxy card or, for shares held in street name (i.e., held for your account by a broker or other nominee), a voting instruction form and our Annual Report will be mailed or made available to stockholders on the Internet on or about the same date. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Why did I receive a Notice of Internet Availability of Proxy Materials instead of a full set of proxy materials? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to rules adopted by the Securities and Exchange Commission, or the SEC, for most stockholders, we are providing access to our proxy materials over the Internet rather than printing and mailing our proxy materials. We believe following this process will expedite the receipt of these materials, help lower our costs and reduce the environmental impact of our annual meeting materials. Therefore, the Notice was mailed to holders of record and beneficial owners of our common stock starting on or about April&#160;29, 2024. The Notice provides instructions as to how stockholders may access and review our proxy materials, including the Notice of 2024 Annual Meeting of Stockholders, this proxy statement, the proxy card and our 2023 Annual Report, on the website referred to in the Notice or, alternatively, how to request that a copy of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the proxy materials, including a proxy card, be sent to them by mail. The Notice also provides voting instructions. In addition, stockholders of record may request to receive the proxy materials in printed form by mail or electronically by e-mail on an ongoing basis for future stockholder meetings. Please note that, while our proxy materials are available at the website referenced in the Notice and this proxy statement and our 2023 Annual Report are available on our website, no other information contained on either website is incorporated by reference in or considered to be a part of this proxy statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who is entitled to vote at the Annual Meeting? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our common stock at the close of business on April&#160;23, 2024, the record date for the Annual Meeting, which is referred to in this proxy statement as the Record Date, are entitled to notice of and to vote at the Annual Meeting. Each stockholder is entitled to one vote for each share of our common stock held as of the Record Date. As of the Record Date, there were 68,805,786 shares of common stock outstanding and entitled to vote. The shares you are entitled to vote include shares that are (1)&#160;held of record directly in your name and (2)&#160;held for you as the beneficial owner through a stockbroker, bank or other nominee. Each stockholder of record is entitled to one vote for each share of our common stock held by such stockholder. None of our shares of undesignated preferred stock were outstanding as of April&#160;23, 2024. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is the difference between holding shares as a stockholder of record and as a beneficial owner? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If, at the close of business on the Record Date, your shares were registered directly in your name with Computershare Trust Company, N.A., our transfer agent, then you are considered the stockholder of record with respect to those shares. As the stockholder of record, you have the right to grant your voting proxy directly to the individuals listed on the proxy card or to vote in person at the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Owners: Shares Registered in the Name of a Broker, Bank, or Other Nominee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If, at the close of business on the Record Date, your shares were held, not in your name, but rather in a stock brokerage account or by a bank or other nominee on your behalf, then you are considered the beneficial owner of shares held in &#8220;street name.&#8221; As the beneficial owner, you have the right to direct your broker, bank, or other nominee how to vote your shares by following the voting instructions your broker, bank, or other nominee provides. If you do not provide your broker, bank, or other nominee with instructions on how to vote your shares, your broker, bank, or other nominee may, in its discretion, vote your shares with respect to routine matters but may not vote your shares with respect to any&#160;non-routine&#160;matters. For additional information, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">What if I do not specify how my shares are to be voted?</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How do I vote? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By Proxy </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our Annual Meeting, you may vote your shares held as of the Record Date in the following ways:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.909%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By Mail</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By Telephone</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Through the Internet</span></td></tr><tr style="height:63pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"><div style="text-align:center"><img src="cccc-20240429_g5.jpg" alt="Mail.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:72px"/></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"><div style="text-align:center"><img src="cccc-20240429_g6.jpg" alt="Phone.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:72px"/></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"><div style="text-align:center"><img src="cccc-20240429_g7.jpg" alt="Computer.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:72px"/></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cast your ballot, sign your proxy card and send it in by free post</span></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dial toll-free 24/7</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-800-690-6903</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Visit 24/7</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">www.proxyvote.com</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mark, sign and date your proxy card and return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717 or return it in the postage-paid envelope included in your proxy materials. Your proxy card must arrive by June 19, 2024. </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m., Eastern Time, on June 19, 2024. Have your proxy card in hand when you call and then follow the instructions.</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Use the internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m., Eastern Time, on June 19, 2024. Have your proxy card in hand when you access the website and follow the instructions to obtain your records and create an electronic voting instruction form.</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you complete and submit your proxy before the Annual Meeting, the persons named as proxies will vote the shares represented by your proxy in accordance with your instructions. If you submit a proxy without giving voting instructions, your shares will be voted in the manner recommended by the Board of Directors on all matters presented in this proxy statement, and as the persons named as proxies may determine in their discretion with respect to any other matters properly presented at the Annual Meeting. You may also authorize another person or persons to act for you as proxy in a writing, signed by you or your authorized representative, specifying the details of those proxies&#8217; authority. The original writing </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">must be given to each of the named proxies, although it may be sent to them by electronic transmission if, from that transmission, it can be determined that the transmission was authorized by you. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any other matters are properly presented for consideration at the Annual Meeting, including, among other things, consideration of a motion to adjourn the Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named in your proxy and acting thereunder will have discretion to vote on those matters in accordance with their best judgment. We do not currently anticipate that any other matters will be raised at the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How do I revoke my proxy? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may revoke your proxy by (1)&#160;following the instructions on the Notice and entering a new vote by mail that we receive before the start of the Annual Meeting or over the Internet by the cutoff time of 11:59 p.m. Eastern Time on June&#160;19, 2024, (2) attending and voting at the Annual Meeting (although attendance at the Annual Meeting will not in and of itself revoke a proxy), or (3)&#160;by filing an instrument in writing revoking the proxy or another duly executed proxy bearing a later date with our Corporate Secretary. Any written notice of revocation or subsequent proxy card must be received by our Corporate Secretary prior to the taking of the vote at the Annual Meeting. Any written notice of revocation or subsequent proxy card should be hand delivered to our Corporate Secretary or sent to our principal executive offices at C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, Attention: Corporate Secretary. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a broker, bank or other nominee holds your shares, you must contact that broker, bank or nominee in order to find out how to change your vote. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What if I do not specify how my shares are to be voted? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder of Record </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you submit a proxy but do not provide voting instructions, your shares will be voted: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FOR the election of each of the three directors nominated by our board as Class I directors to serve for a three-year term (Proposal No. 1); </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FOR approval, on a non-binding, advisory basis, of the compensation of the Company&#8217;s named executive officers (Proposal No. 2); and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FOR the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024 (Proposal No. 3).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Owner</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you do not provide voting instructions, then your broker, bank, or other nominee will only have the authority to vote your shares with respect to Proposal No. 3 (ratification of the appointment of the independent registered public accounting firm). Your shares will not be voted with respect to Proposals No. 1 and 2. This is known as a &#8220;broker non-vote.&#8221; </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How is a quorum reached? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated By-laws, or our By-laws, provide that a majority of the shares entitled to vote, present in person or represented by proxy, will constitute a quorum for the transaction of business at the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the General Corporation Law of the State of Delaware, shares that are voted &#8220;abstain&#8221; or &#8220;withheld&#8221; and broker &#8220;non-votes&#8221; are counted as present for purposes of determining whether a quorum is present at the Annual Meeting. If a quorum is not present, the meeting may be adjourned until a quorum is obtained. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How is the vote counted? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our By-laws, any proposal other than an election of directors is decided by a majority of the votes properly cast for and against that proposal, except where a larger vote is required by law or by our Amended and Restated Certificate of Incorporation, or Certificate of Incorporation, or By-laws. Abstentions and broker &#8220;non-votes&#8221; are not included in the tabulation of the voting results on any such proposal and, therefore, do not have an impact on such proposals. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If your shares are held in &#8220;street name&#8221; by a brokerage firm, your brokerage firm is required to vote your shares according to your instructions. If you do not give instructions to your brokerage firm, the brokerage firm will still be able to vote your shares with respect to certain &#8220;discretionary&#8221; items but will not be allowed to vote your shares with respect to &#8220;non-discretionary&#8221; items. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How many votes are needed for approval of each proposal? </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Proposal No.&#160;1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The election of Class&#160;I directors requires a plurality vote of the shares of our common stock present in person or by proxy at the Annual Meeting and entitled to vote thereon to be approved. This means that the three nominees who receive the most FOR votes will be elected. You may (i)&#160;vote FOR all nominees, (ii)&#160;WITHHOLD your vote as to all nominees, or (iii)&#160;vote FOR all nominees except for those specific nominees from whom you WITHHOLD your vote. Any shares not voted FOR a particular nominee (whether as a result of voting withheld or a broker&#160;non-vote)&#160;will not be counted in that nominee&#8217;s favor and will have no effect on the outcome of the election. If you WITHHOLD your vote as to all nominees, you will be deemed to have abstained from voting on Proposal No.&#160;1, and the abstention will have no effect on the outcome of the proposal. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Proposal No.&#160;2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Approval on a&#160;non-binding,&#160;advisory basis of the compensation of our named executive officers requires an affirmative vote of a majority of the shares of our common stock present in person or by proxy at the Annual Meeting and entitled to vote thereon to be approved. You may vote FOR, AGAINST or ABSTAIN. If you ABSTAIN from voting on Proposal No.&#160;2, the abstention will have the same effect as a vote AGAINST the proposal.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Proposal No.&#160;3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The ratification of the appointment of KPMG LLP requires an affirmative vote of a majority of the shares of our common stock present in person or by proxy at the Annual Meeting and entitled to vote thereon to be approved. You may vote FOR, AGAINST or ABSTAIN. If you ABSTAIN from voting on Proposal No.&#160;3, the abstention will have the same effect as a vote AGAINST the proposal.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What are the effects of abstentions and broker&#160;non-votes? </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">An abstention represents a stockholder&#8217;s affirmative choice to decline to vote on a proposal. If a stockholder indicates on its proxy card that it wishes to abstain from voting its shares, or if a broker, bank, or other nominee holding its customers&#8217; shares of record causes abstentions to be recorded for shares, these shares will be considered present and entitled to vote at the Annual Meeting. As a result, abstentions will be counted for purposes of determining the presence or absence of a quorum and will also count as votes against a proposal in cases where approval of the proposal requires the affirmative vote of a majority of the shares present and entitled to vote at the Annual Meeting (e.g., Proposal No.&#160;3). However, because the outcome of Proposal No.&#160;1 (election of directors) will be determined by a plurality vote, meaning that the director nominees receiving the most votes will be elected, neither abstentions nor &#8220;withheld&#8221; votes will have any impact on the outcome of that proposal as long as a quorum exists. Abstentions also will have no effect on the&#160;ratification of the&#160;non-binding,&#160;advisory vote to approve the compensation of our named executive officers (Proposal No.&#160;2).</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">A broker&#160;non-vote&#160;occurs when a broker, bank, or other nominee holding shares for a beneficial owner does not vote on a particular proposal because the broker, bank, or other nominee does not have discretionary voting power with respect to such proposal and has not received voting instructions from the beneficial owner of the shares. Broker&#160;non-votes&#160;will be counted for purposes of calculating whether a quorum is present at the Annual Meeting but will not be counted for purposes of determining the number of votes cast. Therefore, a broker&#160;non-vote&#160;will make a quorum more readily attainable but will not otherwise affect the outcome of the vote on any proposal. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Proposals No.&#160;1 and 2 are &#8220;non-discretionary&#8221; items. If you do not instruct your broker how to vote with respect to any of these proposals, your broker may not vote for these proposals and those votes will be counted as broker &#8220;non-votes.&#8221; Proposal No.&#160;3 is considered to be a discretionary item, which means that your brokerage firm will be able to vote on this proposal even if it does not receive instructions from you. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who pays the cost for soliciting proxies? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are making this solicitation and will pay the entire cost of preparing and distributing the Notice and our proxy materials and soliciting votes. If you choose to access the proxy materials or vote over the Internet, you are responsible for any Internet access charges that you may incur. Our officers and employees may, without compensation other than their regular compensation, solicit proxies through further mailings, personal conversations, facsimile transmissions, e-mails, or otherwise. We have hired Broadridge Financial Solutions, Inc. to assist us in the distribution of proxy materials and the solicitation of votes described above. Proxy solicitation expenses that we will pay include those for preparation, mailing, returning and tabulating the proxies. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What does it mean if I received more than one Notice of the Annual Meeting? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you receive more than one proxy card or voting instruction form of the Annual Meeting, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each notice you received to ensure that all of your shares are voted. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I share an address with another stockholder and we received only one paper copy of the proxy materials. How may I obtain an additional copy of the proxy materials? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a procedure called &#8220;householding,&#8221; which has been approved by the U.S. Securities and Exchange Commission, or the SEC. Under this procedure, we will deliver only one copy of our proxy materials in the mail to multiple stockholders who share the same address (if they appear to be members of the same family) unless we have received contrary instructions from an affected stockholder. Stockholders who participate in householding will continue to receive separate proxy cards if they received a paper copy of proxy materials in the mail. This procedure reduces our printing and mailing costs. Upon written or oral request, we will promptly deliver a separate copy of the proxy materials to any stockholder at a shared address to which we delivered a single copy of any of these documents. To receive a separate copy, or, if you are receiving multiple copies, to request that we only send a single copy of next year&#8217;s proxy materials, you may contact us as follows: </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C4 Therapeutics, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention: Corporate Secretary </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490 Arsenal Way, Suite 120 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Watertown, MA 02472 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(617)&#160;231-0700 </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders who hold shares in street name may contact their brokerage firm, bank, or other nominee to request information about householding. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How may stockholders submit matters for consideration at an annual meeting? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The required notice must be in writing and received by our Corporate Secretary at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year&#8217;s annual meeting. However, in the event that the date of the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year&#8217;s annual meeting, or if no annual meeting were held in the preceding year, a stockholder&#8217;s notice must be so received no earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (A)&#160;the 90th day prior to such annual meeting and (B)&#160;the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any stockholder proposal intended to be included in the proxy statement for the next annual meeting of our stockholders in 2025 must also satisfy the requirements of SEC Rule 14a-8 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and be received not later than December&#160;30, 2024. If the date of the annual meeting is moved by more than 30 days from the date contemplated at the time of the previous year&#8217;s proxy statement, then notice must be received within a reasonable time before we begin to print and send proxy materials. If that happens, we will publicly announce the deadline for submitting a proposal in a press release or in a document filed with the SEC. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How can I learn about the voting results? </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to announce preliminary voting results at the Annual Meeting and will publish final results in a Current Report on Form 8-K to be filed with the SEC within four business days following the Annual Meeting. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1 &#8211; ELECTION OF CLASS I DIRECTORS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors currently consists of nine members. In accordance with the terms of our Certificate of Incorporation and By-laws, our Board of Directors is divided into three classes, Class&#160;I, Class&#160;II and Class&#160;III, with members of each class serving staggered three-year terms. The members of the classes are divided as follows: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The Class&#160;I directors are Kenneth C. Anderson, M.D., Laura Bessen, M.D., and Owen Hughes, and their term will expire at the Annual Meeting; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The Class&#160;II directors are Bruce Downey, Glenn Dubin, and Donna Grogan, M.D., and their term will expire at the annual meeting of stockholders to be held in 2025; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The Class&#160;III directors are Andrew J. Hirsch, Utpal Koppikar, and Malcolm Salter, and their term will expire at the annual meeting of stockholders to be held in 2026. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the expiration of the term of a class of directors, directors in that class will be eligible to be elected for a new three-year term at the annual meeting of stockholders in the year in which their term expires. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and By-laws provide that the authorized number of directors may be changed only by resolution of our Board of Directors. Our Certificate of Incorporation also provides that our directors may be removed only for cause by the affirmative vote of the holders of at least two-thirds of the outstanding shares then entitled to vote in an annual election of directors, and that any vacancy on our Board of Directors, including a vacancy resulting from an enlargement of our Board of Directors, may be filled only by vote of a majority of our directors then in office. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has nominated Kenneth C. Anderson, M.D., Laura Bessen, M.D., and Owen Hughes for election as the Class&#160;I directors at the Annual Meeting. Each of the nominees is presently a director and has indicated a willingness to continue to serve as a director, if elected. If any of the nominees becomes unable or unwilling to serve, however, the proxies may be voted for a substitute nominee selected by our Board of Directors. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our priority in selection of members of our Board of Directors is identification of members who will further the interests of our stockholders through their established record of professional accomplishment, their ability to contribute positively to the collaborative culture among members of our Board of Directors and their knowledge of our business and understanding of the competitive landscape. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominees for Election as Class&#160;I Directors </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table identifies our Class&#160;I directors and sets forth their principal occupations and business experience during the last five years and their ages as of April&#160;29, 2024: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Positions and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Offices&#160;Held&#160;with</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">C4 Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Director<br/>Since</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Class&#160;and Year</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">in Which Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Will Expire</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenneth C. Anderson, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2015</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class&#160;I&#8212;2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laura Bessen, M.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class&#160;I&#8212;2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owen Hughes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class&#160;I&#8212;2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kenneth C. Anderson, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a co-founder and has served as a member of our Board since December 2015. Dr.&#160;Anderson has also served as the Kraft Family Professor of Medicine at Harvard Medical School since 2002, as well as Director of the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at the Dana-Farber Cancer Institute since 2000 and 2007, respectively. Dr.&#160;Anderson is a member of the Institute of Medicine of the National Academy of Sciences and served as President of the International Myeloma Society from 2011 until 2015. Dr.&#160;Anderson serves on the boards of directors of Window Therapeutics, a biotechnology company developing therapies that advance treatment options for patients with cancer and other serious diseases, since January 2021, Dynamic Cell Therapies, Inc. (formerly Raqia Therapeutics, Inc.), a CAR-T cell therapies company for cancer and other diseases, since September 2020, and Starton Therapeutics, Inc., a biotechnology company focused on blood cancer treatments, since September 2020. Dr.&#160;Anderson holds an M.D. from Johns Hopkins Medical School, where he also trained in internal medicine, and completed hematology, medical oncology and tumor immunology training at the Dana-Farber Cancer Institute. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Dr.&#160;Anderson is qualified to serve on our Board because of his experience, qualifications, attributes and skills, including his extensive experience in the life sciences industry. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laura Bessen, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our director since August 2022. Dr. Bessen currently serves as managing partner at Maxsam Advisors, LLC, where she provides strategic clinical and medical affairs advice to clients in the biotechnology and pharmaceutical industries. From 2001 to 2016, Dr. Bessen served in a variety of roles at Bristol-Myers Squibb Co., </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">most recently as Vice President and Head of U.S. Medical. Prior to Bristol-Myers Squibb, Dr. Bessen served as Medical Director at DuPont Pharmaceuticals from 1997 to 2001. Since March 2022, Dr. Bessen has also served on the board of director of Artiva Biotherapeutics, Inc., an oncology company developing and advancing off-the-shelf, allogeneic natural killer cell therapies for patients with hematologic cancers or solid tumors. Dr. Bessen holds a B.S. in biochemistry from the State University of New York at Binghamton and a M.D. from New York University School of Medicine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Dr. Bessen is qualified to serve on our Board because of her experience, qualifications, attributes and skills, including her medical background and extensive experience in the pharmaceutical industry. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Owen Hughes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, is our most recently appointed director, having been appointed to our Board in November 2023. Mr. Hughes currently serves as Chief Executive Officer of Xoma Corporation, a publicly traded biotechnology royalty aggregator company, where he also serves on the board of directors. Previously, Mr. Hughes served as the Chief Executive Officer and co-founder of Cullinan Oncology, Inc., a publicly-traded oncology company, from September 2017 to October 2021. From February 2013 to August 2017, Mr. Hughes served as the Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, Inc., a biotechnology company focused on type II diabetes. Prior to his operating roles, Mr. Hughes spent 16 years on Wall Street in various capacities, including roles at Brookside Capital, an operating division of Bain Capital, and Pyramis Global Advisors, a Fidelity Investments company. Mr. Hughes has served on the board of directors of Ikena Oncology, Inc., a publicly-traded oncology company, since December 2022. Mr. Hughes served on the board of directors of Radius Health, Inc., a publicly-traded biopharmaceutical company, from April 2013 to August 2022 until its sale to Gurnet Point Capital and Patient Square Capital; Translate Bio, Inc., a messenger RNA therapeutics company, from July 2016 until its acquisition by Sanofi in September 2021; and FS Development Corp. II, a special purpose acquisition company sponsored by Foresite Capital, from February 2021 to December 2021. Mr. Hughes received a B.A. in History from Dartmouth College. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr. Hughes is qualified to serve on our Board because of his experience, qualifications, attributes and skills, including his extensive experience with biopharmaceutical companies and the capital markets.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be approved, the election of Class&#160;I directors requires a plurality vote of the shares of our common stock present in person or by proxy at the Annual Meeting and entitled to vote thereon. Broker&#160;non-votes&#160;will have no effect on this proposal. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each proxy received will be voted in favor of the above nominees unless a contrary specification is made in the proxy. Each of the nominees has consented to serve as a member of our Board of Directors if elected. However, if the nominees are unable to serve or for good cause will not serve as a director, the proxies will be voted for the election of such substitute nominee as our Board of Directors may designate. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Board of Directors recommends voting &#8220;FOR&#8221; the election of Kenneth C. Anderson, M.D., Laura Bessen, M.D., and Owen Hughes as the Class&#160;I directors, each to serve for a three-year term ending at the annual meeting of stockholders to be held in 2027. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Continuing in Office </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table identifies our Class&#160;II and Class&#160;III directors and sets forth their principal occupation and business experience during the last five years and their ages as of April&#160;29, 2024: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Positions and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Offices Held</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">with&#160;C4&#160;Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Director<br/>Since</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class&#160;and Year in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Which Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Will Expire</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bruce Downey</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chairman of the Board of Directors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class&#160;II&#8212;2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn Dubin</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class&#160;II&#8212;2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Donna Grogan, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class&#160;II&#8212;2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew J. Hirsch</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director and Chief Executive Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class III&#8212;2026  </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utpal Koppikar</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class III&#8212;2026  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malcolm Salter</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2015</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class III&#8212;2026  </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bruce Downey</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our director since December 2015. In addition, Mr. Downey served as our Lead Independent Director from January 2022 until June 2022 when he became interim Chairman, a position he held until July 2022 when he became our Chairman. From 1994 to 2008, Mr. Downey was Chairman and Chief Executive Officer of Barr Pharmaceuticals, Inc. (until its acquisition by Teva in 2008), a global generic pharmaceutical manufacturer. Mr. Downey has served on a part-time basis as a Partner of NewSpring Health Capital II, L.P., a venture capital firm, since April 2009. Prior to Barr Pharmaceuticals, Mr. Downey was a practicing attorney for 20 years, working in both the private sector and for the federal government, including the U.S. Department of Justice and the U.S. Department of Energy. In addition, Mr. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Downey has served on the boards of directors of OncoPep, Inc., a biotechnology company focused on developing targeted immunotherapeutics since April 2011 and Cardinal Health, Inc., a healthcare services company since July 2009. Mr. Downey previously served on the board of directors of Melinta Therapeutics, Inc., a biopharmaceutical firm, from October 2018 until April 2020, and Momenta Pharmaceuticals, Inc., a biotechnology company from June 2009 through the sale of the company in October 2020. Mr. Downey holds a B.S. in economics from Miami University and a J.D. from Ohio State University.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr. Downey is qualified to serve on our Board because of his experience, qualifications, attributes and skills, including his global pharmaceutical industry experience.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Glenn Dubin </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our director since March 2021. Mr. Dubin is the Principal of Dubin &amp; Co., a private investment company based in New York. Since 2012, Mr. Dubin has been a member of the board of directors and lead shareholder of Castleton Commodities International LLC, a global merchant energy company active in the physical and financial commodity markets and infrastructure investing. Mr. Dubin co-founded Highbridge Capital Management LLC, an alternative asset management company that was acquired by JP Morgan Asset Management. Mr. Dubin is also Managing Member of DF Investment Partners, LLC. Additionally, Mr. Dubin is active in a variety of philanthropic endeavors, including roles as founder and former chair of the board of the Robin Hood Foundation, an organization that applies investment principles to charitable giving, the Mount Sinai Medical Center, where he and his wife, Dr. Eva Andersson-Dubin, established the Dubin Breast Center, a leading institution for breast cancer research and clinical care, and the Museum of Modern Art, where he is a member of the board of trustees.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr. Dubin is qualified to serve on our Board because of his experience, qualifications, attributes and skills, including his extensive capital market experience.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Donna Grogan, M.D.</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our director since August 2022. Dr. Grogan currently serves as Principal of Grogan Consulting, LLC, serving pharmaceutical company clients across drug development, regulatory strategy, trial design, and data interpretation. From September 2013 to June 2019, Dr. Grogan served as Chief Medical Officer of Clementia Pharmaceuticals, Inc., which was acquired by Ipsen in April 2019. Prior to Clementia, Dr. Grogan served as Chief Medical Officer for several HealthCare Ventures portfolio companies including Anexon, Apofore, and DecImmune. From February 2007 to August 2011, Dr. Grogan served as Chief Medical Officer and Senior Vice President of Clinical Development at FoldRx Pharmaceuticals, which was acquired by Pfizer in October 2010. Prior to FoldRx Pharmaceuticals, Dr. Grogan held roles of increasing responsibility at a various pharmaceutical companies, including Sepracor, Inc., which is currently known as Sunovian Pharmaceuticals, Inc., and Astra Pharmaceuticals, Inc. Dr. Grogan also served as a member of the board of directors of Momenta Pharmaceuticals, Inc., until its acquisition by Johnson &amp; Johnson in October 2020. Dr. Grogan holds a B.A. from the College of the Holy Cross and a M.S. from University of Illinois College of Medicine.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Dr. Grogan is qualified to serve on our Board because of her experience, qualifications, attributes and skills, including her medical background and extensive experience in the pharmaceutical industry. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Andrew J. Hirsch </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our President and a member of our Board since September 2020 and as our Chief Executive Officer since October 2, 2020. From September 2016 to September 2020, Mr. Hirsch served as Chief Financial Officer at Agios Pharmaceuticals, Inc., a public pharmaceutical company, including as head of corporate development beginning in March 2018. From March 2015 until August 2016, he served as President and Chief Executive Officer of BIND Therapeutics, Inc., or BIND, a biotechnology company. Prior to being named President and Chief Executive Officer, Mr. Hirsch held several other leadership positions at BIND, including Chief Operating Officer from February 2014 to March 2015, and Chief Financial Officer from July 2012 to March 2015. Prior to joining BIND, Mr. Hirsch was Chief Financial Officer at Avila Therapeutics, Inc., a biotechnology company, from June 2011 until its acquisition by Celgene Corporation in March 2012. From 2002 to 2011, Mr. Hirsch held roles of increasing responsibility at Biogen Inc., including Vice President of Corporate Strategy and M&amp;A and program executive for the Avonex, Tysabri and Tecfidera development teams. Since May 2017, Mr. Hirsch has served on the board of directors of Editas Medicine, Inc. (Nasdaq: EDIT, a publicly traded pharmaceutical company, and also serves as a member of its audit committee and organization, leadership and compensation committee. He holds an M.B.A. from the Tuck School at Dartmouth College and a B.A. in economics from the University of Pennsylvania.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr.&#160;Hirsch is qualified to serve on our Board because of his extensive leadership and industry-specific experience in a range of strategic and operating roles in the biotech sector.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Utpal Koppikar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our director since March 2022. Since April 2023, Mr. Koppikar has served as Chief Financial Officer of Verily, a division of Alphabet, Inc., which is focused on applying artificial intelligence and data science to accelerate the development of precision health solutions. From June 2018 to March 2023, Mr. Koppikar served in positions of increasing responsibility, most recently as Executive Vice President and Chief Financial Officer, at Atara Biotherapeutics, Inc., a biotechnology company developing T-cell based immunotherapies. Prior to Atara Biotherapeutics, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Koppikar served in a variety of roles at Gilead Sciences, Inc., from June 2011 through June 2018, including most recently as Vice President of Finance. From January 2001 to June 2011, Mr. Koppikar served as Executive Director of Finance at Amgen Inc. Mr. Koppikar was also a member of the board of directors of Flexion Therapeutics, Inc,, and Chair of its Audit Committee, until the acquisition of Flexion by Pacira BioSciences, Inc. Mr. Koppikar holds a B.S. in aerospace engineering from the University of Maryland, an M.S. in aeronautical engineering from Stanford University, and a M.B.A. from the Anderson School of Management at University of California, Los Angeles. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr.&#160;Koppikar is qualified to serve on our Board because of his experience, qualifications, attributes and skills, including his financial leadership experience within the life sciences industry. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Malcolm S. Salter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our director since December 2015. Mr. Salter is the James J. Hill Professor, Emeritus, at the Harvard Business School. From the time he joined the Harvard Business School faculty in 1967, his teaching and research have focused on issues of corporate strategy and governance. Mr. Salter currently serves on the boards of directors of AI Proteins, Inc., a biotechnology company focusing on the design and engineering of synthetic mini-protein therapeutics, since 2022, NextRNA, Inc., a biotechnology company focused on developing the next generation of RNA-directed therapeutics, since February 2021, and Dynamic Cell Therapies, Inc. (formerly Raqia Therapeutics, Inc.), a CAR-T cell therapies company for cancer and other diseases, since September 2020. Mr. Salter is also a co-founder of the Dana-Farber Innovations Research Fund, a venture philanthropy fund focused on early-stage research. From 1986 to 2006, Mr. Salter served as president of Mars &amp; Co., a global strategy-consulting firm. Mr. Salter is a former Trustee of the Dana-Farber Cancer Institute. Mr. Salter holds an A.B., M.B.A., and a D.B.A. from Harvard University.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr.&#160;Salter is qualified to serve on our Board because of his experience, qualifications, attributes and skills, including his extensive corporate leadership experience. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings Involving Our Directors </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material legal proceedings to which any of our directors is a party adverse to us or any of our subsidiaries or in which any such person has a material interest adverse to us or our subsidiary. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers Who Are Not Directors </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table identifies our current executive officers who are not directors and sets forth their current positions at C4 Therapeutics and their ages as of April&#160;29, 2024: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position Held with C4 Therapeutics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Officer&#160;Since</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kendra Adams</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scott N. Boyle</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Business Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Scientific Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Medical Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kelly A. Schick</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief People Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jolie M. Siegel</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Legal Officer and Secretary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kendra Adams</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer and Treasurer since September 2023 and as our Senior Vice President of Communications and Investor Relations from November 2020 to September 2023. Previously, Ms. Adams was Vice President, Investor Relations and External Communications at Agios Pharmaceuticals, Inc., a publicly traded pharmaceutical company, from December 2015 to November 2020, where she held roles of increasing breadth and responsibility during her tenure. Prior to that, Ms. Adams served as Senior Director, Investor Relations at Ariad Pharmaceuticals, Inc., an oncological pharmaceutical company, and before that, as Senior Manager of Investor Relations at Amgen from 2004 to 2012. Earlier in her career, Ms. Adams held roles of increasing responsibility at General Electric, where she participated in the company&#8217;s Financial Management program, and KPMG, LLP, where she led consulting teams on a variety of financial and strategic matters.  Ms. Adams holds a B.A. in economics from Hamilton College. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Scott N. Boyle, Ph.D., M.B.A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Business Officer since January 2022. Previously, Dr.&#160;Boyle was Vice President, Business and Corporate Development at Forma Therapeutics from August 2019 to January 2022. Prior to that, from January 2019 to August 2019, Dr.&#160;Boyle was Associate Director at the Boston Consulting Group where he served clients focused on oncology and precision medicine and, from September 2014 to September 2018, he was Vice President of Business Development at Caris Life Sciences, where he built the business development function and held roles of increasing responsibility. Dr.&#160;Boyle earned a Bachelor of Science degree in biochemistry from Brigham Young University, a Ph.D. in molecular biophysics and biochemistry from Yale University and an M.B.A. from the Harvard Business School. Dr.&#160;Boyle completed his post-doctoral fellowship at the Novartis Institute for Biomedical Research. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stewart Fisher, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Scientific Officer since May 2018 and served as our Senior Vice President, Discovery Sciences, from May 2016 to April 2018. Since March 2021, Dr.&#160;Fisher has also served as a member of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advisory Board to Cobro Ventures Management, LLC. From January 2014 to April 2016, Dr.&#160;Fisher was the Director of Quantitative of Biochemistry and Enzymology at the Broad Institute, a biomedical and genomic research center, where he developed and implemented biochemical plans for therapeutic projects. Prior to the Broad Institute, Dr.&#160;Fisher spent over 15 years at AstraZeneca PLC, a research-based biopharmaceutical company, where he was the Executive Director of Infection Bioscience. Dr.&#160;Fisher holds a B.A. in Chemistry from the University of Vermont, a Ph.D. in organic chemistry from the California Institute of Technology and completed his academic training as an NIH Postdoctoral Fellow at the Harvard Medical School. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leonard &#8220;Len&#8221; Reyno, M.D.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Medical Officer since July 2023. From July 2018 through June 2023, Dr. Reyno served as Chief Medical Officer of Pionyr Immunotherapeutics,Inc., an oncological immunotherapeutics company that was acquired by Ikena Oncology, Inc. in August 2023. Prior to that, Dr. Reyno served as Executive Vice President and Chief Medical Officer at ORIC Pharmaceuticals, Inc., a publicly traded pharmaceutical company, from November 2017 to July 2018. From December 2007 to November 2017, Dr. Reyno served in roles of increasing responsibility at Astellas Pharma, Inc., most recently as Senior Vice President and Chief Medical Officer, Clinical Research and Development of Agensys, Inc., an affiliate of Astellas. Dr. Reyno received his B.Sc. in Chemistry from Dalhousie University and an M.D. from McMaster University Medical School.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kelly A. Schick </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief People Officer since January 2021. From September 2016 to November 2020, Ms.&#160;Schick held positions of increasing responsibility in human resources, including Chief Human Resources Officer and Head of Corporate Engagement, at AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on maternal health, anemia, and cancer supportive care. From January 2015 to September 2016, Ms.&#160;Schick served as Head of Global Talent for Bristol-Myers Squibb, where she had responsibility for global talent management, talent acquisition, learning and development, organization effectiveness and diversity and inclusion for the company&#8217;s global manufacturing division. Prior to Bristol-Myers Squibb, Ms.&#160;Schick served in a variety of human resources business partner roles of increasing responsibility, supporting the research and development organization for Merck and Company, Inc. Ms.&#160;Schick holds a B.A. in psychology from Boston University and a M.A. in human resources and labor relations from the University of Minnesota. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jolie M. Siegel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Legal Officer since July 2020 and, since February 2021, as our corporate Secretary. In June 2020, Ms.&#160;Siegel served as our interim Chief Legal Officer in a consulting capacity. From August 2018 to May 2020, Ms.&#160;Siegel served as Vice President, General Counsel and Secretary of Neon Therapeutics, Inc., an immune oncology company, where she was responsible for legal, intellectual property and corporate compliance matters. Ms.&#160;Siegel also provided consulting legal services to Neon between March and August 2018. From February 2013 to April 2017, Ms.&#160;Siegel served as Senior Vice President, Deputy General Counsel and Assistant Secretary of Intralinks Holdings, Inc., a technology provider for the global financial and capital markets communities. In this role, Ms.&#160;Siegel was responsible for corporate governance, compliance, public company reporting, mergers and acquisition, marketing and finance matters. From 2007 to 2013, Ms.&#160;Siegel was a partner at Choate, Hall&#160;&amp; Stewart LLP, or Choate, a law firm, where she worked on corporate transactional, securities and general business matters, with an emphasis on private equity, venture capital and high-growth companies. Ms.&#160;Siegel holds a J.D. from the University of Pennsylvania Law School and a B.A. in political science from the University of Pennsylvania. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal occupation and employment during the past five years of each of our executive officers was carried on, in each case except as specifically identified above, with a corporation or organization that is not a parent, subsidiary or other affiliate of us. There is no arrangement or understanding between any of our executive officers and any other person or persons pursuant to which he was or is to be selected as an executive officer. There are no material legal proceedings to which any of our executive officers is a party adverse to us or our subsidiary or in which any such person has a material interest adverse to us or our subsidiary. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Nomination Process </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nominating and Corporate Governance Committee, or the NCGC, is responsible for identifying individuals qualified to serve as directors, consistent with criteria approved by our board, and recommending such persons to be nominated for election as directors, except where we are legally required by contract, law or otherwise to provide third parties with the right to nominate. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process followed by our NCGC to identify and evaluate director candidates includes candidate interviews, inquiry of the person or persons making the recommendation or nomination, engagement of an outside search firm to gather additional information, or reliance on the knowledge of the members of the committee, the Board of Directors or management. The committee requires the following minimum qualifications to be satisfied by any nominee for a position on our Board of Directors: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">High standards of personal and professional ethics and integrity, </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Proven achievement and competence in the nominee&#8217;s field and the ability to exercise sound business judgment, </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Skills that are complementary to those of the existing members of the Board of Directors, </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The ability to assist and support management and make significant contributions to the Company&#8217;s success, and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">An understanding of the fiduciary responsibilities that are required of a member of the Board of Directors and the commitment of time and energy necessary to diligently carry out those responsibilities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders may recommend individuals to the NCGC for consideration as potential director candidates. Any such proposals should be submitted to our Corporate Secretary at our principal executive offices not less than 120 calendar days prior to the date on which the Company&#8217;s proxy statement was released to stockholders in connection with its previous year&#8217;s annual meeting. Stockholder recommendations should be accompanied by the following information: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The name and address of record of the stockholder; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">A representation that the stockholder is a record holder of the Company&#8217;s securities or, if the stockholder is not a record holder, evidence of ownership in accordance with Rule 14a-8(b)(2) of the Exchange Act; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The name, age, business and residential address, educational background, current principal occupation or employment, and principal occupation or employment for the preceding five (5)&#160;full fiscal years of the recommended director candidate; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">A description of the qualifications and background of the recommended director candidate that addresses the criteria for membership on the Company&#8217;s Board of Directors as approved by the Board of Directors from time to time and set forth in the NCGC&#8217;s charter (a copy of which is available on the corporate governance section of our website, </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">https://ir.c4therapeutics.com/corporate-governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">);</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">A description of all arrangements or understandings between the stockholder and the recommended director candidate; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The consent of the recommended director candidate (i)&#160;to be named in the proxy statement for the Company&#8217;s next meeting of stockholders and (ii)&#160;to serve as a director if elected at that meeting; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Any other information regarding the recommended director candidate that is required to be included in a proxy statement filed pursuant to the rules of the SEC. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder proposals should be addressed to C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, Attention: Corporate Secretary. Assuming that biographical and background material has been provided on a timely basis in accordance with our By-laws, any recommendations received from stockholders will be evaluated in the same manner as potential nominees proposed by the NCGC. If our Board of Directors determines to nominate a stockholder-recommended candidate and recommends his or her election, then his or her name will be included on our proxy card for the next annual meeting of stockholders. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Proposals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this proxy statement for a discussion of submitting stockholder proposals. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable Nasdaq Stock Market LLC, or Nasdaq, rules require a majority of a listed company&#8217;s board of directors to be comprised of independent directors within one year of listing. In addition, the Nasdaq rules require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exchange Act and that compensation committee members satisfy independence criteria set forth in Rule 10C-1 under the Exchange Act. Under applicable Nasdaq rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the listed company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule&#160;10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries. In addition, in affirmatively determining the independence of any director who will serve on a company&#8217;s compensation committee, Rule 10C-1 under the Exchange Act requires that a company&#8217;s board of directors must consider all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, including: the source of compensation to the director, including any consulting, advisory or other compensatory fee paid by such company to the director, and whether the director is affiliated with the company or any of its subsidiaries or affiliates. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has determined that all members of the Board of Directors, except Andrew J. Hirsch, are independent directors, including for purposes of the rules of Nasdaq and the SEC. In making this independence determination, our Board of Directors considered the relationships that each non-employee director has with us and all other facts and circumstances that our Board of Directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director. In considering the independence of the directors listed above, our Board of Directors considered the association of our directors with the holders of more than 5% of our common stock. There are no family relationships among any of our directors or executive officers. Andrew J. Hirsch is not an independent director under these rules because he is an executive officer of our company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Structure </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of our amended and restated certificate of incorporation and amended and restated bylaws, our board of directors is divided into three classes of directors. At each annual meeting of stockholders, a class of directors will be elected for a three-year term to succeed the directors of the same class whose terms are then expiring. The terms of the directors will expire upon the election and qualification of successor directors at the annual meeting of stockholders to be held during the years 2024 for Class&#160;I directors, 2025 for Class&#160;II directors and 2026 for Class&#160;III directors. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our Class&#160;I directors are Kenneth C. Anderson, M.D., Laura Bessen, M.D., and Owen Hughes; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our Class&#160;II directors are Bruce Downey, Glenn Dubin, and Donna Grogan, M.D.; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our Class&#160;III directors are Andrew J. Hirsch, Utpal Koppikar and Malcolm Salter. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and By-laws provide that the number of our directors shall be fixed from time to time by a resolution of the majority of our board of directors. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each year, our Nominating and Corporate Governance Committee reviews our governance framework, including our anti-takeover provisions, as well as the feedback received from proxy advisory firms and some institutional investors, in light of best practices, industry trends, stockholder feedback, and other specific characteristics and circumstances specific to the Company at the time. As part of this review, the Nominating and Corporate Governance Committee also considers the prevalence of anti-takeover provisions (such as a classified board) among companies of similar size, stage and maturity in our industry. While the division of our Board of Directors into three classes, each with a three-year term, may delay or prevent stockholder efforts to effect a change of our management or a change in control, we believe that our classified board structure aligns with the long-term orientation of the development of our pipeline and has enabled the Board to provide undivided, independent oversight of management as it executes on our strategic initiatives that we believe will create long-term stockholder value. We do not maintain these provisions lightly, but we believe that they add stability to our Board of Directors and our Company, providing us with appropriate flexibility and time to implement our strategy and progress our clinical programs over the next several years, which we believe will increase stockholder value. We remain committed to evaluating these measures on an annual basis to ensure that our governance strategy appropriately evolves as we mature and grow and continues to serve the best interests of our stockholders.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Demographics, Skills and Experience </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NCGC seeks to recommend for nomination as directors individuals who have substantive knowledge of our business and industry and/or can bring to the board specific and valuable strategic or management capabilities acquired in other industries. The committee expects each of our directors to have proven leadership, sound judgment, the highest ethics and integrity and a commitment to the success of our company. It also seeks personal qualities that foster a respectful environment in which our directors listen to one another and hold engaged and constructive discussions. These goals for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our Board composition presuppose a diverse range of viewpoints, experiences and specific expertise. In considering potential directors and in considering whether to nominate an existing director for reelection, the NCGC considers the individual&#8217;s personal characteristics and business experience relative to those of our existing Board members, including the proposed director&#8217;s type of prior management experience, levels of expertise relevant to our business, prior board service, reputation in the business community, character, independence, lack of conflicts of interest, personal characteristics such as gender and race, and other factors that the committee believes to be important. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to diversity and inclusion, as demonstrated by the service of two women and one person of color on our nine-member Board of Directors. In addition, our nine-person Senior Leadership Team includes five women, one person of color and one person who identifies as LGBTQ+. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors and the NCGC consider diversity in identifying nominees for director. The NCGC has defined a diverse board of directors to be one that reflects gender, racial, geographic, ethnicity, educational, professional and/or managerial backgrounds and experience, and other relevant considerations. In its annual review of the composition of our Board of Directors as a whole, the NCGC assesses the diversity of our directors, along with other desired qualities, as well as the effectiveness of our Board of Directors. As shown in the charts below, our Board of Directors includes directors of different gender, racial, educational, professional, managerial and entrepreneurial backgrounds and experience. It includes directors who have leadership experience and financial and other expertise gained from employment or other association with companies in the public and private sectors, manufacturers, the financial services industry, venture capital funds, major universities, law firms, and public service organizations including governmental and non-profit agencies and institutions. Several of our directors have expertise and experience in risk management, strategic planning, operations, technology, and regulatory compliance and human resource issues.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity Matrix as of April 29, 2024</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding the demographics of our nominees for director and directors continuing in office following the Annual Meeting: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:23.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #7393c3;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Kenneth Anderson</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Laura Bessen</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bruce Downey</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Glenn Dubin</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Donna Grogan</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Andrew Hirsch</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Owen Hughes</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Utpal Koppikar</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Malcolm Salter</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Age</span></div></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84</span></td></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gender Identity</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Male </span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Female</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sexual Orientation (voluntary)</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LGBTQ+</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Race/Ethnicity</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Independent</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">N</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Y</span></td></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tenure on Board (years)</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&lt;1</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Other Public Company Boards</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td><td colspan="3" style="background-color:#4a72b8;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Skills and Experience Mix </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding the skills and experience of our nominees for director and directors continuing in office following the Annual Meeting: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:23.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#4a72b8;border-left:1pt solid #7393c3;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skills and Experience</span></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Kenneth Anderson</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Laura Bessen</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bruce Downey</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Glenn Dubin</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Donna Grogan</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Andrew Hirsch</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Owen Hughes</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Utpal Koppikar</span></div></td><td colspan="3" style="background-color:#4a72b8;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Malcolm Salter</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Leadership</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industry Expertise</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and Development Experience</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operations Experience</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit and Financial Expertise</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Company Governance</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitment to Company Values and Goals</span></td><td colspan="3" style="background-color:#b3c6e6;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #7393c3;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="background-color:#b3c6e6;border-bottom:1pt solid #5982bf;border-left:1pt solid #5982bf;border-right:1pt solid #5982bf;border-top:1pt solid #5982bf;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9745;</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has established an Audit Committee, Organization, Leadership and Compensation Committee (referred to from time to time in this proxy statement as the OLCC), and Nominating and Corporate Governance Committee (referred to from time to time in this proxy statement as the NCGC). Each of these standing committees operates under a charter that satisfies the applicable standards of Nasdaq and the SEC. Our Board of Directors has also established a Science and Technology Committee (referred to from time to time in this proxy statement as the STC), which operates under a charter duly adopted by the Board of Directors. Each of these committees reviews its charter at least annually. A current copy of the charter for each of these standing committees is posted on the corporate governance section of our website, </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">https://ir.c4therapeutics.com/corporate-governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout 2023, Bruce Downey, Utpal Koppikar and Malcolm Salter served on our Audit Committee, with Owen Hughes replacing Mr. Downey effective January 1, 2024. Mr. Koppikar currently serves as the chairperson of the Audit Committee and served in that capacity throughout 2023. Our Board of Directors has determined that all of the members of our Audit Committee during 2023 and currently are &#8220;independent&#8221; for audit committee purposes, as that term is defined in the rules of the SEC and the current listing standards of Nasdaq, and each of our Audit Committee members has sufficient knowledge in financial and auditing matters to serve on the Audit Committee. Our Board of Directors has designated each of Messrs. Koppikar and Salter as an &#8220;audit committee financial expert,&#8221; as defined under the applicable rules of the SEC. During the fiscal year ended December&#160;31, 2023, the Audit Committee met eight times. The report of the Audit Committee </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is included in this proxy statement under &#8220;Report of the Audit Committee.&#8221; The Audit Committee&#8217;s responsibilities include, among others: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">appointing, approving the compensation of, assessing the independence of and overseeing the work of our independent registered public accounting firm; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">pre-approving auditing and permissible non-audit services, and the terms of such services, to be provided by our independent registered public accounting firm; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing the overall audit plan with our independent registered public accounting firm and members of management responsible for preparing our financial statements, including the independent audit firm&#8217;s audit staffing plans; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures, as well as critical accounting policies and practices used by us; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recommending, based upon the Audit Committee&#8217;s review and discussions with management and our independent registered public accounting firm, whether our audited financial statements shall be included in our Annual Report on Form 10-K; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our financial statements and accounting matters; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">preparing the Audit Committee report required by SEC rules to be included in our annual proxy statement; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and discussing our major risk exposures, including, without limitation, financial, operational, cyber security and data privacy, competitive, legal, regulatory, hedging and accounting risks, discussing the guidelines and policies that govern the process by which management assesses and manages risk, and reporting to the full Board on matters as it deems appropriate; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing all related person transactions for potential conflict of interest situations and approving all such transactions; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing quarterly earnings releases. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All audit and non-audit services to be provided to us by our independent registered public accounting firm, with the exception of certain services of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> value, must be approved in advance by our Audit Committee. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization, Leadership and Compensation Committee </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bruce Downey, Donna Grogan, M.D., and Utpal Koppikar currently serve on our Organization, Leadership and Compensation Committee, or the OLCC, which is chaired by Mr.&#160;Downey. Our Board of Directors has determined that all of the members of the OLCC during 2023 and currently are &#8220;independent&#8221; for compensation committee purposes, as that term is defined in the rules of the SEC and the current Nasdaq listing standards. During the fiscal year ended December&#160;31, 2023, the OLCC met seven times. The OLCC&#8217;s responsibilities include, but are not limited to: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">annually reviewing and recommending to the Board of Directors the corporate goals and objectives relevant to the compensation of our Chief Executive Officer, or CEO; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">evaluating the performance of our CEO in light of those corporate goals and objectives and recommending to the Board of Directors the equity and non-equity compensation of our CEO; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and recommending to the Board of Directors any agreements or provisions related to the employment of the members of our Senior Leadership Team, including our CEO, as well as any special or supplemental benefits for our Senior Leadership Team; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">overseeing an annual evaluation of the performance of the members of our Senior Leadership Team other than our CEO and reviewing and approving their cash, equity, and non-equity compensation; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">overseeing our overall management compensation, philosophy and policy; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">administering our equity compensation plans; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">evaluating and assessing potential and current compensation advisors to the committee, including the retention, termination, or compensation thereof, in accordance with the independence standards identified in the applicable Nasdaq rules; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and making recommendations to the Board with regard to our policies and procedures for the grant of equity-based awards and the size of equity-based plans; </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">overseeing and administering our Executive Compensation Recovery Policy;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and recommending to the Board of Directors the compensation of our directors; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and assessing the results of the most recent stockholder advisory vote on executive compensation and considering those results as part of its review and approval of compensation for the members of our Senior Leadership Team; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and discussing with management our strategies, initiatives and/or programs focused on (1)&#160;leadership and talent development and succession planning, (2)&#160;diversity, equity and inclusion, and (3)&#160;employee recruitment, development, and retention; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">preparing the compensation committee report required by SEC rules, if and when required, to be included in our annual proxy statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, Pearl Meyer served as the OLCC&#8217;s compensation consultant and continues in that role at present. Pearl Meyer provided information to the OLCC on their respective independence and the OLCC evaluated whether any of the work performed by Pearl Meyer during its engagement raised any conflict of interest, determining that it did not. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Science and Technology Committee </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kenneth Anderson, M.D., Laura Bessen, M.D., and Donna Grogan, M.D., currently serve on our Science and Technology Committee, which is chaired by Dr. Grogan. The STC assists our Board of Directors&#8217; oversight of our research and development activities. During the fiscal year ending December 31, 2023, the STC met five times. The STC&#8217;s current responsibilities include: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing, evaluating, and advising our Board of Directors and the Senior Leadership Team on the overall strategy of our research and development programs; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">monitoring and evaluating emerging trends in the life sciences industry and their impact on our allocation of research and development resources;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regularly reviewing our research and development pipeline;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">review and assess our research and discovery organizations to ensure that they are comprised of individuals with the appropriate skill set and expertise to carry out our research and development initiatives; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing such other topics as our Board of Directors delegates to the science and technology committee from time to time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout 2023, Laura Bessen, M.D., Bruce Downey, Glenn Dubin and Malcolm Salter served on our Nominating and Corporate Governance Committee, which is chaired by Mr.&#160;Salter, with Mr. Dubin stepping down from the NCGC in March 2024. Our Board of Directors has determined that all of the members of the NCGC during 2023 and currently are &#8220;independent&#8221; as defined under current listing standards of Nasdaq. During the fiscal year ended December&#160;31, 2023, the NCGC met four times. The NCGC&#8217;s responsibilities include: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">developing and recommending to the Board of Directors criteria for Board of Directors and committee membership; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establishing procedures for identifying and evaluating Board of Director candidates, including nominees recommended by stockholders; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing the composition of the Board of Directors to ensure that it is composed of members containing the appropriate skills and expertise to advise us; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">identifying individuals qualified to become members of the Board of Directors; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recommending to the Board of Directors the persons to be nominated for election as directors and to each of the committees of the Board of Directors; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and periodically reassessing the adequacy of our corporate governance guidelines and our code of business conduct and ethics and, when appropriate, recommend updates to the Board of Directors for approval; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">overseeing the Company&#8217;s initiatives related to environmental, social, and governance matters; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reviewing and assessing management and Board of Directors succession planning; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">overseeing the evaluation of our Board of Directors and its committees. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NCGC considers candidates for Board of Director membership suggested by its members and the Chief Executive Officer. Additionally, in selecting nominees for directors, the NCGC will review candidates recommended by stockholders in the same manner and using the same general criteria as candidates recruited by the committee and/or recommended by our Board of Directors. Any stockholder who wishes to recommend a candidate for consideration by the committee as a nominee for director should follow the procedures described later in this proxy statement under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Proposals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; The NCGC will also consider whether to nominate any person proposed by a stockholder in accordance with the provisions of our By-laws relating to stockholder nominations as described later in this proxy statement under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Proposals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Identifying and Evaluating Director Nominees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Board of Directors is responsible for filling vacancies on our Board of Directors and for nominating candidates for election by our stockholders each year in the class of directors whose term expires at the relevant annual meeting. The Board of Directors delegates the selection and nomination process to the NCGC, with the expectation that other members of the Board of Directors and of management will be requested to take part in the process, as appropriate. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the NCGC identifies candidates for director nominees in consultation with management through the use of search firms or other advisors, the recommendations submitted by members of the Board of Directors or stockholders or such other methods as the NCGC deems to be helpful to identify candidates. Once candidates have been identified, the NCGC confirms that the candidates meet all of the minimum qualifications for director nominees established by the NCGC. The NCGC may gather information about the candidates through interviews, detailed questionnaires, comprehensive background checks or any other means that the NCGC deems to be appropriate in the evaluation process. The NCGC then meets as a group to discuss and evaluate the qualities and skills of each candidate, both on an individual basis and factoring in the overall composition and needs of our Board of Directors. Based on the results of the evaluation process, the NCGC recommends candidates for the Board of Directors&#8217; approval to fill a vacancy or as director nominees for election to the Board of Directors by our stockholders each year in the class of directors whose term expires at the relevant annual meeting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board and Committee Meetings Attendance </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full Board of Directors met eleven times during 2023. During 2023, each member of the Board of Directors attended in person or participated in 75% or more of the aggregate of (i)&#160;the total number of meetings of the Board of Directors (held during the period for which such person has been a director) and (ii)&#160;the total number of meetings held by all committees of the Board of Directors on which such person served (during the periods that such person served). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance at Annual Meeting of Stockholders </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are responsible for attending the annual meeting of stockholders to the extent practicable. All members of the Board of Directors in office at the time attended our annual meeting of stockholders in 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy on Trading, Pledging and Hedging of Company Stock </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain transactions in our securities (such as purchases and sales of publicly traded put and call options and short sales) create a heightened compliance risk or could create the appearance of misalignment between management and stockholders. In addition, securities held in a margin account or pledged as collateral may be sold without consent if the owner fails to meet a margin call or defaults on the loan, thus creating the risk that a sale may occur at a time when an officer or director is aware of material, nonpublic information or otherwise is not permitted to trade in Company securities. Our insider trading policy expressly prohibits our executive officers, directors, designated employees, certain designated consultants and contractors, along with their respective affiliates &#8211; a group we refer to as our &#8220;insiders&#8221; &#8211; from engaging in short sales, purchases or sales of derivative transactions or hedging transactions of our stock, purchases or sales of puts, calls or other derivative securities of the company or any derivative securities that provide the economic equivalent of ownership of any of our securities or purchases or sales of any opportunity, direct or indirect, to profit from any change in the value of our securities, or other hedging transactions. In addition, our insider trading policy expressly prohibits our insiders from borrowing against company securities held in a margin account, or pledging our securities as collateral for a loan. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation Recovery Policy</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the requirements of the final clawback rules adopted by the SEC in October 2022 and the Nasdaq&#8217;s listing rules adopted in June 2023, our Board adopted an Executive Compensation Recovery Policy in June 2023. If we are required to prepare a material financial restatement due to material noncompliance with any financial reporting requirements, our Executive Compensation Recovery Policy requires (subject to certain limited exceptions described in the policy and permitted by the final clawback rules) that we recover any incentive-based compensation that was based upon the attainment of a financial reporting measure and received by any current or former executive officer of the Company (and any other person designated by the Board or OLCC as subject to the Executive Compensation Recovery Policy) during the three-year period preceding the date that the restatement was required if such compensation exceeds the amount that the executive officers would have received based on the restated financial statements. In addition, if the Board determines that an executive officer&#8217;s misconduct (or other person&#8217;s misconduct who is designated as subject to the Executive Compensation Recovery Policy) contributed to the cause of the material financial restatement, the Executive Compensation Recovery Policy permits the Company to recover up to 100% of the time-based and other equity-based compensation that is not earned based on a financial reporting measure and was received by such individual during the three fiscal years preceding the date that we were required to restate our financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Business Conduct and Ethics </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a written Code of Business Conduct and Ethics that applies to our directors, officers, employees and certain designated agents, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the Code of Business Conduct and Ethics is posted on the corporate governance section of our website, which is located at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">https://ir.c4therapeutics.com/corporate-governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If we make any substantive amendments to, or grant any waivers from, our Code of Business Conduct and Ethics for any officer or director, we will disclose the nature of that amendment or waiver on our website or in a Current Report on Form 8-K filed with the SEC. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance Guidelines </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has adopted corporate governance guidelines to assist in the exercise of its duties and responsibilities and to serve the best interests of our company and our stockholders. The guidelines provide that: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our Board&#8217;s principal responsibility is to oversee the management of the business and affairs of the Company; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Except as required by Nasdaq rules, a majority of the members of our Board must be independent directors; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The independent directors meet in executive session at least once a year; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our Board will have an audit committee, a compensation committee (in our case, the OLCC), and a nominating and corporate governance committee as standing committees, with responsibilities as outlined in the respective committee&#8217;s charter; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our Board and its committees shall have full and free access to management and, as necessary, independent advisors; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The NCGC will have responsibility for (i) developing succession plans for our Board and our CEO, as appropriate, (ii) developing and recommending to the Board criteria for prospective directors, and (iii) identifying and selecting director candidates for nomination to the Board, as appropriate;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">The OLCC will have responsibility for periodically reviewing the form and amount of director compensation and, where appropriate, recommending changes;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">The OLCC will have responsibility for developing succession plans for members of our Senior Leadership Team, other than the CEO; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The NCGC will oversee periodic self-evaluations that the Board may conduct to determine whether it and its committees are functioning effectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A current copy of our Corporate Governance Guidelines is posted on the corporate governance section of our website, which is located at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">https://ir.c4therapeutics.com/corporate-governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insider Trading Policy and Related Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a suite of documents that pertain to and establish a compliance framework related to insider trading, namely our Insider Trading Policy, Special Trading Procedures for Insiders and Rule 10b5-1 Trading Plan Policy. Our Insider Trading Policy applies to the Company&#8217;s directors, officers, employees, and designated contractors and consultants, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each of whom is referred to as an &#8220;insider.&#8221; Our Insider Trading Policy and our Special Trading Procedures for Insiders prohibit the following activities when in possession of material nonpublic information: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">having others trade for you in the Company&#8217;s securities; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">giving trading advice that may violate the law or our Insider Trading Policy; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disclosing material, nonpublic information about the Company to anyone else who might then trade, or recommending to anyone that they purchase or sell the Company&#8217;s securities when aware of material, nonpublic information about the Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Insider Trading Policy and our Special Trading Procedures for Insiders also prohibit the following activities at any time:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">trading in the Company&#8217;s securities or any derivative securities that provide the economic equivalent of ownership of any of the Company&#8217;s securities; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">short sales of our shares; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">purchasing or selling of derivative securities or hedging transactions; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">pledging of securities as collateral for a loan unless the pledge has been approved by the Audit Committee. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of these policy documents also apply to spouses, significant others, children, parents, or other family members, in each case living in the same household as an &#8220;insider,&#8221; as well as investment funds, trusts or other entities controlled by an &#8220;insider.&#8221; </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Rule 10b5-1 Trading Plan Policy, which operates in conjunction with our Insider Trading Policy and Special Trading Procedures for Insiders, requires that all trading plans adopted by our &#8220;insiders&#8221; that are intended to meet the requirements of the safe harbor provided under Rule 10b5-1(c) meet certain minimum conditions including that they, among other requirements, be approved by the Company&#8217;s Compliance Officer, contain certain representations, and provide for delayed effectiveness of varying lengths depending on whether the individual adopting the plan is an officer under Section 16 of the Securities Act of 1934 or a director. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, the role of Chair of the Board is separated from the role of Chief Executive Officer, with Bruce Downey serving as our Chair. We believe that separating the roles of Chair and Chief Executive Officer allows our Chief Executive Officer to focus on our day-to-day business, while allowing the Chair to lead the Board of Directors in its fundamental role of providing advice to, and independent oversight of, management. Our Board of Directors recognizes the time, effort and energy that the Chief Executive Officer is required to devote to his position in the current business environment, as well as the commitment required to serve as Chair of the Board, particularly as the Board of Directors&#8217; oversight responsibilities continue to grow. While our By-laws and our corporate governance guidelines do not require that the Chair of the Board and Chief Executive Officer positions be separate, our Board of Directors believes that having separate positions is the appropriate leadership structure for us at this time and demonstrates our commitment to good corporate governance. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board&#8217;s Role in Risk Oversight </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk is inherent to every business and how well a business manages risk can ultimately determine its success. We face a number of risks, including risks relating to our financial condition, development and commercialization activities, operations, strategic direction, and intellectual property. Management is responsible for the day-to-day management of risks we face, while our Board of Directors, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our Board of Directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The role of the Board of Directors in overseeing the management of our risks is conducted primarily through committees of the Board of Directors, as disclosed in the descriptions of each of the committees above and in the charters of each of the committees, copies of which can be found on the corporate governance section of our website, </span><span style="color:#1e3aff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">https://ir.c4therapeutics.com/corporate-governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full Board of Directors (or the appropriate committee of the Board in the case of risks that are under the purview of a particular committee) discusses with management our major risk exposures, their potential impact on us and the steps we take to manage them. When a committee of our Board of Directors is responsible for evaluating and overseeing the management of a particular risk or risks, the chair of the relevant committee reports on the discussion to the full Board during the committee reports portion of the next Board meeting. This enables the Board of Directors and its committees to coordinate the risk oversight role, particularly with respect to risk interrelationships. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communication with the Members of our Board of Directors </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any interested party with concerns about our company may report those concerns to the Board of Directors through the Chairman of our Board of Director by submitting a written communication to the attention of that individual director at the following address or by email to Board@c4therapeutics.com: </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c/o C4 Therapeutics, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490 Arsenal Way, Suite 120 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Watertown, Massachusetts 02472 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier or other interested party. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of any written communication of this nature may also be forwarded to our legal counsel and retained for a reasonable period of time. A director receiving a communication of this nature may discuss the matter with our legal counsel, independent advisors, non-management directors or our management or may take other action or no action as the director determines in good faith, using reasonable judgment and applying his or her own discretion. Our legal counsel reserves the right not to forward communications if they are deemed inappropriate, solicitations, advertisements, surveys, &#8220;junk&#8221; mail or mass mailings or consist of individual grievances or other interests that are personal to the party submitting the communication and could not reasonably be construed to be of concern to securityholders or other constituencies of our Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Communications may be forwarded to other directors if they relate to important substantive matters and include suggestions or comments that may be important for other directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances and matters as to which we tend to receive repetitive or duplicative communications. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee oversees the procedures for the receipt, retention, and treatment of complaints we receive&#160;regarding accounting, internal accounting controls, or audit matters, and the confidential, anonymous submission by employees of concerns regarding questionable accounting, internal accounting controls or auditing matters. We also have established a toll-free telephone number for the reporting of these types of activity, which is (855) 222-0916. Reports can also be submitted via email to reports@lighthouse-services.com or through an online submission at https://www.lighthouse-services.com/c4therapeutics. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTOR COMPENSATION </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows all compensation earned by each of our non-employee directors during the fiscal year ended December&#160;31, 2023. During the fiscal year ended December&#160;31, 2023, we did not provide any compensation to Andrew J. Hirsch, our President and Chief Executive Officer for his service as a director. The compensation paid to Mr.&#160;Hirsch as an executive officer during 2023 is set forth under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; 2023 Summary Compensation Table</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:47.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.845%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees Earned or Paid in Cash ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenneth C. Anderson, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laura Bessen, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bruce Downey</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn Dubin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Donna Grogan, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owen P. Hughes Jr.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4) (10)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utpal Koppikar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malcolm Salter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts represent annual cash compensation earned for services rendered by members of our Board of Directors and the committees thereof during the fiscal year ended December&#160;31, 2023, pursuant to our Non-employee Director Compensation Policy in effect at the time the compensation was paid. However, the following members of our Board of Directors elected to receive all or a portion of their cash compensation in the form of unrestricted shares in accordance with our Non-employee Director Compensation Policy: Dr.&#160;Anderson was issued 15,834 shares in lieu of $45,000 in fees; Mr.&#160;Dubin was issued 15,482 shares in lieu of $44,000 in fees; and Dr. Grogan was issued 19,353 shares in lieu of $55,000 in fees. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts reflect the aggregate grant date fair value of option awards granted during the 2023 year in accordance with our Non-employee Director Compensation Policy, calculated in accordance with the provisions of Financial Accounting Standards Board, or FASB, Accounting Standard Codification, or ASC, Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See Notes 2 and 11 to our audited consolidated financial statements appearing in our 2023 Annual Report for assumptions underlying the valuation of equity awards. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Mr.&#160;Hughes joined our Board of Directors in November 2023 and the annual retainer earned has been pro-rated accordingly. Mr. Hughes was added to the Audit Committee in 2024 and, as a result, we did not provide any additional retainer compensation to Mr. Hughes in 2023. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These stock options were granted under our Non-employee Director Compensation Policy in connection with Mr. Hughes&#8217; initial appointment to the Board of Directors. All other stock option awards granted to members of Board of Directors in 2023 were annual awards under our Non-employee Director Compensation Policy.  </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December 31, 2023, Dr. Anderson had option awards for up to 92,746 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December 31, 2023, Dr. Bessen had option awards for up to 67,200 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December 31, 2023, Mr. Downey had option awards for up to 99,347 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December 31, 2023, Mr. Dubin had option awards for up to 90,700 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December 31, 2023, Dr. Grogan had option awards for up to 67,200 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">As of December 31, 2023, Mr. Hughes had an option award for up to 52,000 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">As of December 31, 2023, Mr. Koppikar had option awards for up to 67,200 shares outstanding.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">As of December 31, 2023, Mr. Salter had option awards for up to 93,347 shares outstanding.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-employee Director Compensation Policy </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Non-employee Director Compensation Policy, as amended and restated, we pay our non-employee directors a cash retainer for service on the Board of Directors and for service on each committee on which the director is a member, with the chair the Board of Directors, the Lead Independent Director (if one is appointed), and the chair of each committee receiving higher or additional retainers. These fees are payable in arrears in four equal quarterly installments on the last day of each quarter, with the amount of these payments pro-rated for any portion of a quarter that a director is not serving on our Board of Directors or a Board committee. Directors may elect to receive unrestricted shares of our common stock in lieu of any cash retainer payments. Under our Non-employee Director Compensation Policy, the fees paid to non-employee directors for service on the Board of Directors and for service on each Board committee on which the director is a member are as follows: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual<br/>Retainer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board of Directors:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All non-employee members</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional retainer for Chairman of the Board</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional retainer for Lead Independent Director</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit Committee:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-chairman members</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organization, Leadership and Compensation Committee:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-chairman members</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Science and Technology Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-chairman members</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating and Corporate Governance Committee:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-chairman members</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each non-employee director may elect to receive all or a portion of her or his cash compensation in the form of unrestricted shares having a grant date fair value equal to the amount (or portion thereof) of such compensation. Any such election (i)&#160;shall be made (x)&#160;for any continuing non-employee director, before the start of the calendar year with respect to any cash compensation for such calendar year and (y)&#160;for any new non-employee director, within 30 days of her or his election to the Board, (ii)&#160;shall be irrevocable with respect to such calendar year and (iii)&#160;shall automatically apply to the cash compensation for each subsequent calendar year unless otherwise revoked prior to the start of such calendar year. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also reimburse our non-employee directors for reasonable travel and out-of-pocket expenses incurred in connection with attending our Board of Director and committee meetings. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under our Non-employee Director Compensation Policy, in effect for 2023, each non-employee director, upon the director&#8217;s initial election to our Board of Directors, receives an option to purchase 52,000 shares of our common stock. Each of these options vests as to 33% on the first anniversary of the date of grant, with the remainder to vest quarterly for the subsequent two years, subject to continued service as a director through such vesting dates. On the date of each annual meeting of stockholders of our company, each continuing non-employee member of the Board of Directors, other than a director receiving an initial equity award or a director whose tenure in office as of the date of the annual meeting is less than six months, is granted a non-qualified stock option to purchase 26,000 shares of common stock or such lesser number as represents not more than $650,000 in grant date fair value, which vests and becomes fully exercisable upon the earlier to occur of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of grant, subject to continued service as a director through such date. The exercise price of these options is equal to the fair market value of our common stock on the date of grant.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, our Board of Directors amended and restated our Non-employee Director Compensation Policy to (i) increase the size of the option awarded upon a director&#8217;s initial election to 65,000 shares, and (ii) increase the size of each annual option awarded to non-employee members of the Board of Directors continuing in office after our annual meeting of stockholders to 32,500 shares or such lesser number as represents not more than $650,000 in grant date fair value.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This program is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals to serve as directors and to align our directors&#8217; interests with those of our stockholders. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section describes the philosophy, objectives, and structure of our 2023 executive compensation program. This section is intended to be read in conjunction with the tables following this section which provide further historical compensation information for our Chief Executive Officer, or our CEO, and the two most highly compensated executive officers serving as executive officer as of December&#160;31, 2023, who we collectively refer to as our named executive officers, or our NEOs. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs for the year ended December&#160;31, 2023, were: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew Hirsch</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Scientific Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Len Reyno, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Medical Officer</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines to transform how disease is treated. We leverage our proprietary technology platform, TORPEDO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to efficiently design and optimize small-molecule medicines that harness the body&#8217;s natural protein recycling system to rapidly degrade disease-causing protein, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. We are using our TORPEDO platform to advance multiple targeted oncology programs to the clinic while expanding the platform to deliver the next wave of medicines for difficult-to-treat diseases.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Performance Highlights </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2023 was a transformative year for the Company as we executed across key strategic objectives. We delivered on important clinical readouts that enabled the prioritization of our pipeline as well as executed on business development initiatives, which allowed us to improve our financial position. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical pipeline includes two wholly owned oncology programs currently advancing through Phase 1 development and a third oncology program expected to enter clinical development this year through our partner Betta Pharmaceuticals Co., Ltd, or Betta Pharma.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CFT7455, our most advanced product candidate, is an orally bioavailable MonoDAC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> degrader of protein targets called IKZF1 and IKZF3, and is currently in clinical development for multiple myeloma, or MM, and non-Hodgkin's lymphomas, or NHLs. In December 2023, we presented clinical data from the ongoing Phase 1/2 trial where CFT7455 demonstrated anti-myeloma activity and a well-tolerated safety profile. We continue to advance the Phase 1 dose escalation portion of the Phase 1/2 trial evaluating CFT7455 with dexamethasone in MM, as well as CFT7455 as a monotherapy in NHL. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our next most advanced candidate is CFT1946, an orally bioavailable BiDAC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> degrader designed to be potent and selective against BRAF V600X mutant targets to treat non-small cell lung cancer, or NSCLC, colorectal cancer, or CRC, melanoma and other malignancies that harbor this mutation. In January 2023, we initiated a first-in-human Phase 1/2 clinical trial of CFT1946 for the treatment of BRAF V600X mutant solid tumors including NSCLC, CRC and melanoma, and we continue to advance the Phase 1 dose escalation portion of the trial.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our partnered clinical program is CFT8919, an orally bioavailable allosteric BiDAC degrader designed to be potent and selective against epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC. In May 2023, we entered into a license and collaboration agreement with Betta Pharma to collaborate on the development and commercialization of CFT8919 in mainland China, Hong Kong SAR, Macau SAR and Taiwan, with us retaining rights to develop and commercialize CFT8919 in the rest of the world. Additionally in June 2023, the FDA cleared the investigational new drug, or IND, application for CFT8919 and in December 2023, Betta Pharma received clinical trial application, or CTA, clearance for CFT8919 from China's National Medical Product Administration. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since our last annual meeting of stockholders in 2023, we also secured important new research collaborations, which provide further validation of our TORPEDO platform. In December 2023, we entered into an exclusive license and collaboration agreement with Merck Sharp &amp; Dohme, LLC, or Merck, to develop degrader-antibody conjugates, or DACs, an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells. In March 2024, we entered into a license and collaboration agreement with Merck KGaA, Darmstadt, Germany, or MKDG, to exclusively discover two targeted protein degraders against critical oncogenic proteins that we have progressed within our internal discovery pipeline. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to our collaborations with Merck and MKDG, we have existing research collaborations with Roche and Biogen. Together, these partnerships allow us to advance and accelerate our research, enable access to additional capabilities and expand the utility of our platform.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical progress and new collaborations provided funding opportunities as well as cost saving measures. Taken together, we were able to strengthen our balance sheet and extend cash runway into 2027, which provides capital through and beyond critical value-inflecting clinical and discovery milestones.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Executive Compensation Philosophy and Objectives </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our OLCC believes that a well-designed compensation program should align executive interests with the drivers of growth and stockholder returns by supporting the Company&#8217;s achievement of its primary business goals, and the Company&#8217;s ability to attract and retain employees whose leadership and contributions are expected to lead to growth in long-term stockholder value. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, our compensation program is focused on incenting executives to take actions that create long-term stockholder value. The objectives of our executive compensation program are as follows: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Help communicate the priority of and relative emphasis of our business objectives;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Reward our executives for achieving or exceeding short-term corporate goals; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Provide long-term incentives to our executives that align their interests with the long-term interests of our company and our stockholders, thereby creating sustainable, long-term value; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Attract, recruit, motivate and retain highly qualified executive officers who possess the skills and leadership necessary to advance our business objectives and, as a result, grow our long-term stockholder value;  </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Provide compensation packages that are competitive relative to peers and the overall market; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.3pt">Support the well-being, development and fulfillment of our leadership team.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our OLCC regularly reviews our compensation policies and overall program design to ensure that they are aligned with the interests of our stockholders and our business goals, and that the total compensation paid to our employees and directors is fair, reasonable and competitive. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">How Our Pay Program Works </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting executive base salaries and annual incentive cash awards and granting equity incentive awards, we consider compensation for comparable positions in the market, the competition for talent in our market, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and a long-term commitment to our company. We target a general competitive position, based on independent third-party benchmark analytics to inform the mix of compensation of base salary, annual cash incentives or long-term incentives. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following elements of our pay program have been carefully selected by our OLCC and are reviewed on an annual basis: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.181%"><tr><td style="width:1.0%"/><td style="width:45.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Pay Objective</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Base Salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Annual Cash<br/>Incentives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity Incentives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#454851;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Motivate and retain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#454851;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Provide stability and manage risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#454851;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reward annual performance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#454851;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance near-term objectives with sustainable, long-term performance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#454851;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Align our employees&#8217; interests with those of our stockholders and reward exceptional performance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#454851;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">Incent the achievement of shareholder value creation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#339900;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#10070;</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Target Pay Mix </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program is based on paying for performance and driving the creation of long-term stockholder value. In order to achieve this, the OLCC places a significant percentage of NEO compensation &#8220;at-risk,&#8221; meaning that the value of the awards will only be realizable once our corporate performance and stock price growth is increased. The following tables reflect the portion of our CEO&#8217;s and other NEOs&#8217; compensation that was &#8220;at-risk,&#8221; which includes their annual incentive cash awards, which are tied to the Company&#8217;s achievement of short-term objectives, and their long-term incentive equity awards, which consist of (i) restricted stock units, or RSUs, that vest based on the passage of time, and (ii) stock option awards, which are tied to longer-term Company performance. As a result, 83% of our CEO&#8217;s 2023 compensation and 68% of our other NEOs&#8217; 2023 compensation was considered to be &#8220;at risk.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                            </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CEO Compensation Mix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">                                                                         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other NEO Compensation Mix</span></div><div style="margin-top:6pt;text-align:center"><img src="cccc-20240429_g8.jpg" alt="8827" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">     </span><img src="cccc-20240429_g9.jpg" alt="8833" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance Practices </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation program is grounded in strong corporate governance practices that reinforce compensation risk management and stockholder growth. The following table demonstrates our key governance principles. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:67.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pay for Performance</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#10070;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of our compensation is &#8220;at-risk&#8221; and is directly tied to company performance and objectives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Insider Trading Policy</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#10070;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a robust suite of insider trading policies that prohibits short sales, hedging and pledging activity, as well as the use of Company securities as collateral in margin accounts </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Change in Control Provisions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#10070;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No &#8220;single-trigger&#8221; change in control benefits or excise tax gross-ups are provided to our executives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Compensation Risk Assessment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#10070;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Organization, Leadership and Compensation Committee conducts a compensation risk assessment in order to mitigate our compensation risk and reduce material adverse effects on the Company</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Say on Pay&#8221;  Vote on Executive Compensation </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the 2023 annual meeting of stockholders, we held a non-binding, advisory vote on the compensation of our NEOs, often referred to as a Say-on-Pay vote, which received over 93% support from our stockholders, and the results of which were considered by our Board of Directors and OLCC, together with feedback received throughout the year, when making compensation decisions regarding the compensation of our executive officers. Similarly, following the Annual Meeting, our Board of Directors and OLCC will consider the results of this Say-on-Pay vote, which is included as Proposal 2 on this Proxy Statement, together with feedback received from our stockholders throughout the year, when making compensation decisions in the future because we value the opinions of our stockholders.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Determination Process </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Role of the Organization, Leadership and Compensation Committee </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has delegated to our OLCC broad responsibility for matters related to our overall compensation philosophy, the design and structure of our compensation programs and the compensation arrangement for our NEOs other than the CEO. This authority extends to the compensation of our non-employee directors and executive officers, though final approval of matters related to the compensation of our CEO and non-employee directors is generally the responsibility </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our Board of Directors. A more detailed summary of the roles and responsibilities of our OLCC is provided above at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Corporate Governance &#8211; Organization, Leadership and Compensation Committee.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Role of CEO and Management </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CEO makes recommendations to our OLCC regarding the compensation of our executive officers, other than in respect to his own compensation. The CEO assists the OLCC in determining the base salary, annual incentive cash award, and long-term incentive compensation of our executive officers (other than himself) on an annual basis. While our CEO typically attends meetings of the OLCC, the committee meets outside the presence of our CEO when discussing his compensation and when discussing certain other matters. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Role of Our Independent Compensation Consultant </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, Pearl Meyer served as the OLCC&#8217;s compensation consultant and continues to serve as the OLCC&#8217;s independent compensation consultant.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OLCC conducted a review of its relationship with Pearl Meyer and determined that Pearl Meyer&#8217;s work for the OLCC did not raise any conflicts of interest. Pearl Meyer&#8217;s work has conformed to the independence factors and guidance provided by the Dodd-Frank Act, the SEC, and the Nasdaq Stock Market. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Risk Assessment </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that although a portion of the compensation provided to our executive officers and other employees is performance-based, our executive compensation program does not encourage excessive or unnecessary risk taking. Our compensation programs are designed to encourage our executive officers and other employees to remain focused on both short- and long-term strategic goals, in particular in connection with our pay-for-performance compensation philosophy. As a result, we do not believe that our compensation programs are reasonably likely to have a material adverse effect on us. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Peer Group</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the assistance of Pearl Meyer, in the fall of 2022, the OLCC conducted a peer benchmark assessment to help establish a peer group that would be used to determine market-competitive compensation for our executives. The OLCC considered this analysis along with other factors in determining pay including industry surveys, individual performance, and the responsibilities and experience of the executive. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the peer group, with the assistance of Pearl Meyer, the OLCC considered and relied on several factors in setting its executive compensation peer group: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Industry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: biotechnology and pharmaceutical public companies, with a focus on oncology and/or neurology indications where possible</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Stage of Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: clinical development Phase I, II, or III companies </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Market Capitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: between $200 million and $2.0 billion </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Headcount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: greater than 50 employees </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">IPO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: prior to January 1, 2022, where possible </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the OLCC approved the following peer group, which was used for purposes of 2023 executive compensation decision-making: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adaptimmune Therapeutics plc</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AlloVir, Inc.</span></div></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arvinas, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioAtla, Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Editas Medicine, Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foghorn Therapeutics Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IGM Biosciences, Inc.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kymera Therapeutics, Inc.</span></div></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyell Immunopharma, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monte Rosa Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Morphic Holding, Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nkarta, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurix Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMV Pharmaceuticals, Inc.</span></div></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prelude Therapeutics Incorporated</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REGENXBIO Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Replimune Group, Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolution Medicines, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zentalis Pharmaceuticals, Inc.</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Our Compensation Program </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base Salary </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each NEO&#8217;s base salary is a fixed component of annual compensation that reflects the individual&#8217;s scope of responsibility and organizational impact, as well as individual performance. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When setting base salaries, considerations include, but are not limited to: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">each NEO&#8217;s position and specific responsibilities; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recent individual performance; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">level and breadth of experience; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">achievement of corporate and strategic goals; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a review of competitive pay levels at comparable positions at peer companies; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">retention considerations, and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the compensation levels required to attract qualified new hires. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended December&#160;31, 2023, the annual rate of base salary for each of our NEOs is set forth in the following table. Effective January&#160;1, 2023, the base salaries for Mr. Hirsch and Dr. Fisher were increased as part of our standard merit pay increase process, with increases determined based on individual performance and market data. Dr. Reyno&#8217;s base salary was established when he joined the Company in July 2023.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022 Base&#160;Salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023 Base&#160;Salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew Hirsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">614,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">639,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Dr. Reyno joined the Company in July 2023 and his base salary was pro-rated based on the date that he commenced employment. Dr. Reyno&#8217;s prorated base salary based on his July 2023 start date was $262,600.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Incentive Plan Cash Awards </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our annual incentive cash award program is intended to reward our NEOs for meeting objective or subjective performance goals for a fiscal year. From time to time, our Board of Directors or OLCC may approve annual incentive cash awards for our NEOs based on individual performance, company performance or as otherwise determined appropriate. For 2023, the amount of the annual incentive cash award paid to each of our NEOs was determined solely on the level of performance against our 2023 corporate objectives.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Incentive Opportunities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our NEOs had a pre-established target annual incentive rate, which is equal to a percentage of the executive&#8217;s base salary. Under our annual incentive plan, our NEOs can earn between a minimum of 50% of their target award for threshold performance up to a maximum of 150% payout for superior performance. The annual incentive cash awards for all of our NEOs are tied solely to the level of achievement of our corporate objectives. For 2023, our NEOs had the following annual cash incentive opportunities: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.628%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Target&#160;Annual Cash Incentive Opportunity (as&#160;%&#160;of&#160;Current Base&#160;Salary)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew Hirsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Performance Criteria</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2023 corporate objectives, which were established to incent performance on business activities designed to drive stockholder value, included a mix of pipeline, financial, development, and strategic objectives. Our 2023 corporate objectives and their respective weightings were as follows: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Objective</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighting</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advance clinical development activities to have three clinical-stage programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continue to invest in and advance pre-development candidate pipeline and platform</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evolve the organization to position the Company for success in the next phase of growth</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Earned Awards</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our achievement of our 2023 corporate objectives drove strong corporate performance in 2023 and, as a result, the OLCC determined that our corporate goals were 95% achieved in 2023. Specifically, in evaluating overall corporate performance in 2023, the OLCC considered progress achieved across the organization in laying the foundation for our vision to transform patient care through protein degradation and highlighted the following areas of achievement: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Advancement of CFT7455 in the clinic, resulting in the presentation of positive data from the ongoing Phase 1/2 clinical trial in relapsed/refractory multiple myeloma;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Continued advancement of CFT1946 in the clinic; </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Advancement of CFT8919 through the establishment of a collaboration with Betta Pharma, receipt of FDA approval of the investigational new drug application for CFT8919, and receipt of clinical trial application, or CTA, clearance for CFT8919 from the Chinese regulatory authority, the National Medical Products Administration; </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Entry into a new license and collaboration agreement with Merck to discover and develop degrader antibody conjugates; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Continued progress in our strategic prioritization efforts, resulting in a focus on advancing product candidates CFT7455, CFT1946 and CFT8919 and streamlined internal research efforts and the extension of our cash runway.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the annual incentive cash awards for all of our NEOs are tied solely to the level of achievement of our corporate objectives, the annual cash incentive awards paid to our NEOs for 2023 were as follows: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Target&#160;Annual Incentive ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percent Achieved (%)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023 Earned Annual Incentive ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew Hirsch</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;While Dr. Reyno joined the Company in July 2023, under the terms of his employment agreement, his 2023 annual cash incentive award was calculated based on his annualized 2023 base salary without proration.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Incentive Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity incentive program is intended to align the interests of our NEOs with those of our stockholders and to motivate our NEOs to make important contributions to our performance. In February 2023, as part of our annual process to review and approve executive compensation matters, we granted our NEOs (excluding Dr. Reyno, who was not an employee of the Company at that time) a mix of stock and option awards designed to retain such NEOs while creating long-term value for our stockholders, with the stock awards granted in the form of RSUs that vest annually over four years and option awards vesting quarterly over 16 quarters, subject to the recipient&#8217;s continued service relationship with the Company through such dates. In addition, in September 2023, in order to ensure that our employees had equity holdings that provide retentive value and as part of a special retention program for select employees, including the members of our Senior Leadership Team, the OLCC (and, in the case of the CEO, our Board) also granted stock options to each of the members of our Senior Leadership Team who had not recently received a stock option award, with these awards vesting all at once, two years from the date of grant, subject to the recipient&#8217;s continued business relationship with the Company through such date. All of our executive officers other than Dr. Reyno and Kendra Adams received a retention equity award as part of this program, with Dr. Reyno excluded because he had received new hire equity awards in July 2023 and Ms. Adams excluded because she received equity awards in connection with her September 2023 promotion into the role of Chief Financial Officer. In providing these stock option awards, our OLCC believed that these awards would contribute to ensuring stability at the leadership team level, which would help the Company achieve its objectives, both in the short- and long-term.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, as a way to further align our executive compensation with long term company performance, we granted performance-based RSUs to our executives, including Mr. Hirsch and Dr. Fisher. Dr. Reyno did not participate in this program as it predates his commencement of employment with the Company. The design of this program focused on aligning the vesting of these performance-based RSUs with the achievement of key corporate milestones related to our discovery and development activities, as well as future stock appreciation. This program also served to support the retention of key executive leadership in a highly competitive marketplace for talent and leadership. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our OLCC believes that these various equity awards provide an effective long-term incentive for all employees and are a competitive vehicle in our industry. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the equity incentives awarded to our NEOs in 2023, which included new hire stock option and time-based RSU awards made to Dr. Reyno, annual stock option and time-based RSU awards to Mr Hirsch and Dr. Fisher, and a special retentive stock option award made in September 2023 to each of our NEOs other than Dr. Reyno. Each RSU represents the contingent right to receive one share of our common stock upon vesting and settlement of each RSU. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew Hirsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470,832</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">856,800</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,333,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,420</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,550</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The RSUs, which were granted as an annual equity award for Mr. Hirsch and Dr. Fisher and a new hire equity award to Dr. Reyno, are time-based and will vest in equal annual installments over four years beginning on the first anniversary of the grant date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Mr. Hirsch and Dr. Fisher were granted 367,200 and 125,000 stock options, respectively, as annual equity awards which vest in equal quarterly installments over four years. The remainder of the option awards in the table above for Mr. Hirsch and Dr. Fisher, which consist of 489,600 and 120,000 stock options, respectively, were granted in September 2023 as special retentive equity awards and vest in full on the second anniversary of the date of the grant. Dr. Reyno&#8217;s option award, which was granted in connection with his joining the Company, vests over four years, with 25% of the award vesting on the first anniversary of his start date and the balance vesting in 12 equal quarterly installments thereafter. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Elements of Compensation </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Welfare Benefits </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our full-time employees, including our NEOs, are eligible to participate in certain medical, disability and life insurance benefit programs we offer. We pay the premiums for group term life insurance and short- and long-term disability insurance for all of our eligible employees, including our NEOs. We also provide all eligible employees, including our named executive officers, with a health savings account and eligibility for a health flexible spending account depending on the plan in which the NEO is enrolled. We also provide paid time off benefits, which include flexible vacation, sick time and holidays, to all eligible employees, including our NEOs. We do not sponsor any qualified or non-qualified defined benefit plans for any of our employees or executives. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">401(k) Savings Plan </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a tax-qualified, Safe Harbor 401(k) retirement plan for eligible employees, including our NEOs, in the United States. Under our 401(k) plan, employees may elect to defer up to 90% of their eligible compensation on a pre-tax or Roth  basis, subject to applicable annual limits set pursuant to the Internal Revenue Code of 1986, as amended, or the Code. We provide an employer match on employee contributions to the 401(k) plan of up to 100% on the first 3% of the employee&#8217;s contributions and 50% on the next 2% of employee contributions up to IRS maximums.. Employees are 100% immediately vested in their and our employer contributions to the 401(k) plan. The 401(k) plan is intended to be qualified under Section&#160;401(a) of the Code so that pre-tax contributions by employees, and income earned on those contributions, are not taxable to employees until distributed from the 401(k) plan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers, including our NEOs, are eligible to participate in our 2020 Employee Stock Purchase Plan, or the ESPP, on the same basis as our other full-time employees. The ESPP permits eligible employees to set aside a portion of their compensation during a&#160;six-month&#160;offering period and use such contributions to purchase shares of our common stock at a purchase price equal to 85%&#160;of the lower of the fair market value of the shares on the first business day of the offering period or the last business day of the purchase period. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limited Perquisites </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide limited perquisites to our NEOs. In 2023, we did not provide any perquisites to our NEOs other than the standard de minimis benefits offered to our general employee population. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting and Tax Considerations </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, Section&#160;162(m) of the Code (Section 162(m)) disallows a federal income tax deduction for public corporations of remuneration in excess of $1 million paid in any fiscal year to certain specified executive officers. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the OLCC and the Board of Directors consider the deductibility of awards as one factor in determining executive compensation, the OLCC and the Board also look at other factors in making their decisions and retain the flexibility to award compensation that either the OLCC or the Board, as applicable, determines to be consistent with the goals of our executive compensation program even if the awards are not deductible by us for tax purposes. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to considering the tax consequences, the OLCC and the Board consider the accounting consequences of their decisions, including the impact of expenses being recognized in connection with equity-based awards, in determining the size and form of different equity-based awards. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation paid to employees under FASB ASC Topic 718, which requires the Company to estimate and record an expense over the service period of an option award. Thus, the Company may record an expense in one year for awards granted in earlier years. Accounting rules also require the recording of cash compensation as an expense at the time the obligation is accrued. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employment, Severance and Change in Control Arrangements with Our NEOs </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into an employment agreement with each of our NEOs, each of whom is employed at will. These agreements incorporate our standard form agreements with respect to confidential information and assignment of intellectual property, which have been signed by each of our NEOs. Among other things, each of these agreements obligates the NEO to refrain from disclosing any of our proprietary information received during the course of his or her employment with and to assign to us any inventions conceived or developed during the course of his or her employment. The employment and/or equity agreements with our NEOs also provide that, during the period of the NEO&#8217;s employment and for 12 months thereafter, the NEO will not solicit our employees, consultants, customers or suppliers. In addition, each of our NEOs has signed an agreement &#8211; either as part of an equity agreement or as part of the individual&#8217;s employee confidentiality and assignment of intellectual property agreement &#8211; that provides that the NEO is also subject to a 12-month post-termination non-competition covenant.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Andrew J. Hirsch </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;6, 2020, we entered into an employment agreement with Mr.&#160;Hirsch, our President and Chief Executive Officer, pursuant to which Mr.&#160;Hirsch serves as our President and Chief Executive Officer. Under this agreement, Mr.&#160;Hirsch receives an annual base salary and is eligible to receive an annual incentive cash award with a target amount of 55% of his then current base salary, in each case subject to periodic review and adjustment by our Board of Directors or the OLCC. Mr.&#160;Hirsch is also eligible to participate in employee benefit plans generally available to our executive employees, subject to the terms of those plans. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Mr.&#160;Hirsch&#8217;s employment agreement, if Mr.&#160;Hirsch&#8217;s employment is terminated by us without &#8220;cause&#8221; or Mr.&#160;Hirsch resigns for &#8220;good reason&#8221; (as each of these terms is defined in his employment agreement), in each case other than in connection with a &#8220;change in control&#8221; (as defined in his employment agreement), subject to the execution and effectiveness of a separation agreement, including a general release of claims in our favor, he will be entitled to receive (i)&#160;an amount equal to one times his base salary, payable in accordance with the Company&#8217;s normal payroll procedures over the 12-month period following the date of termination, plus a pro rata portion of his target annual cash incentive, payable in a single lump sum payment within sixty days following the date of termination, and (ii)&#160;subject to Mr.&#160;Hirsch&#8217;s copayment of premium amounts at the applicable active employees&#8217; rate and proper election of COBRA health continuation, a monthly payment of the amount that we would have made to provide health insurance to Mr.&#160;Hirsch had he remained employed until the earliest of 12&#160;months following his termination date, his eligibility for group health coverage through another employer, or the cessation of his eligibility for COBRA continuation of health coverage. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Hirsch&#8217;s employment agreement also provides that, in lieu of the payments and benefits described above, if Mr.&#160;Hirsch&#8217;s employment is terminated by us without cause or Mr.&#160;Hirsch resigns for good reason, in either case upon, immediately prior to, or within 18&#160;months following a change in control, subject to the execution and effectiveness of a separation agreement, including a general release of claims in our favor, he will be entitled to receive (i)&#160;a lump sum cash payment equal to 1.5 times the sum of (x) his then-current base salary (or his base salary in effect immediately prior to the change in control, if higher) plus (y) his target annual cash incentive then in effect (or his target annual cash incentive in effect immediately prior to the change in control, if higher); (ii)&#160;subject to Mr.&#160;Hirsch&#8217;s copayment of premium amounts at the active employees&#8217; rate and proper election of COBRA health continuation, a monthly payment of the amount that we would have made to provide health insurance to Mr.&#160;Hirsch had he remained employed until the earliest of 18&#160;months following his termination date, his eligibility for group health coverage through another employer, or the cessation of his </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eligibility for COBRA continuation of health coverage; and (iii)&#160;full acceleration of all equity awards held by Mr.&#160;Hirsch, with any performance conditions becoming vested based on attainment of the greater of target level of performance or actual performance as of the date of termination. To the extent the parties to a sale event do not provide for the assumption, continuation or substitution of Mr.&#160;Hirsch&#8217;s equity awards, Mr.&#160;Hirsch is entitled to receive full acceleration of his equity awards upon the sale event, with any performance conditions becoming vested based on attainment of the greater of target level of performance or actual performance as of the date of the sale event. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, in the event that any compensation or payments payable to Mr. Hirsch would constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended, or the Code, or would be subject to the related excise tax under Section 4999 of the Code, then Mr. Hirsch&#8217;s employment agreement provides that he will receive either the full amount of the severance payments and benefits described above or such lesser amount that would result in no portion of the payments and benefits being subject to the excise tax, whichever result in the greater amount of after-tax benefits to Mr. Hirsch. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Named Executive Officers Other Than Mr. Hirsch</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an employment agreement with each of our NEOs (excepting Mr. Hirsch, who is described above) pursuant to which the NEO receives an annual base salary and is eligible to receive an annual incentive cash award with a target amount of 40% of the individual&#8217;s rate of base salary, in each case, subject to review and adjustment by our Board of Directors or OLCC. Each of our NEOs is also eligible to participate in employee benefit plans generally available to our executive employees, subject to the terms of those plans. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The employment agreement in place with each of our NEOs (excepting Mr. Hirsch, who is described above) provides that, in the event that the NEO&#8217;s employment is terminated by us without &#8220;cause&#8221; or the NEO resigns for &#8220;good reason&#8221; (as each of these terms is defined in the NEO&#8217;s employment agreement), in each case other than in connection with a &#8220;change in control&#8221; (as defined in the NEO&#8217;s employment agreement), subject to the execution and effectiveness of a separation agreement, including a general release of claims in our favor, the NEO will be entitled to receive (i)&#160;an amount equal to one times his or her base salary plus, at the discretion of our Board of Directors and upon the recommendation of our OLCC, a pro rata portion of his or her target annual cash incentive, payable in accordance with the Company&#8217;s normal payroll procedures over the 12-month period following the date of termination, and (ii)&#160;subject to the NEO&#8217;s copayment of premium amounts at the active employees&#8217; rate and proper election of COBRA health continuation, a monthly payment of the amount that we would have made to provide health insurance to the NEO had he or she remained employed until the earliest of 12 months following his or her termination date, his or her eligibility for group health coverage through another employer, or the cessation of his or her eligibility for COBRA continuation of health coverage. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The employment agreements in place with each of our NEOs (excepting Mr. Hirsch, who is described above) also provides that, in lieu of the payments and benefits described above, if the NEO&#8217;s employment is terminated by us without cause or the NEO resigns for good reason, in either case upon, immediately prior to, or within 12&#160;months following a change in control, subject to the execution and effectiveness of a separation agreement, including a general release of claims in our favor, the NEO will be entitled to receive (i)&#160;a lump sum cash payment equal to one times the sum of his or her then-current base salary (or his or her base salary in effect immediately prior to the change in control, if higher) plus his or her target annual cash incentive in effect immediately prior to the change in control (or his or her target annual cash incentive in effect immediately prior to the change in control, if higher); (ii)&#160;subject to the NEO&#8217;s copayment of premium amounts at the active employees&#8217; rate and proper election of COBRA health continuation, a monthly payment of the amount that we would have made to provide health insurance to the NEO had he or she remained employed until the earliest of 12 months following his termination date, his or her eligibility for group health coverage through another employer, or the cessation of his or her eligibility for COBRA continuation of health coverage; and (iii)&#160;full acceleration of all equity awards held by the NEO, with any performance conditions becoming vested based on attainment of the greater of target level of performance or actual performance as of the date of termination. To the extent the parties to a sale event do not provide for the assumption, continuation or substitution of a NEO&#8217;s equity awards, the NEO is entitled to receive full acceleration of his or her equity awards upon the sale event, with any performance conditions becoming vested based on attainment of the greater of target level of performance or actual performance as of the date of the sale event. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, in the event that any compensation or payments payable to a NEO would constitute &#8220;parachute payments&#8221; within the meaning of Section&#160;280G of the Internal Revenue Code of 1986, as amended, or the Code, or would be subject to the related excise tax under Section&#160;4999 of the Code, then the NEO&#8217;s employment agreement provides that she or he will receive either the full amount of the severance payments and benefits described above or such lesser amount that would result in no portion of the payments and benefits being subject to the excise tax, whichever result in the greater amount of after-tax benefits to the NEO.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span id="ic1369963ee01441496ea4ef045ee0536_48505"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Compensation Table </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information regarding the total compensation awarded to, earned by or paid to each of our NEOs for services rendered to us in all capacities for the years set forth below, which excludes fiscal years in which the individuals were not our NEOs: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Bonus ($) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Stock Awards ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Option Awards ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Non-Equity Incentive Plan Compensation ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">All Other Compensation ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Andrew J. Hirsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">639,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,333,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,790,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">President &amp; Chief Executive Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">614,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,624,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,595,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">711,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,533,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Chief Scientific Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">460,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">558,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,888,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,104,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Chief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">709,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">209,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,674,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This amount represents a relocation benefit and a sign-on bonus paid in connection with Dr. Reyno&#8217;s commencement of employment with the Company, which were used to incent Dr. Reyno to join the Company and compensate him for his relocation to the Boston area, as well as for equity and other compensation he forfeited by leaving his prior role. This sign-on bonus was paid upon his commencement of employment with the Company. This sign-on bonus and relocation benefit were structured such that the amounts received by Dr. Reyno are subject to clawback if Dr. Reyno voluntarily terminates his employment with the Company or the Company terminates his employment for &#8220;cause&#8221; (as that term is defined in his employment agreement) prior to the one-year anniversary of his commencement of employment with the Company. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts reflect the aggregate grant date fair value of restricted stock unit and option awards granted during the year calculated in accordance with the provisions of FASB ASC Topic 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Such grant-date fair value does not take into account any estimated forfeitures related to service-vesting conditions. For the time-based RSUs granted in 2023, which vest in four equal installments annually, commencing on the first anniversary of the grant date, the grant date fair value was estimated using the closing stock price on the grant date. For the performance-based RSUs granted in 2022, the grant date fair value for the portion of these awards that may be earned based on market-based conditions was estimated using a Monte Carlo Simulation model and the grant date fair value for the portion that may be earned based on other performance conditions was determined based on an estimate of the probable achievement of the underlying performance conditions. For information regarding assumptions underlying the valuation of option awards, see Notes&#160;2 and 11 to our audited consolidated financial statements appearing in our 2023 Annual Report. These amounts do not correspond to the actual value that may be recognized by the NEOs upon vesting or settlement of restricted stock unit awards or the vesting or exercise of the options awards, or the subsequent sale of shares received under such awards. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts reported represent annual incentive cash awards based upon the achievement of corporate performance objectives for the years ended December&#160;31, 2023, and 2022, which were paid in February 2024, and 2023, respectively. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Represents the Company&#8217;s 401(k) matching contributions they were entitled to receive. For information regarding this defined contribution plan, see Note&#160;14 to our audited consolidated financial statements appearing in our 2023 Annual Report.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Represents the Company&#8217;s 2022 401(k) matching contributions and a one-time cash bonus that was provided to all eligible employees, including those NEOs then employed by the Company, in lieu of a 401(k) match, which was provided to ensure that all employees participating in the Company&#8217;s 401(k) plan received the economic value of the full employer matching contributions they were entitled to receive but did not receive via the 401(k) plan due to constraints set forth in the plan&#8217;s governing documents. For information regarding this defined contribution plan, see Note&#160;14 to our audited consolidated financial statements appearing in our 2023 Annual Report. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">We did not provide Mr.&#160;Hirsch with an annual stock option award in 2022 as, in conjunction with his hiring as our CEO in 2020, we granted him an option award intended to include his new hire award and the annual option awards that he would be eligible to receive over the next two years,</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Dr. Reyno joined the Company in July 2023 and his 2023 salary was pro-rated accordingly. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outstanding Equity Awards at Fiscal Year End </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information regarding all outstanding stock and option awards held by each of our NEOs on December&#160;31, 2023: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.75pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Grant<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Vesting<br/>Commencement<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Exercisable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Unexercisable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Option<br/>Exercise<br/>Price<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Option<br/>Expiration<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number of Shares or Units of Stock That Have Not Vested (#) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Market Value of Shares or Units of Stock That Have Not Vested ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">(#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Andrew Hirsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">10/01/20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">10/01/20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">1,268,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">422,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">19.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/30/30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/23/22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/23/22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">250,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/15/23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/15/23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">68,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">298,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">5.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/14/33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">81,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(7)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">461,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/18/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/18/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">489,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/17/33</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">04/24/18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">05/01/18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">35,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">3.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">04/23/28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/03/20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">06/05/20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">142,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">61,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/02/30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/09/20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">06/05/20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">25,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">22,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/08/30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/11/21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/11/21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">65,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">29,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">45.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/10/31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/14/22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/14/22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">51,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">66,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">22.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/13/32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">75,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/13/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/13/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">23,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">101,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">5.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">02/12/33</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">26,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(7)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">146,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/18/23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/18/23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">120,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">09/17/33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/10/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/10/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">276,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">3.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">07/09/33</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">61,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.71pt;font-weight:400;line-height:100%;position:relative;top:-2.53pt;vertical-align:baseline">(7)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">346,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts represent the number of time-based RSUs outstanding for all NEOs.</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown are based on a price of $5.65 per share, which was the closing price of our common stock as reported on the Nasdaq Global Select Market on December 29, 2023, the last trading day of the year.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts represent the number of performance-based RSUs granted to Mr. Hirsch and Dr. Fisher that will vest if certain performance conditions are met.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This award vests over four years, with 12.5% having vested on the six-month anniversary of the vesting commencement date and the remainder of the award vesting in 14 equal quarterly installments thereafter, subject to Mr.&#160;Hirsch&#8217;s continued service relationship with us on each vesting date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amount shown consists of of a performance-based RSU award that vests as to a portion of the award based on specified market-based conditions and, as to the balance of the award, based on the achievement of certain corporate performance conditions.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This award vests in 16 equal quarterly installments starting on the three-month anniversary of the vesting commencement date, subject to Mr. Hirsch&#8217;s continued service relationship with us on each vesting date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This time-based RSU award vests annually in four equal installments commencing on the first anniversary of the date of grant, subject to the recipient&#8217;s continued service relationship with the Company through each such date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This award vests in full on the two year anniversary of the date of grant, subject to the NEO&#8217;s continued service relationship with the Company through such date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These awards vest in 20 equal quarterly installments starting on the three-month anniversary of the vesting commencement date, subject to the NEO&#8217;s continued service relationship with us on each vesting date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">These awards vest in 16 equal quarterly installments starting on the three-month anniversary of the vesting commencement date, subject to the NEO&#8217;s continued service relationship with us on each vesting date.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">This award vests over four years, with 25% vesting on the one-year anniversary of the vesting commencement date and the remainder of the award vesting in 12 equal quarterly installments thereafter, subject to Dr. Reyno&#8217;s continued service relationship with us on each vesting date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_341"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-5" continuedAt="f-5-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding &#8220;compensation actually paid&#8221; to our principal executive officer, or PEO, Mr. Hirsch, and to our non-PEO NEOs for each applicable year. The identity of our NEOs other than Mr. Hirsch may vary year-over-year and the identity of which NEOs are included in this table is determined based on those executive officers who were NEOs for the years presented. Compensation actually paid to Mr. Hirsch and our other NEOs is impacted by the fair value of their equity incentive awards, which is calculated in accordance with the provisions of FASB ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See Note 2 to our audited consolidated financial statements appearing in our 2023 Annual Report for a summary of the assumptions underlying the valuation of equity awards.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-6" escape="true"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Table Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for PEO</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actually Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">to PEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Table Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-PEO NEOs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actually Paid to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-PEO NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Return</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Loss <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">3,790,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">4,311,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">1,604,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-10">1,945,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-11">17.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-12">128,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-13">2,595,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">21,606,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">3,509,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">2,156,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-17">17.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-18">83,892</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-19">952,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-20">79,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-21">3,937,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">3,013,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-23">97.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-24">83,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-25" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The PEO for each of the periods presented is <ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-26">Mr. Hirsch</ix:nonNumeric>. The Non-PEO NEOs for 2023 were Dr. Reyno and Dr. Fisher, for 2022 were Dr. Scott Boyle, our Chief Business Officer, and Dr. Fisher and, for 2021 were Lauren White, our then-current Chief Financial Officer, and Dr. Fisher.</span></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-28" continuedAt="f-28-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-27" continuedAt="f-27-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts are computed in accordance with Item 402(v) of Regulation S-K by deducting and adding the following amounts from the &#8220;Total&#8221; column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</span></ix:nonNumeric></ix:nonNumeric></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><ix:continuation id="f-28-1"><ix:continuation id="f-27-1"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Non-PEO NEOs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Compensation from Summary Compensation Table</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-29">3,790,099</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">1,604,322</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">2,595,395</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">3,509,439</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">952,200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-34">3,937,239</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments for Equity Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments for grant date fair values of equity awards granted in the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-35">2,804,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-36">891,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-37">1,624,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-38">2,844,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-40">3,395,354</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-end fair value of unvested equity awards granted in the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-41">4,110,779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-42">1,362,669</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-43">284,900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-44">356,546</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-45">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">2,172,003</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-over-year difference of year-end fair values for unvested equity awards granted in prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">198,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">34,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-49">18,018,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-50">2,349,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-51">3,356,456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-52">167,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values at vest date for equity awards granted and vested in current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-53">106,718</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">17,814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">158,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-56">104,252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-57">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-58">216,575</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Difference in fair values between prior year-end fair values and vest date fair values for equity awards granted in prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-59">693,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">113,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-61">5,002,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-62">932,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-63">2,324,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-64">250,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Adjustments for Equity Awards</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-65">521,440</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-66">341,503</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-67">24,201,597</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-68">5,666,393</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-69">1,031,905</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-70">923,929</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid (as calculated)</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-71">4,311,539</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-72">1,945,825</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-73">21,606,202</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-74">2,156,954</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-75">79,705</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-76">3,013,310</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><ix:continuation id="f-5-1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Shareholder return provides the value of common stock as of December 31, 2023, December 31, 2022 and December 31, 2021 assuming $100 was invested in our common stock after the market closed on December 31, 2020.</span></ix:continuation></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Narrative Disclosure: Pay Versus Performance Table</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The illustrations below provide a graphical description of Compensation Actually Paid, or CAP (as calculated in accordance with the rules promulgated by the SEC, and the following measures:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Company&#8217;s cumulative Total Shareholder Return, or TSR; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Company&#8217;s Net Income</span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-78" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-77" escape="true"><div style="margin-top:6pt;text-align:center"><img src="cccc-20240429_g10.jpg" alt="2401" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-79" escape="true"><div style="margin-top:6pt;text-align:center"><img src="cccc-20240429_g11.jpg" alt="2403" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information as of December&#160;31, 2023 with respect to the shares of our common stock that may be issued under our existing equity compensation plans: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:44.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.729%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.793%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Compensation Plan Information</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Exercise Price of Outstanding Options, Warrants and Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans&#160;(Excluding Securities in First Column)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation plans approved by stockholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and stock awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,475,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,358,336</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673,129</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation plans not approved by stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-right:-1.31pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,826,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,031,465</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes the following plans: our 2015 Stock Option and Grant Plan, and our 2020 Stock Option and Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The calculation does not take into account the 904,210 shares of common stock subject to outstanding time-based and performance-based restricted stock units, which shares will be issued if and when these awards vest and will be issued without any cash consideration payable for those shares.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December&#160;31, 2023, a total of 3,358,336 shares of our common stock were available for issuance pursuant to the 2020 Plan, which number excludes the 3,023,359 shares that were added to the plan as a result of the automatic annual increase on January 1, 2024. The 2020 Plan provides that the number of shares reserved and available for issuance under the plan will automatically increase each January&#160;1, beginning on January&#160;1, 2021, by 5% of the outstanding number of shares of our common stock on the immediately preceding December&#160;31 or such lesser number of shares as determined by the OLCC. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. The shares of common stock underlying any awards that are forfeited, canceled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without the issuance of stock, expire or are otherwise terminated, other than by exercise, under the 2020 Plan and the 2015 Stock Option and Grant Plan will be added back to the shares of common stock available for issuance under the 2020 Plan. The Company no longer makes grants under the 2015 Stock Option and Grant Plan. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December&#160;31, 2023, a total of 1,673,129 shares of our common stock were available for issuance pursuant to the 2020 ESPP, which number excludes the 604,671 shares that were added to the plan as a result of the automatic annual increase on January&#160;1, 2024. The 2020 ESPP provides that the number of shares reserved and available for issuance under the plan will automatically increase each January&#160;1, beginning on January&#160;1, 2021, by the lesser of 656,714 shares of our common stock, 1% of the outstanding number of shares of our common stock on the immediately preceding December&#160;31 or such lesser number of shares as determined by the 2020 ESPP Plan administrator. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">As of December 31, 2023, we had granted a total of 351,000 shares of our common stock in stock option awards made outside of our 2020 Plan. The independent directors serving on the OLCC approved the grant of these non-qualified stock options to two new employees in the form of inducement awards, with grants made on July 10 and July 17, 2023. These grants were provided as material inducements to these individuals commencing employment with the Company and were granted in accordance with Nasdaq Listing Rule 5635(c)(4).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Relationships and Transactions </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the compensation agreements and other arrangements described under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this proxy statement and the transactions described below, since January&#160;1, 2022, there has not been and there is not currently proposed, any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed, $120,000 (or, if less, 1% of the average of our total assets amounts at December 31, 2022 and 2023) and in which any director, executive officer, holder of five percent or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material interest. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation arrangements for our NEOs and our directors are described elsewhere in this proxy statement under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investors&#8217; Rights Agreement </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our Series B preferred stock financing, we entered into an investors&#8217; rights agreement containing registration rights, information rights, voting rights and rights of first refusal, among other things, with certain holders of our preferred stock and common stock. The registration rights set forth in our investors&#8217; rights agreement remain outstanding. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Option Grants to Directors and Executive Officers </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have granted stock options to our directors and executive officers and performance-based restricted stock units to our executive officers, as more fully described in the section titled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; found elsewhere in this proxy statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Betta Pharma License and Collaboration Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we entered into a License and Collaboration Agreement, or the License Agreement, with Betta Pharmaceuticals Co., Ltd., or Betta Pharma, to collaborate on the development and commercialization of CFT8919, an orally bioavailable BiDAC&#8482; degrader that is designed to be potent and selective against EGFR bearing an oncogenic L858R mutation, in mainland China, Hong Kong SAR, Macau SAR and Taiwan, with us retaining rights to CFT8919 in the rest of the world. On the same date and in connection with the execution of the License Agreement, we, Betta Pharma, and Betta Investment (Hong Kong) Limited, or Betta Investment, an affiliate of Betta Pharma, entered into a Stock Purchase Agreement pursuant to which Betta Investment agreed to purchase 5,567,928 shares of our common stock at a per share purchase price of $4.49, for an aggregate purchase price of approximately $25.0 million. Betta Investment completed the purchase of these shares in January 2024. The Stock Purchase Agreement provides that, for the period extending until the one-year anniversary of the purchase of these shares, Betta Investment shall vote, or cause to be voted, all of our voting securities then beneficially owned by Betta Investment in accordance with the recommendation of the Board of Directors on any matters presented to  our stockholders with respect to the say-on-pay, any stock option, stock incentive, employee stock purchase or similar equity plan, or any amendment thereto that, in each case, apply to our employees generally. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitation of Liability and Indemnification of Officers and Directors </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation contains provisions that limit the liability of our directors and officers for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors and officers will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors or officers, as applicable, except liability for the following: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any breach of their duty of loyalty to our company or our stockholders; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any transaction from which they derived an improper personal benefit. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors are also liable to us or our stockholders for monetary damages resulting from unlawful payments of dividends or unlawful stock repurchases, or redemptions as provided in Section 174 of the Delaware General Corporation Law. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors and officers of corporations, then the personal liability of our directors and officers will be further limited to the greatest extent permitted by the Delaware General Corporation Law. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our By-laws provide that we will indemnify, to the fullest extent permitted by law, any person who is or was a party or is threatened to be made a party to any action, suit or proceeding by reason of the fact that he or she is or was one of our directors or officers or is or was serving at our request as a director or officer of another corporation, partnership, joint venture, trust, or other enterprise. Our By-laws also provide that we may indemnify to the fullest extent permitted by law any person who is or was a party or is threatened to be made a party to any action, suit, or proceeding by reason of the fact that he or she is or was one of our employees or agents or is or was serving at our request as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Our By-laws also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered, and intend to continue to enter, into separate indemnification agreements with our directors and officers, in addition to the indemnification provided for in our Certificate of Incorporation and By-laws. These agreements, among other things, require us to indemnify our directors and officers for certain expenses, including attorneys&#8217; fees, judgments, penalties, fines and settlement amounts actually incurred by these individuals in any action or proceeding arising out of their service to us or any of our subsidiaries or any other company or enterprise to which these individuals provide services at our request. Subject to certain limitations, our indemnification agreements also require us to advance expenses incurred by our directors and officers for the defense of any action for which indemnification is required or permitted. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Related Party Transactions </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors adopted a written related person transactions policy providing that transactions with our directors, executive officers, holders of five percent or more of our voting securities and their affiliates, each a related person, must be approved by our Audit Committee. Any request for such a transaction must first be presented to our Audit Committee for review, consideration or approval or, if advance review is not feasible, such request must be reviewed at our Audit Committee&#8217;s next regularly scheduled meeting. In approving or rejecting any such proposal, our Audit Committee is to consider the relevant facts and circumstances available and deemed relevant to the Audit Committee, including, but not limited to, the extent of the related party&#8217;s interest in the transaction, whether the transaction is on terms no less favorable to us than terms we could have generally obtained from an unaffiliated third party under the same or similar circumstances and whether the transaction is otherwise consistent with the company&#8217;s interests. Further, when stockholders are entitled to vote on a transaction with a related party, the material facts of the related party&#8217;s relationship or interest in the transaction are disclosed to the stockholders, who must approve the transaction in good faith. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information, to the extent known by us or ascertainable from public filings, with respect to the beneficial ownership of our common stock as of April 23, 2024 by: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">each of our directors; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">each of our NEOs; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">all of our directors and executive officers as a group; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">each person, or group of affiliated persons, who is known by us to be the beneficial owner of greater-than-5.0% of our common stock. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The column entitled &#8220;Percentage Beneficially Owned&#8221; is based on a total 68,805,786 shares of our common stock outstanding as of April 23, 2024. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to our common stock. Shares of our common stock subject to options that are currently exercisable or exercisable within 60 days of April 23, 2024 are considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as otherwise noted, the persons and entities in this table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable. Except as otherwise indicated in the table below, addresses of named beneficial owners are in care of C4 Therapeutics, Inc., 490&#160;Arsenal Way, Suite 120, Watertown, Massachusetts 02472. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares Beneficially Owned</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage Beneficially Owned</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5% Stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State Street Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,153,280</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Betta Investment (Hong Kong) Limited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,567,928</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wasatch Advisors L.P. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,516,718</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RA Capital  Healthcare Fund L.P.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,878,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commodore Capital L.P. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,800,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Named Executive Officers and Directors:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew J. Hirsch </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,834,797</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stewart Fisher, Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">653,223</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leonard Reyno, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,331</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenneth C. Anderson, M.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408,821</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laura Bessen, M.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,947</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bruce Downey </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588,889</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn Dubin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903,382</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Donna Grogan, M.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,579</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Owen Hughes </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utpal Koppikar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,515</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malcolm Salter </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,347</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All current executive officers and directors as a group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(15 persons) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,882,663</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.5pt">Represents beneficial ownership of less than one percent of our outstanding common stock. </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Information herein is based solely upon a Schedule 13G filed with the SEC on April 10, 2024. State Street Corporation has shared voting power with respect to 7,153,280 shares and shared dispositive power with respect to 7,153,280 shares, and SSGA Funds Management, Inc. has shared voting power with respect to 6,983,007 shares and shared dispositive power with respect to 6,983,007 shares. The address of each of these entities is 1 Congress Street, Suite 1, Boston, Massachusetts 02114.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Information herein is based solely upon a Schedule 13G filed with the SEC on January 12, 2024. Consists of 5,567,928 shares of common stock held by Betta Investment (Hong Kong) Limited, or Betta Investment. Betta Pharmaceuticals Co., Ltd., a limited company incorporated under the laws of China, or Betta Pharma. Betta Pharma, as the sole shareholder of Betta Investment, may be deemed to beneficially own the shares of Common </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock held directly by Betta Investment. The address for the foregoing persons is 55 Xingzhong Road, Linping, Hangzhou 311100, China.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Information herein is based solely upon a Schedule 13G/A filed with the SEC on March 8, 2024. The address of Wasatch Advisors L.P. is 505 Wakara Way, Salt Lake City, UT 84108. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Information herein is is based solely upon a Schedule 13G filed with the SEC on December 26, 2023. Consists of 4,878,000 shares of common stock held by RA Capital Healthcare Fund, L.P. , or Fund. RA Capital Healthcare Fund GP, LLC, or RA Capital, is the general partner of the Fund. The general partner of RA Capital is RA Capital Management GP, LLC, of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the controlling persons. RA Capital serves as investment adviser for the Fund and may be deemed a beneficial owner of any securities of the Company held by the Fund. The Fund has delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in the Fund&#8217;s portfolio, including the ordinary shares held by the Fund. Because the Fund has divested itself of voting and investment power over the reported securities it holds and may not revoke that delegation on less than 61 days&#8217; notice, the Fund disclaims beneficial ownership of the securities it holds for purposes of Section 13(d) of the Exchange Act. As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners, for purposes of Section 13(d) of the Exchange Act, of any securities of the Company beneficially owned by RA Capital. RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of securities reported herein. The address for RA Capital is 200 Berkeley Street, 18th Floor, Boston, MA 02116.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Information herein is based solely upon a Schedule 13G filed with the SEC on December 22, 2023. Consists of 3,800,000 shares of common stock held by Commodore Capital Master L.P, a Cayman Islands exempted limited partnership, or Commodore Master. Commodore Capital L.P., a Delaware limited partnership, or Firm, as the investment manager to Commodore Master, may be deemed to beneficially own these securities. Michael Kramarz and Robert Egen Atkinson are the managing partners of the Firm and exercise investment discretion with respect to these securities. Each of Commodore Master, the Firm, Mr. Kramarz and Mr. Atkinson disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein. The address for the Firm and Commodore Master is 444 Madison Avenue, Floor 35, New York, New York 10022.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Consists of 210,741 shares of common stock held by Mr. Hirsch and 1,624,056 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Mr. Hirsch.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Consists of 230,942 shares of common stock held by Dr. Fisher and 422,281 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Dr. Fisher.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Consists of 98,000 shares of common stock held by Dr Reyno and 10,331 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Dr. Reyno.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Consists of (i) 16,939 shares of common stock held by Kenneth C. Anderson 2015 Irrevocable Trust; (ii) 16,939 shares of common stock held by Cynthia E. Anderson 2015 Irrevocable Trust; (iii) 61,265 shares of common stock held by Kenneth C. Anderson 2016 Grantor Retained Annuity Trust; (iv) 61,265 shares of common stock held by Cynthia E. Anderson 2016 Grantor Retained Annuity Trust; (v) 112,351 shares of common stock held by Dr. Anderson; (vi) 47,316 shares of common stock held by Cynthia Anderson; and (vii) 92,746 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Dr. Anderson. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 49,947 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Dr. Bessen. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 489,542 shares of common stock held by Mr. Downey and 99,347 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Mr. Downey. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of (i) 770,607 shares held by DF Investment Partners LLC, of which Mr.&#160;Dubin serves as a managing member and disclaims beneficial ownership except to the extent of his pecuniary interest; (ii) 20,000 shares held by G&amp;E Dubin Family Foundation of which Mr.&#160;Dubin disclaims beneficial ownership except to the extent of his pecuniary interest; (iii) 22,075 shares of common stock held by Mr.&#160;Dubin; and (iv) 99,700 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Mr.&#160;Dubin. The shares do not include shares held by Commodore Capital Master LP, a fund affiliated with Mr.&#160;Dubin, but over which he does not have voting or dispositive control. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 23,632 shares of common stock held by Dr. Grogan and 49,947 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Dr. Grogan. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 5,667 shares of common stock held by Mr. Koppikar and 56,848 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Mr. Koppikar. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 26,000 shares of common stock held by Mr. Salter and 99,347 shares of common stock exercisable within 60 days of April 23, 2024 underlying options held by Mr. Salter. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of the shares of common stock reflected in notes (6)&#160;through (15) and includes (i) 359,142 shares of common stock and (ii) 714,690 shares of common stock subject to options exercisable within 60 days of April 23, 2024 held by Kendra Adams, Scott Boyle, Ph.D., Kelly Schick and Jolie Siegel, who are executive officers but not NEOs. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;16(a) of the Exchange Act requires our directors, executive officers and persons holding more than 10% of our common stock to report their initial ownership of the common stock and other equity securities and any changes in that ownership in reports that must be filed with the SEC. The SEC has designated specific deadlines for these reports, and we must identify in this proxy statement those persons who did not file these reports when due. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based solely on a review of reports furnished to us, or written representations from reporting persons, we believe all directors, executive officers, and&#160;10% owners timely filed all reports regarding transactions in our securities required to be filed for 2023 by Section&#160;16(a) under the Exchange Act.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2 &#8211; ADVISORY VOTE TO APPROVE NAMED </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICER COMPENSATION </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dodd-Frank Act added Section&#160;14A to the Securities Exchange Act of 1934, as amended, which requires that we provide our stockholders with the opportunity to vote to approve, on a&#160;non-binding,&#160;advisory basis, the compensation of our named executive officers as disclosed in this proxy statement, commonly known as a&#160;&#8220;say-on-pay&#8221;&#160;vote. Stockholders may also abstain from voting on this proposal. This&#160;say-on-pay&#160;vote is not intended to address any specific element of the compensation of our named executive officers, but rather the overall executive compensation of our named executive officers and our overall executive compensation program, philosophy and practices as described in this Proxy Statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This say-on-pay vote is advisory; therefore, it is not binding on the Company, our Board of Directors or our OLCC. However, we plan to consider the results of this year&#8217;s vote in reviewing and determining the compensation of our named executive officers in the future because we value the opinions of our stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program, including our performance and the compensation earned by our named executive officers, is discussed in greater detail in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#8220;Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#160;section beginning on page <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i41a0551a7b554b0f83839908f7b5cf88_31">25</a> of this proxy statement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in this proxy statement, we believe the compensation of our named executive officers and our executive compensation program, philosophy and practices are appropriate, and enable us to attract, motivate and retain&#160;top-performing&#160;executive officers, including our named executive officers, while aligning the long-term interests of our executive officers with the long-term interests of our stockholders and without incenting inappropriate or excessive risk-taking. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, we ask our stockholders to approve, on a&#160;non-binding,&#160;advisory basis, the following resolution at the Annual Meeting: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">RESOLVED:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">That the stockholders approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Compensation Discussion and Analysis section, the Compensation and Equity Tables and the related narrative executive compensation disclosures contained in this proxy statement.</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Board of Directors recommends that you vote, on a non-binding, advisory basis,&#160;&#8220;FOR&#8221;&#160;the approval of the resolution set forth above related to the compensation of our named executive officers. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 3 &#8211; RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS C4 THERAPEUTICS&#8217; INDEPENDENT REGISTERED </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PUBLIC ACCOUNTING FIRM FOR THE <br/>FISCAL YEAR ENDING DECEMBER&#160;31, 2024</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C4 Therapeutics&#8217; stockholders are being asked to ratify the appointment by the Audit Committee of the Board of Directors of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2024. KPMG LLP has served as our independent registered public accounting firm since 2016. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee is solely responsible for selecting our independent registered public accounting firm for the fiscal year ending December&#160;31, 2024. Stockholder approval is not required to appoint KPMG LLP as our independent registered public accounting firm. However, the Board of Directors believes that submitting the appointment of KPMG LLP to the stockholders for ratification is good corporate governance. If the stockholders do not ratify this appointment, the Audit Committee will reconsider whether to retain KPMG LLP. If the selection of KPMG LLP is ratified, the Audit Committee, at its discretion, may direct the appointment of a different independent registered public accounting firm at any time it decides that such a change would be in the best interest of C4 Therapeutics and its stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A representative of KPMG LLP was present at our annual meeting of stockholders in June 2023 and is expected to be present at the Annual Meeting and will have an opportunity to make a statement if he or she desires to do so and to respond to appropriate questions from our stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C4 Therapeutics incurred the following fees from KPMG LLP for the audit of the consolidated financial statements and for other services provided during the years ended December&#160;31, 2023 and 2022. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">786,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">781,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fees</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">786,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,586&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Audit fees consist of fees for the audit of our annual financial statements, the review of the interim financial statements, and related services that are normally provided in connection with regulatory filings and the issuance of comfort letters. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Tax fees consist of fees for professional services, including tax consulting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee Policies and Procedures </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent registered public accounting firm. The Company&#8217;s Audit Committee Pre-Approval Policy provides that, with the exception of certain services of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> value, we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in advance by our Audit Committee, or the engagement is entered into pursuant to the pre-approval procedure described below. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our Audit Committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next 12 months. Any such pre-approval details the particular service or type of services to be provided and is also generally subject to a maximum dollar amount. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During our 2023 and 2022 fiscal years, no services were provided to us by KPMG LLP other than in accordance with the policies and procedures described above. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Board of Directors recommends voting &#8220;FOR&#8221; Proposal No.&#160;3 to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2024.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF THE AUDIT COMMITTEE </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee oversees the Company&#8217;s financial reporting process on behalf of the Board of Directors. We have reviewed the Company&#8217;s audited consolidated financial statements for the fiscal year ended December&#160;31, 2023 and discussed them with Company management and KPMG LLP, the Company&#8217;s independent registered public accounting firm. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received from, and discussed with, KPMG LLP, which is responsible for expressing an opinion on the conformity of the Company&#8217;s audited consolidated financial statements with accounting principles generally accepted in the United States, its judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed by the applicable requirements of the SEC and the Public Company Accounting Oversight Board, or the PCAOB. In addition, we have received from KPMG LLP the written disclosures and the letter required by applicable requirements of the PCAOB regarding communications by KPMG LLP with us concerning independence, have considered the compatibility of non-audit services with the auditors&#8217; independence, and have discussed with KPMG LLP its independence from management and the Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the reviews and discussions referred to above, we recommended to the Board of Directors that the audited consolidated financial statements of the Company, audited by KPMG LLP, be included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2023, that was filed with the SEC. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in this report shall not be deemed to be (1)&#160;&#8220;soliciting material,&#8221; (2)&#160;&#8220;filed&#8221; with the SEC, (3)&#160;subject to Regulations 14A or 14C of the Exchange Act, or (4)&#160;subject to the liabilities of Section&#160;18 of the Exchange Act. This report shall not be deemed incorporated by reference into any of our other filings under the Exchange Act or the Securities Act, except to the extent that we specifically incorporate it by reference into such filing. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Respectfully submitted by the members of the Audit Committee of the<br/>Board of Directors of C4 Therapeutics, Inc.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utpal Koppikar, Chair</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Owen Hughes</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malcolm Salter</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOUSEHOLDING </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some banks, brokers, and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and annual reports. This means that only one copy of our documents, including the annual report to stockholders and proxy statement, may have been sent to multiple stockholders in your household. We will promptly deliver a separate copy of either document to you upon written or oral request to C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, Attention: Corporate Secretary, telephone: (617) 231-0700. If you want to receive separate copies of the proxy statement, or annual report to stockholders in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker or other nominee record holder, or you may contact us at the above address or telephone number. </span></div><div id="i41a0551a7b554b0f83839908f7b5cf88_58"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A stockholder who would like to have a proposal considered for inclusion in our 2025 proxy statement must submit the proposal in accordance with the procedures outlined in Rule 14a8 of the Exchange Act so that it is received by us no later than December&#160;30, 2024. However, if the date of the 2024 annual meeting of stockholders is changed by more than 30 days from the date of the previous year&#8217;s meeting, then the deadline is a reasonable time before we begin to print and send our proxy statement for the 2025 Annual Meeting of Stockholders. SEC rules set standards for eligibility and specify the types of stockholder proposals that may be excluded from a proxy statement. Stockholder proposals should be addressed to C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, Attention: Corporate Secretary. We also encourage you to submit any such proposals via email to legal@c4therapeutics.com.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a stockholder wishes to propose a nomination of persons for election to our Board of Directors or present a proposal at an annual meeting but does not wish to have the proposal considered for inclusion in our proxy statement and proxy card, our By-laws establish an advance notice procedure for such nominations and proposals. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the Board of Directors or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely notice in proper form to our Corporate Secretary of the stockholder&#8217;s intention to bring such business before the meeting. To comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the company&#8217;s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than April&#160;21, 2025. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The required notice must be in writing and received by our Corporate Secretary at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year&#8217;s annual meeting. However, in the event that the date of the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year&#8217;s annual meeting, a stockholder&#8217;s notice must be so received no earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (A)&#160;the 90th day prior to such annual meeting and (B)&#160;the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. For stockholder proposals to be brought before the 2025 annual meeting of stockholders, the required notice must be received by our Corporate Secretary at our principal executive offices no earlier than February&#160;20, 2025 and no later than March&#160;22, 2025. Stockholder proposals and the required notice should be addressed to C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, Attention: Corporate Secretary. </span></div><div id="i41a0551a7b554b0f83839908f7b5cf88_61"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors does not know of any other matters to be brought before the Annual Meeting. If any other matters not mentioned in this proxy statement are properly brought before the meeting, the individuals named in the enclosed proxy intend to use their discretionary voting authority under the proxy to vote the proxy in accordance with their best judgment on those matters. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Exchange Act and, in accordance therewith, file reports, proxy statements, and other information with the SEC. Reports, proxy statements, and other information are available on the SEC&#8217;s website, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">http://www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You may also read and copy any document we file with the SEC on the date of filing on our website at </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">http://www.c4therapeutics.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the &#8220;Investors&#8221; heading. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should rely on the information contained in this document to vote your shares at the Annual Meeting. We have not authorized anyone to provide you with information that is different from what is contained in this document. This document is dated April&#160;29, 2024. You should not assume that the information contained in this document is accurate as of any date other than that date, and the mailing of this document to stockholders at any time after that date does not create an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">implication to the contrary. This proxy statement does not constitute a solicitation of a proxy in any jurisdiction where, or to or from any person to whom, it is unlawful to make such proxy solicitations in such jurisdiction. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANY WEBSITE </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website at </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">www.c4therapeutics.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this proxy statement, and references to our website address in this proxy statement are inactive textual references only. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i41a0551a7b554b0f83839908f7b5cf88_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">C4 THERAPEUTICS, INC.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">490 ARSENAL WAY, SUITE 120</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">WATERTOWN, MA 02472</span></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cccc-20240429_g12.jpg" alt="2..jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:241px"/></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">VOTE BY INTERNET </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Before The Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> - Go to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> or scan the QR Barcode above</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. </span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">During The Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> - Go to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline">www.virtualshareholdermeeting.com/CCCC2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. </span></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">VOTE BY PHONE - 1-800-690-6903 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">VOTE BY MAIL </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. </span></div></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">V40508-P05411</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">KEEP THIS PORTION FOR YOUR RECORDS</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt dashed #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">DETACH AND RETURN THIS PORTION ONLY</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">C4 THERAPEUTICS, INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For<br/>All</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Withhold<br/>All</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For&#160;All<br/>Except</span></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">To&#160;withhold authority to vote for any individual nominee(s), mark &#8220;For All Except&#8221; and write the number(s) of the nominee(s) on the line below.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">The Board of Directors recommends you vote FOR the following:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">To elect three Class I directors to our Board of Directors, each to serve until the 2027 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal:</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:50pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nominees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">01)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kenneth Anderson, M.D.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">02)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Laura Bessen, M.D.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">03)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Owen Hughes</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">The Board of Directors recommends you vote FOR the following proposals:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">To cast a non-binding, advisory vote to approve the compensation of our named executive officers.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">To ratify the engagement of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTE: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">In their discretion, the proxies are authorized to vote upon any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Signature&#160;[PLEASE&#160;SIGN&#160;WITHIN&#160;BOX]</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Signature&#160;(Joint&#160;Owners)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Table</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13"> of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i41a0551a7b554b0f83839908f7b5cf88_13">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">V40509-P05411</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:1.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.771%"/><td style="width:0.1%"/></tr><tr style="height:99pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:90pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C4 THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Meeting of Stockholders </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 20, 2024 8:30 AM ET </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">This proxy is solicited by the Board of Directors </span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholder(s) hereby appoint(s) Andrew J. Hirsch and Jolie M. Siegel, or either of them, as proxies, each with the power to appoint his or her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of common stock of C4 Therapeutics, Inc. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 8:30 AM ET on June 20, 2024, virtually at www.virtualshareholdermeeting.com/CCCC2024, and any adjournment or postponement thereof. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#8217; recommendations. </span></div><div style="margin-top:60pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued and to be signed on reverse side </span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:60pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>cccc-20240429.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21890a72-5312-492c-85cd-9bed1985e6ee,g:043d0ee5-1298-4d91-abc8-6300a12bc742-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cccc="http://c4therapeutics.com/20240429" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://c4therapeutics.com/20240429">
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo/>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>cccc-20240429_g1.jpg
<TEXT>
begin 644 cccc-20240429_g1.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2#X4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (-R^A!(X0DE-! 0      " < 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  $1V5N83A"24T$)0      $.')"A7;Y_SV*:I=Z)!5H1(X0DE-!#H
M .4    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L
M  !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG
M3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"<F14
M56YT1B-2;'0               !";&0@56YT1B-2;'0               !2
M<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O; $     4&=0
M<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M     %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M        $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O
M;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T
M4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M    $ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X
M #A"24T#\@      "@  ________   X0DE-! T       0   !X.$))3009
M       $    'CA"24T#\P      "0           0 X0DE-)Q        H
M 0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ !
M *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M   !.$))30/X      !P  #_____________________________ ^@
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             !!P  !/X          0
M       !              3^   !!P                     !
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M;&]N9P   0<     4F=H=&QO;F<   3^     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    $.$))300,     !:+     0   *
M   A   !X   />   !9O !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,2$QI
M;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#
M('-21T(               $  /;6  $     TRU(4" @
M                                               18W!R=    5
M   S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD
M9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4
M;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P
M  @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y
M-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                     %A96B
M      #S40 !     1;,6%E:(                     !865H@
M;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /
MA   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                    9&5S8P         N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="                             &1E<V,         +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ                                  !V:65W       3I/X %%\N
M !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M         0                        */     G-I9R      0U)4(&-U
M<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\
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M321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M  $% 0$!              (! P8'" 4$"?_$ $81  (! P(#! <&! 0#!P4
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M0T4J ADKIS\=_<2;M7J\X;+U$@VMK^4.NRY@S&#PWP!<;UJ<J%$8C6#(>L!
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M[D-?66U3D&,N5U*^/V0##Q"'3BLFC9RK;C'CDYW_ "SL?#&/&K,JA,.NVX!
MZ?+V]".A\NM2G\S6UPMZ^*GKON, = QMF;)TWF?T2*JH%/>ZRV"<8"BN_,Y
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M&AK[<>G,![4]NZQVXKK(<;JZ#3F Y=-.9AV&:NPV),9QB0NB^5@=J0?#63E
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EE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cccc-20240429_g10.jpg
<TEXT>
begin 644 cccc-20240429_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG-^S+XWD^&W[1'[4FC>!]>CC,G]D^*K"\L9WCWL@E19H5,D99& D7*MM.":
M/HZBOE^X_P""TW_!*[3I[&'7OVWO!6D+J2[K"XUVZEL(9UX.Y9;B-$(P0<[L
M8.:^C/!7C?P7\2?"EAX[^'7B_2]?T/5+<3Z9K.BZA'=6EW$>DD4T3,DBG^\I
M(H U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\Y_^#F;_
M (*?>._^";?[!45K\#M<?3/B+\3]6?0/#>K0G$NDVRQ&2]OHCVE1#'$A'*/<
MHXY2OT8K\5?^#UG]F[QW\1/V1/A5^TGX8TV>[TKX;^++ZR\1B!"PM8-4CMUB
MN7]$$UG'%N_O7*#O0!Z#_P &E?[!?PX^&?[!]I^WSXQ\/0ZM\3_B_JNI74OB
MG5$\^]M-,AO);5;=)7RR>;)!+<2,#F7S4WD^6H'V?_P5F_X)N?"C_@IU^QQX
MI^ WC3PMIDOB=-*N+GX>>([N$";1=86,M;R)* 62)W5$E4</&S C."/"/^#6
M+XV>&/B]_P $7?AIH.C:A%)J/@:_U?P]KUO&X)M[A-0GN8E(ZC=;7-N__ Z_
M0;7M>T/PMHEYXF\3ZS:Z=IVGVSW%_?WUPL4-M"BEGDD=B%154$EB0 !DT ,\
M,:?<:3X:T[2KO;YMK8PQ2[3D;E0 X_$5_.7_ ,'3?[:'[3TO[;WPQ^.?P66[
ML/AW\#/'%UHW@WQ-"^8+KQM8FRO=28@$96+S+6U&[@O9WBJ3M<#]X_V[?VC]
M4_98_9?\1_%'PAHJ:OXMG$&C?#[P^2,ZQXBOYDL],M ">0]U-%O(^[&)&/"F
MOS5_;G_8#_;#_: _X(W1_P#!/X_\$Z=3D\0>%+.'7]-\;3?$[1KJXNO$D<DE
MS?ZBT*-ODEO))[_<JG.;PXY H _3K]BS]J7P-^VS^RCX!_:L^'+J-*\<>&[?
M4EMQ)O-G.1MN+5B.KPSK+"W^U&:_*S_@]IAB;]@WX2SF,%U^+FU6QR =+O"1
M^@_*O-_^#+K]OUM0\.^/?^";7C_62+C2I'\6^ 8[B3GR'9(M1M5STV2&"=4'
M),UPW137I?\ P>T?\F$?"?\ [*^/_37>T </\:?#OP7UG_@R[\)ZG\7+'37N
M],\)6,W@VYO$3[1!JQU\I']F)^82-&TJMMY,1ES\NZO6?^#,G7_CYK'_  3A
M\76'Q)GU&;P9I_Q%FA^'CZB6*I&;>)KR.WW?\L!.V1M^42O/CYMU:_\ P1G_
M ."0'_!/C]K7_@E+\ /BO^TU\%M6\=:FOAV6[@LO$OQ%U^ZTNVE^V7"YATU[
MXV4 (4 K'"JG)R#N.?U0\!> / OPL\&Z;\.OAEX-TOP]H&CVJVVDZ)HEA':V
MEG"OW8XHHP$C4>B@"@#S3]NW]LKPY^P-^SCK/[4/CKX.>.?&7ASPV%E\16_@
M"SL;B\TZT/#7CQ7=W;!X4.T.8V=U#;RNQ7=?+?\ @F'_ ,%A?@1_P5E\#>+?
MB1^S1\%?B1IVC^$+M;*\N?&%KI%JUW>&(2BVA2#49GW;&4[Y!''\V-^0P'U!
MXX\%^%OB3X+UCX=^.=%AU+1-?TNXT[6-.N5S'=6L\;12Q..ZLC,I]C7\TO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?"NI_P!IV&F^%;>S\V>]:V$+RS37&HR;E&Z8HB*@59<,9"H>OUJ_X5-\*_\
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M_=RY(++M9B:_1K_A];_P2/\ ^DC7P?\ _"XM/_BZ]_\ ^%3?"O\ Z)IX?_\
M!-!_\11_PJ;X5_\ 1-/#_P#X)H/_ (B@#YM\7_\ !:/_ ()?7WANZM/ ?_!3
M?X':9J[H!97VK>(X+ZWA;<,EX([J!I!MR !*F"0><8/Y=?"7]C[_ ()._!S_
M (*!_P##RWPS_P '#GPVN/B4_C;4O%%T=0L=+:PN+R_:<W4;0I>J1$XN9DVJ
MZLJM\K @&OW7_P"%3?"O_HFGA_\ \$T'_P 11_PJ;X5_]$T\/_\ @F@_^(H
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MT\/_ /@F@_\ B*=#\+/AC;RK/!\.-!1T8,CIH\ *D<@@A>#0!O4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWBC]FK5M3O5\!_"GPI:W6LZ38WLL":QK-[L>+[0T3*9((H&.(2=IERS!MJ@
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MYO?_  +:C_A!](_Y^;W_ ,"VKQC_ (>C?L*?]%R_\MG4_P#Y&H_X>C?L*?\
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MZ1_S\WO_ (%M6Q10!7TW3H-*M1:6[R,H8G,KECS[FK%%% !1110!\F?M(?\
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M5^;?_!$C_DLOC/\ [%B/_P!*$K])*_6.$_\ D2P]9?F?T+X>_P#),4_\4O\
MTIA1117TA]N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !115+5/$>C:+J.FZ5J=ZL5QJ
M]VUKIT9!_?2K#).5'OY<4C<_W30!=HHKQ#]HC6_VBOAQ\5_ /BKP+\3+"7P?
MKGC>PT;Q+X:U#0XFFBAN 5$MO<J0P^=0"K GY\AL#;0![?1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
MX275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_
M *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**\]^+_[1
M_@CX"^$QXY^+-O=:1I37:6PNVMWF'FN&*KMB5FY"MSC'%>8?\/7?V,?^BC3_
M /@COO\ XQ7+6Q^!P\^2K5C%]G))_BSS\3FV58*I[/$5X0EO:4HI_<VCZ1HK
MYN_X>N_L8_\ 11I__!'??_&*/^'KO[&/_11I_P#P1WW_ ,8K'^ULK_Y_P_\
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M6*?_ ,)K4_\ Y%H_U;XB_P"@.K_X+G_D'^N'"7_0PH?^#:?_ ,D?6%%?)_\
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M[3__ )(H_LG-/^?$_P#P&7^0?ZO9_P#] E7_ ,%S_P CU_\ X(D?\EE\9_\
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M\;QGC*^'P56<)25I1ISDG[L=FHM,^9Z*^F/^'/'_  4=_P"C;9O_  I]*_\
MDJC_ (<\?\%'?^C;9O\ PI]*_P#DJOIO]9.'?^@RE_X,A_F?%_ZG\6_]"^O_
M ."JG_R)\ST5],?\.>/^"CO_ $;;-_X4^E?_ "51_P .>/\ @H[_ -&VS?\
MA3Z5_P#)5'^LG#O_ $&4O_!D/\P_U/XM_P"A?7_\%5/_ )$^9Z*^F/\ ASQ_
MP4=_Z-MF_P#"GTK_ .2J/^'/'_!1W_HVV;_PI]*_^2J/]9.'?^@RE_X,A_F'
M^I_%O_0OK_\ @JI_\B=K_P $(?\ D_*#_L4-1_\ :5?M77Y9?\$IOV _VR/V
M7?VKHOBE\8_@;<:9HR^';VT-RNMV$Y\V39M&V&=VYVGG&*_37_A)=7_Z%"]_
M[Z6OP;Q'QF$QW$2J8:I&<>2*O%J2O=Z75T?U!X0Y?C\LX3='&494I^TD[3BX
MNUHZV:3L;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM?!'ZD;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
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M%>"_ [3?$.G_ /!0W]EE?&2R*Z_LI64,'G9_X_DMKC[0.?XPA7- 'U%X-_:
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M *X:9_Z=;.OP>K]X?^"PW_*.+XD_]<-,_P#3K9U^#U?UUX4?\D]5_P"OK_\
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M.@) +QET!(!;)Q7G</\ P4V_X)26T"VUO\:?"4<:C"QIX7N0H'H +:KGP_\
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MOB.;Q/\ $_5->AM-"OQINM0W,#3/M?;-=(D<<*JSYB!"E<H$(.* /M6BBB@
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M_!8W_DT6'_L;K+_T7/7Y7U^J'_!8W_DT6'_L;K+_ -%SU^5]?E?%_P#R./\
MMU?J?@/B1_R4?_;D?U"BBBOESX$**** "BBB@#KOV?\ _DO'@G_L;M-_]*HZ
M_<ZOPQ_9_P#^2\>"?^QNTW_TJCK]SJ_0^"/X%;U7Y,_9O"S_ '3$_P"*/Y,*
M***^Y/U8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>VU?RD#30*V 8[E!ES"P^:,;T9]LHC[*@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RO]L/]D+X4?MJ?!F]^$/Q2
ML-N[,VC:Q!&#<:5=@$)/$3]<,F<.I*GL1^</[&/[5WQE_P""1G[0US^P[^V<
MTS> ;N\\S1=;&YX=.65SLOK9B,M9R'/F1CF-]S8#"17_ %RKP[]O7]A7X8?M
MW?!R7X?^,42QURP#S>%O$L<(:;3;DCOW>%\ 21YPP (PRJPI/HR6NJ/:["_L
M-5L(-4TN]AN;6YA66VN;>0/'+&P!5U8<,I!!!'!!J:ORE_X)U_MT?%'_ ()_
M?&2;_@G?^W@TFG:39W@M_#.OWLI:+2BY_=KYI^_8RYRDG2(G!PN[R_U95E=0
MZ,"I&00>"*35AIW%HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y
M3_X+&_\ )HL/_8W67_HN>OROK]4/^"QO_)HL/_8W67_HN>OROK\KXO\ ^1Q_
MVZOU/P'Q(_Y*/_MR/ZA1117RY\"%%%% !1110!UW[/\ _P EX\$_]C=IO_I5
M'7[G5^&/[/\ _P EX\$_]C=IO_I5'7[G5^A\$?P*WJOR9^S>%G^Z8G_%'\F%
M%%%?<GZL%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0I#*?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\
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M_#?Q'K_@KQOXID\6^#KCPMI37KQ7MRBK=Z=,B<VY#1Q&*23;"4/S2*5(K!\
M?\$Y-8\6?L2_%+X3_&*>UL/&WQG\0:AXHUUXI1/%I.HS3K<6D&]?]8L+QQER
MO!+2A2002 ;W_!0_PEHEA_P2A\8>%/LZ?8]-\!V"VJ8&%-N]LT6/HT:X^E>Q
M_LE>*-:\<?LJ_#/QIXCG>74=7^'^C7M_+*26>:6QA=V.>Y9B?QKY]^+WA[X_
M_M0?L;:1^Q=>_"S7M \7ZM;Z9I'C[7M0L=NF:7:VLL+75Y#<Y\N\\X08BBA+
MO^^'F"/:Q'UGX2\+Z-X(\*:9X+\.6WDZ?H^GPV5A#G/EPQ1K&B_@J@4 :%%%
M% !5?5M7TG0=/DU;7-4M[*UB ,MS=SK'&F3@99B .2!^-6*^-_\ @MYX/^&O
MB[]E/0%^*_Q;;PIHUG\1=+EO3%&\LM_ PEBGBAC13YDR0R2SH"-N8"#C.0 ?
M8GVJU\N.7[3'LE($3;QA\\C![YJ2OQ\E^(__  3/\1^#-)_9H^)W[>'C75_A
M_P" M9CUWX>ZQ8:#J,.H('5DFTJXW676)E62&=%4*L\B?)M7/Z<_L<^/-;^)
MW[+'@'Q]XAN+V>[U3PO:S/=ZDH%Q=*4 2XE XWR*%D..,N<<4 >E5PW[1/[1
MOPC_ &5_A=>?%_XT^)AIFCVDBQ*5B,DUS.^=D$4:\O(V#@#@!68D*I([FOG/
M_@HS^RD/VHO"O@)M0T*?7-'\'^/[/6/$OAJV<B35--"O'<)& 07D57W; 0SJ
M)%7YV4$ ^9OBW_P60_8(_;-^'^N?LP_$=/B7X&T+Q6D=I+XKCLK5?LZK,D@,
MGE32LJ,4"N C@HS XSD?>O[/OPX\)?"'X'^$_ACX"\17&KZ)H>@6UII.J75T
ML[W5NL8\N0N@"L"N"-H"XQCC%?,'[4NG?%7X+_&?P_X=_9'_ & ]%\<:/XC\
M##39K6?2$L=(THK<LRB<&)8URK\HY0X7\*^F?V;_ (:ZS\'O@-X3^&'B*ZLY
MK_1-$@MKPZ:C+:QR!?FC@#<B%"=D8/(15S0!VU%%% !1110 4444 %%%% !1
M110 5^;?[=X^.?[+?B/Q[I?PL^$GQGUZ^\>:W)JO@SQ7X-\>:P-.M)[F*-9H
MKFTM9.)XI5?RTQMDC,0Z1D5^DE?-7[1/Q/\ VMOV0=>U'XA?#GX-W/Q=^'FI
M7+WEYHFGWSIK?AR=_FE\D;)/M=HS9=4"[XB[+D1J@4 \!_X)Y?\ !+NQ^!WP
M@O?VEOVK=8\<:9X^UH275ROA?7-2@U#3K.1@3#(+!O/GGE;$DB_,1\JX#*V?
M=_\ @GYX':Z\7?$KXW0:=\2]+TS5_$JZ=X>L/B-J^I-=7MI;V=HC7\EO>N6#
M/*CK&[C>L487@96O#9?^#BO]GJP=[#6/V=_'UK?Q,4ELW^R91_[IW2AAS_LY
M]J].^#W[4G[6W[?;II?P_P#V?-4^$WPYN<#6O'7B6[;^U+ZV/WH--A")Y<CC
M*_:<NL8+,OSJH(!]@44V*)(8EAB7"HH51GH!3J "BBB@".&SM+:6:>WM8XY+
MAP]PZ( 96"A0S$?>.U5&3V4#M6!\4_A7X1^,'A0^$O&%M+LCNX;S3[VTE\NY
MT^\A</#=028)CEC<!E;D=00REE/1T4 4O#MIKEAHEO9>)-9BU&]B3;/?16GD
M";!.&*!F"L1C.#@G) 4$*+M%% !1110 4444 <CJ/PFL/$WQ-L/B7XUU#^T7
MT R'PKIOD;(--EDC,<ER023+<LC/&)#@)&[*BJ7D9^NHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#XC_P""L_\ P2ZMOVL- ;X^? BS33_BGH,"NHMW$7]O0Q#*PLPQMN$ 'E2D
MCH$8XVM'E_\ !)/_ (*BW/[05L/V6?VF+Q]/^*.@J]O:W.HH87UV.'(=75L%
M;R/:?,0\N%+@9#A?O"OS^_X*V_\ !+_6/BE=']LG]DRUGT[XE:"R7NJV&D,8
MIM7$.&6Y@*8(O(]H(QS(% 'SA0U)W5F2TT[H_0&BOC7_ ()1?\%0-'_;.\(#
MX4?%FZ@T_P"*&@VO^G0,HB76X$X-U"O 60?\M8A]T_,HVDJGV52::8T[H***
M*0PHHHH **** "BBB@ HHHH **** /E/_@L;_P FBP_]C=9?^BYZ_*^OU0_X
M+&_\FBP_]C=9?^BYZ_*^OROB_P#Y''_;J_4_ ?$C_DH_^W(_J%%%%?+GP(44
M44 %%%% '7?L_P#_ "7CP3_V-VF_^E4=?N=7X8_L_P#_ "7CP3_V-VF_^E4=
M?N=7Z'P1_ K>J_)G[-X6?[IB?\4?R84445]R?JP4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KC?V@?@5X _:7^#NN_!#XG6#SZ-K]GY-P86"RPN&
M#QS1D@@.CJKJ2",J,@C(/95\D_\ !7O2?CAX]^$7@7X&?!SQ5+H$'Q#^(UCX
M?\1:W'(R+!;3)+MCD9,,(W<+D C>56//SX(!\7:C_P $>/VUO"OBJ[\ ?LS?
MMF>'-7T6&5@EM:>-[K3[B!,_\M[6$.J'GG:S?ATKZV_X)K?\$F(/V.?%MU\=
MOC/X\A\6_$*\M7MX+BU$C6NFI(,2F-Y0))I7 VF1E3"EE"\DGYH^(/\ P30_
M84_8H^*VGV'QB_;.\:^#=2C\+)J^A>*;*>*"4Z@EP\;&&**WDDVJH5MBOOR?
MOU^EG[+OB[Q?X]_9U\%^,_'DLLNK:EX=MI[RZGLOLSW1*#%PT/\ RQ:1=LAC
M_@+[>U '>5\\?\%*_%W[(?P^^!>G^/?VR?"Q\0:%H_B%)]%\-I")6U/4FMKB
M)(Q&Q56Q'),^68*NS<3D 'Z'KX]_X+'?$;0/@E\+?AQ\<=<^#T'C-O#/Q,M9
M;33KVX46^][6Y!66-HWWAD5MC#!CE6)_F *, ?%W@O\ X*$_\$I=4\4PV7CW
M_@EYIFBZ'-/Y8UBS>"\D09^^T)CCX&02%=B!T!. ?TD^#?[&7[!EO_PCOQR^
M"?P$\'1-)#!JGAO7]+TX*VQT#Q31MU&58$=^:^(?&/\ P<)0^)/!M_X6B_82
M\Y;JQ>"&VU?Q$+FSR5(42P_8E\R,<93(R.,CK6C^PA_P5LFU&;X4_L3^ OV;
MM1T:$7FFZ*_B74=>%QB!74SOY(M4 ,@#J & 3?QG:* /T\HHHH **** "BBB
M@ HHHH **** "O$[G]N_]CWQ+KWQ+^%MY\1+:^N?AOHU[=>/M,ETB>5(;.#]
MW=\&,K<!"?+=4W<MMP<U[97R'^VAK?\ P3W_ &9O"WQ;U7Q'HWA73/'WCOP1
M?G5],%T;*_\ $:21.?)23:VWSG&&9%Y?#-EA0!\4>./AO_P;Y^+O&LOBO2?V
MC?'_ (?M)Y_,DT'1](O3:)SDK&9]/DD13Z;S@=,5^BO_  3E^('[)?C/X%7>
M@?L5Z,]MX'\+Z\^E07$EK-$U[<_9K>XEG;SP)68F<*6?DE./E"UX3I^E?\$!
M)=/@EN!\(XI&A4O$VH.2A(&026R<5[5_P3@U7]E/4O 7C>+]D?0[/3M"MO']
MQ%J-OI-X\]A)=+:6JB>U=U5O*DA6%B".)/- ) #$ ^BJ*** /-OB7^UY^SI\
M(O%]IX%\>?%/2[34[BY,-U;K<JYT[_1Y;@/=;2?LZ%(FP7QG(/3)'=>&/%/A
MCQMH-MXJ\&>([#5]+O8]]GJ6F7B7$$ZY(W)(A*L,@C(/:OSL^!/QIU#]D3]I
M;2/V5_VO-+?P]>O\8];\4Z1\0]1<+IWB&UOM.OX%D>=N!+YL\*9)PH8(VPI\
MWTO^U%\0?#W_  3H_89\8^-?AG:6\<EG=W\_AFS6!1%%?ZIJ$LJ*L8^4QQ27
M3/MX!2+'% 'O&G>,O#.K^(K[PII6JI<WVF!/[1B@1G6U9@&6.1P-B2%2K>63
MOVLK8P032MOBM\-+WXCR_!^R\>:5/XIM],;4;GP_!?(]W!:J\:&:2,$LB[I8
MP"P&=W&<&LK]G7X7)\'/@KX>\ S3RW%_:Z<DFMW]PY>:_P!1D'F75U*QY:22
M=I'8GNWI7S?X!\&^$O!?_!;;7[7PAX9L-+BO/V=5NKJ+3K-(5EF;6H%:1@@
M+$(H)ZG H ^M?%7BSPOX%\.WGB_QIXBLM)TK3X3+?:EJ5TD,%N@ZL[N0JCW)
M[UD_#KXR?"_XM+>?\*Z\:V6J2:>R+J%M"Y6>VWC<ADB<!T#@$J2 & )!(KYG
M_;A\67OCW]O?]F_]E.X<MH6H:U?^*==LV^Y>2:?;R36BN.C(KPRL5.03M./E
M%2_MI>+;SX)?\%!?V<?B9X;E,,GC*]U+P;XFC0X%_9RFW:V1_413RM(OH3[G
M(!]<UQ7C7]H[X$_#KQ,?!WCCXK:+IFI1I$]S;75XH-HDIQ$\YZ6ZN>%:0J&/
M0FNB\:>);;P7X.U;QC>1%X=)TR>\E0'!98HV<C\EKY7_ ."4'AR#XU_L'W_Q
M&^*UNFJ:A\8-=U[4/%\TZY-X)+F:R,9SGY!% $5>BKP * /KB6XMX+=KN:=$
MB1"[RLP"JH&22>@&.]<?X _:)^!OQ3UP^&_AY\4M'U>^\AYX8+.[#&YA5@K3
M0'I/&K$ R1EE!(!/(K\U%_:9^)/B_P#X)(^#/@;>^)KJ34];^+T/PQU'55F(
MFETQ',NW=G/^I\FW/JF0<Y.?J#_@KE?+\!/V:?!GQZ^'-G%IVI_"SQWI-UH0
MM$"!+4AK:6S&.D,D3A&3H0H!Z4 ?5.E^-O"NL>)-0\'6&LQMJNEK&]]ITBM'
M-'&X.R4*P!:)B& D7*%D=0<JP&K7S7_P4H\3:G\'_@EI?[9_P_B)USX::S97
MO[H[3J.D75Q#;WMA)ZQ2)(DF#]UX(W&"HKZ'\->(=)\7>'-/\5Z#<B:QU.RB
MN[*8#_612('1OQ5@: +M%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !67XV\$^$OB1X1U'
MP%X[\/VNJZ-J]H]KJ6G7L0>*XB<896']>H/(P16I10!^//Q2^'/Q\_X(3?M4
MQ?&+X1B]\0_!WQ9=B"YLIY24EBR6^PW#8Q'=1C<T,^/F /4>:E?JI\ ?CW\,
M/VF?A3I7QE^$/B)-1T75H=T;<"6WD'#P2ID^7*AX93]02"";_P 6_A+\/?CI
M\.=6^%'Q4\,V^KZ#K5J8+^QN!PPZAE(Y1U8!E<8964$$$"OR9MKC]H#_ ((*
M?M7FTNO[0\4?!;QE=Y! &+F(?Q#HD5_ I&1PLR>@(,=_%ZD?"_(_8FBN?^%G
MQ2\ _&OX?:5\4_A?XFM]7T'6K1;C3[^U;*NIX((/*LI!5D(#*RE2 01705!8
M4444 %%%% !1110!\I_\%C?^318?^QNLO_1<]?E?7ZH?\%C?^318?^QNLO\
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MYK9ZFOI/X!?$2?XO? KP7\6+F%8I?$_A/3M6EB08"-<6T<Q4?0N10!UM%%%
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M\PAOFEE1 55$)E]1H **** "L[4O#.GZK=&[N)[E6*@8BN"HX]A6C10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M$U&"\LKR!)[2[M91)%/$ZAE=&4D,I!!!'!!JQ4%F/_P@^D?\_-[_ .!;4?\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
M@6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO
M_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5
ML44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1
M_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &
M/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#
MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M'@G_ +&[3?\ TJCK]SJ_0^"/X%;U7Y,_9O"S_=,3_BC^3"BBBON3]6"BBB@
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MXK?#2]^(\OP?LO'FE3^*;?3&U&Y\/P7R/=P6JO&AFDC!+(NZ6, L!G=QG!H
MZ"BH-3U/3=$TVXUG6+^&UM+2!YKJZN)0D<,:*69V8\*H ))/  K@_A]^UO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBR3Q/+-<I,SWX@03DR(2KGS-W*D@]N* .THHHH **** "BBB@ HHHH ****
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MXI_M*_ ;X(>*M \&?%[XIZ3X;U#Q09QH2:Q.8(KDP[/,'FL/+0CS$ #LNXL
M,FO)Y?"_@KX\?M^^#/C[\(M0L]0LO 7@_5]/\5>)M+D66VO9KIH5M-.69,K,
M\7^E3.JD^5OC#8,BB@#WWQIXEMO!?@[5O&-Y$7ATG3)[R5 <%EBC9R/R6OE?
M_@E!X<@^-?[!]_\ $;XK6Z:IJ'Q@UW7M0\7S3KDW@DN9K(QG.?D$4 15Z*O
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M(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\
M\(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D
M?\_-[_X%M0!L5^7W_!4/_@GG\0?V;/B2O_!1G]A+[1I%]H]X=2\5:+I$?-F_
M)DOH8P,/ X+">'!4!F;!0N%_2G_A!](_Y^;W_P "VILG@3194:*6:[96!#*U
MTQ!'H::=F)JZ/SA^.7_!0OX??MZ_\$[8-8M?L^E^,]&\4Z?'XL\-K)S"YBG
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M0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\
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M#_X1/Q+9>-TO9_$+:I/9I:6@T^^CDW/ CN0S2(@4*02XS@<@ ^6S_P $QO\
M@L,1@_\ !2^[_P#"UUK_ .(K[Z_9T^'?B+X1_ /P9\+?%^M1ZEJOA[PQ9:=J
M6HPR.ZW,\,*I)*&<!B&92<L,G/-?FK\;OV1_^"S'P&\!7_Q2\7?M_B?P_H\'
MVC6KRR\<:D9+*W!^>8QR6ZF15')6,M(V,*C-A3^C7[)&D3:!^RY\.]%N?&=E
MXCDM?!>FQR:_IUR\T&I,+9,W$<C@,ZN?F#, 3NR0#0!Z'1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "7CP3_V-VF_^E4=?N=7Z'P1_ K>J_)G[-X6?[IB?\4?R84445]R?JP4444
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M/@C^!6]5^3/V;PL_W3$_XH_DPHHHK[D_5@HHHH **** "BBB@ HHHH ****
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M_B)XKU[3]9\8:UJ<?P^ET_6[BV7PI96\C6]K]G2)U3S1)&TDDA!,I^5LH M
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M1110 4444 %%%% !1110 4444 %%%% !1110!\>?MO?LD_"W]JOQ3\+/C/\
M!;Q8_A'QSK^L.NA_$KP\KQ7+0IH]]=P>:%*F1=UO$IW8D5-R @96OGW]KO\
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M1T_94CTY='C\7_$Q;181"MJ/B%=B,1@8"!<XVXXQTQ0!@?M86<.E_P#!3_\
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MDSX=^%?$N@>*-8\0^(_$TWA"W:#P;#XGU07,6B(R>63" BF27R_D$\YEF"Y
M<!FR >>?\%9;&PMO^";/Q,L+UMT4.AVBHTG=UO+?8?KN"_C7K'[+;:RW[,OP
MZ;Q&7.H'P)I!OS)][SOL46_/ONS7 ?MB?#R3]K2ST[]E#2@TN@76NV5]\2]0
MCSY5KIMM*MRMB''6YN)4A 0<I$'D;&8Q)[Q###;PI;V\2QQQJ%1$7 4#@  =
M!0 ZBBB@ K.U*V\32W1?2]2MHHMHPDL)8Y[\UHT4 8_V+QO_ -!NR_\  8_X
MT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/
M^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!N
MR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0
M;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V
M+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1
M]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_X
MUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+
M_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!N
MR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O
M&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V
M+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6
MQ10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_
M  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+
M_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% 'R%_P5
MZMO$D7[)T+:MJ5O+%_PE=G\L4)4Y\N?G-?F!7ZH?\%C?^318?^QNLO\ T7/7
MY7U^5\7_ /(X_P"W5^I^ ^)'_)1_]N1_4****^7/@0HHHH **** /&OVB;[2
MI?$UM8VMF@NH;?-U<#JP)^53] ,_\"%>>5VGQZTZYL_B#-=RJ=EW!')$W; 4
M(1^:_K7%U^VY!"$,FH*+O[J?S>K^YZ']*<*TZ=/AW#*#NN1/>^KU:^3NK=+'
M:_L^_M!_%7]F'XIZ;\8/@[XGFTS5]-E!.UCY5W%D%[>9 0)(G PRGV(P0"/Z
M(_V=?B]JW[1OP,\*_'+PMJMI%9>)]&AO5MW@W-;NPQ)"Q!P620.A/JIK^:>O
MT>_9T_X(Z?M^^,O@9X6\=>$_VN6\'V6L:/%J.G^'&UG4X&L8YAYJ*R1?*C$,
M&( X+'/.:]2:3/HX-H_6[[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&OS%_X<W?
M\%3/^DA/_EZZY_\ $4?\.A?^"N-E^XTO_@H=MBZ@?\+#U^/GOP(B*CE7<OF?
M8_3K[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7_@,?\:_,7_ATU_P62L_W^F?\%$\3
M#[I_X6?XACX[\B FC_AUG_P6Z_Z2,_\ F7O$O_R-1RKN',^Q^G7V+QO_ -!N
MR_\  8_XT?8O&_\ T&[+_P !C_C7YB_\.V/^"YT'[F/]OK>J?*K_ /"U-;.X
M#OEK?)_'FC_AWA_P7;TSFU_;E^T;_O?\7-U1]N/^NEOQ^%'*NX<S['Z=?8O&
M_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-?F+_P ,$_\ !>F+]XG[:&XKR%_X
M6-?'/MS!C\Z7_AC#_@O]_P!'8#_PNG_^,T<J[AS/L?IS]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XU^8W_#)G_!P=I_\ H]M^TP)UZ[_^$RC;\,O%FC_A
MF7_@X;L?])M_V@Q,R](_^$KM&S^#Q8HY?,.;R/TY^Q>-_P#H-V7_ (#'_&C[
M%XW_ .@W9?\ @,?\:_,;_A0?_!Q9_P!%J'_A1Z9_\;I/^%3_ /!R!!^XC^)6
M]4^57_MG0SN [Y9<G\>:.7S#F\C].OL7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&OS%_X0#_@Y.TWFU\:_:-_WA_:7AQ]N/^NB\?A1_P (S_P<N1_O%\0;
MBO(7[7X5.?;D8_.CE\PYO(_3K[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&OS%_
MXZ<?\_\ "%T?VY_P<PZ?_H]SH_GMUW_9_";?AE#BCE\PYO(_3K[%XW_Z#=E_
MX#'_ !H^Q>-_^@W9?^ Q_P :_,7_ (37_@Y4L?\ 2;CPEYR+UC^P>&6S^"-N
MH_X6E_P<A_\ 1.?_ "D:#_\ %4<OF'-Y'Z=?8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C7YB_P#"]_\ @XO@_<2?!K>R?*S_ /"/:6=Q'?*R8/X<4O\ PTA_
MP<0Z;\UU\!!<;_NC_A%[)]N/^N<G'XT<H<Q^G/V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C7YC?\ #5/_  <)Q_O&_9O#!>2O_"(0'/MQ+G\J/^&S_P#@
MO]_T:>/_  A7_P#CU'*',?IS]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_X
MU^8I_;K_ ."]^G_Z/<_L;^>W7?\ \*]NV_#,<^*/^'@G_!>&Q_TFX_8B\Y%Z
MQ_\ "M=2;/;HD^[\J.5AS(_3K[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&OS%_
MX>1?\%T/^C"?_,6ZU_\ )%'_  ]&_P""WL'[B3_@G7O9/E9_^%1^(SN([Y6Y
MP?PXHY6',C].OL7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K\Q?\ AZY_P6@T
M_P";6/\ @G5M#?ZO_BU?B*+GO]ZX.:/^'N/_  5_3YY?^"=_RCEO^+;^(!Q]
M?.XHY6'.C].OL7C?_H-V7_@,?\:1[7QI&ADDUVQ55&68VQ  _.OS&_X?(_\
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MQ'3(DMU /;>1W-?NM64E9FL7=&/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%!9K<%7!E>)4>39M\EI%W98!@#[PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0&"1"6"LP&<X#'U-?-_[.7PI^(/_  3^_;7T3]EGPIX]U?Q#\(OB1X=U._\
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBJ^FWD]]:B>XL)+9BQ'E2D9^O%6*
M "BBLCQSXPA\">&YO$MQX?U?5%A=%-GH6FO=W+[F"Y6).2!G)/8 F@#7HKRS
M_AJO2/\ HAGQ3_\ #?W?^%'_  U7I'_1#/BG_P"&_N_\* /4Z*\L_P"&J](_
MZ(9\4_\ PW]W_A7I6BZFFMZ-::S'97-LMW;1S+;WL!BFB#J&V2(>4<9P5/((
M(H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!\O0_"#]M?X=#X<> ],O_  5XOL_"?B.Z.D>)
M[YKRREM;0Z5J%O"+RV1)1((Q,D8:.92Y$:D+N:09OQ;_ .";5MJ?_!/;QK^S
M#X<\1'6/%GB&_N?$]QKUS"MN-1\0M.MR7" E8$=HQ !D[(SR202?K.B@#R3P
MK\0_BA\?/V2['Q=\$-;TS1/&>J:*EO+-XCLY)$T;4DQ%>130CYC-#*LJ;&XW
MH,Y7@^+>!OV8/^"I_P -_"?_  B7A']K+X9V\;/)-<7LO@B6:YN;F0EI+F62
M1F,LSL2S,V<GV %?6&E^"_#.B>(M0\5:/I2VM[JNPZF\#LB73JH5970'8TFU
M53S"-Y554DA5 U* /&?B;\/OVR]'T?P+!^SO\:/#,LN@V?V;Q?;>/=+EF3Q"
M?+C47!G@_>PR!ED;:F%)DYX4*>@^'7P>\5KX^7XU_&SQ'INL>*XM)?3-*AT:
MP>WT_1K21TDG2!9'>1Y)7CB,DSL-PAC54C 8-Z-10!YYX#\*_M&Z9\>?&GB7
MQ_\ %'2-2\ :A!9CP3X;M=*6*ZTN18\7#2S!09 S9(RS]1CR\;3YSX7_ &4?
MC'\#?#_C7X3?LX>,?#NG>$/&6K7>HZ9/J\4YN_"4MVH%RMK%&/+NXPV9(D=X
M?+9B&,BC%?1-% 'B&N_L#_!/5?V+H?V([&.ZL_#MGI<<.FZE&0;NVO$D\Y;\
M, !YWGYE;& Q9EX4XJEXB_9G^+OQ\UOP';_M0>(O#=SH?P_UF#6A9>'8YR?$
M>K01LEO<W E51;1(7>0VRF8,S#,FU=K>^44 ?.G_  4Q\/:Y\8_@/;?LG>!Y
M#_;_ ,4=>LM-B9%W&RT^"XBNKZ^<=HHHHMI)ZM-&@^9U!]]\+^'-)\'>&=.\
M(Z#;^38Z58PV=E%G.R*) B+^"J!4-AX-\-:;XEO/&-MIBG5;^)(KF_FD:23R
MEY6)2Q/EQ@Y;RUPNYF;&YB3J4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
M&_'GQA\3/!?PWN[[X,^ E\2>*[J1+30=-N)#':K<2''G7,@_U<$:AI'.06";
M%^=U!_/?5OV[_P#@IO\ L4_MA^$?A?\ MKW?AOQ+X:\:W\$<">'].A6&."69
M86>UE2*.4R1,RDQS!MPP/XU<?IU7QIKGPETO]NO]N32/VE/$)BC^$_P066#0
M-1N6"Q>(=;CE\RXN(V/!L[=XXU,GW7DMR%++NP =)^W)^VEXP^%_[1'PI_8Y
M^#^HP:=XD^(^L0'5]?EM4GDTC2VG\HR012 QM,Y28*9%9%\HY5MPQ6_9J_;,
M\<0?MY?$/_@GU\9O$0UZ\\.VT6H^$?%4]I!;W5];O;6]P]M<I;I'"TJI<!@\
M<<8(C?*]*^=/VTK6^7_@N_\ !/5[F3S+*_T[1Y--F5MR-&)[Q?E(X/SAC_P(
M'O4>CZ?JNH_\'*NJ7>F(YALK(2WY7H(O^$4BC!/MYCQCZXH Z_\ ;G_:)_X*
M]?#+PS?_ +5/PZTWPYX4^&FEW2-%X:FL8;K5Q8M($CN;^.>(F,N60M'$ZO$'
M"L 4=J^J/V-_VHO$G[5W['GAO]HG3/ UNFN:O9S)/HWVPP6YNX+A[>0K*P<I
M$7C9P<.RJ<89ASQO_!2!O%7QS\#0_L)_!T)+XJ^(GDMK5ZREH?#VA13H]Q?W
M&.@=D$,:'!D9G"\H<>S?L^?"OX=? ;X2Z/\  CX8W,;Z;X.M(].=!,KRK-L6
M9VF"_=ED\T3,,#/G!@,,* /E#]B7]O\ _:8_:+_X*-_$#]F[XN:!H/A_1O!7
MAK5!_8.AYN0;VWU&SMQ,UW(H>7"R2@;5B4AP2F0,?<=?F+_P3D_Y3C?M"?\
M8-\1?^GJPK].J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#Q/\ :_\ $/[95Y8V?PV_8K\.Z);Z]>V[W.I^
M,?%A9;#2H5(5(XUV/YUS(V[ VNJ+&2X&]#7S7_P35_;^_:Y\7_M8>)_V'_VU
M-/M+SQ+H]K<S0:O:6,,$L4T!3='(+<+%)$\;ATD50>!]X.-OW/\ $+Q_X1^%
M?@C5/B-X]UJ+3M'T:R>ZU"\FZ1QJ,\ <LQ. JC)9B  20*^8_P!A/]FW4]$^
M,7C;]OKX^:8NA>,OBSJ)A\.>'=1=4GT?225,%M(">;J2.&(N@Y41 <$NH *.
MD?M;?%O]JW]N+XC?LM? _P"([^#-"^&?A^;SM:T_2[2[NM3UE98XC')]KBE1
M+:.0R(R(JR,8R1(NX!;O["/_  44\9_M:?L;:Q\6+;X:KJOQ#\,W8TJ[\-Z0
M3'%J-[)L%K,"Q/D0.9!YCL2(A%,WW5KY[_X(^6&J:+_P4H_:1T[Q KB^@OM2
M%SOZEAJ[[F]\]<]\U'_P;6Z;JT7AOXOZO,CBPGOM$AMF/W3*B7K2 >^V2+/U
M% %?]HC]NO\ X*P?L ?&7PWXN_:ME\'Z[X,\27+L-%\-V,7V5(T93-!%.8TN
M(YT1P5,C.A_V\-C[7_:V\4_MC:OI&G^ /V)?#FBV^MZE9M>:CXP\7!DL=*@!
M CBC78_FW,C;L+M98UC)<#>AKR?]H?X,VW_!1G]KSPOX1DMO,^%WP7U.:Y\6
M:F1F+6]<8QG^RX3T=85C7SV'W3*\?#\CZH\7_%+X?^!?AM>?%_Q)XJLX?#=C
MIG]H2ZM',)(7M]H970KGS-P(V!<ERRA<DB@#X>_X)J_M_?M<^+_VL/$_[#_[
M:FGVEYXET>UN9H-7M+&&"6*: INCD%N%BDB>-PZ2*H/ ^\'&W] *^2OV$_V;
M=3T3XQ>-OV^OCYIBZ%XR^+.HF'PYX=U%U2?1]))4P6T@)YNI(X8BZ#E1$!P2
MZCZUH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *KZMJ,>D:7<ZM-;W$R6MN\SQ6L#2RN%4L51%!9V.,!0,DX JQ1
M0!^:G[;/[4W_  6/_9JL;?\ :CU;3O!V@^ )M2CB'@RVMX+^;3HY#^YCU"1D
M$F]N%9X)=@<X&W*U]!?'3_@I1I_PL_X)R:+^VQ8>$8QJWBK2[-- T&]D8Q#4
MKA6)1V&&>*,1S2<;2ZQ8^4MD0?\ !13PCKO[9FH:/^P'\-;EHUOM0M-:^)NO
MHFZ+0-(B<O%&QZ&ZN)%!BBZ[8F9@$.ZO"?\ @O/X(\/>#?V&/AQX/^&$<*^&
MO"7C.WT=;:TF$BVOE:?<111N03AE$;*<\Y//)H [[Q1^V_\ '#]DSQ_^S]=_
M'/XDCQ;X;^-FCI_PD27>DVEH?#]\RV9\VT:VBC)MU:\0%)O-?:C$/D@5Z3^V
MKK__  4J\4ZK?^%?V%-$T#0K'0+19-1\1>)!&;K5[IHQ(+:PCGC>(HJ,@:60
M!6D8H&4Q/GXO_P""UEAJ>M?"C]DW1O#JLU]=>'+J*Q$?4RO!HRIC'?=BOTS_
M &D/CCI_P ^%EYXU.DS:MJ\[K8^%O#UFI:XUG5)<BWM(E')+-RQ'W45W/"F@
M#YK_ ."1'_!0CXL?MA^!O&?A;X\Z$C>*? ,UO]JU#3[#R3?Q3"8!7A7Y5G5[
M>0$*%#!EPH(;/!?\% OC_P#\%:/V:?"L7[5%AXH\#:'X+CU2&&?P+:6,=[<V
M44K8A%Y-+%F5R<)(;>10K,-FY?GKWO\ X)L_L=VG[%_PHE\/^.==LKOXC>.+
MB37?%TD4RY>12H,,0ZO% 9PI<#&^<G@.HKRW_@M?^SO^TM\3O@;/\4OAC\6U
M?PWX(9-<U7P%+I$.V<6X+-=^<03-Y2[G,$@*%0Q&6 4@'UI^S[\2]2^,WP*\
M'?%O6?#K:1=^)O#-EJ=SICDG[,\\"2% 3R0"W!/)&,XKL*\3_P""='Q\\9?M
M.?L8>!OC3\0K*&'6M4L;B'4&MX1''/);W4UMYRH.%WB$/M  !8@  "O;* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** //OVH/A3\2_C?\&-6^%GPL^,G_  @=_K,?
MV>Z\1QZ*;Z:*U8$2I"HGA\N1AA?,W$J"V &(9?B30?\ @@Q\4-.M[+P]J_\
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MV>F641)$42# R3RS'J6.2Q)))))K;HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^;9+>VPB18?-3G,<LVS!W8Q7+_ME1H/^"E_[)4H0;C<>,@6QR0-,@P/U/YT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC7IRP\.9).^J77S:/S#C[AW.,ZQ=&>"I<ZC%I^]%:W_O-'P#17W]_P .,_\
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M$72K&VU6UU636/@SIWAS2+&S<32W6MM816L5I'&N6>=;H ; "P*$XP":\O\
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M1\7B[7C\8_">J^*[V/5MFF^'[8QSR2PM:Q$6VG+&PVJ)5$[+"^YY/+<CW/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX@TSX)_\-5:1^SMK&H_#%8/MKZM#JL2:L=,!YU)-/9,&W*_O0#,LOE_.8UY
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M%+!?-&@5<NH??&K+S@.0P ![K17QO^PE^V#^T7\1/V3==_:!\=?"&+5TBO\
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M^&I=<T^*]AT:[NUFGMX95#QB4J %<J02G.W."<Y  ,_XC_M0_LX_!_6$\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOA+XV>!7%[\-O@GI4\4GB:'FUU?792^;>UD'RS+#F)G=25#1E2?F!/V'XO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;B[,<!5 Y)/ %>=:;^V7^RUJ\@;3_CCH,EJ\WE1ZL;HKI\DA.T*MV0(')/
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M=2FM$:>UWZK:(XCD(W(&5V! (R&- 'US%+'/$L\+AD=0RL.X/0UQ=_\ M(?
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M:M"LO"/C^S%]HD.JPWNHZ-.@:WU,1!FCAG4\/$)?*E*'AC"H8%20?EO]MO\
M9P\!6G[5G[./B+X"^"].T#QT/B,LEY<:#9):F;P];1>;J!F$0 9%39&"W_/P
M4'W\$ ^LO'_Q(\!?"S01XF^(OBVQT>Q:X2WBGOIPGFS.<)%&.LDC'A44%F[
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MI^GJ <+++($#''(5<[B>P!/:OI__ (<5?\%(/^$A_L7_ (5-I'V;S-O]K_\
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M7/B?1A_P2_\ V;OC?IN@6?C?PW\*O%UM<_$CPY;QQ7A@LS]I@E::%LJ&02#
M<#'FJQPN37Z5GX4_"YM?U#Q6WPVT ZIJ]JUMJNI'1X/M%[ PVF*63;ND0C@J
MQ((XQ6II^@:#I.BQ^&]*T2TMM.A@\F*PM[94@2+&-@0#:%QQC&* /F;X1?%G
M_@FI\7/'_A4?LP_#'X>>)_%4LZWEG-H?@ZWAN= ME :6\FE^SAK,J %53M=Y
M'C08R67W/]HCP7XC^)'[/_CGX>>#[H0:OKW@[4].TN8OM$=S/:R11-GMAV4Y
M[5J^"OAA\-?AK'<P_#GX>:'H"7D@DNTT328;43OS\SB)5W'D\GUK<H ^1O\
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M&AV]Q,99X-'TV*V220]798U +>YYH UZ^(OV=?$OAZY_X+<_'JRMM<M))I?
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M ?-?P9^(G_!/'XK_ !1T%?V3OAWX UWQ&EO-<R^(?#'A.WAG\-VA@D7SY)Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>cccc-20240429_g11.jpg
<TEXT>
begin 644 cccc-20240429_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDC]W+(BI+@J0=A..^,BNJH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUQ*@DGQTAC#MD,#@JP'Q3_P;92W":G\95M@&;[%H;*A. S!M0QG\_P!:H_\
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M1"C,#M?:KJVTJS+P<YKX<_X-W(81^TA\5)!$NY/#T2HVWD WAR![<#\A3_\
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M8Y(!<X&>V3]37JO_  @O@C_H3M*_\%T7_P 31_P@O@C_ *$[2O\ P71?_$T
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MN99)+IC*^(8QD!%^7A1DU^@/_""^"/\ H3M*_P#!=%_\31_P@O@C_H3M*_\
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M ()K_ /]ENX_9@^ '[9'@+0+:>PG@;6[[6;>\GDFG&V:ZE421B29ES@Y"KA
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ8:7K_BC4]3UFXDC\0>=)#]OL[B%G,8MRDTGEHJ#R?*C\O:1D_77P\\;:/\
M$OP!H?Q&\/%C8>(-'MM2L2^,^3/$LJ9QWVL* -BBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]?\ %&IZGK-Q)'X@\Z2'[?9W$+.8Q;E)I/+14'D^5'Y>TC)^NOAYXVT?XE^
M-#^(WAXL;#Q!H]MJ5B7QGR9XEE3..^UA0!L4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !53Q!KVD^%M
M!OO$^O7@M['3K.6ZO;@H6$44:EW;"@DX4$X )XJW5/Q#H.D^*M OO"^OVGVB
MPU*SEM;V NR^9#(A1URI!&5)&00>>#0!\8?MI?L61>+OVE-!^.7[(WC%?AY\
M2IO!&O>(/^$ATC"VVN36EQI2Q17:9V,DB7<H9]IW94N) N*^@?V%OV@M?_:F
M_9,\%?'GQ5H<6G:GKVG2'4+6!2(_.AGEMWD0-DA':(NH).%<#)ZUR;_\$^_#
M\>K:-X?M/C9X\_X0?3/"NIZ&WA>;Q"&<6MU+8,+6.[\K[4MMLM"C+YV[ C5&
M5=X;L?C'^QQ\'/C'\,/#OPFD_MGPOIOA"\M[GPM-X*U9]-GTMX8VCC\IH^
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M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M7!?&']MO\
M9A^ ?C ^ ?BS\3?[)U86J7!M/[%O9_W3YVMNAA=><'C.>*Y7_AZ-^PI_T7+_
M ,MG4_\ Y&KBGF674IN$ZT$UNG))K\3RZN=Y+0J.G5Q-.,EHTYQ33\TWH>S_
M /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5XQ_P]&_84_Z+E_Y;.I__(U'_#T;
M]A3_ *+E_P"6SJ?_ ,C5']K97_S_ (?^!1_S,_\ 6'(/^@NE_P"#(?YGL_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;5XQ_P /1OV%/^BY?^6SJ?\ \C4?\/1O
MV%/^BY?^6SJ?_P C4?VME?\ S_A_X%'_ ##_ %AR#_H+I?\ @R'^9[/_ ,(/
MI'_/S>_^!;4?\(/I'_/S>_\ @6U>,?\ #T;]A3_HN7_ELZG_ /(U'_#T;]A3
M_HN7_ELZG_\ (U']K97_ ,_X?^!1_P P_P!8<@_Z"Z7_ (,A_F>S_P#"#Z1_
MS\WO_@6U'_"#Z1_S\WO_ (%M7'?!']KO]GC]HW6;WP_\&OB%_;-YI]J+B\A_
MLF[M_+C+!0V9XD!Y(& 2:])KKI5J.(ASTI*2[IW7WH]'#XG#8NDJM":G%]8M
M-?>M#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV**U-S'_P"$'TC_ )^;W_P+
M:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'
M_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!]
M(_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'T
MC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W
M_P "VK8HH KZ;IT&E6HM+=Y&4,3F5RQY]S5BBB@ JIX@U[2?"V@WWB?7KP6]
MCIUG+=7MP4+"**-2[MA02<*"< $\5;JGXAT'2?%6@7WA?7[3[18:E9RVM[ 7
M9?,AD0HZY4@C*DC((//!H ^,/VTOV+(O%W[2F@_'+]D;QBOP\^)4W@C7O$'_
M  D.D86VUR:TN-*6**[3.QDD2[E#/M.[*EQ(%Q7G?QT^,GBG]I7X#_L>_MQ^
M,_#Z:=#8_%W3QXK2!6$-L6OA;M= $DI$SV99<DX\U!DYR?IE_P#@GWX?CU;1
MO#]I\;/'G_"#Z9X5U/0V\+S>(0SBUNI;!A:QW?E?:EMMEH49?.W8$:HRKO#>
MLZ]\"/A!XF^#DG[/NL> -/?P;)I2::- 2+9!';( $1-N"A7:I5E(964,"" :
M /F?_@LEH=_\1/A]\(/@OX=C:75_%'QMTB.TA3[PBCAN?-E]E3>I8] ,DU]B
MUYQX+_9C\%>%_'&F_$KQ%XG\0^+=<T+3Y+'PYJ/BO45N6TBWD 640!$1?,=5
M57G<-,ZC:TA&09?^&9OAQ_PTW_PUE]IU?_A*?^$5_L#RO[3;[%]E\WS<^3C[
M^[WV]]N[YJ /GS_@C?H-W\.? GQA^"OB",Q:SX8^-VKK>POPS120VWDS?[L@
MC8J>X&:^6OB#\(_%OQ4_8N_;*^+_ (8LI9[#5?C;-J&DA%)%U9Z=J!>>=?5!
M',[%NG[EAVK](O&?[,/@KQ1X]U+XF^'O%'B+PGKFNZ=%8>)+_P *:BMLVKV\
M61$LX>-QYB!F5)X]DRJQ42 8 Z?P)\*/AS\,_AS9_"/P/X/LK#PW8636EOI"
M1;XO);.]6#Y,A<LQ9F)+EF+$DDT ?.G_  4.\?:'J7_!)OQ-XQTR99;77_!.
MEKI@B^8S_;)+5(@@'WB?-!X[5[E^R_X&U?X8?LT_#SX;>((RE_X?\#Z3IM\C
M=5F@LXHG'X,IKFO#G[$WP>\/#0M%>_U_4?#7A34AJ'A3P9JFJ>=I>DW*DF-X
MTV"241%CY2322)%QL5=JX]?H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,ITO_E9^GG_ !$>_P#5FW_F0_\ [WT?\1'O_5FW_F0__O?7YAT4?\0\X/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?E3_P %@_\
MD\%_^Q8L?YRU\LU]3?\ !8/_ )/!?_L6+'^<M?+-?B^=_P#(WK_XF?S%Q3_R
M4>*_QR_,****\L\ **** "BBB@#[8_X(D?\ )9?&?_8L1_\ I0E?I)7YM_\
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M &#R-LICV;?LTN[IG.1]*^>/^(CW_JS;_P R'_\ >^N1_P"#B/\ Y+Q\/_\
ML49__2IJ_/&OZ?X4X*X9S+A[#XG$T.:<DVWS35]6ME)+\#\3XZ\1N,LFXLQ6
M#P>*Y:4))17)3=O=3W<&WJ^K/T\_XB/?^K-O_,A__>^C_B(]_P"K-O\ S(?_
M -[Z_,.BOH?^(><'_P#0-_Y/4_\ DSY/_B+'B!_T&?\ E.E_\K/T\_XB/?\
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MB\QJ<]3VDHWM&.B4;*T4EU?0****^*/T8**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBL[Q??ZWI7A+5-4\,Z8+W4K;3IY=
M/LFZ7$ZQL8X^/[S #\: +CW]C'?1Z7)>Q+<S1/+#;M(!(\:%0[A>I52Z D<
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M>>-M'^)?@#0_B-X>+&P\0:/;:E8E\9\F>)94SCOM84 ;%%%% !1110 4444
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MW_@A#_R?E!_V*&H_^TJ_:NOQ4_X(0_\ )^4'_8H:C_[2K]JZ_G7Q1_Y*9?\
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M1H=:\5^%(I#J&D:9 OF2R0-&CF.663R8%;:<+)*P!*8K9_8,^"?P8\/:5/\
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M (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
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MI+V*VZ>&3=^<&E,F[=]HCV]<8P?K7@'_ !#C:A_T>!#_ .$&?_DZOU"HK[+
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MQ6UOQ#KGBKQ1%IATVQUWQ/>1S36-F6#-! L4<<<08@%W">9)M&]VP, 'SO\
M\%S5O/\ AB_3Y='+?VI'\1-';1RGWOM6Z4)M]\$]*^R:\#^./PU7]K3XW>!?
M"PA\[P/\-?$X\2^(;XC]UJ&LVZ/'96$1Z2")I)99R,JI5(SEF<)[Y0 4444
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M ^4_^"QO_)HL/_8W67_HN>OROK]4/^"QO_)HL/\ V-UE_P"BYZ_*^OROB_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% 'RG_P6-_Y-%A_[&ZR_]%SU^5]?JA_P6-_Y-%A_[&ZR_P#1<]?E?7Y7Q?\
M\CC_ +=7ZGX#XD?\E'_VY']0HHHKY<^!"BBB@ HHHH Z[]G_ /Y+QX)_[&[3
M?_2J.OW.K\,?V?\ _DO'@G_L;M-_]*HZ_<ZOT/@C^!6]5^3/V;PL_P!TQ/\
MBC^3"BBBON3]6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFCRZ]\//%EGJUM!<M;736LN6MIUP6BE0X:*0 @E' 8 @XY%?+WCCQ9>_%O\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
M@6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q1
M0!\A?\%>O#5AI/[)T-U;37#-_P )79KB6<L,>7/V-?F!7ZH?\%C?^318?^QN
MLO\ T7/7Y7U^5\7_ /(X_P"W5^I^ ^)'_)1_]N1_4****^7/@0HHHH ****
M.L^ T2S_ !R\&0.2 _BS3E)4X.#<QU^W'_"#Z1_S\WO_ (%M7XD_L_\ _)>/
M!/\ V-VF_P#I5'7[G5^A\$?P*WJOR9^S>%G^Z8G_ !1_)F/_ ,(/I'_/S>_^
M!;4?\(/I'_/S>_\ @6U;%%?<GZL8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% 'RG_P6-_Y-%A_[&ZR_P#1<]?E?7ZH?\%C?^318?\
ML;K+_P!%SU^5]?E?%_\ R./^W5^I^ ^)'_)1_P#;D?U"BBBOESX$**** "BB
MB@#KOV?_ /DO'@G_ +&[3?\ TJCK]SJ_#']G_P#Y+QX)_P"QNTW_ -*HZ_<Z
MOT/@C^!6]5^3/V;PL_W3$_XH_DPHHHK[D_5@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV< I($$F59VC3?C^$'PEBU,:U%\+O#JWBSB=;M=$@$HEW;M^[9G=GG.<YYH
M^;?V[/!MW\//VOO@%^VI+'C0/">MWGA_QA>-]S3[;4H&MH+J0]$A225P[GA=
MZ9Q4?[3OA7_AI?\ X*(? WP9X-N([W3_ (5_;_%GC2]MG$D=B9! -/A9APLL
MDL+,(R=QCRX&!D_6=[966I6<NG:C:17%O/&T<\$\8=)$(P593P01P0:H>$?
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M@B6.='EA<V\=K.PA*(<&8M(002"#FOO;]CWXF?';Q9X7UCX=_M0:/HUOX_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y3_P""
MQO\ R:+#_P!C=9?^BYZ_*^OU0_X+&_\ )HL/_8W67_HN>OROK\KXO_Y''_;J
M_4_ ?$C_ )*/_MR/ZA1117RY\"%%%% !1110!RGQ"^-6M?"+4].O_!-VL.NP
M7$=Y9731J_V5HW#))M8$,=R\ @C@Y!Z'RCXB?&?XN?%SQ%)XM^*'Q,UW7]2D
MD+F\U;5)9W4YS\NYCL [!< = !5KXZ_:/^%CW?G9V^3#Y6?[NP?US7'U^R\-
M8&A@\JIRAO-*3?=M?IL?T5P;EF&R[(:4J?Q5$IR?=M7M\D['U7^PC_P5C_:-
M_9"\:Z?8>)O&6J^+? ;SI'JWAG5KQKAH(<@&2S>0DPR*,D("(VZ,.0R_O-X*
M\8^&_B)X/TKQ]X-U6.^TG6].AOM,O(C\L\$J!XW'U5@:_ENK^@7_ ((U^(6\
M0?\ !.#X;"YUR"]NK*TO;6X$-RLA@"7]P(HGP3M98?*^4X(&.*]N:6Y]=!O8
M^GZ***S- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
ML[QAX1\-^/\ PGJ?@;QCI$6H:3K-A-9:G8SC*7$$J%)(VQS@JQ''K6C7F_[3
MG[67P)_9!\!?\+#^.GC6+3+65VCT^RB0RW>H2@9,<$*_,YY&3PJY!9E!S0!R
M7QQ_8DB^-7[,FF?LR2_&;7=)M-%O[232_$-G$G]H16UL"L4)=2H9PAV>;@$@
M D$DD];^RU^RS\+_ -D7X9#X9?#!;^>.:\>]U;5]8NO/O=3NW"JT\\F &;:B
MJ    H '7/QEK/\ P7ZN)[][CX?_ +"'C?5M'SF/4;S43;R,A. QCCMIE&>/
M^6A'/6O=_P!D#_@J_P#LU_M:^)T^&*Q:IX+\:N#Y7ACQ5"L3W9 R1;R@[92!
MSL.R0X)"$ F@#Z>HHHH **** "BBB@ HHHH **** "O*/VZ]'\*:[^QI\4--
M\<ZC?6>D'P/J,E_=:9"LL\,:0,^Y$9D$A&T'864-TW#.:]7KD?CYJ?PRT;X)
M^*]3^,]DMSX3AT&Y/B&T,;/]HM/+(DB"+\SEQE0HY8L .M 'Y%_#_P#:%_X(
M06_@?2;;Q[^Q?XW_ +;BT^)-6:VO[B:-[@*!(RN=3CW*6!(.Q>OW1TK[W_X)
M)>+OV5O&WP8\9ZY^QW\,M<\)^#F^($J+I>O7GFRFY&FV'F2*#+*8T/RX4RN<
M@ME0P1>8_9'\5>"/VDOBOXA\#^._^"7OAWX9:;:: -1\,3>+/!MNEUJ*><(M
MSQ-;($ RI*J6QG&X]:]R_8^\1?!C6-&\8Z/\*OAMI'A#4]$\:W.F^.-!T1$6
MVCU6"&&(RQ;%16C>%(&5PB$C[RJX<  ]@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /E/\ X+&_\FBP_P#8W67_ *+GK\KZ_5#_ (+&_P#)HL/_ &-UE_Z+
MGK\KZ_*^+_\ D<?]NK]3\!\2/^2C_P"W(_J%%%%?+GP(44V::&WB:>XE6-$&
M7=VP%'J2>E>?^,?CQIME*=)\%VO]HW;':LVTF(-_L@<N?I@>YKMP.78S,:G)
M0A?N^B]7LCTLLRC,,WK>SPM-R[O9+U>R_JQW&KZUI6@V3:CK-_%;0IU>5L?@
M/4^PYKSCQ!\:M>\37I\/_#+2)G=^/M319<CU5>BC_:;\A4.D?"?QIX^O5U_X
MDZO-#&>4MLCS,>@'W8Q^&?:O2/#_ (8T+PM9?8-!TV.WC_B*CYG/JS'EC]:]
MGER;)_BM7JKI_P NXO\ ]N_+T/HN3AWA[XVL5771?PHOS?V_R]&><:=^S1\1
M?&LUO:V5^M_XCU2]B@M-/:89FDD8(J&5R &+$#GY1ZXY')_$3X,?%SX1^(I/
M"7Q0^&>NZ!J4<A0V>K:7+ ['./EW*-X/8KD'J":^L/V?_P#DO'@G_L;M-_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#L!R0-V<=\5VM>=_M<>#?'7Q"_9@\?>"?AEXA_LK7]3\*7L&E7QNO($<QB;
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MH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\
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MQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH T
MJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?
M#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?
M]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#
M2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH T
MJ*AL;^SU* 75C<++&20'7IFIJ "H[JZMK&UDO;VX2&&&,O++*X544#)8D\
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M\-/#%U/K?A[5)]+UWPAJES':WECJ$#@36DC O&)-IW(P8Q2;D/F*K%U^>?\
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M$WQ-L/B7XUU#^T7T R'PKIOD;(--EDC,<ER023+<LC/&)#@)&[*BJ7D9^NH
M**** "HY;.TF;?-:QNWJR FI** (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ*
M (?[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (?[.T_P#Y\8?^_0H_L[3_ /GQ
MA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (?[.T_P#Y\8?^_0H_
ML[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (?[.T_P#Y
M\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (
M?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\ GQA_
M[]"IJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[
M3_\ GQA_[]"IJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8
M?^_0H_L[3_\ GQA_[]"IJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[
M.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]
M"IJ* (?[.T__ )\8?^_0H.GZ>!DV,/\ WZ%>$_MC?\%)?V7/V)]-DM_B;XR%
M_P"(S%OM/"&AE9]0ER,J77(6!#UWR%01G;N(Q7Y_ZM\9O^"HW_!9G5;CPM\'
M?#[_  ]^%4LS0WES'<R6]E)'G#+<7FT27S]C#"H3IN0?>JE%LER2/J?]MK_@
MM!^RM^RZ;OP5\-(;7XA>,H=T9L-'F3[!92=/](N@"I(/6.,.V058IUKY;\*?
ML@_\%+/^"N?B&U^)'[4GBN7X?_#MI1/IVFR6+6\9C/(-II^X,Y(/%Q<-DALJ
MS@;:^Q/V)?\ @CI^RY^R$+3Q?K6F+XY\:P;7_P"$BUZU4Q6D@[VMMEDAP<$.
MQ>0'HX!Q7UK1=+8+-[GBG[)G_!/O]EW]C/0!I_P@^'L+:I)%LO\ Q/JX6XU*
M[]=TI4>6IX_=QA$XSMSS7LO]G:?_ ,^,/_?H5-14[E6L?)__  6(M+6#]DB%
MX;:-#_PEMD,J@!_U<]?EG7ZH?\%C?^318?\ L;K+_P!%SU^5]?E?%_\ R./^
MW5^I^ ^)'_)1_P#;D?U"BBBOESX$**** "BBB@#K?@"JM\=_!2L 0?%NF@@]
M_P#2HZ_<G^SM/_Y\8?\ OT*_#?\ 9_\ ^2\>"?\ L;M-_P#2J.OW.K]#X(_@
M5O5?DS]F\+/]TQ/^*/Y,A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHK[D_5B'^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_
M0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T_
M_GQA_P"_0J:B@"'^SM/_ .?&'_OT*;-I&DW,+V]QI=O)'(I62-X%*LI&""".
M15BB@#XE_;'_ ."&O[+G[17VKQ=\((E^&_BF7+^;HUJ&TRY?K^]M 5$9/]Z$
MIC))5S7R]IWQ]_X*F_\ !(G4H?#7[0W@?_A8OPWAE6&VU*ZF>ZMECS@+!J 4
MRVS'@+%<*0 /EC'6OU[J#4],TW6M.GTC6-/@N[2YB:*YM;F(21RHPPRLK A@
M1P0>#5<W<EQ70^=_V/?^"F?['O[9L-OI'@;Q1!HOBB11YGA#Q$D=O>%L<B$Y
M*7(ZG]VQ; RRKTKZ)_L[3_\ GQA_[]"OA+]L+_@@W^SY\99KCQU^S7J8^&WB
M?<9DL[6-GTF>7.1^Y!W6ISC#0G:O7RR:\#\-_MQ?\%/_ /@E9KMK\/?VS/AW
M>>._!(E$%CK5Y=-,60=/LVIJ&WG'/E7 +X &(Q1RI[!S-;GZT_V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ%>)_LD_\%%?V5?VS]/C3X2?$*.'7/*WW/A/6MMMJ4.!
MDXB)(F4=WB9U&>2#Q7N52U8J]R'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"
M'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?
M^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.
MT_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&
M'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_
M0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T_
M_GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\
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MC>R)M@O)[3SUB.1EMFY=QQG&3C."01P0#Y9^%_@V\^)7_!7?XC_&RVC+:1X
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M )2VC'3R8,X!P&C(Q7Z0?"7X-?"OX#^"[;X=_!WP%IGAW1;4?NK'3+81JS8
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MDEM8Z?:QVUG;IG;%%&H5$&>P4 ?A5JBB@ HHHH **** "BBB@ HHHH *^(_
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M "7CP3_V-VF_^E4=?N=7Z'P1_ K>J_)G[-X6?[IB?\4?R84445]R?JP4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7/?$_X3?#/XU>$+CP#\6O
MFE^(M&NA^^T_5K-9H\X.'7</D<9X=<,#R"#70T4 ?F9^TE_P0?\ $O@#Q/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+&_\FBP_]C=9?^BYZ_*^OU0_X+&_\FBP_P#8W67_ *+GK\KZ_*^+_P#D<?\
M;J_4_ ?$C_DH_P#MR/ZA1117RY\"%%%% !1110!UW[/_ /R7CP3_ -C=IO\
MZ51U^YU?AC^S_P#\EX\$_P#8W:;_ .E4=?N=7Z'P1_ K>J_)G[-X6?[IB?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
MY\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT
M*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_
M .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B
M@#Y/_P""Q%I:P?LD0O#;1H?^$MLAE4 /^KGK\LZ_5#_@L;_R:+#_ -C=9?\
MHN>OROK\KXO_ .1Q_P!NK]3\!\2/^2C_ .W(_J%%%%?+GP(4444 %%%% '6_
M %5;X[^"E8 @^+=-!![_ .E1U^Y/]G:?_P ^,/\ WZ%?AO\ L_\ _)>/!/\
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M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
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MITOP]\0F\/#PKK%_H<T<-S]ALI(9M_&Z'+-E?,"Y'H<"OHKX4_#J7X4^&(_
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M_P#;'@?\0J_ZC/\ RG_]N?@'17[^44?ZC_\ 41_Y)_\ ;!_Q"K_J,_\ *?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"_L]6G_!2]OB'!=?M/\ B#X)R>$19RM(G@.#5&OIIBH\H*UR%C5,DL6^8G:
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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METD60728/AW!J/GFX+C+2O=[5"! 0 H));.1MPUW]J']B+]FS]L>RL;7X_\
M@6;5Y-*BF32+J'5[FV>R,NW>R"*15+'8F=RL#M&00,5XS^Q+X?\ C/\ LM?M
M)^-?V#O$?Q#U'Q;X2L_!L'BGX;:SK4GF7=A:/<-:M92OT(60?*!@ 1EE"A]J
M@'8_#7X]_&_]KC6?'_B+]GGQ;H7A[PQX*\0W'A_P]<:IHK7I\1:G;HK3RS,)
M4\JS#ND:>5^\8;GWCA*[[]CW]IC1OVLO@5IOQ;L-';2[XSS6'B#19)=[:;J,
M#^7/ 6_B 8!E/!*.I(!) \&_X(30M;?L%VUK=HRWT7C'5DU-)/OK.)5R&[[L
M;>M,_P"",2WDW@7XTZG$"-,NOCSKCZ;_ '2-EON9?;&T9'<'TH ]L_;$_:;N
M_P!G7POX<T?P;H]KJ?C3Q[XIM/#G@S3;YV%N;N=P#<3["&\B)?G?:03\JY7=
MN&#JGQX^)?[.W[0G@3X-_';Q9I_B/1/B8MS9Z%XDM='%A+I^L0JK_998UD=6
MAG5\1$?.KJ58N&#+Y?\ \%#;>Z/[?_[)%Y? _P!F+XLUE"3]T7)CLS%GW)''
MT-._X*V+>77CK]FK3-$!.IR_'G27L]GW@%==S>P!*DGT% 'J6I?M ^/_ (Q_
MM6>(OV7/@;K]CHEKX!T2UO?'/BFXTT7LJWEV"UK86\;.J*?+5I))6W]-@4'+
M"?\ 9X_:"\9_'6+XA_ [Q)JUIH/Q(^&VNC3-7OM-L0]M<1N/-LM02"5F*Q3Q
MJ=T)<LN'"R [7'DG_!-JWNK7]M?]KB'6<C4#\0K!V#_>^S,+UK?\-AX]J=^R
MR+R\_P""P_[3.H:8"=.AT#PW#>,GW?M/V"V"Y]_DF'X&@#Z%_9Y^//\ PM^'
MQ#X/\4:7#I7C/P/K']E>,-&@E+QQ3%!)#<PEL,UO<1,LL989PQ4_,C5Z/7QW
MX9UB^\&_\%OO$WA?2W/V+QC\$[2_U6%3PUS;70AAE;U*QJR#/:2OL2@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^7H?A!^VO\
M#H?#CP'IE_X*\7V?A/Q'='2/$]\UY92VMH=*U"WA%Y;(DHD$8F2,-',I<B-2
M%W-(,WXM_P#!-JVU/_@GMXU_9A\.>(CK'BSQ#?W/B>XUZYA6W&H^(6G6Y+A
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M+\_K_P"R1\$->\"W'C3XZ?$C2UL_&GQ3UY=7URQ$BN=,M(HQ#8Z>77Y7:&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(9HF8*<=CS7R/\3-5T+0/^"['@V^UG4K2RCE^!$BB:ZF6-6D-]? #+$98@8
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MK]CCQWJ]I%X_;PUXBDAN+;.B*'1?/F 8AV&YF=(RRQJ@+RKYB;@#ZIHKYO\
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M\N#<Q_UR*I"C).$:,G=&ID]R_9_MX(_VD/CQ/'"JO)XPT;>X7EL>'].QGUH
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M\4?#[4+6SGT:]U2PMA,TJ2N9);CS6MX$ 1=N))'D\P$)A7*@'T?17S'\-O\
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M^%/C?XLVOP_?P%I/A+QAJFGZ[%J[P(ZR6L44US=3^22B-^\;=AG_ -63N.:
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M2>/_ (>:]_P1%TJQMM5M=5DUCX,Z=X<TBQLW$TMUK;6$5K%:1QKEGG6Z &P
ML"A., FO+_B=X;\._L1_%;]G3QA^U[X!LM<\ 6WP8@\!^)+[4='34K30]6C,
M<_G%"K@<J(PP&XQI(5SM(/UM^QE\#/#/@SX'> ;[QM\ M-\/>//#_@W3-'U?
M4+S2K)K\S6UE%!(PN8"Y="5(!WY(Z@=*]>\0^'/#WBW1I_#OBO0;+4]/NEVW
M-CJ%JDT,RYSAD<%6&0.HH \-_9T\;?L.>-?BA>:]^R=\.O MRVG:'(?$7CSP
MKX>MK6.Q5FC,5DUTD*^8T@#R-&&PBP N!N3/@'[ >MZ,?^"*7C:Y&J6WE0:'
MXR6=S,N(RWVIE#<\$JRD ]0P]:^X])^&GPXT#PF? 6A?#_1++0B#G1;32H8[
M0Y()_<JH3J >G:JT7P;^$,-G+IT/PJ\-I;SNC3P+H=N$D9<[2R[,$C<V">FX
M^M 'QC\.?"'[,?QR_P""<O[/'P4^/^O2Z8GB.Q@A\)>)M-U5;6?2M:MX)60Q
M3'*K(0LJ!6R"V%QN*XO?"KXR_M4_LGWOQQ^"_P 5?%/_  N33?AA\.T\1>'?
M$EQ;[;Q]R2E--OV7<6<JC2'<6?8K-DAU5?L";X-_"&XT9_#EQ\*_#;Z=)(9'
ML'T.W,+.5"EBA3:25 !..@Q5[PAX"\#?#[1?^$:\ ^"])T/3M[/]@T?3HK:#
M<>IV1J%R<#)Q0!^9O[4'QK^$GQ/_ &/OA#\7-6_:#A\3^*KGQWX9U/Q%8Z?J
M)CTWPO"69I;4V4!\BQ2%@8EDG'G.(V_>,,@>Z_M._%CX:>'/^"D?[.'QE\2>
M.=,TWPG>^%/$R6WB34KM;>RDW6HV$3283:^]-K9PV]"I.Y<_6-I\(OA/8>'I
MO"5C\,/#L.E7-T+FXTR+18%MY9@P82M&$VLX8 [B,Y -:6M^%/"WB;[*/$GA
MK3]0^PW"W%E]NLTE^SRK]V1-P.QAV88(H ^3/CYXK\.ZC_P5C_9LN;?58U%U
MX.\1RPQSYBDVS63F+<C@,I;:P"L <J1C((JG^R!K\OP%_P""B/Q^^"_QBODT
MZ^\?ZS;>*O ][?R"./5[+$JR1PNV [0AXTV#)_=R<84FOK'5/A9\,-;U=_$&
ML_#C0;N_D=7DOKK1X))F90 I+LI8D   YXP*?XW^&GPX^)MC%IGQ(^'^B>(;
M:"3S(+?7-*ANTC?^\JRJP!]Q0!\H?!3PO!KG[;W[37[4NA7\2^"YO#ECH4.K
MI(/LNHWUK81_;)$?[K"W,8B9^FYF&<JV."_9MU;2D_X-Z]59]1@ B^'7BF"0
MF4?)*UY?A4//#$NN!U.X>HK[UF\&>#[GPTO@RX\*:;)HZ1I&FDO8QFV5%(*J
M(B-H (! QP0*S5^#?PA2P?2T^%7AL6LDRRR6PT.W\MI%#!7*[,%@'8 ]0&/J
M: .,_80O+2__ &(O@_/97,<R#X8Z%&7C<, Z:?"C+QW#*5([$$5RO[9/B'PQ
M\6/%OA']AQ/&L=C>>/;U[SQ,EK=QK=0Z)9+Y\BJ&!PT\P@@ *G=&TYP0A%>Y
M>'O"WAGPC8'2_"?AVPTNU:0R-;:=9I!&7( +;4 &2 .?851O_A?\,]5UL^)=
M4^'>A7.HM(LC:A<:1"\Y=<;6WE=V1@8.>,"@#Y8_X*+_ +#\GCW]D?Q7JLO[
M0/C;4-3\)63>(M 'B'6;8V\5Y:(T@.5@0J[1^;&K!A@R ]JY+XW?%W7O^"BG
M_!&75_%_PLF74O%HT>PG\2Z)88>;[98W<$MW&8EY&Y87F1,992@&<U]RZ]X<
M\/>*=.;1_$^A6>I6CL&:UO[5)HR0<@E7!&15/PW\/? /@VXDNO"'@?1]*EF0
M)-)INF10,ZYS@E%!(SV- '@WPE_X*=_LR_'7X>^';WX<^*K76/&WB&."*S^'
M\&XW\5^P&])4VDQ0Q-N9[@C8L:%P6X!X/Q?\1_ GP?\ ^"T%QXC^)_BJST.R
MU7]G9+32I]0E""]N?[95A;PCK+,PC?;$@+L1A020*^K_  [\+/ACX/U^]\5^
M$OAQH.EZIJ1)U'4M.T>""XNB3D^9(BAGR>?F)YJ_J7A7POK.K66O:OX;L+N^
MTUF;3KVYLTDEM2PPQC=@2A.!G:1G% 'QW\/_ (K_  S^!7_!5_X^3?&;Q]I'
MA:+Q)X1\,WNA7&OZA':1WT4%H(I3&\I4.5<$;02?E; ^4X\__9O_ &H= ^$_
MA+]LKXB^&=+MM:UO3/B%JVNV/A/4T:*>YM60()9K9P)1"IR9 5!"JP.TU]]:
M_P##GX>^*]<T_P 3^*? >C:EJ>DOOTK4=0TN&:>R;.<Q2.I:,YYRI%6=*\)>
M%-"2]CT3PSI]FNIW,ESJ2VME'&+N:0DR22;0/,=B3N9LDYYH _-7]J#XQ?!C
MQE\(/V=/B[>_M'Q>+M>/QC\)ZKXKO8]6V:;X?MC'/)+"UK$1;:<L;#:HE43L
ML+[GD\MR/<_VM_&?A76?^"C/[(.L:?KMN]M=-XKG@D=]F^.?3K=8&PV"!(PP
MN1\QZ5]36GPD^%6G^'E\)6'PR\/0:4MX+M=,AT6!;<7 .1*(PFW>" =V,Y'6
MGZY\+/ACXGU)]9\2_#C0=1O) !)=WVCP32L , %G4DX  '/04 ?,/Q:UG28?
M^"SWPJTZ;4X%N&^$VK*(6E 8LTLI48ZY(1R!W"GTIW_!2+3==_9X^(/@+_@H
MW\/]#N;VX\"W8T3Q_IUBN9=2\.WDFPC'\30S.&0' W2[B<+7TW>_"KX7ZEK#
M>(=1^&^@7%^THD:^GT>!YBXQABY7=D8'.<\5XA(/VN_VC?BC>_"KXQ?L_:5X
M,^&^@^,8[X^(5\51WLWBBSM)_.M+=+>-<PK)+'!+*TA V*T6TEF( /2?V6/A
M_P"(? 7P>LY_'< 3Q3XCNI]?\78.=NI7CF:6$'NL(9+=/]B!!VK&_P""@.I:
M?I?[#?Q>N-2O8K>-_AOK,*/-(%#226<J(@)[L[*H'<D#O7KU9GB3P7X.\9PQ
M6_C#PGIFJQP,6A34K".<1D\$J'!P?I0!\^?\$NO!WPOUO]ASX4^,[7PGH5UJ
M<'AJ*-M533X7N(YHW96'F[=P92"#SD8J/]NW]IJ;X/\ QE^#_P 'M1\56?@O
M1/'>K:BNM?$>]AA+:/';VZE8+>2=6B@EN&E6(S."(U8D GE?H7PSX&\$^"_/
M_P"$.\':5I/VG;]I_LS3XX/-VYV[MBC=C<V,],GUIWBOP5X-\=Z<FC^./"6F
M:S:1S+-':ZK81W$:R+]UPLBD!ADX/44 ?$7[*?C[X):)_P %6_B/I_@SX@/?
MV?B'X?Z/%X>O;_5KF^EUJ56!DD@FG9WNT #-YB,T:HC$$(AQ#\ =*U;XGWW[
M=/P^^&FJPRZ_J^O:C9Z2D%PN[[1+I]S#'R#\O[T%=W8@^E?<G_"'>$#K#>(3
MX5TW[>UC]B:^^PQ^<;;.?(+XW>7DD[,[>>E5?#_PR^&WA/4/[6\+?#W0],NM
MA3[3I^DPPR;3U7<B@X.!Q0!\2_LQ?M9? O4/^"3FI?"_7O'NE:'XL\)_#K5/
M#>M>%-5NEM]0BOHK:>%$%NY$CF0[2-JGYF*_>5@/<?\ @E5XN\+^*OV!/AI'
MX;\06=\^F^&XK/4$M;E9&MKA"P:*0*<HX_NG!P0>]>PW?P;^$-_XCO/&%]\*
M_#<VKZA;/;7^J2Z';M<W,+H4>.24IN=&4E2I)!!P>*W-*TK2]"TV#1]$TVWL
M[2VC$=M:VL*QQQ(.BJJ@!0/04 6**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH _G6_;;_Y//^+O_93]?_\ 3C/7F%?K)\;O^"!7_"X_C/XN
M^+W_  UA_9W_  E7BC4-8_L__A!/.^R_:;F2;RO,^W+OV[]N[:N<9P,XKE_^
M(<+_ *O)_P#,>?\ WPK^DL#Q_P )4<%2ISQ-FHQ3]RINDO[I_'N9>%G'F(S&
MM5IX.\93DT_:4MFVU]L_,.OV+_X-[O\ DS#Q/_V4^]_]-VFUYA_Q#A?]7D_^
M8\_^^%?8W_!/;]BC_A@_X,:G\(?^%E_\)5_:/BB;6/[0_L;[#Y?F6UM#Y7E^
M=+G'V?=NW#._&.,GYCCKB[A[.<@EAL'6YIN47;EFM%OJXI?B?:>&7 7%G#W%
M,<9F&&Y*:A)7YZ<M6M-(R;_ ]VKP7]MOQAX=\81^&/V,HO&<.GZM\6M4;3]1
M6*\2.YAT.&-KC4'4-G#2PQFU3(.6N<@':V/>JPM9^%_PS\1ZJVN^(?AWH5_?
M/MW7E[I$,LIV@!<NRD\  #GC%?BA_1Q\W_ML?L"V?Q9_97\5^$;WX]>-;Y]/
MT>2_T2UU_5K0V45Y;1L\&_;;H47(V$AAA6/;BNK_ ."9?[66E_M<_LE^&?&5
MWKT-SXFTNR73/%MOYP,R7D(V&9UZCSE"S ]/WA'4$#WC6]"T3Q+IDNB>(]'M
M=0LI]OG6E[;K+%)A@PW(P(." 1D=0#6?X<^''P\\'WKZEX1\!Z+I5Q)$8I+C
M3M+A@=D)!*ED4$C(!QTR!Z4 ?$GPR^'GC+X5_M9?$#_@G)I_AZX;P#XX\06W
MC[3;I%_<6.A.Y;4K$^D<MU#!9B,?\LYY&X)%;_\ P4QUKPM\%_VG_@O^TI\<
M/A[!XB^%UA%JV@>+#>:.M]#I,MV(3!=-$RL#\T8Y )Q$P&6*@_9QTG2CJHUT
MZ9;F^6W,"WGDKYHB+!C'OQG;N .W.,@&DUG1='\1:7/H?B#2;:_LKJ,QW-G>
M0++%,AZJR,"&'L10!X!\ ?'?[!7Q#^+EM??LE_#?P%JVJV&F23:SXP\+>&K:
MW&BVKJ0D3720@^;*Q($ 8'8LK-@* W%?\$:]=T76/@=\1(M*U:VN6C^-/B!Y
M%@F5BJ2/$R,<'HR\@]#VKZ@\/_##X:>$_#$O@GPK\/-"TS19]WGZ1I^DPPVL
MFX8;=$BA#G SD<U)X<^'7P^\'7;W_A'P)HVE3RQ^7)-INEQ0.Z9!VDHH)&0#
MCV% 'Y[^-/VH? ?[3G[)'QYU[XI_$L:+XDL4\2Z=H'PATB^>TDLC#;R;;BYM
MK?$]_(Q#22RS;K>/8QV1^6[5J?%KQ?\  CQE_P $FO@7XDU#XJ1:7?\ A2[\
M&P^&_$EO";BSTKQ%;V<2D797CR(E,_G8.4*%<&1=A^](/AS\/;75]1\0VW@3
M1H[_ %B$Q:O?1Z7$)KZ,C!29PNZ5<<88D5XG^V'\._CO;0?#Y_V>?@WX=\8>
M#/#.JSS^+/A?)>0::-501!;3R6D7R-L$A>;RGPID2(@94$ ' >$?B5^SC^U+
M^UC\./C!XV_:M^%]UK'@2ROK?P;X0\*^)A,]_J%]&D4UP[3B-V^1%$=LJ,0W
MS&1L8KSS3?B!^S-^SI^WY\8?AO\ MV>!?#4%OXWUBV\1^ O&/BWP_#<VUQ;M
M;)%);">2-O*"% HR0NZ.0$@E=WI__"AK?]I33?\ A%M7_P"";OASX80S7$;W
M7B[6ET=K^R59%=GL5L/,D%P=N%D=XE0G?^\V^6WT[XV^&OPY^)=G#IWQ'\ :
M)X@M[:7S;>#6]*ANTB?^\JRJP4^XYH X/]E'4_V?/$7AW6?%/[,7PLT'0O"5
MYJ>VVUKP_H46GP:_,BXEN42.)/-C5B8A,<[V23;\H5FR_P#@H!XAT'PY^SS!
M=Z_K%M91-\0O"&V2ZG5 =GB/3I&P2><(CN?148] :]GL[*STZSBT_3[2*"W@
MC6.""&,*D: 8"JHX  X %9GB3X?^ O&4T5SXO\$:1JLD"E89-2TV*=HU)R0I
M=3@?2@#R;]NW]C'PU^V;\)8]%MM4_L7QCH$_]H^!/%ENQ2;2[Y<,IWI\PB<J
MH8#D85Q\R+7G7_!*OQS\;O'L7Q9U7]I+PV-*\<6/C6STSQ' $VB6>UTBSM_/
M 'RXE6-9<K\AWY7Y2*^K-(T?2- TZ+1]!TNVLK2!=L%K:0+''&,YPJJ !R2>
M/6H[OPYX>OXKV"^T&RF34E"ZBDMJC"Z 7:!("/G&T ?-G@8H ^'O^";/Q5^&
M&A_M9?M62:W\1="LEO/BBLEHUYJT,0G02WJED+,-P!XR,BOHNS^(_P"SUXR^
M)VM_L^?#;5-,U[4/&MC>:QXX.B:G'*EC;?98+'SI6CW*)9=MO&L9(+!9)/X"
M&[K_ (49\$O^B.^%?_">MO\ XBM+PUX \!^#)9;CP?X)TC2I)U"SOINFQ0&0
M#D!BBC('O0!\?_\ !*J6^_9'M/$W_!/_ ./-W%I/B30?$EUJ/@ZYO6$,'B32
M9]I$]HS'$I5U<N@)9/, (RK8N?\ !402_M>:/H'[ WP-U&'5?$>O^)+2^\87
M-DPFA\-:1 69[F[9<B)F?9Y<;$-)M8 =,_6GC3X?> OB1I7]@_$3P1I&O6.[
M=]BUK38KJ+/KLE5AG\*7P;X!\"?#G2?[ ^'O@K2-!L V[[%HVFQ6L.[UV1*J
MY_"@"SX:\/Z;X3\.Z?X6T:(QV>F645I:(3DK%&@11GZ 5\-3-;_\$\/^"GWB
M[XP?%,/8?"WXX6,(B\72(?LFD:RA4^1=R=(5=O.(9L+B93G"2%?O*JVL:-I'
MB'3)M$U_2K:^L[E-EQ:7D"RQ2K_=9&!##V(H Y;7OV@?@WH.AP:Y_P +$TJ_
M%[A=)M-(OH[JXU.0_=BMHHF+3NW94!]3@ D?+G[2GB'Q!\%O^"EOP2_:=^+-
MA_8W@S7O!5QX2U.\FN1);:%JLS33*LTPPBB1I(HQ(<*1$YSA37U;X%^!_P %
M?A??3:G\-/A!X7\.W-PI$]QH7A^VM'D!ZAFB12?QK<U_P_H'BK1Y_#WBC0[/
M4K"Z39=6-_;)-#,O7#(X*L/8B@#Y6_:7\*1_'#_@I%^S^GPYO8KJ;X>6NN:Y
MXROK&0.-/LIXH([2.5EX!GE2150G)7S& (!-0_L&ZSI%]^WE^UA!9:G;RN/%
M6A$I',"?DLYT?H>S@J?0C%?4?@WX>^ ?AUHY\._#[P/H^A:>SEVL=&TR*UA+
M$8)V1JJY/KBJEC\'?A'IDCS:;\+/#EN\D+PR-!H=NA>-U*NA(3E64D$=""0:
M /F7_@D[K^A3Z?\ M#74&LVCQ)^T?XFNFD6X4J(&%N5E)SC80K8;H=I]*^:/
M"&H6%]_P;L>,8[*\BE:#5IUF6-P2C'Q#"X!QT)5E/T8'O7Z8VOP=^$=C%/#8
M_"SPY"EU#Y-TD6AVZB:/<K[& 3YEW*K8/&5!Z@5X3_P4?_9^U?QK^Q?XT^#'
M[-WP*AO-?\61V44=OH-M962?N+V"8M,\CQ# 19-OWCDD8&<T <M_P4&UOPG\
M9?\ @F3:^!/ =W:^(-6^(EIH6G^!;"QF6234;TW-M(/*P?\ EFD<CNW1%C?=
MCFO.OB_>_"/]D3]OC0K_ /;,\&Z5K'@#Q?\ "G2]!TCQ=KN@I?6FG:I8,RLC
M>8CF(.K%F8#_ ):H3\H<K]C? [X7^ =$T'3O'47P.TSPQXHN=,BBU>=]'LX]
M0,@10XEF@+>9DCKO8'K77>+?!?@[Q]HDGAKQWX3TS6M.E(,NGZM81W,#D="4
MD!4X^E 'SIH7B_\ 8[\2_#/XJ^+_ -E7X=>#;;2+/P-?0^(/'GAK0K>RM[J?
M[/(PM%GCB7[3Y: .Y#%8]\0Y+,$\6\/:MI7_ !#T2S'4K?8/AU<P%C*N!+]M
M=!'U^]NP,=<\5]W)\._A_'X5B\"Q^!=&71( !!HRZ9$+6, [AMAV[!@\\#K5
M0?!OX0BP.ECX5>&_LIF$IMO[#M_+,@&-^W9C=@D9ZX- 'RMX\^&7[-G[2OP4
M_9W^#7Q)\=7_ (:\5ZG\/UU7X9^-- U<6MW97EK:::LL4#]':03H_E]2+=B"
MK*".4T+]JG]JO]FW]G7]HSPW\8FTWXK7WP:FTVRT#Q;)88BUI;U4#QWB)P[6
MJ21/,N=V&96<\.?M+4O@M\'-9T6/PWJ_PF\,W6G1%S%87.@V[P)O*E\(R%1N
M*(3QSM&>@K2T/P1X+\,^&1X+\-^$-+T_1EB>)=)L=/CBM@C9W+Y2J$P<G(Q@
MY- 'YU_M(_%?X#WOB[]F7XJ#]IQ/&MY'\4-+O/%?BBXUK_B7:9&\6\HT41%I
MIH!S^Z*I+LC)D+[&:O5?B%\5OAU\./\ @L5H'Q$\?^+;31=%UG]FW[/I5]JC
M& 75P=8DF$$:N S3%!D1 ;R2 %R0*^M+/X5?"_3]#M/#-A\-] @TW3[Q;NPT
M^'1X%@MK@9Q-'&%VI(,G#  C/6M#5/"OA?7-2L=9UKPW87EYIDC2:;=W5FDD
MMHYP"T3,"8R<#)4CI0!\HZGK6D/_ ,%Q],M1J4(E/[-Y@\HR -YO]L2R^7@\
M[O+^?;UV\]*R_P#@F7XE'P/^*OQS_94^,>IQ:;XK3XH:AXMT]M2E$1UC3+U8
MPMW"6(\U1Y 9B,[3( <$$#ZS;X6?#!]<_P"$G?X<:"=2^TBY_M$Z/!Y_G!MP
MD\S;NW[N=V<YYI/&WPH^%OQ+:V?XC_#70/$!LVW6AUO1H+LP'.<IYJMMZ#IZ
M4 ?#_@'PDMI\)OVX?VD+.Z2+PAX\@UB+PQ=LX$%^+33KV.:\A;I)'+/.45QD
M.8SC/%5_C?JVE/\ \&]5A(-2MRK_  ZT"!&\U<-*MY:*8QSRP96!'4%3Z5][
M:OX/\(^(-'C\/:]X6TZ^T^';Y-C>6,<L*;1A<(P*C X&!P*S&^#?PA:P72V^
M%7ALVJ3-*EL=#M_+61@ SA=F Q"J">I"CTH D^$][::C\+/#5_874<T$V@6;
MPS1.&5U,"$$$=017B_[2>J>&?VA_V@_"?[&>G_$-]/.GQ'QGXO\ [)OHENXX
M[.6,:?;J'5P&:[=+@@J<+9#.-ZD^^Z'H&A>&--CT7PWHMII]G$28K2QMEBB0
MDDG"H !DDD\=36:OPO\ AFNO?\)2OP[T(:G]H-Q_:(TB'S_-SGS/,V[MV>=V
M<YH ^-_^"I'[*6L>'?V:W_:,\._'KQ=J'BGX5ZI;>(O#<GB;5+:2*)XYH_,"
M;(8R'*@,!GYFC5<<C!^W+\9KG]J+_@G-X*_:U^!-B-9C\,>+=#\8:[HEC+YD
MD*6C-]IMI N3F&5P7R.%B+]!FOM7Q'X3\*^,;)-.\7>&=/U6WCE$D<&I623H
MK@$!@K@@'!(SUP3ZU%X;\"^"?!J3Q^$/!VE:4MUM^TKINGQ0"7;G&[8HW8R<
M9Z9/K0!X_P##K_@H7^S'\=F\-:3\"?&]KXLU_P 0SP/#X>LU;[7IL!(^T7%V
MNT_9EAB+DE\!V"QJ29%SY/\ "KXD>!/AE_P5S^.FE^/O%5GI5UXF\.>%$\.V
MMY+MEU1Q;+$4MT^],P=@-J GJ>@./K#P=\+?AE\.[B\N_A_\.M"T*74'WW\N
MCZ1#:M<M_>D,:J7/)Y.>M7KCPKX7N_$,'BZZ\-V$FK6L#0VVIR6:-<0QMG*+
M(1N53DY .#F@#XU_9*^,GPJ^!?[9/[3WA/XO^/\ 2_#NIW_CNQU'3-/U6[6*
M?4+>6V/EFVC/SW#'<@"1AF)=  2P!\D_9P_:UM?V?_\ @FM\:_'W@G2-,UWQ
M%HWQ5U5Y/#VJQ[S9Q7=Y;Q)<W5MD/Y2^83@@!F0KD<D?HW?_  Y^'NJ^+K7Q
M_JG@/1KG7K&+R[+6[C2X7N[=.?E28KO0<G@$#DU+I_@;P5I&@3^%-*\'Z7:Z
M7=&4W6FV^GQI;S&3)DW1A0K;LG=D<Y.<T ?GS^T+\4/V?;/]I/\ 9F^)-A^T
MZOC<6_C"YE\3^-;W7?,L(3):(47;&19V!);/D(J.%*EPW#'UKXB^(]#N/^"S
M7PNC74HTDN/@SJ/EP3'RY,O/*ZJ4;#*Q56.T@'Y3QP:^H[/X8?#33]*T[0M/
M^'FA06.D70N=)LX=)A6*RF&<2PH%Q&_)^90#R:2]^%?PPU'66\1ZA\.-!GU!
MI1*U_-H\#3&08PY<KNW# YSGB@#YA\(:SI+_ /!;KQ9IZZG 9Q\ [:(P^:-W
MF#489"F/[VQ@V.N#GI6;^WC_ ,)W^R%^TYX3_;M^#O@NXUQ?$MDW@CQMX>LQ
M@ZA/,"=*F/.-PN0D1<\[=B#[U?6$?PK^&$6N?\)-%\.-!74OM)N/[071X!/Y
MQ;<9/,V[M^>=V<YYKP_X:C]KO]I#X@Z7-^TW^S]I?P[\,>"?$<FJ6MK;^*H]
M3F\17<0=+-ML2@0P0LYG)8[GEC@(50K4 >N?L_?"QO@Q\'="^'=UJ'VV_L[4
MRZUJ..;[49G:>\N3[RW$DLG_  .O&_\ @L!J6GZ;_P $Y?B9_:%[%#Y^GVD,
M ED"^9(U];X1<]2<'@>AKZ6K)\2^ O OC.2&7QAX+TG5FMP1 VI:=%.8P<9"
M[U.,X&<>E 'FW[&/@[X87/[-?PS\>>'O">A-?3> =(/]L6FGP^<[?8HE;,JK
MN)SD'G.<@UYQ^UK^T_9>"OVQ? '[-WC+Q_9_#WPSKGAB]U74?'ES+#;SW+*Y
M0:7;W<XV6F[RP\D@^<@QJC1L0Q^E?#?@_P )>#;:2R\(>%M.TJ&63?+%IMC'
M KMC&XA  3@8S4?B?P+X(\;?9#XS\':5J_V"?S['^T]/BN/L\O\ ?C\Q3L;W
M&#0!\8?\$Y/'7PDTS]NS]H_P=X4\5O(-:U7P_<>'8-0O+F>ZO[:/3YVEN@]R
M6FEB^96\]R5;SHB&/FQ[O//@KX:\2_&/_@FQ^U=X)^$,_P#:&LWWQ=\3S6EK
MI\F^6YAW6<I1 O+>;$DBJ!]\G S7Z*2^"?!D]_J.J3^$=+>YU>V6WU:Y>PC,
ME["JE1',VW,BA20%;( .*B\-_#OX?^#KJ2]\(>!='TJ:6/9+-INF10,ZYSM)
M102,@''M0!\-_$3]L+]GSXM?\$;-5TW0?B5HL.N)\,8M&NO#$E\BW\%_!;I%
M+ +?/F$ QLP8+CRQOX4$CZN_8N\7>&/&O[)OPYU?PGX@L]2MD\$Z5!+-97*R
MK',EG$KQ,5)VNK AE/*D8(!KIG^!_P %9-1U35Y/A!X7:[UN-H]:NCX?MC)J
M"$@E9VV9E!(!(;/(KI;:VM[.WCM+.W2**) D44:!510,  #@ #M0 ^BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,\8^-/!_P\\-
MW7C'Q[XIT[1=)L8_,O-3U6\2W@@7U>1R%7\36G7X#?\ !6/]N[QK^U[^T;K/
MAG3_ !!,G@+PGJDUAX9TF&4B"=HF:-[YP#AY)"&*L?NQE5&/F+5&/,R92Y4?
MK/\ \/?/^";_ /PD/_",?\-2Z1]I\S9YO]F7WV?.<?\ 'QY'E8]]^/>O?_!W
MC3P?\0_#=KXQ\!>*=.UK2;Z/S+/4]*O$N()U]4D0E6_ U_+=7U7_ ,$G/V[O
M&O[(7[1NC>&=0\03/X"\6ZI#8>)M)FE)@@:5EC2^0$X22,E2S#[T893D[2M.
M&FA*GKJ?OS222)#&TLK!55268]@*6BLS0X_P5^T)\"?B1XOO/A_X ^,/AK6=
M>TZ$RW^BZ;K,,UW;H"JEGB5BZ@%E!)'!8>HK7\=?$/P+\,= E\5_$7Q=I^AZ
M9 "9]0U2Z6""( 9)9V(51@=2:^(_V^/V<OC#XZ_;0N_C_P#LJ:N=.^)7PW^&
MNC:SI-G#$H37D:_U2*XM)<8,C/#$B*"<, 8SC<&7U;PY^U[X _;6_P""=OQ#
M^(WANW^Q:G;^ M9LO%?ANX.9M)OEL)A)"X(!*'DHQ W*>0&#*H!]%^#?&_@_
MXB:!#XK\">);+5],N5#6VH:=<++#*" 05=<A@00<CCFM2O,9?B[X>^#7P5\#
M"YTNYU#4M<M=.TGPUH.G;!/J-X]L&6)"[*B*L<<DCNQ"I'&S'H >8TC]L^^T
M7]I"T_97^-/PCE\->*-=T2;4_!LUAKD=_8ZXD2NTD"3&.%HIU",=CH%PI.[E
M=P![K5+Q#XBT+PGH\_B#Q+JT%C8VR[KB[N9 D<:^K$\ >]?+7["W[2_[1OQM
M^.WQ<L?B/\+8K>QT;X@-HK_9O$4<D.@1VUL%6!4*AKAG<%FD7 +2DX   ^LJ
M ..^&/[0OP)^-<D\7P?^+_ASQ0;;_CY_L#5XKL1'KAC$Q"GD<&NQKX>_X(J:
MA/X9_8Y\>ZOHWA2\U::W^+&M/'I6E&!9[DB*T 1#/)''G 'WW48'6NK\.?\
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MO[(.I?MA> ? GB/7]*T03QZ_H-NEM!?Z/<0X\Z*Z2:90AC)7=L,C;7#*K T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M15>[.K^'/"5O#/X>L_*?=<2S?9PULS,4A6,E9':7IM5ROTG)I6F3:8VBRZ=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cccc-20240429_g12.jpg
<TEXT>
begin 644 cccc-20240429_g12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1.@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $X2^298X0DE-! 0      !$< @   @  ' )0  5$96QT80 X0DE-!"4
M     !#C?*;(JC_4;-3S<Z3Z+->M.$))300Z      #_    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    . $$ 4 !. "  +0 @ %$ 5 !! "  +0 @ #$
M  ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U
M '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN
M4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2
M<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O
M;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B
M;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U
M8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M          !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M              !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A
M8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&
M(U)L=                %1O<"!5;G1&(U)L=                %-C;"!5
M;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC
M<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M    #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M     #A"24T#[0      $ .__C4  @ " [_^-0 "  (X0DE-!"8       X
M            /X   #A"24T$#0      !    %HX0DE-!!D       0    >
M.$))30/S       )           ! #A"24TG$       "@ !          (X
M0DE- _0      !( -0    $ +0    8       $X0DE- _<      !P  /__
M__________________________\#Z   .$))300(       0     0   D
M  )      #A"24T$'@      !      X0DE-!!H      UL    &
M      "O   "\0   !, 0P T "  <@!E '  ; !A &, 90!M &4 ;@!T "
M4 !# "T ,0    $                          0             "\0
M *\                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M *\     4F=H=&QO;F<   +Q    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
M 04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!
M  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_   L( #@ \0$!$0#_Q  ?  $  @,  @,!
M            " D&!PH"!0$$"P/_Q  ]$  !! ,  @$" @<%!0D!   % P0&
M!P$""  )$2$Q$T$*$A05%E%A%S=Q>+@F.(&1LQ@9(R<H.7-YH:/_V@ ( 0$
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MJBFF@(B5G-;HKADGHB'CK"NQ&NKEIMRDNZZGM*;M*2L ),^9NG%6+I_OS?T
MP&Q2>'&8[;\,D;JJ0C"INM[WB+53&VRLIIF9S9@.2SHG(TP!+#@8WFOX\><X
M_IQ_W_\ WA_/TQ_VN@'V_P#GLG\OS_Y9_E^?G1)G'S\9S]OMG/Y9_+/Q]?C'
MU^WTQ]<_7[9\^,9^_P!?O\??YQG_ !_E],9S]\_ECZ><^WZ1'\?V <6_7Z8]
MC'-O]/C_ ,":_./R_E_3X^GQ_3H>\>/'CRCGWD=W7;Q15O-HNE9E&Z7<=%]
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MJV.ZEYI/:K;3US9H<*W4L#1#.()FM98WD#AZZ9I:.626C#+_ %<:*8LV$O\
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7,6 0_<N[<D]@F7ZZSE25'CQX\>//_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>cccc-20240429_g2.jpg
<TEXT>
begin 644 cccc-20240429_g2.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1,"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $N:^2#@X0DE-! 0      " < 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  $1V5N83A"24T$)0      $.')"A7;Y_SV*:I=Z)!5H1(X0DE-!#H
M .4    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L
M  !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG
M3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"<F14
M56YT1B-2;'0               !";&0@56YT1B-2;'0               !2
M<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O; $     4&=0
M<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M     %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M        $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O
M;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T
M4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M    $ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X
M #A"24T#\@      "@  ________   X0DE-! T       0   !X.$))3009
M       $    'CA"24T#\P      "0           0 X0DE-)Q        H
M 0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ !
M *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M   !.$))30/X      !P  #_____________________________ ^@
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@              DP   M0          0
M       !              +4    DP                     !
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M;&]N9P   ),     4F=H=&QO;F<   +4     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
M  =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L
M;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U
M='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT
M3W5T<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M       ! 0 X0DE-!!0       0    &.$))300,      B5     0   *
M   @   !X   /     AY !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  @ * # 2(  A$! Q$!_]T !  *_\0!/P   04!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                     /_A/T)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-
M,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB
M861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC
M,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*
M(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY
M+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO
M;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&5$
M871E/C(P,C(M,#0M,3-4,#<Z,3(Z,S4K,#4Z,S \+WAM<#I#<F5A=&5$871E
M/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O<VAO<"!#
M4S8@*%=I;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z
M36]D:69Y1&%T93XR,#(R+3 T+3$S5#$T.C4X.C,P*S U.C,P/"]X;7 Z36]D
M:69Y1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,BTP-"TQ
M,U0Q-#HU.#HS,"LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^36EC<F]S
M;V9TPJX@5V]R9" R,#$V/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L
M96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @
M(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^1V5N83PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E
M871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M
M870^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @
M>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B
M/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.D4V0S T1C X
M,$-"0D5#,3%!.$8P1$8S-$5"-#4X.#=!/"]X;7!-33I);G-T86YC94E$/@H@
M(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C9%,C5&034T0T-"
M045#,3$X-$8Y13DR,S W0S5&03DP/"]X;7!-33I$;V-U;65N=$E$/@H@(" @
M(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-D4R-49!
M-31#0T)!14,Q,3@T1CE%.3(S,#=#-49!.3 \+WAM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @
M(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C9%,C5&034T0T-"045#,3$X-$8Y13DR
M,S W0S5&03DP/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z=VAE;CXR,#(R+3 T+3$S5# W.C(S.C4V*S U.C,P/"]S=$5V
M=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N
M=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A
M<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO
M<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA
M8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM
M<"YI:60Z135#,#1&,#@P0T)"14,Q,4$X1C!$1C,T14(T-3@X-T$\+W-T179T
M.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P
M,C(M,#0M,3-4,30Z-3@Z,S K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO
M<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I
M;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP
M87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV
M97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O
M(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D4V0S T1C X,$-"0D5#,3%!.$8P1$8S
M-$5"-#4X.#=!/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z=VAE;CXR,#(R+3 T+3$S5#$T.C4X.C,P*S U.C,P/"]S=$5V
M=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N
M=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A
M<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO
M<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@
M(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED
M.D4U0S T1C X,$-"0D5#,3%!.$8P1$8S-$5"-#4X.#=!/"]S=%)E9CII;G-T
M86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED
M.C9%,C5&034T0T-"045#,3$X-$8Y13DR,S W0S5&03DP/"]S=%)E9CID;V-U
M;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$
M/GAM<"YD:60Z-D4R-49!-31#0T)!14,Q,3@T1CE%.3(S,#=#-49!.3 \+W-T
M4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I
M=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!H
M;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(^
M"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H;W1O<VAO<#I#
M;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI2
M1$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ +P#H P$1  (1 0,1
M ?_$ !X   (!!0$! 0             (!P($!08) 0,*_\0 -!   00" @$$
M 0," PD!     P$"! 4&!P ($1(3%"$)%18Q(E$7)$$8(R4R-$)A<9'P_\0
M&0$!  ,! 0                (#! $%_\0 .1$  @$# P($! 0$!04!
M 0(1  ,A!!(Q05$B87&!!1,RD11"H<$CDK'P%3,T0U)B<H+1X?'_V@ , P$
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MI**W(._^VI#%$YB)CNK--XX1"*C4:7WG8S:O_I5OE1M1J.5SO+OM/$OQ&F
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8CBE'%*.*4<4HXI1Q2CBE'%*.*4<4K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>cccc-20240429_g3.jpg
<TEXT>
begin 644 cccc-20240429_g3.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" .  ^@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO.?C!\9-.^%^EE!MN]:
MG4_9[,'I_MOZ+_.L*]>GAJ;JU79(\_'X_#99AYXK%SY81W?];M]$7/BK\6=+
M^%^C^;<$7.IS*?LUBK?,Y_O'T4>M?$_B[QAJ?C?6Y]5U:Y,]S(>!_#&O95'8
M"JWB3Q)J/BS6+C5-4N6NKR=LL[= .R@=@.PK,K\ES7-JF8SLM(+9?J_/\C^0
M>+.+L3Q)7Y(WA0B_=CW\Y=W^"Z=6W;J-U-HKP3\_L+N-&324;A0 44FZC=0,
M6BFY-%,!V:3=24F: ';J-QINZDW4: .S13=QI,FBX[#ZZ#P#XSNO /BNPUJT
M)+0/^\CSQ)&>&4_4?KBN<HJZ=25.2G!V:U.C#UJF%JPKT96E%II]FMC](] U
MRT\2Z+9ZI8RB:TNHQ+&P]#V^HZ?A6A7RM^RG\4/[/OG\(:A-BWN6,EBS'A9.
MK1_CU'N#ZU]4U^T9=C8X_#QK+?JNS/[<X;SRGQ!EU/&0TEM)=I+?_->3"BBB
MO3/J HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBO)/C?\=+3X<6;Z=IS)=>(9D^5.
MJVX/\;^_HO\ 2N;$XFEA*;JUG9(\O,LSPN4866+QD^6$?Q\EW;[%OXT?&RQ^
M&>GFUMC'=Z_,O[JWSD1 _P ;^WH.]?%^M:Y>^(M4N-1U&Y>[O+AM\DLAR2?Z
M#VJ'5-4N]:U">^OIWNKN=R\DTARS$U5K\DS/,ZN8U+O2"V7]=3^/>*.*L5Q)
MB.:?NTH_#'MYOO)_ALA=U&ZFY%&ZO%/B!<FBF[J,F@=AU)3:* L.W"C=3:*-
M1V%W49-)29% "T4FZC=18=A:*;DTF?>@+#Z3<*;NI-U,=A^ZDW4W<:3)H"Q8
MM+R:PNH;FWE:&>%Q)'(IP58'((K[V^#?Q(A^)G@VWO\ <JZA#B&\B'\,@'7'
MHPY'_P!:O@&O0O@C\39/AGXRAN968Z5=8AO8Q_=SP^/53S],CO7T&2YA]1Q%
MIOW):/\ 1_UT/T;@CB)Y#F"C6?[FI92\NTOEU\KGWM14=O<17=O'/#(LL,BA
MT=3D,I&00:DK]=/["335T%%%% PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2[?3M,M(K*R@7;'#"N% _P ?>KRJ%4*H 4#  Z"EK]3P&74<OA:FKR>[ZO\
MX!_4N0\.8+A^CR8=7F_BD]W_ )+R_-A1117JGU04444 %%%% !1110 4444
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MR/;$8M>D?\_\OO/W;A+@CX<?FL?.,'^<O_D?O[#(84MXDBB18XT 5448"@=
M!3Z**^\/W78**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :S+&I
M9B%51DL3@ 5\7_M+?M -XSNY?#/A^X(T*!\7%Q&?^/MP>@_V ?S//I71?M0?
MM!><USX-\-W/R#,>HWL1^]ZPH?3^\?P]:^6-U?G^>9OS7PF'>GVG^G^9_/\
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M9*L/:OB5>?1=O^#^1_1'"7!<<!RX_,8WJ[QCTCYOO+\O78HHHK[ _7PHHHH
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MS5WMVAZ>?=_)=V4445]0?IX4444 %%%% !1110 4444 %%%% !1110 4444
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MF?TQPKPG2R2"Q.(7-7?W1\EY]W\EIN4445](?HP4444 %%%% !1110 4444
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MTBOU?F_PV';A2;J2BO&L?'6%W4F3129% ["T4FZDW4PL.HIN324#'4;A3:*
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MHUJ>(IJK2=TS^H\%C</F%".)PT^:$MG_ %L^Z"BBBMSM"BBB@ HHHH ****
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M("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N<^('CK3?ASX5O=<U23;!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]5U3[/\ K4****[CV@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%:)+H@HHHJS4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&:86%W4;C3=U&Z@8M%-W&OI/]DW]G)OB!J47BOQ%;G_A'+23-O;R#B]E!_\
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M17ZM1HPH4U2IJR1_2V%PM+!48X>@K1CL%%%%;'6%%%% !1110 4444 %%%%
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MU&XTW=5C3[&YU:^M[*R@DN;NXD6**&,99V)P !ZDT;Z(I1<G9'0_#7X=ZO\
M%+QA8^'M&BWW-RWSR$?)#&/O2-Z #^@[U^I_PO\ AOI/PI\&V/A[1X\00+F6
M9A\\\A^](WN3^0P.U<+^S+\ [;X*^#U:[2.7Q-J"K)?W Y\ON(5/]U>_J<GT
MKV:OTO)\M^IT_:5%[\OP7;_,_?\ A?(5E='V]=?O9_\ DJ[>O?[N@4445]$?
M=!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"?M(?L
MP:?\7+.76-'6+3_%D*<28VQW@'1)/?T;\#QT][HKGQ&'IXJFZ5573.#'8'#Y
MC0EA\3&\7^'FNS/Q[UW0M0\,ZM=:7JEI+8W]JYCFMYEPRL/\]:H5^F7[07[.
MND_&K2#/'Y>G>)K=,6NH!>' Z1RXZK[]1V]*_.3Q?X0U?P)X@NM%URSDL=0M
MFVO&XX([,I[J>Q%?E^8Y;4P$]=8O9_Y^9_.>?</XC)*NOO4WM+]'V?Y]#(I,
MBFT5Y!\J.W4FZDHHL.PN3249I-U 6%HI-U)N-&@[#J*;GWI-PH ?D4FZF;J-
MU/4=A^ZDR:;DTE [#LT;J;118+"[J-QI**!AFBBBF 44F11NH 6BF[J,F@=A
MU%,W>])NH"P_<*-U,W4;C0.P[<:,TS-% QV:3=244!87=29-%)F@=A:*3=2;
MJ L.HINXTF:!CZ3(IM% #MU)NIN11NH&.R:2DW4F30%AU%-I*!V';A1NIM%
M6%W49-)1D4#"BDW4;J %K[K_ &*_V<_[!LX?'_B.UQJ-PF=+M95Y@C(_UQ!_
MB8=/0<]Z\A_9 _9W;XI>(AXDURW/_"+:9*,1N.+R8<A/=1U;\!W-?HNBK&JJ
MJA548"J, "OL\CRWF:Q=9:?97Z_Y'ZOPAD/.UF6)6B^!?^W?Y??V'4445]T?
ML(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-06B_%]6_4****ZCT HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK]0RO+U@:7O?&]_\C^@N'<ECE.&O-?O9?$^WE\OQ84445[1]8%%%% !1110
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M._GY'UW#N2O-<1SU%^ZAOY^7^?D=OH.A6/AC1;+2=,MDM-/LXEA@AC& B@8
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M7;DV.H[>O?RWQT<?J.1[?G6;94\*W6HKW'^'_ /PWB3AMY=)XK#*])]/Y?\
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MF;J-QH"P[=1FF9-%,=AV:3=244!87=2;C110,***2@!:*3<*-U "T4W=1DT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?H2T445]V?K@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR/+_ &<?K51:O;T[_/\ (_6.%<G]C#Z_67O2^'R7?Y_EZA1117UI^BA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#(\6>$]*\<>';[0]:M$OM,O8S%-#(.H/<>A!Y![$5^4/[1WP!U3X!^
M-'L91)=Z%=EI--U CB1,_<;T=>X_'O7ZZUQ_Q6^%NB?&#P7>^'-=AWV\XW13
MJ!YEO*!\LB'L1^HR.]>/F67QQU/32:V?Z'S6=Y/#-*-XZ5([/]'Y?D?C!NI,
MFNU^+WPGUOX,^-KSP[K<6)(SOM[E0?+N8B?ED0^A[CL<BN*K\SG"5.3A-6:/
MPZI3G1FZ=16:T:"BBDS46,A:*3=2;J=ACJ*;N-)F@+#Z3(IFX5[;^RC\ YOC
MI\1(H[N)U\,Z85N-2F' 89^6$'U<C\ ":VHTIUZBIP6K.K#8:IBJT:%)7E(^
MD/V _P!GC^R[$?$K7K;%W=*4T>&5>8XCPT^/5NB^V3WK[7J&TM(;"UAMK:)8
M+>%%CCBC&%10,  =@!4U?JF$PL,)15*'_#L_?LNP-/+L-'#T^F[[OJPHHHKL
M/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M \I_:*^ >E?'KP3)IMP$M=:M0TFFZAMYADQ]UO5&Z$?CU%?DUXO\)ZKX%\27
M^A:W:/8ZG8RF*:%_4="#W!'(/<&OV[KYT_:^_9B@^-GAHZSHL*1>,M-B/D,
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M\]O)?\'\@HHHKZ<^Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
3%%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>cccc-20240429_g4.jpg
<TEXT>
begin 644 cccc-20240429_g4.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *7 N,# 2(  A$! Q$!_\0
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M %S_ -_6_P :IT4<L>P<\^Y<_MB__P"?ZY_[^M_C1_;%_P#\_P!<_P#?UO\
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M^M_C1_;%_P#\_P!<_P#?UO\ &J=%'+'L'//N7/[8O_\ G^N?^_K?XT?VQ?\
M_/\ 7/\ W];_ !JG11RQ[!SS[ES^V+__ )_KG_OZW^-']L7_ /S_ %S_ -_6
M_P :IT4<L>P<\^Y<_MB__P"?ZY_[^M_C1_;%_P#\_P!<_P#?UO\ &J=%'+'L
M'//N7/[8O_\ G^N?^_K?XT?VQ?\ _/\ 7/\ W];_ !JG11RQ[!SS[ES^V+__
M )_KG_OZW^-']L7_ /S_ %S_ -_6_P :IT4<L>P<\^Y<_MB__P"?ZY_[^M_C
M1_;%_P#\_P!<_P#?UO\ &J=%'+'L'//N7/[8O_\ G^N?^_K?XT?VQ?\ _/\
M7/\ W];_ !JG11RQ[!SS[ES^V+__ )_KG_OZW^-']L7_ /S_ %S_ -_6_P :
MIT4<L>P<\^Y<_MB__P"?ZY_[^M_C1_;%_P#\_P!<_P#?UO\ &J=%'+'L'//N
M7/[8O_\ G^N?^_K?XT?VQ?\ _/\ 7/\ W];_ !JG11RQ[!SS[ES^V+__ )_K
MG_OZW^-']L7_ /S_ %S_ -_6_P :IT4<L>P<\^Y<_MB__P"?ZY_[^M_C1_;%
M_P#\_P!<_P#?UO\ &J=%'+'L'//N7/[8O_\ G^N?^_K?XT?VQ?\ _/\ 7/\
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M8_\ >?\ ]#-%>1-+F9[].3Y(Z]#E-7_Y"=U_UU?_ -"-4ZN:O_R$[K_KJ_\
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M?_T(U3KUH_"CP)_$PHHHJB HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ[KJCU\JS&ME.+ABJ.ZW7==5_7J?=%%>=?!OXC+XST7[)=N/[6LU"R9/,J]
MX_D??ZUZ+7]!X/%4L;0CB*+O&7]6^1_4V!QM',,/#$T'>,OZL_-';Z)_R#8_
M]Y__ $,T4:)_R#8_]Y__ $,T5Q3^)GV%/X(^ARFK_P#(3NO^NK_^A&J=7-7_
M .0G=?\ 75__ $(U3KUH_"CP)_$PHHHJB HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3KUH_"CP)_$PHHHJB HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4_@CZ'*:O_R$[K_KJ_\ Z$:IU<U?_D)W7_75_P#T(U3KUH_"CP)_$PHHHJB
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MG_(-C_WG_P#0S17CS^)GT5/X(^ARFK_\A.Z_ZZO_ .A&J=7-7_Y"=U_UU?\
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M$Y4J?NS3=D^J[K]5NCIJ***^D/K HHHH **** "BBB@ HHHH **** "BBB@
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M[5.CZ2_R?YG[CPYQ5''6PF-=JG1])?Y/\SU:BBBOO3])"BBB@ HHHH ****
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M-C_WG_\ 0S17CS^)GT5/X(^ARFK_ /(3NO\ KJ__ *$:IU<U?_D)W7_75_\
MT(U3KUH_"CP)_$PHHHJB HHHH **** "N.^*7Q"@^'WAR2YRKZA-F.UA/.6Q
M]XCT'^ [UT>N:U:>'=)N=1OI1#:VZ%W8_P AZD^E?&GQ!\<W?C[Q'/J-P66$
M?);PYXBC!X'U[GWKY3B#.%EE#DIO]Y+;R\_\O,^,XFSQ93AO9TG^]GMY+O\
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MK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% ';Z)_R#8_\ >?\ ]#-%&B?\@V/_ 'G_ /0S17CS^)GT5/X(^ARFK_\
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M])_LS_!'[4\'B_7;?,*G=I]M(/O'_GJP]/3\_2O2R_ 5<QKJA2^;[+N>EE^
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MK+]Y+\%V]>_W'Z]D&3K T_;UE^\E^"[>O?[@HHHK[$^O"BBB@ HHHH ****
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MLK]?\OO%HHHK]-/TD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"0;'_O/_Z&:*-$_P"0;'_O/_Z&:*\>?Q,^BI_!'T.4U?\ Y"=U_P!=7_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ';Z)_P @V/\
MWG_]#-%&B?\ (-C_ -Y__0S17CS^)GT5/X(^ARFK_P#(3NO^NK_^A&J=7-7_
M .0G=?\ 75__ $(U3KUH_"CP)_$PHHHJB HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!V^B?\ (-C_ -Y__0S11HG_ "#8_P#>?_T,T5X\_B9]%3^"/H<IJ_\
MR$[K_KJ__H1JG5S5_P#D)W7_ %U?_P!"-4Z]:/PH\"?Q,****H@**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M111]8F'U2GYA_P ([>?\\F_-/_BJ/^$=O/\ GDWYI_\ %444?6)A]4I^8?\
M".WG_/)OS3_XJC_A';S_ )Y-^:?_ !5%%'UB8?5*?F'_  CMY_SR;\T_^*H_
MX1V\_P">3?FG_P 5111]8F'U2GYA_P ([>?\\F_-/_BJ/^$=O/\ GDWYI_\
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598E=P/5B:***X)5&VV>G&E%12/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cccc-20240429_g5.jpg
<TEXT>
begin 644 cccc-20240429_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !@ & # 2(  A$! Q$!_\0
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M5I+^S3XPT]+J%[^#Q=//+:K(#+'')9VBQNRYR%8Q2 $\$QMC[IJS_P %J_\
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M .0_X+5_\FL^%O\ L<[7_P!(;ZOQ6K]J?^"U?_)K/A;_ +'.U_\ 2&^K\5J
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MV"/^"AY^)5U#\*/B](="^)]E*;"VO+Z/R/[4D4E3%(I \NY!&TJ<;ST^;Y:
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MJG_R-1_P]&_9B_Z*9_Y0-4_^1J^5?^'&/_5;/_+4_P#NVC_AQC_U6S_RU/\
M[MH ^JO^'HW[,7_13/\ R@:I_P#(U?%G[?7Q"_92_:4TZ3QGX*^)<.B?%/3X
M]T<JZ#J<4>KJ@RL4K?9AME&,)*>G"M\N&3J?^'&/_5;/_+4_^[:/^'&/_5;/
M_+4_^[: /SQ^-GQ\\6_M!:EX9U/QI>+J>L:'HL6AKJ+#$UW%'--*DDQ_BD_?
ME2W&X("<L6)_H-_9._Y-9^#?_8F:-_Z0PU\ ?\.,?^JV?^6I_P#=M?I3\)_
MO_"K_A7X-\&_;?[3_P"$=T:STC[;Y7E?:/L\"1>9LW-MW;,[=QQG&3UH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cccc-20240429_g6.jpg
<TEXT>
begin 644 cccc-20240429_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !@ & # 2(  A$! Q$!_\0
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MHW4__H,J5U?@/_@B#JMQ"DOC3XGV=E)@;K30]-:X&?\ KK*Z>_\ !7K6F_\
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M.\ZUE@_UOVI]N/-W?=.=N.,Y !]_T444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cccc-20240429_g7.jpg
<TEXT>
begin 644 cccc-20240429_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !@ & # 2(  A$! Q$!_\0
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MEOX8?LU_\*N_X5QX9_X1S^VO[4^W_P"GW5UYWD_8_*_U\K[<>;)]W&=W.<#
M!^NWP;^*^A_'+X8^'O'?AMY6T;6K;[1"LZA9(R&*/&X!(W(ZLIP2,J<$CFNS
MKY5_X)<?\F)_#+_N)_\ ITNZ^JJ "OE7_@J/_P F)_$W_N&?^G2TKZJKY5_X
M*C_\F)_$W_N&?^G2TH ^5?\ @AC_ ,UL_P"X)_[?U^JE?E7_ ,$,?^:V?]P3
M_P!OZ_52@ HHHH **** "ORK_P""YW_-$_\ N-_^V%?JI7Y5_P#!<[_FB?\
MW&__ &PH ^JO^"7'_)B?PR_[B?\ Z=+NOJJOE7_@EQ_R8G\,O^XG_P"G2[KZ
MJH *^5?^"H__ "8G\3?^X9_Z=+2OJJOE7_@J/_R8G\3?^X9_Z=+2@#Y5_P""
M&/\ S6S_ +@G_M_7ZJ5^ /[#'[<__#%O_";?\43_ ,)C_P )+]A_YBWV'[-]
MG^T?],)=^[[1[8V]\\?57_#\[_JB?_EU_P#W%0!^JE%?E7_P_._ZHG_Y=?\
M]Q4?\/SO^J)_^77_ /<5 'ZJ45^5?_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\
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M9V)9A]U3@9)P 2/ _P#C6+_G_A)Z/^'&/_5;/_+4_P#NVC_AQC_U6S_RU/\
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-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cccc-20240429_g8.jpg
<TEXT>
begin 644 cccc-20240429_g8.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
M^ )8 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3_)FQ11170=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5SOQ5^+7PT^!_@>]^)/Q;\:Z?H&AZ>FZZU'49PB ]E4=7<]%1068\
M$UXK^WM_P4M^!'[!_A@P^)[H:[XQO+<OH_@[3[@">0'I+.V"+>'/\; EL'8K
M8./Q#_:\_;<^/_[:_CP^,_C1XJ,EM;NW]C^'['='8:8A_ABBR?F(QF1BSM@9
M8@ "HQ;)E)(^N?V^O^"\OQ(^*TM[\,OV/OMGA+PVVZ&X\5RC9JM^O0F'_GS0
M]B,RG@[HSE:_.Z]O;S4;R74-0NY9[B>1I)YYI"SR.QR69CR22223UJ.BM4DM
MC)ML****8@HHHH **** "BBB@ HHHH **** "BBB@ KVS]G0_P#% 7 _ZC$O
M_HJ&O$Z]K_9S_P"1#N1_U%Y?_14-?/<5?\B"M_V[_P"EQ/DN.O\ DE<1_P!N
M?^EQ.]HHHK\</YX"BBB@#Z$_X)V^+/A_I_CWQE\-/'_B.TT5/'WP_P!0\/:=
MK%]($BM[B<*%5W/"!@#R?XE4=Q7H_P"P+\!OB!\%/BSX^UGXN6%E8:3IOPXU
M6/6(_P"U[:8SP$QDMLCD9C$0C$.1M.WKGBOD3PWX>F\3:D-.BU33[(!"\ESJ
M5ZD$2*" 3ECECS]U06/. <&O5-;^,WA#X3? S4/V??@GJ;:C=>)IHY?'?C!8
M'A2]2/)CL;5'"R"W4DEG<*\A9AM5>#[> QE*E"$JJ_A<SCKO?I:VNO72RO>^
MB/J<HS*AAZ=*IB(_P.9Q:=G)O:/+9W][=II)7O?1&SX"^/7PPUWX??";PO\
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MH@HKY]_8<_X*-_ S]M_P^+?PQ=_V)XNM;?S-6\(ZA.#/&!PTD#<"XBS_ !*
M5R-ZKD9^@J_",;@<9EN)EA\3!PG'=/\ K5=FM'T/Z>RW,\!F^#CBL'452G+9
MK\O)KJGJNJ"BBBN0[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"GAVVU>*UN3']G>[EN;B;R7#,L 1%544&5BQ^5=AYO\ ;._9>G_9A_:CUOX
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M.BBBOQP_G@**** "BBB@ HHHH **** "DEN]/TRSN-9UB1EL[*$S7)0X9ER
M$7@_,S%5'& 6!/ )I:X#XV>+/-O%\!V$O[FPFWZBP)Q)= %=OTC!*=/O-)R0
M5K]#\,^"JO&_$L,--/V%/WZK_NI_"GWF]%V5WT.',<;' 85U.NR7=_\  W9R
M/B?Q%J'BS7KGQ#JA7SKF3.Q,[8U "K&N22%50J@9. H%4***_P!!:5*E0I1I
M4XJ,8I)):)):))=DC\WG.523E)W;U84445H2%%%% !1110 4444 '3I7Z\?\
M$</^"EG_  NG0;7]ECXYZ_N\7Z5:[?#.KW<OS:S:1K_J78_>N(U'7K(@R?F1
MBWY#U<\/>(-<\)Z]9>*/#&K7%AJ.G74=S87UI*4EMYD8,CHPY5@0""/2OG^)
M.'L)Q'ESP]722UC+K&7^3V:ZKSLU]5P?Q9CN$,WCBZ&L'I.'24>WJMXOH_)M
M/^FRBOFS_@F9^WEHO[;?P42YURX@M_''AZ..W\5Z='A?-8C"7D:_\\Y<$D#[
MCAEZ;2WTG7\MYA@,5EF,GA<1&TX.S7ZKR>Z?5']M95FF"SK+J>-PDN:G45T_
MT?9IZ-=&K!1117&>@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7)_'3XU> /V=?A+KOQH^)^K"ST70+%KB[D&"\AZ)%&"1ND=RJ
M*O=F KK*_%+_ (+F?M]M^T%\8?\ AFCX::WYG@[P/>LNJ36\F8]4U=<H[9'W
MD@!:)?5C*W(*D5%78I.R/E7]KW]J;XA?MC?'?6/CA\1+@K+?2>5I>FK(6BTV
MR0GR;:/V4$DG W.SL1EC7F5%%;& 4444 %%%% !1110 4444 %%%% !1110
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M\4X.-TF")A]WB0,0JA59.M8NK_#F_C@EU/PK>#5[*)&>4PQ;+B!!DEI8<DJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KV']F[_D7-0'_ $^C_P!
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MY3_T$UY%7KG[-9_XE.J#_IYC_P#037SW%7_(@K?]N_\ I<3Y+CK_ ))7$?\
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M."48I;))627HC\VJ5)U:CG-W;U84445T$!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'ZG_P#!NAXM^T^#?BCX$>7'
MV/4],OXD)Z^='<1L1_WX3/U%?I37Y%_\&\7B22T_:2\<>$!)A+_P0+PKGJ8+
MR! ?RN#^=?KI7\S>(E#V/%M=K:2B_P#R5+\TS^R_"3$O$<"89/>#G'_R>37X
M-!1117Q!^DA1110 4444 %%%% !1110 4444 ?BI_P %W]9_M3]O&:QWY_LW
MPAIUOCTSYLV/_(OZU\95]5_\%JKDS_\ !1;QK$6SY-EI* >G_$NMV_\ 9J^5
M*_K'A6"I\-8-+_GW!_?%/]3^%..*CJ\8YA)_\_JB^Z37Z!1117OGRP4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $MI?7-D6
M$$@VR "6)T#I( 00&5@589 ."",BJE[X<T+4P9+)_P"SI\?<;<\#\>O+H>/]
ML$M_ !4U%>%G7#>49]3Y<73O+I):27H_T=UY'T_#O&'$'"]7FP-9J/6#U@_6
M/3U5GYG.ZKHNIZ),(-3M#&7!,;A@R2 $@E&4E7&01D$C(-5:[&&\EB@>T8+)
M!(<R6\R[D8X(S@]" 3AA@C/!!JE?>%=+U)C)HLXM)F/_ !Z7+_NB2>B2'[O4
M !^  29.U?C&?>'.;99>KA/WU/R7OKUCU_[=OZ(_HKA;Q=R'.N6AC_\ 9ZK[
MO]VWY2^SZ2LEMS,YNO5OV:#^ZUD?[5O_ .U*\OO].OM+N#::A:/#(%#;9%QE
M2,AAZ@CD$<$=*]0_9D5I?[8B1<LS6P ]2?,K\<XJA/\ L.M"VONJW6_/$^MX
MXE&?"E>47=/D_P#2XGHGB7Q#;>%=#GURY57,>$MX6!Q+*<[5..W!8\CY5.#G
M%>*WEW<ZA=RW][.TLT\C232N<EV)R2?<DUT'Q.\7IXHUP6UA-NL;'=':D9Q(
MQQOEY_O$#' ^55R,YKFZ_I3PEX&7!?#<77C;$U[2J=U_+#_MU/7^\Y=+'\<Y
MUF'UW$\L'[D=%Y]W_EY!1117ZF>.%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'V?_P $'=<_LG]N]+#?C^T_
M!VHVV/7#0S8_\A?I7[4U^&O_  11N_LW_!1/P=#G'GZ?JT?UQI\[?^RU^Y5?
MSQXIP4>)8OO3B_QDOT/ZT\$:CGP=-?RU9K_R6#_4****_-C]@"BBB@ HHHH
M**** "BBB@ HHHH _";_ (++2.__  4B^(H<8VC2 OT_LBRKY@KZI_X+36WD
M?\%&?',N/]?::2__ )3+9?\ V6OE:OZUX::?#N#_ .O5/_TA'\'\8IKB[,+_
M //^K_Z7(****]L^;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^XQ:***_7S\ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK6\ ^#]3^(7CK1?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOP^T%J_YI/64GZO[E9= HHHKR3W0HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2:W:**_GR<YU)N<W=O5M[M]V?U;3ITZ--4Z:2BE9):));)+HD%%%%26%%%%
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MW;SM9'?E^6XG,ZKA1<597;G.%.*UM\4Y1C?717N^BT/G6BO<_P!L#]F+X)_
M#POX&\6_!K]HBY\?6?C>QO+ZWEG\)RZ48;:&;R%EV32&0AY5F49501"2"00:
ML?L2?L1ZA^UA-XEUW6_$YT+P_P"'="O;H7BQJTM_>0P&5;:%6/S87#R-R$4H
M#@R)GG><8".7/&RDU35]XR3NGRM<K2E>ZM:QUKA_-99LLMC!2JNSM&49*SBI
M)\T6XVY6G=/\3P2BO4O@7^SY8?$/X8>/?CQXXUF[LO"GP^M;$Z@FFPJ]U?W=
MY<>1;VT6\A4&=SO(=VU4^ZQ85%^U)^SP?V>_%>@1:5K\FJ^'_&'A&P\3>%]1
MGMQ#-)8W:%E29 S!)4971@"0=H88W8&T<PPDL6\,I>^KK9[I*35]K\LD[=GY
M,YI93CH8!8QQ_=NSW5[.4HIVWLY1E&_=>:OYE179^/\ X86'PX\!^';SQ#JD
MP\3Z_"=1;150!;#3'4?9I)3U$L_S2JG&(?*<Y\T;>,KII585H<T-M?PT^[SZ
M]-#CKT*F'GR5%9V3MVNKZ^?=;K9ZA1116AD%%%% !1110 445H>%?"GB?QSX
MCL_"'@SP_>:KJNH3K#8Z=I]LTTUQ(>BHB@EC]*4I1C%RD[)%1C*<E&*NWLC/
MK[G_ .":G_!(/Q;^T;<V'QH_:*TV\T3P""L]AIC[H;S7UZC;T:&W/>3AG'W,
M ^8OOW_!.C_@BIHOPWDLOC/^V!IEIJNO(5FTOP866:TT]NH>Z(RMQ*/^>8S&
MO<N2-OZ)*JHH1%  &  . *_'.+_$:,%+!Y3*[VE4[>4/_DON[G]!\ >$4ZCA
MF&?1LMXTGN^SJ=E_<W_FMK%T/"GA3PSX%\-V7@_P;H-II>E:;;+;V&GV,"Q0
MV\2C 157@ 5H445^*2E*<G*3NV?T;&,8148JR6R"BBBD4%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?#X2C&C0@H0CHE%))+R2T04445D;!1110 4444 %%%% !1110 4444 %%%%
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M^;9^G9-X><(9&U+#X6,IK[4_??JN:Z3_ ,*0V&&&VA2WMXECCC4*B(N H'
M Z"G445\N?:[!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'Y9?M"?\%'?VS? WQ]\<>"O"WQD^RZ9H_C#4
M['3K;_A'M.?R8(KJ2.--SVY9L*H&6))QR2:X_P#X>C?MU_\ 1<O_ "V=,_\
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M'GCGQ%XF\!Z\=,O_  _]MLH'&Q29)I9A(\,8R"L:(\KS<E5PK%0#Z-\=^/\
MP1\+_"MYXX^(GBJPT72+"(R7FHZE<K%%$H]68]?0#D]!5;X5_%/P%\;/A_IO
MQ2^%_B!=5T'6(FDTW4$MY(A.BNR%@LBJP&Y6'(&<9'!!KQGX6_M>_#S]M7]C
MSQQX^\(Z+?Z3=Z?HVJZ7XD\-ZQ&%NM,O$M7WQ2#^($,"&P,\@A65E'GG[&?[
M1?@O]EC_ ()&_#KXO>.+&]O+>VTM;6TT_3HU:>\NI[^6*&%=Q"KEF&68@  G
MV(!]DT5XMHG[6.NZ3^TIH7[+_P 9OA.OA[6O%>@7&J>&=0TK7AJ-G="W!:>W
M=FAA>*9%&[&QD(Z.>,\UI_\ P4!UGQ-\;/'_ .SSX(_97\9:AXM\#06+_P!E
M37UA#]L-S&TH=Y_.:WMX1'Y;!FE+MYH CW*R@ ^CJ*\G_9"_:LT?]J_P-K.O
M)X(U#POKGA?Q-=^'_%7AK4YDEET[4+<KOC\Q/ED7### #D,,<5U?QM^-/@GX
M _#^X^(GCN:X-O'<0VMG8V,/FW6H7<T@C@M8(\C?+)(RJHR!SDE5!( .MHKP
MR[_;'USP%\?/!7P'^.OP7N/#4_Q%CN1X2U73M;34H6N(%#R6UT%BC\B3:R\H
M94RWW\ L*/B3]N+5+D_$_5/@_P#!E_$^D_"&YFM?%UY=:^MA-/<P0^=<PV41
MAD\\Q)U,C0AFX0MP2 ?0-4/$WBCPWX+T"Z\5>+]>M-,TVQB\R\O[^X6*&%.F
M6=B .2!]2*\MO/VS/A]=_!/X?_&+P=I=QJ!^*-_8Z?X,TJ\F2U>:[NHWD6.>
M0[EA"+%*78!^4P@=F4-T'PR^+GCKQ7\3/$7PH^(GPF_X1^]T'2;"_CU"TUD7
MUCJ45U)<H/(D,43_ "&V8,'1&!8<8(9@#7^#7QL^%W[07@6'XF?!WQ;%KFA7
M%S/;V^I0021I))#(T<@42*I(#J1N P<9!((-=57YR_\ !.W]J;QI^SM_P34T
M_P 4^#/V:_$/C72O#%]K5]XJU"RU"VL8-.M4O9I',?GG?=.L>798D*J!AG#?
M+7WY\+/B/X:^,/PUT#XK^#9I)-)\2:/;:EIS3)M?R9HUD4,N3M8!@",\$$4
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M_P#+)_\ NVORC$<-9W.O.4:6C;^U'OZG\]XS@;BFKBZDXX>Z<FU[\-F_\1\
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M)XZU]BU@ZU\*_AAXDU236_$7PXT&_O9=OFWE[H\$LK[0 ,NRDG   YX %;U
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M7&XDJ0"1J_M$?MS2?LW? [P;\>+GX(76I^&/$L&G)<3V6LPPC1I+M%:(3!T
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M4.GZ]XYN;BW\*Z?);RL;^2!%>50R(53 =>7*@E@!DG%==7BGQI_:B\-?#/\
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MG]@^(-&M+FS^T6BJ0CSOLD=&;S-ZK'$TN1&SLZ)AJ]8U/]I+5O$7Q4U_X._
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MF]A0!ZI\??V>OB1\?=2T?Q5\)?VQ/%7@+3(M+5%M?"<=M-;WP9BZS[G!SE2
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M?A?WV03G?G.:34_A=\,];M;2QUGX=Z%=P:? (;"&ZTB&1+:,8PD892$7@<#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cccc-20240429_g9.jpg
<TEXT>
begin 644 cccc-20240429_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT2X_O?9-7FAS_P!]*]>''BS)7O-K_MUGS,/$+A>3UJ->L9?HF?HS17P=H?\
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MG3!<LS'.V-%R-\C8.%R.A)*JK,/(/'7CG4?'&J"YGC^SVD *V-BC[E@0]<G
MW.< L^!D@8 4*H?X^\>7_CC44=HC;6%MN6PL5?(B!QEF/&Z1L#<^!G   554
M8-?W-X6^&&%X(P7UK%)3QE1>]+=03^Q'_P!NE]I^21\)G&;/&R]E2TIK\?/T
M[+YOLBBBBOUT\,**** "BBB@ HHHH *5'>-PZ,593D$'!!I** /W1_X)+_MJ
MG]KK]G&'3?&&K";QKX.$>G^(C(^9+N/:?L]X?7S%4JQ_YZ1N> 17U/7\^?\
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MB]\/0?J_T7ZOY!1117]*GR@4444 %%%% !1110 4444 %%%% !1110 4444
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M?VAX.U&WQGK@PRX_\A_I7[4U^&G_  12O&MO^"B?@V$-@7%AJT9'KC3YW_\
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M*** "BBB@ HHHH **** "BK.EZ1J>M7!M=+LGF=5W/M'RQKD#<S'A5!(RQ(
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MQYC\5+'8ZKB);SE*7WML_P! LKP4<MRRAA([4X1C_P" I+] HHHKD.\****
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MY)3X<R##Y?#[$=7WD]9/YR;MY!1117D'OA1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7YC6K5L15=2K)RD]VW=OU;/VC#X?#X2C&C0@H0CHDDDDO)+1!11161L%%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1-/EO+C3=%-N+AXHT+NR^?+&APJDXW;CC"AC@$ Z:BODK4?^"I.IP?LWZ/\
MM8Z/^R1XNO\ P-+;1W'B;64U2TB&EQO/Y/[F.5EEO2I*[F1%C!;'F$J^WO\
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M0#W%?)7[54:#_@JQ^RM*$&XV/C0%L<D#23@?J?SKZU/3I0!R/@[X\?"7Q_\
M$WQ3\'/"'C*&]\2^"C:CQ/I:6\JM9?:$+PY=D"/N4$_(S;>C8/%==7AGP,_:
MOT+XL_&[XN?#71OV?]:T37_AXFE_VTMV]@+W6)+B*=X4!CF,6!'$NQGFQB49
MV8-<1X,_X*6^*?BQ\*O%/Q(^#?['/C'79O".OW]AK.ESZK9VGV6*T1&D=Y7<
MH\QW.!;P><P\O+$;X]P!]545X]HW[;OP:UG]E?0?VLX?[1.B^)(K>/1M(BMU
M>_N[^:;R(]/BC#;7G,X:+&[;E2Q8*"PSI?VQ=:\$?M!^#?V??CG\&IO#=U\0
MK>Z?PEJNG:VNI023VZAY+:YVQ1F"4(5.5\Q,L/GQDT >Y45Y%XK_ &E?&5Y+
MXJ7X!_!:3QQ'X*NY+/7)VUZ.P6:]CC626SM-T<GVB:,,H?=Y<89M@D+JZKYQ
MXS_X*J?"C1OV2-"_;!\$_#/Q'XA\/:UJ"6$Z0RVL!TF[,OE&&[WREU(8'!B2
M4'Y3D!E) /J2BOGS6?V[=2\&_'GP=\+OB1^SCXG\.>&_B#J;Z;X0\9ZG>VV+
MN\"[DCELT9IK429&SS=LGS#=&N'V\7XL_:=_:4C_ ."G<7P%T;X1K=:'I7PM
MO-5T_2X_$D,+ZDLVHV\']H2LP*)L,#I'#RX65F)&_:H!]$O\>/A+'\;D_9Q?
MQE"/&K^'SK::']GEW&P\WRO.\S9Y?WP1LW;\<[<<UUU>)Z5^U%X<U7]N*Z_9
M7G^"FHZ?XBM/ <VM1>*M2:T"W=BMVD*)"87DD,3R%F^<H08SF/D&F? /]L'5
MOC-^T)XZ_9SU_P"#T_A?6?A_';2:NU]K<<WVI+@,T,MLJ)F2,J Q8E=N] 1D
MD  ]OHKRFS_:@L=,3XD>(_B-X8BT'PK\-KI[>_\ $PU3[1'>R)!%.ZPQK&')
M59DC8=?.S&N\J37)?%+]N;6O@!?>$_$'[0'P%O\ PSX,\8:Q#I=KXC_MV&YG
MTJYF4M"FH6J*/(#!7+-%),$VG)S@4 ?0=%,N)6@MWG2!Y2B%A%'C<Y Z#) R
M?<@5\O:7_P %)O$/CG5_'G@WX0?L>>.?$7B;P'KQTR_\/_;;*!QL4F2:682/
M#&,@K&B/*\W)5<*Q4 ^C?'?C_P $?"_PK>>./B)XJL-%TBPB,EYJ.I7*Q11*
M/5F/7T Y/056^%?Q3\!?&SX?Z;\4OA?X@75=!UB)I--U!+>2(3HKLA8+(JL!
MN5AR!G&1P0:\9^%O[7OP\_;5_8\\<>/O".BW^DW>GZ-JNE^)/#>L1A;K3+Q+
M5]\4@_B!# AL#/((5E91YY^QG^T7X+_98_X)&_#KXO>.+&]O+>VTM;6TT_3H
MU:>\NI[^6*&%=Q"KEF&68@  GV(!]DT5XMHG[6.NZ3^TIH7[+_QF^$Z^'M:\
M5Z!<:IX9U#2M>&HV=T+<%I[=V:&%XID4;L;&0CHYXSS6G_\ !0'6?$WQL\?_
M +//@C]E?QEJ'BWP-!8O_94U]80_;#<QM*'>?SFM[>$1^6P9I2[>: (]RLH
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M70$ ^I_ 7CGPM\3O!&D?$?P/JOV[1=>TR#4-)O1"\?GVTT8DC?9(JNN58'#
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MCYXRZDHW Y7!XJ>Q\,>&],UF]\1Z;X>L;?4-1V?VA?P6B)-=;!M3S' W/M'
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M!^$],T338F+1:?I%A';0(3U(CC 4$_2@#3HHHH **** "BBB@ HHHH ****
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M?_D.O*OVZ_\ D]WXQ_\ 95?$/_IRN*\KK=)6,&W<^J?^'V/_  4X_P"CF/\
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M&O$NB?#7P;X6?7_%_B'3IM0L=%6]6WBMK.$QK+=W4Y#>3"'EBC!5'=GD 5"
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M_5Z__F-__OC6RE$Q<97/RMK]I_\ @W)_Y,B\4_\ 95;[_P!-NF5Y5_Q#-?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140443939611856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">C4 THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001662579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140443791573408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Table Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for PEO</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actually Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">to PEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Table Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-PEO NEOs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actually Paid to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-PEO NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Return</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Loss <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,790,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,311,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,604,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,945,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128,175)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,595,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,606,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,509,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,156,954)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,892)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">952,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,937,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,013,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The PEO for each of the periods presented is Mr. Hirsch. The Non-PEO NEOs for 2023 were Dr. Reyno and Dr. Fisher, for 2022 were Dr. Scott Boyle, our Chief Business Officer, and Dr. Fisher and, for 2021 were Lauren White, our then-current Chief Financial Officer, and Dr. Fisher.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 3,790,099<span></span>
</td>
<td class="nump">$ 2,595,395<span></span>
</td>
<td class="nump">$ 952,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 4,311,539<span></span>
</td>
<td class="num">(21,606,202)<span></span>
</td>
<td class="num">(79,705)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts are computed in accordance with Item 402(v) of Regulation S-K by deducting and adding the following amounts from the &#8220;Total&#8221; column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</span><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Non-PEO NEOs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Compensation from Summary Compensation Table</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,790,099</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,604,322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,595,395</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,509,439</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">952,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,937,239</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments for Equity Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments for grant date fair values of equity awards granted in the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,804,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(891,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,624,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,844,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,395,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-end fair value of unvested equity awards granted in the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,110,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,362,669&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356,546&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,172,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-over-year difference of year-end fair values for unvested equity awards granted in prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(198,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,018,970)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,349,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,356,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(167,996)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values at vest date for equity awards granted and vested in current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,718&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216,575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Difference in fair values between prior year-end fair values and vest date fair values for equity awards granted in prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(693,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(113,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,002,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(932,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Adjustments for Equity Awards</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521,440&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341,503&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,201,597)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,666,393)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,031,905)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(923,929)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid (as calculated)</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,311,539&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,945,825&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,606,202)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,156,954)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79,705)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,013,310&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 1,604,322<span></span>
</td>
<td class="nump">3,509,439<span></span>
</td>
<td class="nump">3,937,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 1,945,825<span></span>
</td>
<td class="num">(2,156,954)<span></span>
</td>
<td class="nump">3,013,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts are computed in accordance with Item 402(v) of Regulation S-K by deducting and adding the following amounts from the &#8220;Total&#8221; column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP):</span><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Non-PEO NEOs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Compensation from Summary Compensation Table</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,790,099</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,604,322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,595,395</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,509,439</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">952,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,937,239</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments for Equity Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments for grant date fair values of equity awards granted in the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,804,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(891,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,624,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,844,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,395,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-end fair value of unvested equity awards granted in the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,110,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,362,669&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356,546&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,172,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-over-year difference of year-end fair values for unvested equity awards granted in prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(198,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,018,970)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,349,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,356,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(167,996)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values at vest date for equity awards granted and vested in current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,718&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216,575&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Difference in fair values between prior year-end fair values and vest date fair values for equity awards granted in prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(693,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(113,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,002,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(932,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Adjustments for Equity Awards</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521,440&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341,503&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,201,597)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,666,393)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,031,905)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(923,929)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid (as calculated)</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,311,539&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,945,825&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,606,202)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,156,954)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79,705)</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,013,310&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><img alt="2401" src="cccc-20240429_g10.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><img alt="2403" src="cccc-20240429_g11.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><div style="margin-top:6pt;text-align:center"><img alt="2401" src="cccc-20240429_g10.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 17.05<span></span>
</td>
<td class="nump">17.81<span></span>
</td>
<td class="nump">97.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (128,175,000)<span></span>
</td>
<td class="num">(83,892,000)<span></span>
</td>
<td class="num">(83,892,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Mr. Hirsch<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding &#8220;compensation actually paid&#8221; to our principal executive officer, or PEO, Mr. Hirsch, and to our non-PEO NEOs for each applicable year. The identity of our NEOs other than Mr. Hirsch may vary year-over-year and the identity of which NEOs are included in this table is determined based on those executive officers who were NEOs for the years presented. Compensation actually paid to Mr. Hirsch and our other NEOs is impacted by the fair value of their equity incentive awards, which is calculated in accordance with the provisions of FASB ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See Note 2 to our audited consolidated financial statements appearing in our 2023 Annual Report for a summary of the assumptions underlying the valuation of equity awards.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Shareholder return provides the value of common stock as of December 31, 2023, December 31, 2022 and December 31, 2021 assuming $100 was invested in our common stock after the market closed on December 31, 2020.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 521,440<span></span>
</td>
<td class="num">(24,201,597)<span></span>
</td>
<td class="num">(1,031,905)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,804,021)<span></span>
</td>
<td class="num">(1,624,400)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,110,779<span></span>
</td>
<td class="nump">284,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(198,377)<span></span>
</td>
<td class="num">(18,018,970)<span></span>
</td>
<td class="num">(3,356,456)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">106,718<span></span>
</td>
<td class="nump">158,875<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(693,659)<span></span>
</td>
<td class="num">(5,002,002)<span></span>
</td>
<td class="nump">2,324,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">341,503<span></span>
</td>
<td class="num">(5,666,393)<span></span>
</td>
<td class="num">(923,929)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(891,745)<span></span>
</td>
<td class="num">(2,844,379)<span></span>
</td>
<td class="num">(3,395,354)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,362,669<span></span>
</td>
<td class="nump">356,546<span></span>
</td>
<td class="nump">2,172,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(34,088)<span></span>
</td>
<td class="num">(2,349,947)<span></span>
</td>
<td class="num">(167,996)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">17,814<span></span>
</td>
<td class="nump">104,252<span></span>
</td>
<td class="nump">216,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (113,147)<span></span>
</td>
<td class="num">$ (932,865)<span></span>
</td>
<td class="nump">$ 250,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>39</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="cccc-20240429.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cccc-20240429.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="cccc-20240429.htm">cccc-20240429.htm</File>
    <File>cccc-20240429.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cccc-20240429_g1.jpg</File>
    <File>cccc-20240429_g10.jpg</File>
    <File>cccc-20240429_g11.jpg</File>
    <File>cccc-20240429_g12.jpg</File>
    <File>cccc-20240429_g2.jpg</File>
    <File>cccc-20240429_g3.jpg</File>
    <File>cccc-20240429_g4.jpg</File>
    <File>cccc-20240429_g5.jpg</File>
    <File>cccc-20240429_g6.jpg</File>
    <File>cccc-20240429_g7.jpg</File>
    <File>cccc-20240429_g8.jpg</File>
    <File>cccc-20240429_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="72">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cccc-20240429.htm": {
   "nsprefix": "cccc",
   "nsuri": "http://c4therapeutics.com/20240429",
   "dts": {
    "inline": {
     "local": [
      "cccc-20240429.htm"
     ]
    },
    "schema": {
     "local": [
      "cccc-20240429.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 7,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 39,
   "entityCount": 1,
   "segmentCount": 7,
   "elementCount": 266,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 72,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cccc-20240429.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cccc-20240429.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cccc-20240429.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cccc-20240429.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001628280-24-018785-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-018785-xbrl.zip
M4$L#!!0    ( &Q G5C%(/8$^DL! %#-#  1    8V-C8RTR,#(T,#0R.2YH
M=&WLO6EWV\B2)OR]?P5>]W2W?5Z*)JE=KG(?6HNM*FL9256^-5_F)($DB3((
ML+!(9O_ZB24SD0!!B;)E$Y1Q3_>]%@DF<HF,/9[XY;^_3 +G5L:)'X6__E>W
MW?DO1X9NY/GAZ-?_ZE\?GI[^UW^__;=?_K^-C7^]N_KH'$5N-I%AZAS&4J32
M<^[\=.RD8^E\BN+/_JUP+@.1#J-XLK'!/SN,IK/8'XU3I]?I;>G']+?Q0:^[
MM]\1N[V-[<UN;V-KO^=N[&V[WL;^0'K=_;UMN2-E:W30V=KT.E)N;W1[^WL;
M6]Y^=T,,W+V-G<U.1W1[ W=WJ]?R#K:ZHK.]W16[@^WMK4%GN+>YM[F_W]D;
MP@?N<&^/WCM.8<VP[C Y\+_\^F*<IM.#UZ_O[N[:7P9QT([BT>M>I[OYV@\#
M/Y2X[A?\>.'9NTUZLKN_O__Z"PZI'CJ0KF<>I $3Z;9'T>UK^.(U;H)^T$^B
MK5YW=]$,.C #?D+_ *;S^9ZG\>N!2*1^_$OB5\T8GNV^_M?9QVMW+"=BPP^3
M5(2N^566;(R$F)I?#D4RH-^I+XI+^))NP/(*K]'+S;?O=1J+,$&J$"G0&>[N
M]D9G;V.SJ\?QI%^]9_!%X85?YO:@< [XK7D4QO'OV]S2PO%;KS0-]?#.:_[2
M6G;UP/>MN=?9Z/2 ?FF0@T# #7LAPXT_KE^\_64LA??VEXE,A8/#;LA_,O_V
MUQ>'49C";=NXF4UAFB[_]>N+5'Y)7Q/)O7[[;__V;[^D?AK(MR[\9P/WJK/5
MV__E-7_XRVL>>A!YL[>_>/ZMDZ2S0/[ZPO.3:2!F!V$42IB _^4 'Y0Q_]/W
M/!G2/^'[<[CRL>_R^[^D5W+XZPMW \XN%!,<2?H'QR&\;G8(LXM%<!IZ\LOO
M<O;"\>$F##=Z+]YV@.9V=GK;NS"QPJ"/>(?F/;P9//3FB[='QR=.=ZO_]>/V
M85 /!SX)Q.B%PT?VZPLXXX.A_T5Z&T,1).:-6R_>GO0_7A_/O>]U<=]B.90Q
ML%*95!PWDNE!0O</9N00V1ZDL*Y?7R3^9!H@3=)GXY@F;)]L^TOBP;G3^_*7
MJ'<F41;37T3\!VK5-'5<M?Y<TG'IOWP/_Q[Z,G9H3K+R.A^>_EX\Q_*/W^J/
MBJ-/87LB3_\%5RY.CT!TO(7U;&YTNO!_^G?Y=V::7OXH2(?-;OX*_D;_K5_R
MNK!N/4X6^KP'&6R=_G B19+%\JWBL0=_7!_IG^NO]-_X^^HM[=5M2WO+;VGO
M6[:TN V;==N&[O+;T'VZ;=CZWMN@5B-'R*[X3P]>]F4:^*Z?GLG) %[A^? M
MZ7,O0.,XZ'M_WT2'T63:_^(G+][B1\?_I+/^7>PEI^%U-IG$,_PZ2<.;07 2
MQ?UI, C^BGFT7UY7OF3)=Q]_D6Z6^K?R$+9T%,6S? Z7,GK@#:]+JZTK=RG2
MP'9# TO3P'D4 AF</U-*V&DHH4;<8#6"<;>A@=IQ@]50PEY#"37B!JO1#_<;
M&J@=-U@-)70[=22%;[J27TML?\7'H7<2_RF"BZ$AO/=QF'JGX>%M[/T57V1I
MXH6C?NC]$=XFJ?<LM<7N=_?./#%%+'M!&[KX-KKX[BZFAE.LER;9_>[>MH93
MK"5=U-+]V'"*%6J9M71&-IQBY7112]?D2CC%X3@<G8:*),J'7R:1RSC^*TZ>
MIYI92T_E"EE%0QB*,&KIN&QXQ2H5S5KZ,1M>L7+"Z#5>S?J2Q&I4S5[CUFP(
MHY(P&K^F'OG/) U'1VFE70JD 5\;\_19JIB]6CHTO^M!_2@NM:8$T7@RZ\<;
M5J12UM*%V?"&U1%$X[NL'V]8D0I92Y]EPQM61Q"-K[+"S.PG%T-%@1=#LB@-
M!3Y_TZ)Q539T44$7FXVGLK84L:(2QL91V=!%%5TT?LK:4L1JM,S-6KHK&TZQ
M<KIX?E[+-57N:NDSK(%5OJ+C>'X>NS5596KI+ZO!O5C1<3P_;]6:"N[GZB2J
M_W&\+J)6O;9@R%Y[_BTCEN$I^0\A^_U?M-_SWRB4LXD?;HPEP@\>;&U/TS=W
MOI>.#[J=SG^\H.?>_I),1:B?=J,@B@_^'<ZR,QR^&<(D-X9BX@>S@_^Z@<-)
MG'-YYUQ%$Q'^5RL18;*1P++4@XG_/Q(&AG?0GW?\TMU.YPTBPNE)='N=_WB#
M2]_PI!O%! UWD(6P8'P*YB1J,Q>'L<?^?8F=!X/H1@P"^<MKL;XK<**AL]8+
M4&"!"2WB-=*UOA#F6C"YO_UE$+\N/4+_E>(AZM4/HACFL0&;$(AI(@_T/]YH
MY$#&.MR@'[V9B'@$=VT0I6DT.<"K=BOCU'=%L"$"?Q0>T"KYZ_P6MCM\$U.X
M[ZFGWZR^;L-7K^<_W]]K[W>JO^JTN_3Y:QHOUE^JS=Z<IB_H-[ 27/JO+S9?
ME!:KI@]/.EZ4X6;@Z;^9"@\!40\Z3A?&T"]X32NO8CJ\%VDT90J@I?,NN'!
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M2&2'T4C/D;H0$SX>@B2,DV=[D)OU.T@4=,.93FV-_##58;;?+\_>.Q\_7F+
M%$\+=Q".$+<1;AP&#B5Z!*?9 $2K(UPWPOL*W&#HQQ-*#B/.[R=@]#@SN+J.
M)$)QCJ1+!;3,CC:[K&*\00;P3,]]JW[GCE%?L'/@$H<Z+7V0)?#;)$$E8 IJ
MS\P9Q%$&XP"SAN.45?(=3AD'$-[?0"(ADT[L@$*03J-0:E*JTAW63D\G90=V
M)DI@&9J\27@IEI:+57*JPIN3*)"PC< *R\\ND,=AA,&:-*\%F9?,;<ZNK%3M
M6T4Q##^+49?U'&5*N('2U,Q1PVSZT]@/E+J_J8PHK<Y3*3O6,, 26)5/JZ@
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M19DS$3,':TA5*L9$S1/TGA0F%,S@7X*^.2534*8XH#Z^BI/HRDWQK8R11CS
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MI0HJ4Y]99Q!'GT%+@.\XQ*E,_%<M^ YN.+=4,O7?.,AD0?JASK[B$"V.2 7
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MSPB;*P:$A8WN.!1VN&J\*KJF&74L86JZFQ)5S5<V%Y>H-M6F-2UU;*I-5[Z
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M?^/>+4-?L@<G$6-42\W+CZV(5E4(JH0=:1IQ/E3:F+<^ISY=&6QA#,0#0_*
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MER!@56"Z/-&^4HDIME*"6V "AHLFE;  (RNYA]$I!/M(G,\A6$1<NZW*O13
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MOLKMH E0X(#T&QZV!=_K!SZ=WGSX</'QR.K*PSCYQ1]@OHCOWSNJ-DC8XT&
M=!0?]MW\$4I!A$5-2#N<?S?G6:A#T<A.'K^*H'5]%XR"W$OYTICG>,1L&>!A
M*E-!NP@H647IE3D.%(ZM%F2K?]I!0'8('(MZEXF5#,6M,LSRO+<P<N1P*-FT
MP(.*LA2(R9"9)E6C&"^Y[?BH/F1/RHGJIT#6#/M%D'WBIJH5P^LK+FPK[P9C
MC+-'S%ZSXN6MI(85_QA6W*L!*^X;R0T&>7Z[=%B2/RG&)A>%)C5.8&4H,N?E
M\)XAFH9D)!EVOM"QNQ+F_I<-. 7\J^7TW_=/SZ]O\$7]=]<W\(?A!NKOAV]R
MK[7X%J>ZZ9&ZR\02Z?7ZS86[W%SE>EWES1I<Y9M'!IJ;*PGG]N.O9&U,ND\Z
M8D,Z#JV1SE94NH"+FM<CNHXU+.C;\TCZH4VB)HA90C$W2JY]F]UQA.G."&\K
M77R77=LA+.V0 E^%S@*@ F#$@)SUB/AJI463;NVCYS492U9]6:,M7#G\D4[&
MA5OJE[-X*X%U&:@=?^H"<8 B&YN2U)S_*"AM5V08];,IEOD&?Z^\$WH**356
M*^5 6H##)C)8Q9<699;GIDNK,(]\_,P4(BT*4S(?P9=3_R\<A_]IQ2*-R4)E
MQ(RS+!+MCE%!IOP\D1&[(B$KE$),EH?&9ENY%" ^^!@Q\/CM<E[*]JC=JN+#
MK]K.A^A.WA)I2#K7LC%381K!@%4!NU>6V65JXBAZ4O0CM,B YQ-0$]9CY%8O
M6_#ZF,B&K[3?6TZH>M#89! N#GE;HZ@(U\P*<<U9<E;X$ \^B+B#@R$0^<5/
MTG($#VEEL:G(NUBA,SQH"+"HCK1\?KP]\+)"/5X^'ZV1*4\@4RH%._\5N6X6
M)XP LC3+5FR!DX_G@-N]R'(**=F3NX0,9=MW_X'WFA%+Q8N"Z9/:(%#3S'+8
M;R[H#"/P2*8$J0J,157@5H/2YWRQK9H#E!0FRU5UCU1P1>!2X/QKDE?F8J'+
MRIXPHSQ1=KW!(YC 4&@.6NU^LY8T$9^MM*E)1%TWA.=CU6>*>@%%?@OSH\,$
M_8&D#IW,O._*T(J5L='XL7XDERCD7&JI2XF79#HL&4$O)A3H6V4G$13Z$E2B
MK^C&N";MHY#[4.PFH/+V[*>5$Q4]VT7Q;:64+4AV,7FC%7H+7LJ*1G)%;H2[
MH!N'62&#JM2-NZI,B2@'N^'W2X0;\+% -.>".M(PS[/J7N6_N'G=5,P2I5NH
ME"JK!EX5OJ]A3MHG[DL]$9]-9VBU+@51H'5]6#];YZ#/Q6H7J .XG*H"7:Q)
M!;TO]@>9+NRW:ZLK>SHB_%2^C4SB^HJ"N8A7A""(#.K77*-L%?28J[%NF3XN
M>'OQ6B 9<RK<+*_$5D.[8\QZRR\#W6$_!-6C[6">L%$6R<*83(-H)AF]*8=,
M*"J=>2X?@Q+$<D3JA?U42R_>P$'I3F_#+%9H!%10C;G'Y,H2E!P,:^4!X/.A
M<!-_@DTS;8 -^(+[<B:YMH("CM 02$D94TI6#@7IG(!D#$F3N,8,(!X$"X#I
M!&!4./ LT5EU^4FSAEUULJ2(V,1DI+HG@2?Y V1U SBYMNH;47@8>Y*'B3Z3
M.YF3H6[#QRR4- JB0K6G:L]:"K12TZ;. [2*SWU9[X2]>YQEQ&L1OD6*D&MI
MC<(X85@"ZL9J-Q>?U]+6D%\IWJ E3'&MQ=9A"\#\JK>B6)6J,JKC0MNMXKNH
M6UM$W:=TD[]4EY7DG6TM8,(J/1[)''-4%!" M3*2WT#_6:S+#0)RF)13-2FN
MW>0%Y@2RT^0%UF N35[@FBW@&>0%GJKNM8*:H<>HUI'UIM%E[( "J;46S@L5
M*)(($:!H@8XUG5GNZ2*$-><?@@ZIL65%:(-@W?/;-92W6ET47C0ETQ37Y$H/
MY1*B..?U5: #)U(YX%K:3&5#$WU: ^Q]JV.H&@#IC_9U&]%@,H0'DJPU'G]1
M$">'T<1 RZGBM^OCP[:C*\38"N6YM(R"J&!Q\A/5YU%E?Q@<6,1WBIQ)%J3^
M-"BT/.7<.:8L$X;5]/72IW.>X<((W(!L[@G5.IOD%/H%'\XK)PL#(DRUK88
M$1<F)@-]SF;FF#@Y]IU"X^7K\BS9B\FP9@B=;)V(*2P$)20CHTJK4 FKSK;V
ME#AZ769^HG0S[ME)E9"8TPGH3QDB#&D$(A-Q5YHZ&9-PL?Z81J'!1D*K)59!
M(9FD^0'#N),I8KCIDQ;Y$NZY>]IY4^ "&*:BH_7,D<)C3+1WTH)8@L=@HD'^
MAH(?R(M<0KJ"-=SD&UN:%Q)Q"S<VMTMU-,?0'3Q' (UT/+1N8_T0/5-#E+FY
MA, LJ-S>1%U+:\_;UFGXH8P:3[-VFBP/NU(7):\2J&KQ*NHR[?O!L.H__\5
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MVAA&7":M4Z H"<GCY";.+RFFER08 C#US@[Z(MK.4:Q M/4":2BNUS;C88;
M[[$8ILX)K0A!:S%+)J(WG$G/=['R1:3.!Q'?XKOH,P3412CC0+VZU^GTJ&#[
M3@;4/D.+!IVV\IN,$7?^HS]%P*TSC0UU-I,![)MS2'1/Z_TH!]&=<QKJ-"K,
M#]&/V0$@G6-V)$*Q<2)B7/@AUN/$UH_-[#H,JM[I[+8T\CEE]%1MDU_<9@9@
MUB/:NZ*^/!<*):_O"D].*,7LVJ5$#)W,H;?[$MY-22#YP(C9K ?0Z[R.X.?I
MC/,?X32[3A:F?K#P8.D%!M9A$ F5WIGGE, ?G_S0@YTM8DP)9^!'J73'(=#X
M:$;I19@EYTG8G6BJDDC@![[.3U60'$X:2Z&:GDT5L!L"-<!2J/*?RHU</@]"
MRF:X0K@86 OO^0G6B<,$^(1^$V&&9<; H+LMYV@6 C&Z0!5 3#?Z]0H0ZR4"
MX<@82/5*_..+"LRL5[BLP_[5QHWCX@CY O3J.(.V-+?RG*[E--7WJ=?A=,CK
M5,0I;//\2Q=OY3!RLX3R49U!$$6>?K/9P 5OK+S!4>!10SED54P>OT5CV/L/
MT?2S#_];O)TMU9T(<X3QWJ<Q-T7U0\ZG"RE?G*F9%TA9<1*S%<=R(E):28N?
MH2:6+J^-DHBR"9;Y3R:96C"-3JF\#]_,6F>L+2R1'\C E[<J>;R2<?R3P52'
M/F=-<TIJ(?M9]U^!^XAX@GG*5DO_U-4@Z")5"8B*B7SV@Z"0,<T#I#),,+O+
MROY2J?XP&G! S8C@]L/VQ;-Z[OPCQ?=B3]TJ**-5$M)V;KFZVOULA* >Z.^A
M>ZWF;E6;*AY.F#6A&%$'!F V(4,ZGHDOB9@X?6X0!63P\>.AOMT)IR1S#0$<
ML4CE"+@G=J.C6TNHE.H&B^%0^#$!*ZFV=? 8,6Q%-$4>AC^=CD4\$2XQ.T+[
M(#HBF/D3ED^=+@X$PFFG9:]-;0C!/H#J0!(->\M%@23I_2[V$^ P&R#U8$;7
M_V3^8. <1L!*&^ &35I[#?)W#>;28#"LV0+6"OF[^N93)T1$@.*ZF,3Y$QEV
M;D @:_X@!=46$.2T4OVP[XC";:MBL%4<6N1ZH[';4,')+F&6SF6!_ROXJ^[^
M_BXS_4ZW[5 *&LBHV!V3B"N\I&QUVE:*;:10'GH,C!P$NQ^E51IVF&N@%88*
M[@A;)UPO,=R 039 .@;#%K::B$8RE" 8P=S"+I4.*E2(_ERT$>:M&*,)HU E
M/99:]'!PE[3@I"#3E9+NO,-3 >D'(M6%,;"YS"P'#[M&["_G#P8D5$5I2#I_
M1?%GDHZPB+&8I*I^45@JOWG,^K4RQRWSM,X=DY?6L/6>/E*UAF/]-M4:VQ2I
M*Y'[\;A1TCT:=[6J]#Q4[HHPR6IT;9\5[!)_Y";LTK.*_\:"4$TT2+_Z'H@G
MIQDXM_/HUMC<F\!%@>94O6.5;GXX]N70.3;XJIQ03;SK7^3(RHM[T2-@,/5
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M7 X!;^4L.N2D+2Z<R(-K"Q<C,G@C5R#),,EK.L)B2F*EY6[2I!)F7?F"V3A
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MJO1OSY&R298**^DY%RN)IMV!=$66$.JI7XU/8*T&64ZM.4FU]XR/^SJ-,Y<
M2&J\@&I6>#KOK4?RP^N7Z.,1RMVM<JA2DA<NMI^BE!>E#=NX&\04JGXUF'$0
MP-22%C4*/R'T-(X5D23#G@EN(!+%&<VC0*"*1=WO$4>]F'Y??)&)*JCH(SM[
MZ74;Y)_##5"Z!X)DE.Z]3A5%#SZ/?D=9YKQM@NZK1(*?^C&Y^&[L/2V.15.A
M)Z63357"3%XN"[M7R"YB-S25/T3V-5:IDO?OAE*%".K00FSA9+->I[=%&W&(
M*V+;XM066/# ]MP#I_8<8++PT,[\0Z?VR351W1\7U455I_H\B4Q_EZ#UPIT_
M)(9/1H[")78^BBP6SCN,4)K/\( O[H"R/V0CX/1-DL<JC[)\EN] "$GG"%4@
M,([?!W"TSE$V\$,^MR,P< 3V\AD)=9Y-CL7*C[!\AO,&Q!\IYA3_'DVG_F?!
MV5=G(H E3)QK$:0(\K1V2@=M0U%_.)W3'U3"@ 7NH$1<F&DO5%&13<:"A?K0
M_Z)3"0I)K5B53PBC068G[]JQOVJ]9 VW^!A5(Y3KK&L]"FC$P4HH><=0FU;8
M;QB#OH/0?K8!1@IBF/H;J?@LJ6D"'5C"T4@T%"7F&BH@!5"E,*^DE/#!H7?C
M\4 /&2L3231!$XQ[$&A<"&Y*2 8T&& ([0%G-4#\L"E"A/@*C=G+".8[C3$C
MHU6(U^MI,&-DRU6[K"BQ&8:1"-FK:_Z+QJQYM%B=JE4PI#7,KB$@$B8RRHG"
M/57QW4>=!H5,M1&9Z J"6ZR7TU["ZNUW7I)GB'QJI*5RM)CH^Y4R"0TR(JF*
M/E"B0$#7_Y&X8V(D59$N0ALS[C7#K_+FMIU/8S^02J'EM^I;5&$(SZOT*ERM
MD/M*ZG>+_-,>V+'DC,(UH\5I'Z0<8KB"U%H&<\:5LD]33<-R\I&*K[YEAU\:
M1T$+86<&,D!4@=Q-4=XN>*LV\>AV6Y9Z -NX0>8"<!%3NZ35_"*,/67V^%,9
MJ&YXY$F1(<9./,NW9$':9*$RB%H%LSLB.$E%^W9)->QRJ@QMF>ADHKQ'I8\(
MIN1]5CX9:_%DB"" =&HORMYN3,$"TOX$ZXK(&3 1<*:"HS.)M$F/+B:Z[P=9
M.K?#\#1>=]Q5RT>[@&KHBE*EJ0+*Y:W!RY.I8Z 2AVE,<(W#0'XQ;0O09Z8D
M@.D=8^^([E08C;@6D$Y>M2-0W4(3[@1C$K 26$6L"W1:RAU=WD4%Q"T7[%XL
M<>.,%YD.7.6W*9,L0<\R-?;E_J.A-NPXQPZ?#_';G&+MP@JSN'Q?@AF\(0KP
MW(DG\YUF(D205)7L 9PDS#C_C:,,[%]+4@/2:+P"A;RS&LO'^QPW1W*BLQ[A
M+!4$!;<AGLK87\]4J!M=_9U(^9F.,B\4'Q;PF0I@7(4B<HPU47@4_?X(M8Q>
MNP+D$FE*=G6=D;CPQVM."W8&[&*(K-"@$9[X&Z)Y#!SG'*J RD3Q1Q,W-2U=
M4 RI3&5Z)T7:BOA-$@X07=$V\FPA;8M6-V50F4 *C]W&+04&DV/ D#/61VLW
MK40!4B# %DJ!6JYRTLSY.$]3W><03\= #I&3)P=,&$;4<(3T55S), O@RM_Z
M<13JB!6SGN+"R"%-<::()(P"LPVYME7!<7GZLK-0PZ/-TQQY)Q/,]T)"0()I
MTJU,NM56DVY5@[DTZ59KMH!GD&Z5:Z?(R364'^(5(+!1(BF-@>&K8VV H,4W
MC4!44(18:Q3*M-5RD+Y(_43.Q1_G@5JT["D\9H+[=LU"F$-DF1#=D& 4"P4)
MK"@4C<M<#_A_[+UK<]M(DB[\5Q ]EV/'"]$B=6_O;!RU[.[V3/MR+,_T[OER
MH@@6R6J#  <%2.;^^C<O584""%*4+(F@A(W8Z6Z1!*JRLO*>3Y;X*E9+-3G'
MS@HHMQA8)5 ![F)0<;,JIJ5)K=<SNJYS8ZFF(U_,Z5D,$.-9"N7+<?X/>%T,
M/&^)6ZE"\6V7T#S*6"<\^")$*(K"N'*F^,QMTTZ" %?$D2.L):AC#')0]4<R
MCE64F_$\;$*'J^EI'?:)3&RO)7PN_4"%K;%Q\;#2Z#$^B$WS@,L#WK% <,N=
M,V)_EQ8%KG215DQGHBC3""SYA*U(U^]C#I-\\>LTN$YGDD.+:!N5%5VT)>LJ
M)[@24^>V[(S6ZKG<#\S#S"B3WYPY&7R18E:BK1+< RTC;%Q#;6UHA+LQ!^2W
M_?;+3U_^S_^W@\>YHN+&%K54I)!WSG#U?$QCU]DU]E*?;/G3$[B 9TS5.Z4X
M7MFV@:2F6P2J+"9O@:]=B'=.X9"2B;3N88C&?Z(BNO8>9DA8Q0DUO@_+):I.
M*]OH>+N^G"HOM9-.%;0NYC>5.Q@J#B)Z$+<EINS*J!N%_X"58NE)?(J^69B)
MD3^<I.)/P!(Q$F2Z^&BEP,?D@SE_92G(6QVKMG)A%"+5T_3:25B"E,"ZD3B]
M7EE-XRY3)1L_4F.LU 4"UH]PY5F%_BDQHEQ. $2)+&XX.7+B&A;BO.;2H?25
M8CFDQ[Z225HJJ8D@WJ6@N <<4TXE\6J'&*C;A6]M[S9/$3*(-#0D1]NS+,?4
M2:Z)EMYRW,@GZ\<O3]49%Q1)IWQ)4-B1-L0"=@B0@60TJW "V)O!HCU5SS$K
MPOB,3?-1LH=GI'*$[X&%26OQN!0 ]3AR"&[)K2?:E]2L'AJ-.E7Z:V5Z8!EW
MP!G2"55>XE M8;JIRK%1%O1\4L1<@>F-V2+_NC*_+E!:%W)-7.SYN<Y'G>O<
M@K5TKO..;6"G7.>UL?9R=++(,_6-9CF.[9# ,RHO.]PYP_9+!=HSIV"VR=WI
M-4 :(R_Q8/58HW4;\%A:KY88,S0,(VK*:/WW3[&$A$S%]UP!N#G":).BR$UP
MWB@?[%+: \K&8J[EC_9?7H^4!NVY^%$E1!_ZT6OS=*.Q4$I?H5J.1&Q>0N_C
MCXT /SOK'1T>H0S/,_C_D7VQ$>\]H/>KY;\/#GI'1R>-'^WW^HU_7_6HD][@
MI/D7W9.Z)]WM24=KG_2*.)VY'>X3WM2__7#P@[MRS@79,P+M4)P,AJ>OS5WD
MTK)Y'H 1J$;!GTX.S@ZB _LIWNSE#TU9VH^#^;>@7[WW^+CZ-9VIT2B6]RU=
M3V]2'&3+G4\<9-ZK?'17(MTO&1[3M-Z,2K:&UQ;PUJR$CG"K".=7.'=$VY!H
M?I5Q1[0-B>858W<TVY!F?KUZ1[1--2;7CW/Q>$>U#:GFM;1T--N09M6^A(YL
M&Y*MVKO10+:;/()FP__H['0P'-\K$=DUKQ*QTM)R=O^]/6>;8;UY;L'M^6UX
M$!W+XU4>U'<2DEEK)2D?EUC$<">#35RH9T*,X_Z=_,GGQC+''<N4+'/2L<Q]
M4>F9$./HH&.9FZET>-:QS&.R3,:O>\)$/#VL$/&>8^MKR64^;$5LO4ZL%2$I
MKC!]1^5U^>(>XNS?0[!]))=)E'2O[E[=O7I77GT[M;)J90\0]6@6R0']<[\M
MLKE9D;T7L==W^D@VY,TJ;)L:OUF)_?5/9R>'1Z\?R)#\WFO4'<:#7^>;*;)-
M&^L6%'E YKF);[O#Z&YR=Y/;P3S?94WM+&]UUI]/H9_E3,1W*WSKE,:.WOMM
M'\8NV+8[P@<[?1@[SFF/$XQXWH'C2_D-^TL^>F!W+Z[2N$APJNC++H[<O;I[
M=??J+H[< D^"X4(ZX[7;7+>Y)[:YSM)]>$OWLXCDJ[<6]J>S;+M7=Z_N7MU9
MMBVP;,^U\KH".\.VVURWN2YSLW,9VTZZ-Y[=[U.5;SL!^M28O*-(QSP=\W3,
MTS'/]BG2,<]3J:9XG'J]MIU5%S9>1[%WY9R^+<>,=X+!_KLC4D>DCD@=D3HB
M[1:1/G1$ZCAI1XCT].WT_^XL](UI]44F.-<F3<R H1<TS'G;M<L[P68;@?8\
M=R+=#67NF1&IXZ0-B'0W6*AG1J3NNFU I,..2!L$.^/\=<=-&Q!J(U#9SF*_
MA0+\3HO=S%E:2:\G;M%_*&AB;SH./M*@S$\\@/*"QF,NV,S7]\"SCTSF]C'M
M?D?$CH@=$3LB=D3LB-@V)^[9$_$^S/)G3\3M7^>G[_OL+_L^KVAN;"M'_ZX;
M:WSY5<4Q3ZE_6\Z:?Z^^W67P[D[.,M8E!61)@6ZH<3?4N'O2$WW24QYJ/*;_
MNXN8W6P"7*/"> )CCA^:;D]VS/%#$^Y)CCE^:*(]R3''#TVTISCF^*%I]B3'
M'#\TT9[FF..'IMI3''/\T#1[HF..'YIL[ULSYG@G  _>?I-1D:LK&?PF!9JW
M4S7?\@S)!X 1N>M,P=N>S._P='R#WL5^WB=+I(=GR>X8VC50M?6TZ!BF8YBV
M(D6MDGT=4E2MU[[0>;;@4&JN]).%C=J%>_]D:=$QS.Y#M73'T.GKCF$Z0=\6
M Z^# MW$P/LLM119-*5\^1MY)>-T/@/>^M[<>2<(.D'0X89WMZ&[#=UMZ'1^
MNW3^1]#L5&BLVZ/E=QA5_RE)BZ=#I);+M>X8NFA)QS"=H.^B);MD.9T7(Y53
MJ.1GE8@D4B)N369LQPW]YW*G.UKLZFWH[)+GS*L=+=I@E^P@#3L+RJ=0#3CL
MEQ36AI;4T[>>=I!U.WW1Z8N.8=K+,)U%VC%,1XO.(GT0B_01<,IVPF(%4W6F
M<JJ)RE-GN/Y+Q(5DE)%?4A'?#?NVRJ0["0RW):G7T:ICN([A6D>KCN':R7#/
MU5'H&*Z3<#O$<,_2$=E17%IV"W*$7MTY(-J/168F\Z7CX(W#B9T*'4B-QZ'T
M5([ N0FXX,'M-0P^9A.1J/^A\M'00U,A3PB=(YEH!K%U/PI>9'(LLPR>" [4
M.$MG00Z[P?^@?ZHDR*=*(Q3NMP600N22O"U8#4+3?OSMXN)E2,__@&"W A%J
MS>NR>9K!U[TTPKV]]L/%+Q<O>\%;$4V12O GC:"V\%Y\?52>?DK5M/ O!0(G
M!B*(IB*#:P<_$7!78;EZK"0_5,SG,=Q$QL>%1^'4%'SZ!Z%'XM^T*?S:Y=N+
M7K#FD,#?3*LG%5Q&# N,C_@BHVD"K#19W!LU+K_@&5Q/%5)CU89'1;P(Q"B=
MY_"6X8)^N+R#.DT]4F;R2LEK':A<NX<"#6,I-%;=($1QO.@%YT%4P$Y@=5$Z
M7Y@GN1\@$+*\\=1PJZG&A:8)_]PQTZ1D)@U+1EXV8,O7<JA5#K? WOB&R]N7
M!^)NR$_EY:4G_JARD!71C0*)Q<I(1BD7=?](QX+?^N$_IWD^US^^>J6R7G2(
M@WO$7!:@"W0/2/'*;7EOLI2&>R"Q=*N=_?"?O0=>SEHIV4JY?DL"UN1W*[=T
M V8Z6%N3:5KDP6!_<! &/G!H&%3AXTCZ5:'1X IG5WS+\08OZ;-KE4\##[@/
M9- \%A%*B_=9S[PGD.,Q2H(K&?Q=@!3*%D$_Q/4<]NA;[OU&+H$8I-=J*SY!
M-JEL3K"Z5ES53P:7;M9*LACD7B3FL)(<!6F%"&MUPTC"KA$3?L0/ 9%I7SF3
M.,1+6VE67\&HR'#;^ 9:3;D9D<G@KW\Z'0SV7RL0+J#C1_ !_:7_F@2NH&<Y
M^1K,"Q M6NJ0*0#KP%6AU!W),2U.L=C-BEAJNT#0>TX'6A$/&HX4?H.^9*/
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M/Q(+.)J]$8+.F2X6$H.P-V'=7KJJ]'+X=0R'OP;?$<M94,<(GO'DJ,0WU ^
MI7QU_?I:*K*A"$DZ#KVZW)5#TS%R LKV?Z1V'?4A7GQT#BA-"U[<9%&6YJRB
MBM*5%O:1O$ISPOB8<BT*8S1;5&)3TN*Z?KRI5J&O=@WN&1A"I'K]-W ?&7QG
MF=U"@U%;Q"+#4>[Z!HSFDFA+Y>LH.U7":"63++T&7J.3]8=IE!/;UG?/C5)"
M'C";\$FZ=%_6L:@EIB:,0W.K?&R7*DHTWPNC)$W0V_[*>Y;2%L3188+'I9#2
M3DBA?B@,8C3^AN!'*8<-:@N^1EK?]/'98T/:I6ES8\&NBG"G<3_C]02^_HP@
MD!\=)[5X5\W"G-:O4 )AR2R?FB1TCDIOWC2]-K>S_#N+&<TXF!$Z.S'P!9QS
MO/"J]E"NF8I.DMAC0>U$)08S_KP"8T!_J,RJJ2)B.$LJM%6C#EJ4PL$9?DO]
MCXG1NLAC:,Q3-GZ89R<J,E8%/8[%*FP 2\O1BL%; >;3HA>\+WL=&B:&,+B'
M4PC51D?>SS5OW>J(YGO+M>D8\(ZE07PR8P(JQ8XA>9$-5;2Y <FWNH#/QM<'
M[UC3,)QK*0#A?2MER=1(TMK[4!@#-?68QG_)>.QA\U3?:G'UI<6F,< M"HQ6
M^H*9-.&UDV1V@F;.=/ K.T7YF%:+D=5.LM7M:]">JU/IJ@R%Y\1,I=Q\4,3Y
MS>#V9>@16Z[9!,D\Y&D$C ?@FK48!6ON@$U7S+H6P_1*FFO#GW$?UYK?H&,R
M-_BF[#6BZ!CB/<*)%G<I7.TJ0KN*T);>]%5#&UX88>T;7F6O9=6),C=",-X"
M7WP7OBAGL,T+FB/#2'&E)5P^]J6=V(*)SMKD(+Q/U-7-LEM^ Q.QH-DSC,L\
M3[& "+4O"&T1$=9'4<YZU+F<DXJCX4VN-1 _FZ'M3(,9*OM;H6L:=*LL)XJ1
MR;U.,E8V;B'+C8%AQ%-I<[NY)^7"& +,(7\;>GD=9-YY>L!?RP\@)#$6502Q
M CQIVQO*&5T*/2"LCEOEJ33U.2!Z89IF(YX3Z+1M79=77"'7HVN X.@7!,'!
M5A:0&\S]=4-,GU^I:;\K-6W!6KI2TQW;P$Z5FJY"?9K-BL1,@RLAK-XW@9Q4
MI/7.62CG!$S+2$SH0(#.,,HB0M2/+-&FQLE':,+:.U9S0!;$$'/?73VTS!],
M2'&OF5@]7YM1-FD$(2E]AZ\850[&O(V&X)2Z%J$^/7!.^TBQ5)$T&F64WJ#7
MR9E0-*N-%O._EZWSS8MTVZ+ HE=I<'&(R%EN(R%X_]$:)=^6I1^>[0?G8.0A
MMO+O IMZJ+<(/FS_VG_'&H \O4["X+W0&ES@0LL<3+C]P>')H/WK_V="@-B7
M.45T=TZB_7=:D(!B^8%5W9F53V!,I\EBEA8X'(3Q3,<,*D%P R %L'>6Y@BI
MN!?8)U&M HH4[(EUV4XL%V?(<P^H+@S 6P"#%_]-%]0@EI65 G5!NX.QJW/7
MC4SXE(UBF:0PHBTSJJ0C(45XLFL0KYS(P9/!:<08SRT2+6.#%H*Y:CDR-31@
M6>N47"0+"8Z/ARTALJP3[@S/S+KBQL78J:4&Q!KGF[ORA,IZFA%LJ!9XS_,Z
M2RPM4X#N>Z09O9*<8C-X-[+3G)+4_H<)K[KM>!#AX/M3"F4L8(EA4&B&PG=$
M^:,835SPFPIJ\ NX8ZH8R[ <DW8,=(57<3JP2G6L"<BNC N:D0>)Z2I*=])Q
M54FJ#9SY@M@?Y\I2T+ "M:&IJ[6L,QB!;YHK;>L9= 'O6\"_F-*,/XKDJRW+
M(#U,9*,$@XIY2B3=5D*@1,3)4K]/,H4N?"3U\CWS@B2,5<S36"E40H:.9V-8
M)[[D',XF( H\)^\,R6G"6$0IKX+Y>$CA#"MC*$-)%0P+;QPR+XQ^IO)"FIGB
MMJ>?2\=W3QI<5/G"C%^K7G+:>'E%+.]PDR_U^,[0DL0HC ^+RQ?3Q#\H,23A
M\\F$QR(;AIAY7<;FY>73QN5TK=(*38.O"29SW\&UXE'<89V[_;138Q :EX13
MR_9HE&[Y%9-0XGM!4U%C]55RA5N5+ A.LN:M'-NI). 8&#,L^=CC>UR/(Q?M
MD:/J&(R3B0&6)_AZM-HE5JM=43_$J  %%0D'R%8N9P=Y\<MR :6-%)KJRVHY
M&<?_@"SS'"O*C O!&< <A_S9B"+UJ(-*RK69Z(&49" *G'6;<66& TP/6?PD
M511U4QO(M8N,WV>.+'0A5-\<"4M;A:44QR#)4;&H\*700?:Q*[&3PTD[;+HL
MMRK3K9,3YN[ODA4W]?G[P\\%\%0<[Q$87"YC.9]BTXU)Z);$M<,47!EHOICS
MNDU.=N%!CKPX/3IZ&0P&@[W]L_YQSR!*T]!M9SZ48^FOE"A=-A-R_=\QL@.5
M>.Y1N1!<#O3< EH0NY_H=";(/#Y5L3[")&:NKZ][*Q[SJN83=J'2,E0Z6!TJ
MQ>6JT=]^N#EX-#C]H8NOMCRXU\57M[Z!>XFO/I*X6#$^_-WGMQ=?/GX.+CZ^
M__3VP^7YEW<?/^RFQ9&3FAW*.+W&@;)8%,CSX[W!4V;@T,*50Z#1CSZD5>6>
M@>JE%+TI0@'7I[\!VP-5+!L?!_W0S&1[<_L?T2"(D6+?QI: T\"PRMRD-#A/
M1AF0Z^^]X%<P0*,IUPA] BM*C:S;N:I@$2V!*54 DQ;ERJ:RA/L+NUSEZ^9"
MD;7Z'GLE<+7\2M.KL3RXS! +]\.%QF3T@R?/*7'C7&ZK@J*9:59,Q+)3BFDO
ME\5LAN9_Y1M&\FZO_,(ZZ,3L&SL(<#?YCC@K!UR@;(]ZI>9:_FC_Y?5(:3"S
M%S\J,L_VZ$>OS;.,:82:G0()P.)& I PX(^-TC\[ZQV<':#>SS/X_Y%]L3$)
M>K"55\M_/SSI'9\V?[3?Z]_R[X?[9[?ZQ:I%]0>]DY/;O7S5HP:PJ./[6=1A
M[WC_?A9UV#L]/+J?10'13T_7/NH5L0.S!# =,N_??CCXH;0SJ=/OQ\'\6]"O
M:AEL_JOS';/<?2N>TYO4)QFT'\3,"8)7^>BF'>WC?@QE[G'CC^F&;$:7G]$I
M?LO:%C3/)]0F*@DNA)X&+_[\\D%DYU&O#@W0M+8&+Q#%X]Z@=[HLTG R(7L)
M+_HO:P9>=]KNM#]2:6IPCC$UO:/G.WC,\^7#:I,@^Y)BLLT[.MK_#8(:Q^Q.
M,JP4WC/+C"(IP7$SE@42'G9.*8A1@'MXW0K9?G:3D44D^8=,$@D6[$4/+6\*
M]H;!^]Z;W@8"?R5EFGCG?JBY'^P 3?]<I]T][=W?,Z7-VK3IPZ,0GE_%2[[?
M_>-'MZ+#2J'U'0OI6/KYL/3Q<0B>U9-GZ3N89O=N])P>;7 BJZR>@UZ_P5/W
MS)ZC%69/=X&?]@7N]_MMO,&W-CC']'^[9%;^)HI,!#]A!^;WV).UC3?Z(H/;
M$:[QMK:.<P_/[F!--;/)@RF89WLX=[(+MGLX3U_'']]6QV_*?FT3K9MK\J8=
MMOIB]?M'V[M9=PT#[9!6]@&.[CN^LY'(;R#9;HC\LWYX=-?HQB,[?,_O<+['
M3]_2X3Q]?7QR1Y_[">OCIAVV^F+UCT["LVW=K&?@)?\2RR0)WA1#E73N\:W<
MX\/./6[MX73N<0O5\6GG'C\!]WB_<X\?D+YOTB01P2]9.A$/5 3QM/VPH^\H
M >B<Y#9JY<Y)?EBM?-8YR;OO) ^^(\G\K)WDF_M N/#V6B;!IU[P:S&9PE/_
MGG6YY-NIY9WSE9^^X#^XJ1#[27+B\6EX>C#H6+%5K'CX,GC1W^_" SL?'C@Y
MV-[M>@;1@7_F<Q$'_TCG<_559%UDX%:"?[^+#+3W<+K(0/NT<G]5*V87&M@=
MC=P?;/%J[71H8#/ZOA<QO&D67(HXEW=3R<\W*G!TAXJV+H7>8I7<.<H/K))7
M=<]W3O(NJ>3^'4K:[M-+?D5(0S?#CE5&P1/(X#(0&?])$5[TCWN#0>^( ) >
M.4I/:$T>=LCCO[Y*K/Y^[_00"7$^0]Q17<ZA#D22((ASA! M3:!IB"!F,3CA
M9XB(8"8%WCB*HT15+0<GX8!+^-(=0-9"'*ZE"\'C,?&5'WP -S>XH@+996:;
MXU!Z&JAM9U#0[-2\CGYV+30AH/6"7]-K', 9U@96W+QGB5,K907Q%^'H"$B]
M.H]*90U$-W/&@.@S_%J1((AVINB1>BHRAB-'^-AL1$C(#C9]8V+\&+RQX&X6
MWX(VKK1&-.W^47AZ<.B]+%:RP+7\F?$,\$]C.,K7)48<E6O6GG%X.FA\QF'U
M&<@BL!Q38E)YQEEX<'30](RCRCHVQTG>-?$Q:+/X&,<TQ@QGOTPF"'V, -T9
M7LX1_BMB90<X,X[GS#%0D&"@(/J:K,QN(\P]D@#?R]TA7*H81Z[E/$>S_C #
M0WVEM)VJ^;.;:7M>HC)?YL"9M%HSU1K>]O/YY4]ATY=@'2,U-L#=]-7SRXLP
M^)+.512<]$_7#L>\CX.D)VX.@.B3C5 /!Z\O<8!&A9[;Q#GL!9=PS!]2G'XR
M(!G1[UNA3QC9<D1 _MB SF/MW1EJG)G"F/1B/@>.PH-2/"V>N.R<]1UC6_.$
M"Q X,S-EE1%A%Y8OS=1#EMDX.SQ?&"Y^NF+GH'UBIT0CY8*'/U(:3[)J?&4"
MK'-%FIJ/W-HAQM0QXTTR:^'@:.6AE G*A;V,^(FE!BPDQJG3F:NT0/T$*V3]
MGC? W<.[X96'^$HS1AJT5Q'G*\%><;^$%>^MJPX ZRV GW_P=+GOL'W<]X6
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MS<A48GKJ(=+@;Q+G.W\6#PV--2J@KG"_\SCK=3!@^JA1Q;>M!W!66(75>Y>
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MYU*L"0>WU8UQ;F\F)T4L,NJ#OE+R6C<X-HC^8V/CEE>M<V'JN:EB$(,WS/M
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M'X1>M7_N,2VQ'*F_8%VEF@.XQ(HNQ55@&_3_>:TG];%"_,Z&DJ;*J%7W8BJ
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M/VL?G,(-,VVV$&DMW/8;C$0N>K2PSW*1I(UQ-RP*=\W%TH#,P'[_2 T4AH.
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M?F3K8+&YA4&P6<PY'F=HA'+*"8I*X$8!+Y;K!HU GNL-C7+:]N0473#\L0;
M%DD@?\<B:*>QLRW%51PSRQ-0.XB5+0K?%BQ6MIF86!4P2X1&*F"6)N)5,;,<
M.;.;T-F:PF.KV697?XA06R55-I,JI1,GS_4RJV,LM/_R8-YEGI4@69]R*J-Z
M(U]R!.W*I5QNES*7 G*WWF1)PP=V*:L"3_E^Y74LW!FGLB_Y<^5;GO4MJ[-<
M7)[J]259-*HDBP*LI4JR*-D&]I%D80W^^<;JZXU6M]MJ"%'7FTV]V6T)WA3#
M>M.$;\Q&Z]_-CEDWW\23'N)N[VTX'J-)F"G23$A9/L4$?2TI-R)M NPT7[E;
MTE=('[@7EQD(W !MRLR];M0L22?5HA*+&+[QDOOQL^X:5)'5578?QD=4E#IM
M2.X!-"+Z?,+[%NG;D4(M6PI@Q3OX!A36>P&+C^[B@K3$^KI^NMZ)GZW@FX2J
M?%FU';7V:$VGZT(0P"4/*Y:!U&H1P&;SB2].HS\^#"Q_8O/IJ>70X=-+']18
M2G"BL)CM_83X(7].Y$BM+F6):CVE9E8_U^"G]SG?F[6F;N;^5*_I&W[?K+<V
M>F/1HAHUL[O92/M?4[L&W&4G:S)JAM'<R9I:M6:[:+#KUHQZHW!KJIN;SKUO
MV&%SC5:W< =E;CC2_@^J4].;[:4CK>BWMVWS^)V*VS:VE%DS'X:LOFO/<C C
MP6;7RFI:HZ_7FMW.EIR(M+8*<R8DT/X$(?TBFU^*#B]IG:Z++;<J+/&W=S-*
M=G5*J5/ZY#IX*^EO[]A>K()FK=->Q[::=YB@KGABU%K&O(*'OE-IAJ<ZCU7
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M+$@'+DR$O2\#_@.[8F*+<0 *RB]D)P!M:TS04@P:>)\?M_*&AU7GSA-L!H^
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M&3#RCJ?46J12M\;-Q6,]!YEYDG,,:Z+VP?>YWC8O^1BLE&T:;&U()\4_#[(
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MTLXC*@+/0/31\$=XAHC3,A#\#UZ8M3#@\,-_OOFOU0#2&\ 3,.;VC_>\O#M
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MA\,IT6\^UMBM -QP09<U(E+@(7 G&54 ;<X:$$"&E@.@L("V0&D-A%1:@3P
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M8--W4LH6\55?*H%OSW_V[9!@EIK"<M@7R_,#>,T.Q\Y<=LOS0+9MK<J%4ZR
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M3[8-%Q4+];I:QVAM[<Y<<I0[.[YC\G5NO/?B(H[>J'7-[2RX32BGT.;=<;
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M,>!?7*GBZNO9&1ZOY4<O1)PBQ;]XW#D+<PKQ-?&('V!L'G&[B6T%FOH ? '
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M>?]#T'XLBA71<J+U19N2#R/P@KP5*#X,0P$.8J)D:',/N*K?'P&.8\K96(B
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M>L!4CI)T-X""JH(_JCZG<C>ZT9UA>;'%?:*"C%F%:QY%;Q>#)%U,/;J-&M4
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M44-4#_Y$RTHAVOSZ/XD^!QLZ.2C:AX6'B?TY U_80US*7*O15(=9]U'9/I[
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MD&AP?!$.H-G6&OI"H3Z[N.1E)&L8 $;H&J!.[%TM2"_]>!W J6I+AZ9P,X?
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M&_FH9'S&89M:#U8;F%\1"3"YBJ.[X=SLU+KUW=QP7F.HO5\F?O&RCDM9QHU
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M;IC\3,>C(>#[N".@<!\+][.'$PKT!QR\HS9L@1I[$1Q5=#5^L4W@C$)BO/[
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MM[-$%L#AS+/D6/Z>]T?T-]LM3N+AS0=QM,D ZB9F$"@&Y?N][6A?P<.>@R@
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MIM\6]<W \HH:0H7*AA:D6NR%YS'MR^\?5KE.8^,R(XPLD=N]P\BG]80XN4'
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M]KQVQK,DXC>MIY[64FU'GS)13>W;ZL><NV^4(=@VI)E&9?$DSOQ]0D"R8L"
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M4XI#_BI"X>& 1YM)F<&IWS_&;^N#TCQ 8V^R&W#8J=]X!]*>.='M>A\A\F:
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MI;\T00!4O7"5@K.AMJ$AX%&ZO#$LF**]^QSU$S$'YO?H>K/GWP TK7F$]:N
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M\TN-C[\6F)0\,?P4@#']Y)[_0B;G*D9IY\,=WJGS[ZN>FK-?3&XQN#B[YB;
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MHO.Q?W[DOL12%)1-NTN,0G12+5C$(F@-1%$[3HZ,!-Q^PY*>*Z/V[[#T<SK
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M!^,',[?Q),-[:5U5[T8$Z;+HD@V;>7 F]Y7R Z%_:DO3@][QUVE*Q2OM^L!
M=ED>7@PGJ1Z6[*CZEREF W01P =#B@<2'-\8%L:^&"$!(G9./*)(V\Y2'O"(
MAWIMZ([_Y;QYC<7\#^C39%-+SX"0>#: K_LO-EW"5,3(8=Z;RH^+U <OYW5(
M,%-3F\0,Y*-CF&@CSNW0#A[50SA%*6D*OH-\TV*3?73DV6;?E8>"#JLJ>L!F
M'+P)9<(J]E_2[8,#"\Z0TXC%;9+^"CG2H8:"R&&**^#4O?Q;Q52)]S3W/T8
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MNNG,$44W)H;*85OSMD&*=="T ?TP'-#;H7EAZ9&]^U +\(_5]+WW:LH4<H<
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M8AF(^/X2J-ETVPQ;_=)ZC5Y&=?E#S<+6!EUR6[9D>U&[*[!S(L_[TN"J4L/
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M9KJ96D$K247'Z6?X(8W/2EFO!H,/8R86I$U^E%'>G8VE5.8<>ZE0OQ7IHM"
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M0I&\=;"7*\SR$=Z*)L*8 (.I *>&\:?JC8HAA9D<5 O_?42&.$Y+5G):O*E
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M+V!?$L_T/C!%+U5'_5\.&/\)&<]+_P]02P,$%     @ ;$"=6.?*BQ>H30$
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MPYLB,OM3GQ;5BZH:'67(GK[8+2:G9DQ39ZZ)]A?)_C'!HO]-DOT/P?Y)KB%
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MP)]NC=CX$+2!>:"!S(AOID5Y>["]3!WH)GJQ=3OVCQPB&9P0[KA]H.S&U@/
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MI;].5)2XG=XZYC:^/\W0L/SKAW-&9_AGW'5^IHXE$0:=8#%Q!%(.CATD5_.
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M[W?^I&P$QZM:P01P:@.B][IWT+Z_EN19"K05Q2'>1[.T@C#L0^2@&>8Q6.0
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MB:-F**TQ^BD+!Z/4;:-[SM\VC9E42=](DV;Y\/YT7R]'^15W&SQV.=V$#!G
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M2,WT60&&(N,B\R>H>3__>[-=_U,>M#J]!A4(O<]D=1^4U&U(+,VX.^Y? EE
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MB&!!*>C0FEJSK>39MD@!\QO>U)=UNV8L=W[=2KADPH]\C&:Z"7'W:9[T0J0
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M57_P+W)UV'4SLER5/1:W+K>[]/7LGUT]]C#,RW?,B7R,.I)KT>L4/JYOY??
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M_=X=B#Z6^T7<--V4MU:9_='2_&4-(5\?]NPC S_0E)/2!VV6%/"MF 'H8=>
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M>.>;?I66"[J67)\..K&[IZ1'']:WJ:U;EX3RKC*,+AOT5Y;Q6+5^<5Y_1L;
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M!C7U75'1'[ONH[RITOGHA;Q9^HN'[]8NGSB(OF:@BR;-4A-H$HADDA=1&SD
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M!\F*Z:3.U=I0MK5+C(DR&\3X8HY.@"@W:DZX(]8[>+$!SN;;6'I)_V6Y+L>
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MM2VS*WSK2;,I9H530@\39 !G\I\N>%5-N[_@Y"\,'S(X=;HOR*5(75C;^E5
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M=J'F9.V,2!I(;RI^?VM1GCA<#)@3COXA7EQ@@,+_T&4!KT+CK2#LU*^7^-!
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M].#,UYL>LM\E[K/ZN*XFBO=4'U:A775Z+WZ<0@U#CV7.OOK:#XDCON&0O+4
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M^%YG=8WQ1SMM1$,@:(^L%'HB5/9 I1&WJ:\@, @37-.$E)B-)]C9S(:<@,0
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MB!_2]_&3\9J>S6OY]XV6I54W?*+9KC5P S7$S0%P<P-%P)-L [B1'+_:^VI
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MN\*!K?=GK^X[/.&/FA2W'U>7BD::UU]?1^K+%G*;#4.<_^:%X8Q.#4IG0'I
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M-\GOJ)4T!@0/4>I(_+4KF!0(X >;EV^=R[*<]3LE*G[?.>'8L-D$'"J3C!&
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MTH_D\M(7Z)XZUYXV\(P[A;N()1G&,GHH:IH[>3/,/M_M^0\Q6_CM]D57#2"
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MRGJ3MWH:JKMSGAOMTC"2F?.T<^VL ;^K8A2/XE%,'_S_)@!02P,$%     @
M;$"=6'DOI\"J* $ 7X8! !4   !C8V-C+3(P,C0P-#(Y7V<Q,2YJ<&?LO L\
M5&^[-[Z<<XB<3V40D4.*4)%)Y92?)$51)N0X#DE"C5E*SC2E4,04":')6<C$
M."254 GE,,@A,N,P%C.SYET][W[V_[=_S_/N_;S[LY^]]_O?S_*YAEEKW?=<
M]W5?A^]WW??@?.&, IN.6-I8 ES<7, YY ?@_ 1$S<\'>W@!7@!R<'&&@$,
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MFP"4N:^;BI+U>SYK;%/$U30S5O?@; D_\ZW+G(S;Z*XY7YYE188MNP[/BQ]
M;5@PV\G2_[Q#I[3JOILNONOLX5JB;9C]SOO/WV8;X5HL/![SO-9Z%?FRD"6-
M&>M/PLE2R2DC0DU\$5-M1%&<..YSDRJ]Z?Z6N\>N/W*QT9V?JK.9.FQEY5E^
MI,1'[OL+U-!5!,[8,17 9H,F@QE4!1@]="#P\N!PU-ES3;GA&;(-U[>WSYR]
M[^GJ<R^05Y.O;N+.)$BSFPY0Y@#7%5DNZ2WS=RSI,5^G7L!OMQ*A#2X DW"
M700K1*PRPNXP'D"',X?U:>LS:6YM@0]UM,.UVNVSY6SOJYS,,#6:"'=<W*1O
M+=!L)@4V^Y%]@F\.BI+#:#&C'6VZH2X?QI).T%X2XQYF,1C;)&2S=O&]3;IM
M-1F]L'6;2/G3>&]AMXT<@%?IHZF]\9P#/?_HR\BC!+[E[D+^]\T7!D.66ICS
MIP25QC]7(CAG,")?FY[KJ; @0'F#VAP-5E480&)OHLTR(&G$^U+8V61?%!?F
M1RX?S3EEP=31\X)*\MCWG'SA=VY,K;?JM=8/\@]R&ZV=O>VIS-\<L;H"/D<R
MFQ1IE#S?58:%16A@7/6(:,0="O;[K()8PKE4+]_P->_#FF]%^P>?E565Z--"
MLZ!0>./7.'&F->[$K<,-=R@]6D;#!XSCE:]>0*O8(Y8TVY4,"_V@9VB^_[0/
MDVCNT,=SIHH#" %L7HC(](<4F\E;RM!>(_%-XI\:0^BBX_98)DG,5W^H/<OK
M:5&PT4\J]?#-+:^>?>K:.TS4%'T\@W\S4LT!6DB#0Y3UMM7H_(^[OV$H^_)G
MFK1H[;5"%N#CLR7Z]R9/>!\7M!J<;3O:OEGZ'-H([0Y*XD[UHT?+,?*7<C2H
M^,PQ4 KKC%>MBEO T);\/=Q%"Q39:7MBW_)9)VULKMVL)C?TWFH(7;[*DOSA
MR$XG^Y&5</A^M.^I1JLBEHUMPTMG\QB*IWW"F?W4K_M;/>>/IQ7UU@=V*$5T
M78F.LK"0.L;U/T7<3)@VN*OLA-*Y,$PTJEJV#>1SM7CJ-UM?&,>R>=HF:</[
M(%_:6Z0Q^@V%5UID@[("0RN_* *9LNKFQD^F)IZAVP'Y(%WQ(9Z'G?(/Q=ZC
M8LTDV!G@^6ZIV2N9<S:($U^A%=ZHVN@Q:@^.<@ 9]=S:\[V>7.F-T.D-<F<I
M4UI/Y;.Y7_J80_W,K5!#JTMP$NA/A+9G7F>![.3(+=_OC#7(SRVG2B@^/M?S
MU28@K5/]8\(K_<C>^JT;WUQ[;M4_0KL.;85OS&LCG]0#TG>#+<*CA'7)*A)+
MUH(#M'X0Z #E8&/\6Z(T4NLWL"*0XGD]+T+ )OY5IJQD1"A%R:Z4@3_/F _>
MG<G[M>3M=^,P$:$ @4DA6YD5-@86DF5N^0IYE5:!0_9CL4VE'_+8];/PWK):
M^LO&:Q=28Y;<<</Z^JZ;F7HLY:8-'."1R1$$;U_"L.Q0?]"+:RV6N1]^!SZ/
MGVNCMW>/(R& @;11-^96LFV>>/JIR5B^CRC@M0E6L[WP(B$F]>'UNN./I7FO
MH.8GW9GB\$AFO1I&'!Q]TL33<XDL:G-A_6A.7D=@3M\&2E6%[:5VRU9__@_1
M(JP7>TE-Y#$^FA5;<- 9%L[C %1?A"?(-J.6-?PPT X$"28^%+M/]NH>)#'V
ML7/PXLAE?D/"$ <8ZT^\U"WJ=^N+;Z9="%_!&W,Y%2<GUWB;G0U2TH>5]4P2
MWUTQ9IEZ,L0X0'X=30R6N@723\Z"_Y;Y,T!*._H<!U@W(0#(A]@(< !I-^W(
M<2*T37IJOA/+O-C)/!L!8#.:) /53H%!KO/8O,NZ#/;:$E^EJ5R[T:W0#K0;
M8JQ_T6T/!]B@=QT]?;273#LKRP$D#Z ,\!^)51USVYE'<#OLXYW(M2,W&K>'
MBC84SF9D,6Y3A;WKJS,^CVDXRDQQG;K[RO.!SY[]VEUAWSP9^Z!.>M\KC#SY
ME]L%4S#RA92]N>,M@V[I[MB"R%4=^IY<AGF8<>XABF1 JL=OA=^X[MM_^S>'
M/45J(\6A:7:D) Y0.WR'&7H6\0M+G*XW8U]N=O%9R$/7:>#&JM-VB9;C4^_Y
M-0FW9286OQ")(@UUZR.PTBXF8J:>KQ'(JY U&GJZ@H;,<>(<X.#E=,1]I\E0
M%OH/D\PS@4+!']"5Y!0.X$L4@S^X@"QIU-C[>\,R5>2*'M;^+>F-&<'8RSWW
MCX]6?TES-OM-/LRWW8/OY$5SQCWT:-[(\XI7R:%,-YQ9)+?8KK[6G4\K/=.X
M0J_E#J =W4K^:&ZK/WH[@,NF:5##69**C#"(3E<<1U/T!L=?R1AQ  E)^^SC
M'SSZ S\KNG9=KM=_)R[6TL6(;ML5Z^4A*J<%%<X3:,ZP8!O3DA4>P\B!T(A)
MU6DD"EHQ<2QWU:$OS'J'9Q956<;D[LE<V;C IP\K7FRLVO)"Y]VZR=^@5B73
M&.Y!E=LW8_U8YG0#6 @]MI PO.MEC2VV6QH+JU0G= 3%JPX/#AMM#Q0/SHG6
M>?]EQ[MJ;BB<8A\S0CLZ<IT#5!$3F@Q9JK_RQHS2E@^FI[81W&AQQ))3"[G#
MIP_WNI2-[XKPV/&0/U7&ZTSL7<EZ,N(!_V8(ZJ!H#N 74Q&QP9%7:.BX.0=H
M<WZ#KLV]QA2%1V"5'D.Q1!3-,9A[>C \#O^Y7B8[7[W&TS4NX46&S8Y[;Z"X
M7;?$\6Y2Y_NGQ?[-Q+.(I@031BH**<0!/[(7A!Y]#&XDZ<Z;[JY72B39B@B'
M^F&?M^):9:]N"Q$7NL$+%.FH3:!TV*F-6Q!=6K/$;EX2BT/13HCQNEF-Y^S0
M=BTV/#5_NG0RX4AYM])0.F]L+B:]0E +C!=8UH,W87C!#SD%X&B]'KR-\$>G
M!2!A6) ]1OXBB?RBOKMZAN;#DB(V7V$3$@.5XT_V56\O\_!PUY?+W2L!WHK1
MGI ^9]XAP!N"0H'>' #2"$\%??O9A61O,J0E&X>7@I)^',,RFY]@FL,4OIGA
M!LYIAPH?^A[D,6U;(NL>79;$WOU'N^?_2P6CS5P@*WH7+#@T:A^?U1_3I Y_
M,Y.'$HN@9UUS37K]C:[4DDBOCZ.+W_CJ4D^I&<U6')&1DN-W]CB=<P\*CC>5
M9*KB=D+&X_8#X"B"<<%76<84^\UN78:,.T\'7$=F+^]ZF[B9YNJ6_/J6VNV\
M1TLJ%P$UW-NWX-_B('>:Y%G.B-VP+!YVQD^TMU@TJL8JNDK8;T[C6G7#O/?P
M8N2V!X%9LR<E+-7N9^[9*U1W0.HI+TF7'6>ZGRD&OUJ,J(81"-E\%"=<K)<<
M<"YIQK!H_IZYJ5+X;?V ^C/S2Q-O<A6WWDYB\_Q;1D*;HCWTN/ MY.>UK?N#
M$:9.@K9/73>,#&.KSY'F#1]7[\KXUK3W1,?%Q])W>%/&[E;0K+WL!ZS&.,#<
M5N9V?)\"<7[O([ 9H2"ELUF+;A:D4[/</:KU-[]?RCT6NX,KM;'5R?&U7#-O
M"";OC[[[%VGU.P>8#Z<=@@6[Z:OC+$RU;+,]M!T3VR0'?7KF\:*IJ2],<X=G
MQO>=TD&>)^MB']V-YMG4YBJO)>@Q8H]OS35D9_>?S3[<B]!8850*6<+0=I->
M=7:.R[=G&Q_O#=XV."CA-,RG<_;Z1*71E'?+_+KPO[1$81]+;RQGVZB;'WY+
M><U=;MX:1D)JS,?S(A_X9O^KGP#_0_X#I'1!=N3'%><;U7:.E'WG7GXLJYJ9
M[)O++FC]H2@W/LY\"[!\N<='OG1$*66JS]F&[K;7,9I7EC#U/6$2.WO2]J':
M!>%G5Y(RR*9D]V_V8_'SU5&C\SX=:(E&.Y NW2A)K1QG)N!.7O4LGJ[/FKVR
M)[[3NL#!1R*_]N[MIZW-UE[>SCPS]DCY5L39,V7P+6C:<[/MV$6LF?8'G$'@
MN>#"E+>#<:6OGY>^W^25^?8MB3#JO+^(9]B7E$ ^1XY#58JUDZ2_X/RA74CL
M2$']=*$ERBKWE!.-G&AZ>2;(V^O<QK88\\VY3HNG#WC*:_)/ 3&,>4#*^?5(
MI0PI$&D#0+?IP=3XUD#[D\06-SGZ UB,MBW5O?3, ,6_ICS?ODA,Y4/UVS(M
M_3<7>S2%8B.[MX]V0YK.J; X3"'+KXPDU&<R1E)A :B"V;)SUOB5S*<"6=4A
M^X9[.XPESD3>:PX1-C+W\.7Y>42;BMRVB;XZU\D4GB%73\4V!C_#X([1VN(R
M25"^X\>5[,2M=($<-71P95WL@W;=-W8:&4DQG8OYBXS;=U;Z*=V*2+J48'$]
M8EG2Z)[NU(U*0\?+]5+6#%HKGH2,8(5^K<;]-UB>_ ^7]_0HN+8@PO;$)U.#
M)\+?C@P=S3UKUEE_YFAY^4TS=.,KL?;H'?O9*>$],Q?=6FL-#B]2@GJYMK;'
M'JIS*SA1SVT%U$\5%6.7NAA;/L)R^"'G8='/N%"Z=FL_!Q!W;3;3-D/7Q;<Y
MU^S+32Y^5IB?@+N;=%(F1,LDTD:A]#>I.">O"_NQC!=0%YW$N,S.;)+!B531
MOU%8OT&)I.EAX6!I',E4OZO"I,P\HOG.9IZ!)QM9N[E6<J07K>;W%PTBA0B-
M\Z)E4SLHJ<Y.!(K":FI@H\KXO+;#YV?!$NN*=5_;BM"#:A=WN$><3LG?J'SQ
MF76[6>U#[J0U18;'IWGRZ$.4A)DNZQB46CQ;"=E2E R(S3!O3ZEA<O:>0*?/
MN_U6N";VR;Q(+[ \?=1%G>L8:>^DJ3SBU$)T<@OZ2_BX60-=]C@\1">_0B@H
M)L)RBR7$/5B5-^'JMQK*UTZU)1C([5#Q?JUC!T1U6N!<D59*9NS[:/<H8T8C
MK39UI6LA24GN>>\*!Y#ROY);&:*&5UYZ'#_/"-]4>:_MA<WCQ9YCD68G\&Z]
M^OAZ*'(\$$7%1.]&)PPKZ028FN</^3NITXG;(C).O#>9=S^@*.5@ ?Q[1-JQ
M58%Q9RR0G]FZOC):6]Y7.EG_LD[SE(64_]DA(<$]QXX"&DFU)UB''LZ8:7W0
M:]0C#4;E48Y79GQF<,\UG==7L3I3S.ME(\^K%+&;BQX_7\"4L: N##J:0Y/,
MK1%M>"7<D>QFA=4$])A*[\Z:P8G/F0K'VZ0'?3S5$L,U?0;#O6P3N:E-U]BQ
M9%]=D/&$?<=4FC[5YK+9Y7(AR:]WR\'/?*KH??*3M9&;C*RM?).+U,;.B.16
M=Y)9D@L4^NR@<?R\F5'$$KPIRJ"E/C=N6#:[5>6!RS?;<RV?3<C:\[:!%1_R
M]7(:N TM3PXKED,=S,VXS5 'C4(A"SZ&!VA-V6/"75>)PG:C9:>7!Y9KXXQN
MHK?GCP(IEAO,\@6R /K"H#'C(L(<%H9*1C/GN6@:%K4]ILY4,:EA/[-=U;T>
MFSI*9OC;_0KKZBQ:RI.[S!M3,C)TTIQ,HP+/H%NZH\U$(&<<K!+OW(\S?];I
MK:M&UT@VO!\FO%#Y<^-$_NO+%/ESI9T2>96:WGS1ALZP?/98!VOW",LP<S ,
MA(Z 8]((Z")7#<UAO)9P7]?V,)DO&:M##=\?BA'1HZGK&T<H1&Z<.Z1-W?#6
MI3O.S-C_QU5AVCNI6T.1!F"#<FI2[JAWDPL40R.TD:71'@M#VE0.$*=3D$LY
M"0T9/7I\X[C%I]R<(MG<L!7SS>_;ZO&3\?YL53IQCC)*DHI8/0YECRU(122W
M7/G>4&CA3K5%F*._=L#@R\;3XCICXR'?E;U/Y.Z_HU7NH"S'4TC3:"'$HT7@
MS0.LK31TS%RIJ;'[^<\9ZP<MFO34*U^>,OLMMFN7MX=MAD=K&D*B9I!($J4S
MXHO!YFTLN_$M^EX9_1C:T8SZ<\G?#=@5MB<2E%$1Q-U*)LXO\%TP_R<DO;Q#
MBYDI1ES7SX11-+,[3T:VAIU^6)FD@8K9_@Q+(98;-R^(;12VN,H&'6C]L88J
M11&.S5E/BJ?\KMB]2?.,Z#N7YB#N.:G6:WT[I-S9?[Q_^D\YL'3>EK(/7W(I
MZ*?&"R<M?M4ZK3T,Z7P+P),#M(@]!KO?+<!\U2A:S QJ:>DJ![@6Z"IUC!_-
M4EZW8K&&.<"HJP/"&,UN<P"T,1F2^53^CY;_:/F/EO]H^;N6S3AW=@T'\$9%
MXW>:<4&5=&.FAI-,\85 ='FP#[MO"AL4)^MV(>)]Q#-G6"F5*03V7.0 73Z.
M'&#"GYKKE7D\^\8/<\/ZBS:DUL79J4A=H9LY9^SV=/KV/7"T?V?\:(X#_$X5
MJ]^IX9P"4GK([O;K.S!K ;,@*]6*M5^1(<4!\B8Y0,;[0@[P^A-J< ##X@#Q
M,!]JR8 #G+HHMBY<P %B5&"?RO_3<-T0/B!FR8Y%3[\ )RN+.<"B(8JV'/S%
M$4[.A%WW$3G 5@=V63H'Z(; 4<06._^+^ST3WHP:7&!$L//#LD?$6 I0++LR
MLG P.?DU6!$TSZKKXMMXGWH@4OF<!+87^RS=?T]":&]:VL^<_F&"E5@BQ6-&
MJVI;H>QG7</5,A$0,E\FK*V]Y "O:O(1V+$5Q@>#--T2CZ2/7SLXP V4-0<@
M9H^PA/W18P*]Z*GOJQR >[!&\^&_TA+X;]90:#THAS_=7U=WV/)8ZW=GG<A5
M0P^D5#[-5>ZO(@K[&@]K])/X7M[,\=']--]\L$4S__C/+\=L6JY?X#(]65](
MW2)@0W>Z%C46A>^;EU%(?U!3^US6:TGEMM"^2>NM6M:OE9>:'XJEH /UOE3H
MR>)[L\0Z] 84V[5I2]03PQOZ&\TY@*#H[=B:_FU5=;T9FL_Z3.35;%\<,NMK
MT#IC+2L]!6XQTX\H9*1#8DPE^"O>@+;N]^$+ZVQ?1U(OG_O&<NQ84/\!B2.'
MN[U/7SQJ^E%^;^>ZUZ_-7W@4P:FG$>U'K^P@(KZ1*_UQV8C6.*PB0OT\Z\HO
M4_YM#>/O&I@1*X^;_R+^5/\9;;B2A-L F5.#8]+PW?4=T;M7:0%9Q_WR#UC7
MF&^I ,0E@X2D!PM.6WMY_5K! M:(L+#ZHQ'682B*%C-*CO?T"P.E<(&]6ZMB
MS6A)>X)P U'IQL6>'T3N8#SZ'T3H,3QISK&LD">L(W391-8AZK?0@WT3Y;3O
M^=27%D&NUK6W^.X>$!?'=9P\&?EU]_M\K+6E>>8_ .)_/D#\'R \BX6PL  '
MT+C. 1@ZISC 7NQDUGKV7YYC84PXP.V7(-U@+3D)G,AO V]B[CE82$_F @X6
M4K^$B]'!$M\*V^JE<("Y4P0.<$2";*.]% QO0,JA>F8[R-"QX@ %@IC'Z>L=
M@D@!RE"J8'5/8\3 B7N%\'9PYC?-O*3U0_,M29H(4_]_0,A[\-O!YE=(#2[#
M;X,(8]TL??LA\+GACW?&\T1:[AH>O&W0]CV R1/XK=;D8LB#\RNDGEGX MG?
M?FTO*8',V#_+ =9==?&$L<^'[D[5E1[>]7'MHZ=,=5KU$.Q$>(USI::LQNT\
MY7+?*]A[:OOVJ^7IO4=&I+R";Z_S< !Q)0[P*1O\?H@#+$2AZ.(+[-.U\'DT
MO-K_?8OT.HEUZ+T8!W@8S,I%2OTV_!:D@6>KV+H(!WASB;QV>CWR7^]!"FPU
M'46TX^< G;/@HOO?N7G4(R8/_@N1]A7-XP7U(*GD!RP.:I^MZP,KP6IXB+A=
M-=C@[:+'C^^>0<-&*WO'UY9(@V*0<CCKWJ=^-N%*/)Q834H9;Y(88V6KK+>+
M$M36\DCOC/-?+M_-8HGUF.X<;]*F[M!8?^*>,%78J1%T).23RV#[]I6?4>46
M4L[4CN53_^3"?P_A6D/0'%\,![C3##)E=, 'U8OOHNS^XA1>+P<)B6$R=)_5
MUH9>=*"2._3>(@&QV/W/F_*9GG\EE-9J.0 O4LW3NL;13)FM'*#W!JGW"-OS
M!@(A;<5.XWV6]>+)B[\A.DB1EY](.5A$J3#&_JLWB?RM@GDO.V^#)")#NBS<
M\1+# 6R]2-,,\@.]P3OP42Q5#YE[,IS1A2%%6,',) X@ AKA^<;[6<G/,>/$
MB9L229JDKX3OT7_.=W_I-&WK[(<<X+H V)EZ%ORR6@1.9[NP%EHYP-HV%#2^
M3BR+T$4,GL<!2*$<8,B^!ID&.!3][/K?,:V(O2%".BA6KC '^%+NR9HD96!G
M@_]XAHY;@"U7.$!K]_<=VY'))TC#>_'NB#-G1/S9> )#*-IAPII.$P+MRSW0
M;,TC;#72.S*D:L7*P,C_Z@H%WU7'ISG_V*S! 51/7>E:0C_"[4<Z\R!""*PN
M,)@@09J9+.FML!RJ(Q=%LV)I=D.VZ-I+\4U,9Y8:!SBW:/3&<Z!VKO?GS(.)
M*.TI I2P"I<.<0!]% >X^@-QU9@$Q L;<6A$ TN0K>7/HI-F8*G19_)OZZZ*
M);9^^/[@3N"2'<:IYK@M#2TY3A*OZ]I&?>LD)I T62"H+MUI-_3-/IQ_F%2"
MMD=3MXZL5P:S7H/LA7Q8%=&SQ(@#O(WG ,/K+$I>4SRL,H74K _&L#WBZW?,
M[&'5C@34,C+0NS/@8N7RTA_:_+X_TMM]FAP@(;*9 RQO1!I_1+2F_,>V9R0S
M-B&.AMQ!"6!%VE_'T-XC=2-EH7=',+F* XSI,H-,R\@:F0SK^I\_&E(N&3*J
M\5I@\P9P@H4X:/DAA/(,GF0Z8U)"?CIF3KQ8^$2[,!&O=O;9<%E31> R.@^W
MH[LR:.M89O);_]"/C+34>;GINP%E4IG.'Q"7A?*7S_W],,0_%A+^IRTD2+/&
M\!^)BZ$8<7#NZB?$Z6M<8 )VK85=C)[XWJ2*Y);5$@XP$U"]OGH#7*@CT3J6
M?$;=]H.O&_C@O;#U&.*2[->P[S^OE/Z5'(SYRUS]GF6/)"<$2]Q$%Z_W7Q]9
M=-%;7T6SJY@>2)J?,EB?UOS]%]C^@X55_+^CMW.4S$Z60;]W6?-N>O(7I\BR
M2%1/!&-8O\$>5.*:)ATSGOD=L5BD3_2?;1=5_M?J-0O)FM?5P$XO.I&=+([8
M[J#SC#J^O 5<5(\O)1NLRU)&UK8AB3X)L^Z(5@='J>@U/10"\.8<B C.SB*;
M8I=-8%&DMS0ZC0/ ;8B/+1>7++63*_8HPC:F>A &OML].2()3M1W@(G@C#AB
M]Z;GT($_LX"Y$4A%C$6\BV)H^J.91\C^/^B.\ 8$FVE,"K"3% AP+VFP'@ZC
M6\%'$$;M-K[V&JZAV</6'1P X[-V&+$0:X(=\2^-5MF( <MFW"0^&=J+S%Q?
M/5[35YAI7Q&4*5D:X$D@+.SDH3\4)H">6Y:OG,DLUWW;8_I\J"K:FO[HV$_9
MXI,[HF^_VO%B5LN%M<B.#T/'H6H^K<94$S<CE-D0*7M.-/ND;L)/%?K)^9N%
M>;/8XFDJ2ETUW>+!D9O#QRU+)/E4TN^?$7N,WX4+H9/F?)BRONL+-X/!,0WZ
MXJF9853OYT6WL+(K%YZWG\V4YUL] C4/$FZ&'%!:LX@\6D([1-U2V#P)71U#
M)?;7Y&[K_W[-U)TN>)D#^$HU8^_/4[C+7W#EQ0(#0>K'2Q(8Q$PS,[@;1K2Z
M'L4Z!]G1[S""H?'Q=T[];2,2RPM"$;4M2CITG?J[^^K=9,TN+)G-/2WO7+IH
M[N5>Q2_"M?I.>G&$);7$*(9":>AF6!ZR&U](,E.A>1$)AI;Q+G1,K.JM607+
M^]QK:9T\EC<],TZ;WI.N>:"3]ISWB;8/0P32H'E2!D]P $58"/\%(X'7\=LW
M?ZNJMHY.O'FT.-"OFE)G?=AAS>"\IKOJPK%=L5WG>:;KM=.A2;JC#:1(P[9A
MY%9>BWQNDOVP8V7O.:?F[,[$!Y9B'JU\2G/:DWI\D![5OA4%:83USZ<_91WZ
M/ Z]+()<%MJON)&#G[Z_?5I?H+ZF;ZQF9*+L?JR$S(T2[87P@/)O!U#8'HPT
MSI5=CW.@$T=1<ZL/<3L^%=)^-C#-L9=K]CW)+WCC%+7MC8S%)[N212<+[\6>
M]2(/B@C7%KWVD4WF3!%\+UD@R PU/-(\2DK<MP39MNV3_EZR_Z,JXUA<.VQ@
M\N*FNTI8>C.;*MZ@\_05SP\A[:F%%(PXBG$86AO-\2-M,>6B6[42:03L/MS-
MWUPL&_95963>\F&[G)'*V'O+W3CP+M#NJ/%A]_\UH#]IOPD[:!];I;@@^:/_
M^G#'T<J,6<;H(W<IA^+P $VU,?,]0*[6-T>Z:,QCJ.1 $ZV)[,=(WGCDO:OK
M%^&*M5NO8[=<?"R>KG9^4^3H!X%V5$WFW&G99+*?G<!XYESJN#042=<*YL4.
M*W. &_'6+4/8.RYG_&REG/UR4M+4OSXB^GU+WZ$FG+1$ODF4-W5D'F$)L E@
M$%H>BMH]'8#?,3/>YL?]/.Y+-:T6^U!07=6G4N>%AI*_R(,)MCX"-^S)8ATE
MOL.H*FA@O!LR7^X6FKVB&.$6O"DN!!NF&R-\ZB>+5*U;TW4PI>GRW(9/\LX1
MP:?[FWAQRG3CYDZTSS?/5PI7(2.[[;M['JJY*M\< #8DUO()S1\O?:Q?$<>[
M:2. ZT9J6]J'!5@59P:9TS"4\JIZ<I*9T8SXX$%BA,5F8[. IC?9'\NG^6U(
MY=CWIK+,79!V"[RG#Z\>D=P*J]"#7CSR6SP%A3K0W?)J=1^[ON9^H[PAH<GS
MZ=/&GPH^#M6/MRIW(3#_'6T<5@B&%;KF]Y%9ZF@: OW/16(& QEZ%6M-0;@'
M4>QAYM7Y;TO'!+J)-$LV_\)8]S6SG2QI.J^WK@\%I5@=]C(6\DZR#FR\3_YV
MR[+-_H(!1A=G#EE11Y*(Y>'SZ720(G.\V_TI*S#[6._![:JSW4<_"G?O6W]X
MT\?C&_HBI1I_.Z*;X4YS3C*]6HRSHZTFF5J,[0\]VY?WG*[. 6(-I6L"W89U
M$C(NT.N6-AEHV2MUII\JNB7"U0=)CEE1B'&@:  L#J&:&4Y*BL\KL+91*JHC
MLFD#PZ6H;0<G[U7N4N_:Y6&S+=KL$I)6XB.8ASZ21^_@M]%OWM?OPI(@#=NS
M.RV6Y.$!]:>'-XDUVF>);2GY2D8R,X\_8AVT-S&>N+'17-Z6 XA!*)N^X-OU
MI1].MTD2FN_V&XYU?\D>78V/B\U["9.+(&Q+UJV/IMM'WSF>6*IZN6W29E>C
MWW,;S83RQ30_->NZ+R75(3^6_^3Z3I<+ JE^0<DS5]*K' +E;-QU0D>R>O*B
M=\%MX^#ZQ@%P=!<'4##[_9LO__^_RJ)#V1R GS4+2IBI0?%4-7+U#9E4TH_,
M*\DN!%[9Q=^63!N,HZJ"VN=\>/9,:R]G)3'T4YA&KPOWCOI?W*N6>SN\%KIC
M*L*,7=RA42@4F8/R?3A$>*DY\!*6M^0 !HNKL$K[1_0T384#M(AP@,4P%%W4
MZ!$'L+HF!F_R0<A&R8I0TBJ:JD*/9_,BX.,NPEUYOH-420CD  ? M>,D#J"#
MU@.IFP,/P01N%$L9B5$-A$YL&O='+4<@I&2,'US;1SY6A+ JE!SXP1ZV07#6
M+3'H!HS0N \H^ 2"Y;K$ND:@>,5C'"#_%4)_-B"<LO,CV+IG,)ZMQ(N&S(GP
M4=)'K5\D*+X=M2R)X)!?2U@\L H:N7L9X67I6HCNE+\<350B4PANQV]G)YH)
M=M&P]E AEKIAHE_C(WYX7:5:^<WM9^]R W),&Z?"]\ZT75V1GO)^X-HJ_UYV
M%GKSE59_>?+ZI\!2#R+URIH>]X5"T7%\;>;8FM;IDJ6/&80H]6WUE__5J6RZ
ML#Z.FG,SY@ /OV7"/"AZ_N_?E"&XZ+_GU59R@-Z@23NFPJ?E,%1LE(HE"7QZ
M5,X4ZF9XF+9='B%[+@_T;5GO[R+2F-W(7/1PQW  H6!XDG0>R2;MR-3E43B
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MX]9O^U:]?,SH%M!H=W?!YB!GL7_06F/]AU@(1#V3( 6T8:" Q'(XZ9'?BNR
MMOL*,AH'-_NF?558:N>"_+8H*"I'R>.V3R7X+?_LRWBP+S7)WIE]H'Q'TNL(
M4T; #'!=]W)[^!T\(C/H;,:+3C-QW1@;]RP] OF[H^B#@<V1$N4^'L)51YCS
MRDS7'CW483.;#7<A(7]A\VY@1D+ONX(>+\G)M:P)96D%'S/Y[&H:3 [.2HO(
MQDYAZL-?E(BG3[]=55T;HV]L)'E8[5*B]?XSJ?1[FS/TM-LR>YOS\BF Q>%&
MW1PX_,6PSJ%M49J08=YS).:6.RUVO6/8F!""GXGZG2/L.N2!03.Y/]\R<Y*+
MW4-O7@KS")=)YIKF\[H4>5R0RL%S_X;3H> _%E:T[N)&<DH6A9IB=BUB0Z,K
MF%]?C7 9_ZMG^7\PP+#L.4N#^A^].*:0_Y=#Q#^4,/^*_%?D7]'3>62'0[/J
MHWS*P-BBK<GSX1,0DWT&UGJ(-="7H'H<^O^>:(V&C%.9DW"S &TR+5!E>O<^
M!K/0!ZW['_U)H#'_R[LG_Q,+&JN%G-+_6C?]7Y'_BOQ'),_O14TVF2D;V^;X
MW)BO%0\.=MW^0E9K, ?<4IL)(^_5QVBF[J@_H>"54#+P>7BM>^+98GB=EO=[
M8>?<\I?2M*O@>:Y1@@JY^C>$!5C&0N)?Q*$8ZCJA9S?G F)6VO32C1ILLT[W
MR%S2L!YKNAB];_1$QD</=M2C!7Z=1.EO^Y+3"YGC@+:6K^3$9<AE7TBYRT:(
MWGG2?&'"]0C>01EE/1\'GU\[;GWLOJ=Q GJJ&,)-,OT"="(X #_MZX\\O%G5
M\1NUF]M/DYD$+<\K3Q2'^FMHO=$."3ZP 0M36&%2A C K)PD#$2Y2C1:-KBN
M?<7IS#Y\WH'-OK#^+*F_6"S[>?^5J](T)R!^BBI)GIQ#8E?LSHEWN%0W5GU%
MX5%=IGECPBR7D9W$PVW+<[SGG/E%C$!/F\4)K<A7R%I3% 8:@61L=OH(Y'5S
M $?Z,SNJBNS+/3 5+2'W4/F>W\DWOYZW?&7$Y2G^-?FFQ0@3U ,G&HK="5C9
M@E^E4MD/KHW?>JIE78N@-<T^UNY%C'RBNFN]PR&CW&&< \PC'S26<*A0.#>5
M81A3NJGPK;J<J[_!USG?%6^KUS3SQ(TA&'\-K BWP+U9IJ4^ZE($,[E -:R6
MP@]$8+10# Z;R5F?9S>+I1OJC.QPV2^[D_IRFC<,[M)SPFY 44B<E2PTKE70
MKP&WW'$"BD(50-T^UVYDVC4''MG(GA&8F L>H9%DLGC(POP'[8"CA&.SQ)#L
M0,[-ZJEG"BE.PZGDRF'6H1G6U\R?"6+O5D99 :^./RJBPKCTJ.T7+3JS_O,/
M7*=CZ)18UYFC3Q4-;$O3]B&D@,P5OIU%'!_V:)N(0_81&K,+G5R+8.Y6IP0<
M[2'W]Q?TRY[HG?EH =;TO%<3\O@Z6@C'WF>BW@7%&1R3M,HC:_&1H1BMG%/&
M*\X_R7X;*\$Z+(KGX#NR;6\ZKDGD10K[0A^[(+AQZ$BI5NJ_%5E-UC&YBZ\X
MO"CW+/E"4_U#6I.+U[3[SK%6/7E_QJTZYTPKV'B5'HA0#%5Y.C.A**_:.X%5
MCWW;.ZZVB'&,=^;_P!ZN'4B4@>40S  AHA3):GI[2+'#/I"Q6U%\7=#O4ZG8
MU9TASJ.\NC>)7R$1<2_H4.;D.FT-]IWK1"LX#2"/,?[N=P6NA$4#IMI0;V?I
M9'G-SBE]C_BR!A;".Y8^_LWOCZ_0H2J>1@J]=: "VV2-LZ5Y%;JT'72B'RN;
MP1AV&M+5RG03''O8BX0S2X'Q5?,;?YY9#DA$E5;V?N ]TAYC'$3B;#UX#WIS
M*E%1.GP;X^]4H;PD\W&5!%$)\.6%6Q.IM,O,[MN:^SO.F)\%>/?5V@B\+5;_
MO7PUDN9J%Z!U,UDO:5>5R6HP^%9P?LEVG,]U42-SV7[ IQA<-/9O1-4NO6\T
M^F5?)R1TZ1)0O+)W1NT+<J6-==G-_Z7-.EGFP;E 7AV-#AF:7E/-4^[E'T+T
M3W]@_]IR>;6/)*R$S5);[I[C:X>R!T>9ARJ4$70+2H[O@GZ%2O[$J25UP9>:
M9]Q/0'1D<CX$4\1-\L3G1$)<ET/46\7'#:)SJZ=WJ[.L3%^;L2QG:KFJ&7#;
MA4HVZ4IP5>J;3OL[#?'I'K6FY+O:G,DZ@\K]E4:P3/M5N30]P?/Z2OKXO_$/
MO0*8>U<&SVYNL0L"7%E5_ZVB9[K4V]4EJ64-JQ)M+"O-8,#9)^CY+.M+R3HS
M"-3T3^TO,I%U,&"=* ^@^AJAG:.O<@0.M_9$W7W<6EGQT'!X8!F;YD30VSSK
MCPW5-2DQV%3HT&V/Y,L<OP1X_AA!51'C$.X3D+O7+*/#%.(\7 -0]\4'K/PL
M\#E*S[B0 _]5#O@$'!?LZP_HS+@,I]]G:17;;N LH0?AP(!4.HEKMP\3T,FR
M/&=+*)_6]OX$(]IPV=NA(PZ';['IFE8EA5[JEQ,:S0ZTY3)L4P++8)1K@Y<I
M3,<8_T9\0#<Z8<QUF>MWRV4KO,RO)='/0$+IIHE?D*N7LTL"4K)E*XUU/Z_,
M<_5E#[\#@V6S&A2X@B:\_!SP>1KBC 3;+'?W2%8A*YW Q,(7N5&0[?6Y%BW,
MT8X1T1:Q[)D!I?+ZV8/[@ GNYSJM#7XFQG.>>/?/=_*&RO<;4NGB\>@YGRU^
MN:&#DC : OW9[Q\-'S]X;"<C;2&P0:_Y'^X"KG/OGXW<'.I26(1.0!?BV,D)
MT] _"B]):/0@T$8Q !,VR6;M\+_SX2C* FKSK+D>O %W_K];>M@3(=2?@N',
MR ES7I14 VC#-\#QWW_V!TR'/%570GI'5(_(V7V;@S?8_^L-0@6)]&?-K_VG
M7X%].S%8$]^.MDIH]QX?\/C7AZEJ-,CM* />K^R8K:5ASW]F33G< 66GOJ.U
MJ@6-@E0A4:WGH3"$B(T(2T=C6JY"NK>X1$ <6UDROW5Z(K_"A(&X"LUQL=<)
MB!Y)O=TM9:<+"1(3/SI12W5=5X,4]WK&P(E%-4A CIW$L_*B-"V%H#PIQ_/P
M\=$0;M*.88$F^3CY1Z(C^NOIU22'> AF#1(&6R<\PYM2L4SWW#Q)=A,%2*WO
M]!0BEI;/:.OAC6_BY.88<@I@;W]9^J<'B%GGL[A[73;\H3]F?+N=9M; ]YIH
M%HYA?\\<X,24WZ"L_,Q&,KE6FJ@DI 6X/QAX')1LZEY>,J> ^@0+,*C&4>)<
M:@G^:N/S<]=>8:\DW2B)/P@!@2.L_XGB13:,7*PC!:O#U&W_6/6*<Z##S;G]
MZ8N"JP8@"W_MRRH;27BGT8<E?BU-^$I#%W&.\_T8H[L"*G_T9<;[/_95"WV4
MBA7,W:W?SYY8Q)(&)U3!P)6AGCD3=&RUAU77V.RFY2\_=Z["J,]?^G.GX(-]
MN2)&.H>'SB3NL'G"2 W@O4I';O3\D=EKLAK@'GC9?8T<1=3I&^2(NR-V6N@K
MHPLC8G]922(DF/L_P2CH;R/Z=Q2M"-GAB%P;?W0"^M(X= +2&X6F'AY#^4Y
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ME>#1SA,0'Y!.\,%913=?Q:$M\,Y9& _%[BJM?O]Y79&%L>-DPRW/@U(/UNT
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MI#QQ(0"A,S7NU']HL9%'_D2*T,V'2^$+46@K*)!2.LSJ_*:V_T!I@W$Q'B%
M0!OB3D"1*HHLUL'AUR<=ZU! +.K=:*G2#]1T2[9=IA10[E#RZP2D@#T!$?:&
MQOXHF(JL["646?B-(YD5A\EM0^/9WH6(83 GW%VUI3SUSS* NM\2RV)R]9-
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M2D*3K,EOX2;NOLZK [Q=>M^JZ\X%9D0,"=6MLPG7JY\+CS1BZJ?WO@:^!5<
M:@KA#U_O=3LP3\8O";QVKIMLOG8 RLA/:C 2701IE7<QF"N=T[AK;JW6OX ,
M.P$]0]/ #@CH*2K)3P!W4"1KIU^@F'3: HK=_AC/S@^ ZL/H'Z39&5^P>1RP
MS;(OS+NS@61K9LN'*P$!'TCJ.!(3S^O0/%O7:>_>>A9A)3GWT-_FT,L;[>R
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M_FHQUNR[CDGMMKZMMI-8YX$[6RKME+K57-_=-O087^9%ND5X@(CPW8<<L=M
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M*GCSV&H6-0ETCYI\$GXU\F[J!N_>]9'>/?O^8XOWO/O'W1I?E^[R,Q@]G4@
M83166WKTQ?V7RH,W(WAE"C<;_LR_51X8I. \ES;<^6G2\A._*P^Z)-3<CROF
MZU$?%&.%D6QM<"Z4O.\B-J*%8\1[0'3O2FK:@Y('J>PWX-/:!X6]F<N73;U\
M)7K*5V$5@QM#9 7:Y![_*(V9HE?=U!QW0F(K?,O#O= RCG;_B"\/<^RW>I:O
MW<T^.&6ZK7('CX>%I>'!>O(ABEXC (\H_J)\(>WHYMNSM;K:QZ?GLA6ME;/<
MS]Y?\F3%_V[59+T/<1N<U.\BT263'OWD8 XIN=D-'.O#L)]FX7TS),^D\\68
MY':5F?%$<L7-;RR$:*GWMB6#8PVR Y@'6],_2=[4DM\O 5FT6S&1XX*?X\Y.
M-#S&R)#Z5.^Y^'8F;+?>NU"C=EM;Z9NIQ#\T^1-%)>LAO4A-H":!;2MVH7P@
M+(%0M\N>B"S#ET5(*+!]-.(Y]"4$G_KQ=7=$O!"74,@1OOY/^Y"LAUG03\WF
M-+8 \G4D_!;F*/([C25@247$ZISQ>EFQK?;*V4'UZ4>//=J$*BX=G,BAG 1_
M;X$,H]9)Z;/M0Y[) GRMRL+.>RN%'J?WJ*/,6QKW*GKXGF_FB_JW7V"L9W$X
MT-+W)E#FJY5D,CZ#<[ CC2?1VN(;J7S&<B;/IXO;F8?=\?TM9KQ9P=\H, 7C
M6Q&UJ1WRD\&D*#"2+(,>KZU5$ZK!$4O?$N(/(O/T3SE4-K\?.R.ZWKFB]$ K
MSD_2 )SZ49&8J^9>*]L+=UZ8+",]I592)*"AZ$N@XD;\?8MO5ETOYC5)F0.Q
MW:?4586/O&6ZIBZA"PD\)M^-!<PPH%19T/E+2GV#T_;7<2P"#S?.6ZPT91K'
M<8OK/#8T3'\H\N$=### 1%K]W!#)0^E02]U1"MYOG6#L%-<2O#Y;JVKWB*OK
M8D6<3YN85]/M1Y#G CH' X_ZF7?\;C762)('4J/%B,Q1JK9+""[+J]+('3?]
MVT'\$A#JE-4\=T(XN3CY)U^XZJ4L)%R] L@//6]MJW)CI.3V='M[[Z$X(:31
MM9R'41!3" 22Q5;U_S:]_*\?B(OH:1A@$C_E2)*IP6H1?:/@M12K\A4H\U?.
MT[5ZDTN#KNLU=E=_?2(<,Q4-26=:#Q Z77Z5RU U*B+*<FZ&07U-=UT6OS!C
M36-+)JNB!]V]%^&!Y1U$6-?7&Y8CFW""J:.\X;S-&12)&29^B?F@ /M$?R48
M3&-]11>LO%'1OJM5=*_E"T3Y17UH^U(SDALAJO'QV84\2L"8J(Z# ,=N62WN
M7CPHWK->21:0*(NLHK+1. <%VAGAT:BK!RK;I+Q<H*=<+R_&#M]Y?O_DNX^/
M#&9KU,X"VNMT6WQ(A&ZKWH%O1@@+&VU$Z"T $4094DM_,VO-G\N1.9Z&OM:6
M_ OU;1^"U!J)U$1'TWKIYA>V/D,60MK3.+:>X:!RZZ4.$9+9I7.$ *U]B#"-
MY*G,D>ES9K+MZYOF>U$W#8*BKFIRWY;^L]_^9?C7]=!CT+]J?"I+H!M\8<Q,
MT2Z<@2A&TX.3/>$%1IH\/U9;_[]4<A'?]7W(/D1BJ8V.<\+MF8J@5\WQ\7_C
MR[^1)?2[0M$37?S_)P \@RA#T  87#(/.:/*2'1I34-$5+EDDS?@9I66;S\=
M$_&%)G0CO3L8/QR?T-"$H!^@AQ' U=\5=XR=^Q"@X7??2AB?-^S(=Y]S ANJ
MES!%NFR="W-5+<;-%Q?%9YY]G),6-H.U84 YJ0T5>GC<+?\, ]S>"KI<GKE
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M^K%VV^:C4F[OIUN+>W/3$RU?F9I:O@KD25V4G[XV8@/2K0Y#BSA29JM=[6R
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M/ M7BR8MD7<6K+]??_@TYZ2U4TFM]=E4S_K8C M,J, (JR9K.D%<YR"JM",
M7:@H\HSAT3PL 0;>V&P*R >UNKTSGEA[7(:3GIYSL'U;;0Z7O/H\^?:L I4W
M[=/PBH5C776<KMQL<V/#@7OW<O5/P9]L/! 0>1FW0S)UD&EEUSI\Y2MCX'C+
MI5Y<94EM3UEX"\.8JKUD+I[LIJ_Y^<DALTS*K%8\9Y'"=/1VT">OZJL7[QW
MOJ0)T,80U8C@W-$F7\(@*(GM''#O3EMVH1:]$^K3N:LSXA'5.\MK?[38/]WY
M1W__#[55'Z5=Q_;X$"O?MG3_,C90]K8"TG;5;Z<,^O&8N9Z?<%."]4=LRFSY
MZ??/417]'"'^8C?; ]4>4/-:F"@VQ-(RP)K4-(0ZP3,8C^9?._"]TXY_.$^@
M<63KCD6UD,N#A,!$B[ ;=U]IX'L.!>82H>V#'.AQ>(UC!RY.,#_8.U:H=8'E
M"9F<(=>DD7\E^5-Y\?QIIY":%RRW^3G%,0ICOKJ!SU*]S$>X;S&_1L()^?$H
M7V)M#YRIR9JLYMR@'?9$2 6Q7B9@-R<[C0PQ%'6(NT@ZVGC.!(_-GGO_'!J!
M[J=[@WHR"XJ7"%]OS*5($F%14D.[&5J8D)][!O$93H73MHT&!\V5#T:L+T<Y
MB7.^ZCVS\(IME6>WFIN!Z/.6'G6U3SR)!R4SP\D*H+5-92H!&J:D@[+,7ZM0
M(*O.G]"U>G"[D_%+<L+&V"<UVV+M@^:Z9#VD?/<^!+AU5*@5=N@1FA.,[Q#D
M*8LJKMZ*K!45'QFHL-9PCKOYBE&9SU-?]ME*1XN$R6F$A G56A/RNW/((:>Z
MT3+<W3(NBBHPEF[[?5YI] D.BO0WU-B>FYM=:#WHLO6E.'9'P^X+D-[ZGG(&
M-,=CPWPF#EA05/!DN7.7U+MW:Y^=/ JN#QB-HKDLD.D$M_!.G. :;%H^2P :
M^F1![+Z@:X66?>)RD&[*EX1,A1.M.G/)//H?!B?^K>>949^CDZ)[VKBRNYFZ
M@:XF1.-OI@.;C-XZ")^:QE! NO%!A\+^F!K\LT+\H!MSY+M(0])Q:D:U82SZ
M9(7U]Z&34TA_G7.NET,ISV(\DJ8@Y@D?EL7=8EXS@J?(VK096-7"AC4A&LN)
M<@#+W]EUG,_-&I(KS12Y/.#Y.,&Z<#+KF#*[S=+* ]4QK3/7>_6D=I+^=O+T
MMAOY(GIZ'U*UL)Y/B';G1 G0E[/H.IB=/_3H3*;;Y0W/<XDSY9.M<<H08<<O
M#JH3<RV7]R%!\^AQ3'5H7A*@3^*E8K?.[T/XG-.>V%N.9D<@9J]>NB5!/L?Q
MI8.U'(Y+OVB<R!X[.LO_8FCO$-D436=#%:OK3OBRC:TXM?,5E0UI)_?0SQPY
M!PL6[.%K6<)+8D(SKG=V[R(RU,Y3:^&+;Q" *9;;EB)-C53CMP&EVJX9'\LM
ML1Y8_B!V97-7F.&8^<J/X[\^B*-WS//0O3C@FO46%YA*XTNE<!L3E+:B41H!
MTO4-P%A+D?B['YB1+WBU^SWE.E$%,[3RB2@J+V#^C"($+'3P9K*"&+PM_/KP
MZ9,_UJL&S@P=#SJT8Z(.V?VI.MQT:T,294_FION.HSA'Q-1<"<J;.)8-QA-V
M3B+ ES.8SG>?;N(::UU_]1]#^U4<8SRH@7#KR75ZWEVNF=?Z+NN0::@ZY GD
M7OZ;)+=8\8B_5[&B\4^;F/T?@*@9TL6DT\JJC2Q^#9C1"J=QSIQ(5H?NU7__
M\>D_\\H+!S&U7L(%)0<>!VL-#HKN0[X936P:DGRP^Q"UOQ3X(.@<]-_[ NSO
M::KY++:(G<[PG/8AVTM0ZAXWYG]->92X&:!_.IWVG^;&1NK_0OW7HGB(\A1>
M.$F1FJCD/N5"]U]5$Y$T?HU\L%%]Q,Q:SE]=UNG*0'^E]L%KRPP5^".)DH0U
MQ,,3EBZ;K#_@,SV+%PK)!N@/HFJ@6-;&Y93J[/+AA$F9CWX'(ST.<")O#7=&
M&=[Q,E!1N&)$F1DR4W*3,OFL9)W!9C.27]E<48>4ESOS1J'O8$&7K8CU(8NS
MQX,_G"P:7V%>0 #N/1ML94AY4DD=-:.L-&8/&O>DZ-6]\M05"V\VBS3O5U?)
M.1W"'R;)D_'PQ^8;4G\6S^@%P!V[CB?$B]#&4N%5)GNNY5]%#PUOWHW[]3PD
M_59#:):%24+820%)GYZY?C\R >?T_11%ZSVH\_?,1M"'?YY"N_\=PM3#?:OT
M@[T)0M.&U9ONP2UA[(;1S('5E8O'CS52$[RH44(/U":^*"?1*I?)9/3/ON]=
M+D/JL),H=?!+$4J?Z!A>Y2Y"ZU53JB/*[4/:#;F=&O(#W5&7K82*ZC>?G+7G
M"TG7JCD=<X3V:/1V:%#E&^PI<)<L"2Z0K*E!=!EJ=NELB%JSBF_%1C38X0B%
M)2\_/)_J0X_8A%RQ/.%WTG:2L2\V/5!V1ZEX0W1#B;DZ9I#;7=CKA= 0?Z$#
M<\'!-YPJ&XBKM[X_/1-/L!7<ZF@Y,;S8\AY7DSA/ZET[(6[<OF:ZY*UZKB+Q
ML"K[PP->'NRURGI=2U--_*,U^!B 29=R>:(77A&7L-3,16-E(?XD.$:J\2#S
M]8&?G9(  )268[('A)7A=RL2!6J)#<*5#JC6>M'P RU1H#&PA@A5XX]O3;$3
MKQL][W;%3(1)%K C](X>D6OLMW@UQL0C$!@0Q5@5PY:9&:AVGUJCIDQ!C5 L
MG0 O?.UZ_M(6+](*J3K(]QTM@"R9WI2$1+/YV;:I+Q*<3!ZQO;@F$).P ZMT
MW& FCA!\8]U0C(7HSKV%]GT(JY.@BLJ:Z(GZ8'O7*6Y>L_=M[<!,+5?U;<YL
MS]9X_S>!JGQMF.J%[C(^@R*DUD^2(!CZ%DSK);GXBX^*3C[\"5&P6+T<Z8V0
MCE%TU7ZL6.YPD6DUM$F$X#[I0I*[K-R!#??%L%?O0XY.#CS=.Q:UX)AD@:MO
M<-I$O2YZ87C.S]+<Y?UU5D9AQHW16\P#F.J>-D3$/D2TB0-()R4#\,#\*N)6
M1^S3CDXBJ+:YIJ#Z62\A0T-O6_>PI,R!,/%32(]6UZ@%+C4A9#SI$S4/S8-L
M0!SXW@![AN9U5D2&T58[&VQ2%->>=D]VY5:=U3N8?M?AG&HNJN:#R8/E^/R'
M6=!75?!0FC@U:1_B!HN "^W@F+Y?'GR&EG-*,;^<#9!>26Q\2BB9"E<7G#\^
M7*7,\6%KY>1[RW,PYPWG<6K,[YQB?B2"$-]E.%U&R S9,X] RR"#!%QW]",Y
M5D?.1^OT7_#HOU51O(E5C2AN0VM^E/'8$3&>V*ANG!,EC'2D55U0KI"<E)>J
MVAX72TB9JO<5=A2X^(GEX&-U-4L0L3@S&(D S#'T&R(D]U8N!\F('\_ G_!4
M6TZ+[9/X_B8SI(?K;BLYSW0@P,%FJP,:2N,!=?$84),B>Z18LBGMIQ&N\?F5
M3]E^BJEI:[X0]^39Q)L089E04U,1GG]06N/_/M#W,&U],. Y79$/ >GK\XXD
M<U)+"6G6T7%:M0@A=:6R<H.?$O#]AQ4N!SK32+H"8#=P9!5G["%5S:<URGF:
MS0"IU'[^"1GL.+PLUL ^*/3LHZX0_T4QP)@43Z6[<R?<E'[G3S5A< # FI2'
M">BUE<Q8-4U[3R_C"75&Y<^$-\0O#O:_0Y;<&2MV.+_EU5NTFT0[FELYEMH.
MXY-?K>Z*7K,Z[U/I2AXN]GU@.HB2O>8QX]N,1J(_P<JU-Y3)9L@W,QT8)C37
M6NJ0H;3E;E&T>?C-*IN8IMHC%Z09,[)2+_XRC><A3Y"9:3V97-1PN@%RDU\L
M"W<WV]O1F6@Y.=;IK[: .6XD'NBCSB.F[L<BN"HEGN0\?EC*/_.C)K>95O9_
MIO$SS0@A^_KQ(*E4<89L9\M9*T?:7M%N]9!BQ!1?2AVGE7_<S'UTTZULXI7O
M.IIA"(%[89Y*HX>1H]HTW7W(C"@SY5K97LP^I!=#K0>9->G+:>_%[T.,8+^D
M]B&N,"(K;DUQ'W)J'T):713A(?_2A*W!J=<QRUCJ>TRGS#ZD8)!"9T\SV+^9
M>Z3)LV,IJ4^-O>E!>CT[<*6D=@#KV#ZK0"L>*H*Z;%R:QD#E2C!;*J'<1G;X
MW;O_J9;8L)H>"L<VR8Y:B;JJW&E='H"'\MM =THP'6OI[B^/,-4_ZYZRP 3H
M76H]% &!'@!]]R%,4Q2QH29-D7U(YSYD&F$[436Y?.3)AE0'T6GP.+.*E5D:
M&JI1?75'K 2=8F0Z(&YXVK*/(@3* S@2&O2["Y0M;@6[G9=C-C"H&;\0Y2>U
MI5+).:S3D^(C\?*';NF;*!F]_^X]@OXU_C7^D4,-#DAM*!)G2!433^2%41)@
M1@Y20SV=D%>.SU#4N\R%,#AI^<UW^-?>,\6\+06".>]7L<E<H7ZOH"O?\8@N
M#*\5ZG 3F$S6TWS[E8\&2S<WY)S]-N\\F7-!V9<]O:XS-\,^4=KL#HLX<[<!
M*IULCJ:S?GKH_0 V+=NQ#ZF66F=!PJR)RM&/2KW=0_=R<$29T2VM5YCS$^R4
MWI/)B]8OV+H%,<G/4?EB)#*UYCQ=J;UH+*<*4)K F=2 +!L7FFP%,!A5%3U\
M?<^TWZLXE;=_4@#6>/,QFWCP"5T9B%HYH-T='RDJ 8IYD'4&%LGU;\=WOFZB
M.!9U.#@)%@\<>!%.KYZ=4OVRY+BL?4 WB+][6#F0]AE;94[A+B-)#[O271$T
M+AJ8Z<)!DTQJ@[OF18&,T%$^J]-<'\J+GQLHHLG'>M.Q1>=BWPEY!A3F?/.Y
M+)KL\N;;\\,EQ1O#;,B)-R>E36&!!YH42>\!5UAU::$#^<2D5 9^9\S5&Q%E
MWM?O0SJKEWIA[R%\F^AUVD/AEI?PX4^3VR>/,<RA/R\(E;1 48)U1%H,2='Y
M:;#U)/+VS&WLQZ"MVXW>46/B]D'E6]Y^0N^Z$Y6!"3;R%2M,F_X,09@/02?T
M$6HL'_$<CK(ZF8S!)B[?\F14LTH\>95N)':UW/,)9!ZH\X57&:Z7 6*D4B"@
M++#E"A)&]M*K:" ;9!2,EKJ%**Y+BS.QL*>P]C-Y!?:,3@S0 _'4=FP$'##<
MFD%<IZ:@3BW-(3KAAUO$D;[&.*#F5:G-KVW0<Z]3:_MZ?/RNA(0-A.E&=$(]
MVT7FZ>NAAUXN'LN9Z,>QX1ZZ3W.1*@'S&/1E]*?IE= \I/OUL=\;?#-\LXJ+
MF=#N.OKP[/;L#0GC(XHZ1SPB6N\S^O-]:MN"\\GM1N-"1:6J , +(Q]>=KM3
M^V=,-S-+?,!D609\,3*LAR92")#70WTC=^.KE@HP&RXM.$ $%R;-Z/*[-W$B
M12F8=+B26OO$X(#+VW<SVBZY(&(#8G"FXD<ZYCU?#]!?EMJCD/VXZ9DA&$]<
M7<I?3_58E!= #Z%E/U<O'$-V=%[8@T8=2WJK]!*8H_8J!#T4[EVQ5O\Z!$_?
M7BP*6PO?'FGGG:[NH7 UXL/*?6 TCBF<R]=5X_BYZ&LQ[Q8VW;F@-[!69$,:
M6ZF=X:3@7O>8P-:9)NN<KOP<3$">(N<!\J(2Q)]..&,%%UJAD9DP+.'HCKD:
M$S&SDC?>O;!*7[B!J5"&,'])+U"\^G6A^KJRYJE;_=^D?S1;M3R@7U_MP]@B
M3)NRVHF>0OWH(I%S[3\N#;W_J*H\/LQD/"I<*" 2ZV^XOKTD8DV0:H4QHM0G
M(I6GMX)W!J[M) 2O#+@(TQE"O$+6L?:_;.DDJW)[W)M-Z.TA7'CI(_.':JXW
M%'96 L\_+,: NMZ8/6YYS%;N6QJG+8(6RK9 _O:0\5Y4SSXD))5^H[.O_:3M
M6<'Q$F/[D*^WFO<A+2F!%Z3_!?P7\%_ ?P'_!?RO!;[;<UO^.?[&/YI%[F6Y
MJ$F.X_<NBZP#!<BWG5:8$%7% K#2C#,@5?]]VN9JK\' E^[0&<;Z]M>L.(/,
MPV>R_%U>WM99OE:A?3*H..=.$/26)@05#""6RC9,R;?[%A$Q,*B:#!+10:(I
M -J1WFY\[15?S]E-SD0;:-\(XG=WL Y)="I7#$M1@+VP'#.JE]N$DG4L*:K4
MI!*,$R)^[\[GG!J@JR6[[)O/G0]#M@W2%YZ'M?DZO;P>F&GYPO'U1 ^"&^,H
M'[, &!A.JXT0!M>5\P<).!8[T-UN7 D7*IC;QS.R;E\_3)NCOOXEKO)*SD+Z
M]J+UG5^S$N[H67@5)A3NC C#5'27+PIL\K5CN%J4'E8@.CRS$?>53YZ2<X \
MU^O]=/A@T.<@%O[S#"3']E]JI^S B\AT@I[UU1+GQW(?@)TCAUJ2DGNG?[7I
M]WY_7J'G*?!,.JK.Z@=LRIR4#.*)UJ1R< Z0)VS&XK^SN8?+9>?%,P4.]PJX
MWZU[W92DQ]W;=5 C1/WP19'!(:4?CNO!]*A:A5K<TL*V#QFQJ6)81U0CNA%\
M*#D _0H_&+*-1(+;W8(5W^R.!7<IR_,$8NWU3T\PP;&]<?S+]K42K[N#4WF2
MR8I3F#;U$T31M\H;P24HR51=WJM/7JJ)M!7\6EFLZ]/[Z6]R7%V=E46B,J'V
MJ"\IFQJ!>S X(]K;/;&T#WGV8&QY^,VK\]$%WO[ICA7G-N8_G$PP*9]\-5M\
M;.BY>A=R<%T?OP^)V8=43&Q(+2$F53HQ[+LP7E!OL.T],A]?4UFBNV([:76E
MPZKZ1=GGT.>HK#L, @ZL,.= '_A1]!6*.[54"0L#HTE^Q$>A^*TC2-E.95$8
ML-M=^*;Z&Y$W_U'42)\BBW%OY;%O@GZ(IKOU/^,X&[<F?Y)>#N%<Y)]9N?\_
M[+U70%/!URT>1$"D1+J @E*D]Z:4!!M%1%1Z%^D@1:0$B F]=P0$A"!%1 2D
M5^E%!*1*AQ B(D(@H7DPA1M_3_?Q^[Y_N2_W85Y/]IDU>\]:.;/7#+2S7&YH
MQVK."ER9=,H)=6]+ F^,T_BLTX0Y:[*GE(;IT_9TK45--#;O\'AY!B8U3\*&
MS P-18C;U[/\^#MWO+;O4[F.@LR/53I@NJ+_W+1LI^9VZKM3D']R-C'W96V#
M4Q##5)A6_7$_^=WN*<C5G@EXH8OW3O6L *:'.B4:\)N1RDN;#M[>F[XL_<1S
M/D*B)VCWLZ3*K)66)[]1 A!1RC=T@U@XA(442'!!K6MQK#]=7OAE)](X.1#5
MAJ@]7TG.MIC5-8L)@-_1_59=9M'R9&3CWW?XI= 2(I(RS)/3314W<HDJKT3(
MDWZ.]0JNR^E#$]-=:U6)P0'8FH7*^Y,TZF^Z!/QSZA?^A)G;CNW02.H?<M+\
MMLK!T5+Q2T(VNL9U.8^'MY%3XCW7+K//_AF"2+1,W]VI# YDLIJW'OSVOGS$
M+$/?&FD8?G.$D?J&J8M,@\C+3X%8O$9_7N.[2((PIJE-><R.:%@+]GK.GZHZ
M\E!/U$6*DU"QPN@W$LMT1<,F6(S$X;'Z>^YXCEQ]==9/A99POF<>NDI48IIM
M)JD*:%6@Z[YT=%#GN8\RK1[SFG'Z[82F&@M6;(5H-"\3L8G^\1I!'P:))A<B
M-$]!O>C8?@B8H)/#FH6%TFX++MC)3Q:]ZGA^_Z$^RZCHIS&?YQS2M=F\?5Q0
M1940+7@0IN IL:<+;[W' ;,W>'$L=Y'$T=#UW<&XSV;)]IQ#UN=[@Q\CM4IK
M:O_KS4P;OQ 7_GWV9HWM2Z79RJ&<)[Q$19%T_?U3.= J&Z^:FF+OS<A@>+*_
M9,2??>J4I/Q"PD_X,<\+/26$S"FH1[6J$0J(-2<C701987'; M($%O)X_*[*
M]FNS90_(5??9'RW:][I3)N- PPN\/S(8H9:3V@+Z&/LX)"<$@A@.A,@"5ZNV
M\L22C@RY9#;R^P/]]/)42U\G[$N\%53(XS4SF5_VN?FFAF&@@X4HC^PQIO #
M1A0VN7.467MF'-8UPS-Q <XF/:>FIL@^93,BDC1H61#OXO+-Z-.9SD]3)!Y,
M 4>_56Q"PTL)+Y\ VUACV.5TV0(3R:^_6 <S/3X$1_E(?BA-^T!?!H*-]Z-C
MT4UVJ24 -W@!C=6-<<ZY64]42\1UA):-*,*B3IZ_;U'J(<X[,=>ISO1FBFF*
M&T_ U0&M]4;"/LD36%C74K,@V%@9;.69J*M$+FW]52E-R7B0)IVRKYG1\9SW
M6B!_E,*'TB?R/CK%89H'W0@N<HG_>"I$F2"72A'?XLL)4SDG/10!5_,LDS:W
MLDD4D.6SC(B\XC+,Z_I;80/K?H!BHGR%7J30 \C!+L8N5_!%(.@!/C:IT?.S
M[GV4><*+((R$]PQ35F."PL;*(+_BG13\R;-^A70=J5]YXK3]*NAYP;7"2B+/
M;2+;_%" *V9)2_:Z_\H]19:5QG7]31G@">B@@_1UOOOI:(?$P&,"S\XX(0C[
MLWE- [D8V6_'WSI!$=R6][PUTE?[S2CNR$W8J;FUA?U#HEM:^Q>O5Z.\KUT,
M*QL_[R> 3J8IYQTQN!=8P>Y0GP6-[GU!W"DH0?TH.Y]#:%?5"L[#9FMO?QW'
M^>AN0^;W=\D,H[_!G8!]7YY19(=2.4SW9O/^,__*B\]VBK\%WF4_>Y?$I?W^
MF28_IDJMO[E0H6F:\W<S0<1<[4!O2G]#3HH]6VPDZ5)S=HOMZ%CRJ/[,_]F[
MJ?^_&G60*X )L-UMA8Z@+W[VK;[49CZQ,34X\EM\";I9.%#-E9=WZ)'5X4.&
M4;4NYE.0CP3<&9-\YA1D@U<9PZ7VK03=R5Q7%UWE'']>ZM62W?T.W9#5Y&HQ
M,)2]X212I)WZ#3%]"OI$)2M(A[TS,*;CD*D:%4/K-9^XAE,0)Q XO[;\N\[J
MVX%MT1"I(7\T[V'"C32AE.+.GN(P1?AEK!$8?AMO5X!%TWKX_N;SKBD?"GYG
M4X*YEG*7.?:Z:$@2(7V<]V(-&T!+5"9Y ]9$*])#<HFF<27,ZG??>J([TG/J
MHZSLG46+3\UN0O-[%RS_2,$7V Z^;$7N"O#C[6/@5V4."R].90\'\#>UM36'
MS]]R?6KPI7;SJ5*M](;V:G^]<[Q*A;: +B&S#]54#[>>UC0E0DBZ>$7@H;N]
MZZRF%);EFM\@=M2%:*+&C>Y8-BD^\8KB9^R1R?J%X"0)=.%3XP-2$^PO:.K2
MMV/E+BPM+7FH%U3%-S4UUH=]<:AKC"]8O/ZH+&O8-2A8-- Q.:Y@A9-F#<%'
MSJ7(P6D)8JD<QT\)X)@J?\$X]9F\)4M8S(T#S)B9DTEK:[/>JZJ9Q\_TZ=J5
MK]H^$%F<YQ.X1,XF61,AE,$IRKA@G5JJUR&4TVI>88ID6;,@,Y[_7E\^.[1B
MHC+&G3&3UYRQ56?V',WQ5W':(<AURLC?.1PMWKP7(4@H3\;A*%=@ZG_NSRG[
M7%S80K=%VC:8RER/]/O)* AS"P*G U<^I%L)+HP/(;D@6H Q=A/'%5!4"9R9
MVH)?Q=2P&B@?;X7Z?<BT'U<>Y@V:#W>,NR8T[+7;SX9[]9 A$<@\]B.D1D+=
M98R.2P#:%\7)Q@-\S.KVR9I:-6/2W&WYUJA#Z^^%G.DEA:*C3A<7[!09ONA@
MJXB*B+$T.'WJ $2:0/]9H!$K* #$&'H._)U1?7>Q]'5RK?5-7A>GYFC('>;1
M(>G^C4]:]RJV_W(7K'L)8&]^GW7T],\7LY MC<[U8[0EU'UBN'A%X.85O%X1
M^$V7JURL,>D^N8TB@5B8UGF0R)KKLX8\NYP^L*,Z6O/>1LQ1<'&B/T61_VM:
MB@+JG4=G5IE["'>N3_&OO&?<@8%ITJK9V9\^/K_-%\;%9@+Z /K7DU[Y7^OR
M_G\P:(9)[H2<9!+/FGXUY2)P2R:HO[F9;<%-W6MFC*O=YLL\^[A0Q.-S,YIU
M%]0XDR,B!FZ>N Y!&U#4:DGD)9G@'Y03S6Q@X$$H&/YB/?0E_2ZQYZ_S0-FW
MR%!?HU?:Z?$9TO2:N]+"#J^\VCNG:FB!GK41GT4TMCP:SL+YU(<.+DVX;W>%
MH +P&N "SSJXOAL,N1[U=?I!,"BN>".W%V1/?GL*<CL%<0!!6%0XTFDO<NQ)
MH3RA(TCM3UYUF?=TSUMW[B]C,I/1EO?KOGQ]&F] M\KX+'IQDJ1(?JOI@!E?
M+#$F)U-4/ )#8JK$8H0)8I&:^N[.Q_8X:UKAVYH<=WBSO(72];]>J.%=:3S_
MYH1K[/,,%&_;'GS4O6K3!1J>3#R\8G^A!REXG7*M@'BS:F..Q%VR=DG]H<@B
MP&";;[*TN%*UQZ86&MS^?$^;'\4#=ST%T>G.==RH( 4"3)[X P,\^97BZB\!
MVKF&[=PC0ZL!Q:]_V&-,8X(?^ECP>'?_3B)&LNT(UN[AQ-R)UI11!"_YK;(1
MF,KWAFLLOKI,7WN3%?&;MS3"H@\W;*1Z;7')SR0RB6#6Y0Z-@PCA]R+0W8+,
M,M@.PESBD[R^WNS[:&E9$^F< ^RNM34#N][*MR]S<I(2$^0W$#K _-@-X,6@
MPB%,02^A?2%/ET3[$VAM[ND'NSZYSB+R<?_"=;IOXK0C4!?HHCDVIQ^]Q(&%
M[IR"")YW\;CH\KZ1EQ>V+OP"*R]%[[#;\&2XW\KE=XA[S@<R61,H_Y5WHG9L
M=0IZ54F901^SXETI>97;DO\C_XO]\47!?F1# >XHM@^Z$&0T(:.2..(N>X3D
M@E5+.-=.R42>O:M7W&?T7,I[OO5<)5/]D?:J$5$!,0-MY(D]!7EJ&1T+D>L.
M4UE7MU,Q)>M@1EA?;YH^2U.YB^C^BDC\\/S:WB6ZGOAPEJS OSD/9Z25$QF/
M;,W^\GM:6UA9Y^?'W]+E]&!T==&4#&,4P8-JP,!E_"XR =W@W4ST@>489B\R
MU;#>Q:!BS8(4.%^YC2@9R9#B^L3GE%1_S82-G-&QIM<Q!544P^% /E$7,5&H
M!4#Q4@,A0;'*@C&&/@[5L(QM79X##_7^#]]F:X7UXM*Z>=@S<UR??'AX9M H
M0K )&M<I!N<@I-0$X4]D.X5(4(+,>/31*>C\UHNLF&V+%.<([FCT-0W+!:R#
M\.:(\36#8.?4'&2/8-5NE1PU3T)M_>6_3V-_UJFPB:''1R(053^-N];>, 5#
M<9^)-A[RM.0\"F3:(2RUS5O8>A*B=7*?PDE30" >IU%50!JBGWO1!\= O 7M
M2^6!J^>81\P-M$&CE+<K0ZM8;[R1'#Y;K^I"$V?3&:3PJ#'(V[X8ZB;'09GB
M*Y@MP&./+6LG9!H]MW4[OL/-UUM<,H;T&\]*>Z0-Q!2NF\G4ZE.QROG]MC5U
M,:<G^Q34.!3?,+[P^-M5:$S#BO>(!?#V95)_]O%N,_?B0ZW-EO2GZ6$W4LY*
MSRL.M*\TLMSJT_N$,OWN\[:IL3&ZK+6UY97(<YVB[$#'WO>@#"/0>=")Y_%3
M\GNDAQR8,AN"VKE+=-X2N/QY3K!/MU^ G1 ;?26#W^O!J,%&FSY'9FW/ZG6F
M2(XS_)*X(UN84?=>[ N2&;DDH&LIM+_M6=.$+<Q/CIFD7M\:5UJB8YD7[/-#
MAU>G-;=9IY3>@EUQ7E&QIOV__Z';],CKP=S=J=V Q/5U)H.@O*=QEDV2V==I
M,WS560W_F4I?!_;^W:95CS_ ')<3'_^R@O:Y:6J46$$J@_"=/Z=^VMZ34>#\
MLF[]J<=J2VA$?2B*3L]>/DQPLE,$@2X$XUUWH,64^1#SZ/*V_ &K@#A\5XSS
M:^EFJZR?W%*W@$&N/]F^D!_WM35I)RAS;3&?L>-G5B@C72QBQNNI<7Q.LQS+
M7LMYLIGB"K:_E4+HD@N$[)@S%<4QMIF;/H DN,^0"0/M'5] 8;JBGQ6"SP&N
M6+58?RQ'08]0@EJ*T&;[,TO%H0J1/T5@.R"6@,;Z[.37P"&S76ZI/+\05_!S
M*?#;#+&-2U52=SWE -U&@RB7Y@QVYQ<RN?XP]-C)W,;+S5=572E_:W"56#2O
M'2!X;-*!CXUNP+&*QU2LHW@MQOW_-&<(?96I>I)Z7EAO5?$ XC?U[.;KY;ET
MJJX+&%@^!=5R-164QJ@G;Z8VQ/E_0L&7N=/>VR-87KICT9<!3PPJ2D[3"\M_
M0)><].2+8W*AOFV<28*(34-&>UVQ3E%]N^1[D7!M 38B'56L782H>* O=-(C
MI@J9IAMJXE!,*@:AAB&V#,%U,T]:] 56UR_\J,NQ>(W5C-&A">*TDSMN_(_7
MVR5R8><E>\IL=@9<ZQ0497PGCS_9&%/Z%S[VDKMP_P/\S[IAC1]MA6^"\&-6
MM++<^/8IJ$ZWAR6TNUE &=@B"!M80_G@QG,YYG/2=Q(V[S<D*+"D%-HBS-V>
M@#18F3/T(TPDJL&4\UYKX,6N?OMS8H2A[BY^X*F7<*^<P.=*&(\E?C*?&"S]
MI45!_\;KV(>3#!?BIH,?,AT6@4L[%*I2V0'/!X2+GPHG/+CEEQ.MLY9$($_I
MY['US&NIC\PK8\EY"(4AXBW$. 4,+.;=G%[JIP@VS8C6RK18#PN=^<5(_,KO
MR] "(N3M_O]N8O+?,CP)(Y>19 A[@Z<@QIH.4>)UX(\>OBNN\<Q5"OI[E5/^
MSL,+01V2J/VE(C--6?U![9HS^)J=82IZ4'QSU [ETB_!QM2^9(X[S7'6NY.:
MS.L_SR6ZZ"9OR#(/2:\Z[DKO6,:+Y/VEBL=]< JR7F8S&2($X\&B^U@\EHP(
M0WVSA9<A7C;#HIV5Y<MWGK;4M@6,OG:(U??]>8,>5]42,1Z#JL^)VZ%H4J%O
M3!W()TO^&5Q$Q19/^,M [[NSI$2_T\')+4Q9<FKNB8PZ93R-7S#EI&V??U\$
M3OO8Y8(")*]E$6CM@<PRR@R4F>/1W*:]JD$JO<U]+R]CB.D;T>57X8K]XK^_
M[0X4Y*9V4KYUG@/0:SZQTSU$;?CC)@(R8:^1M[IZ;^<C9<3U_(4*S@MW&':Q
M)G?%(@S::X=OU&A3BU (($A5/[[ <Z(#R8#\#F[T 3!;[UMW4K<Q#]%*'AO/
M?R<3_2GBFK[ %3'IHNRSNL-?A"]";TW^S\Z6P<1P!7CH<1VP'5#\"WH6(0F#
M]E'X:[.\&Y,U^M4UYV+-6LQ$A7--HCT#K@J.:&J 49*J>>AS$#9JTM]\"Z!*
M/9$-<C@HQM:X=_'%B-9J+,:(N?%5\_[)LUKIC%J1.]4]7ROX$T!^I0E_V1-
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M5UC /FAD@\D1;:_T?>C&OBW'46[G@J7XKVB/WLO^6]-#+4:=9TF:<_S]JR!
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M6U.0K)/=YGDA2P9R-WVTF3ZA>DQ:L!Q4!LW$>^/) MV1$9A3TYC3KKZNJ+C
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M[LB]5.RI\U%)B:>F]K+3X%M\OGMHL=N^.^3^Q^-&/PJ&8R04CUU0CT5-NWW
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M?_MG8J2AHV=@!M%NH]0K<  @.AH:$!V(EH:6>4.*%K11S0@P@3FYN/<R\^R
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MT(\3DCX9SW^]073?L8]P =,;OGZ'M8;9BAX]'AC?LR0%JU!]]4$OFI;1QSU
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MER"$^\BLJ:FGI"?4%..?#>=LM]E]@JV]*,#9\:A[@1UR4 [SE [I"TW$.8*
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MG$]P\#\*U@Y)[A!B"W0Z764-?\98KKH 77)9-@YP-^(VMKJS8Q_?;1H%#U8
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M3@)O-*=I:$Z>I*&CI3UUFH&.@8&>CI[^+./Y<V<9F1GIZ<^QG6.^P,+*RLK
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MAW;IXM\>0/]N@$TGEXJT+-70.DN^_O2]&/_*NC%:K+74<.KP"'1K+/\?F+R
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M!T1L93=U=J;^S19K_:H$-:IC%4+='J  NOTN*1)7_H48*CQ-G]"A74^?T)V
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M5<:9Y#RK5\*LY"ZAD+RJ"B,D\9[.LASM9&;SBT05C/ZY(U!2N(H*K0\>9CR
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M@5X@Y=S0[,J]KE+?M/>E@4:B!",Z+D\A*"V2V.<@/A?11NL"E+$>'8]C,FP
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MK^)%<'T0?'7&21H)^-(%A6L,$\BQB &D_F2M*L8@S33I4GPN9$*6$$$3UK#
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M^COB'@R9X3XC?:Z^][UIQ._>>!*<H>*LLO'%46E8K\63+=@8]6S+V+K0IF2
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M27\\/#@06,-;!=DE0O?>/T_CG4*NHX>*#[C!3"3J=#_YS=K,@+2;%\M>(NS
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M5HOUD#Z86UVW_O8&:W.0$H1PP>8+JBOI2E? 1X%.\"?1'N1K)&_^)Y>F.UA
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M5>%/R59 37R'V\:8ZU2!K:$&8 R6VEKI$NKWV%S&<=J]"S8B=':BC[:Y.*4
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MHT:/ _80W2N0*H-M%0(C_0#X ] %,5=W ,-])],=E&G8\BP%(-QMY[7;%RF
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MBPSZ-0B>"&=50Y=U^REA;+LLCFLX=,5&C)I;11AY:WH/#,_RO J_/8%YE%O
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M>=!3!MKD_E8XDPR?\K1>?6ZN>:"<7Z5JQW=X^=C8B_+SX]=3WG7.1^5["9!
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MHTZ(@DQ!V]@V5L B1K.-K[37=:&4BV '%S/?^\IQH[9TN\" ^2XJ:UQUZQW
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M_JE7 "YT$ERG" Y@9]=[O_,MH^K0F.[\._LU.@UIU!6"K_]F._(.>L ?5P>
M(L'-M5U$WM,=C^T%_NL7B1CX3 L>1YAWD670&D)8,Z@:JN)DO14!4D_W+<O*
MBEO,]J'HM8E-%I-Y>..$%\)ZML[8:F+A?H5R(@I9_J<[Z_9#DE,.&%1@G'+^
M^^NA*?GRY^[4YCF[[;+Y=X^5!XH.W2?"ZZ8^F_ U5QC,$O1FX! 3(0VAPMG7
MF>6(K<H[9$(5J]S;Z##@.GW0LK[F>="S?M#))TOFQ.0IA]4#0/'L0%<B3^PY
M)+=Q6X[>HI8E*QPT@!^J*E&1!W+$AO%<6",?C&)MYT 5"]^Q>UXMV9W<GG2:
MTB 2Z,10\(GW 6$I"H8J)IZB5XROR$5R>4B'Y.]X8X5X:I4?6\=^>)( SH?'
M<8"MWCK-AMJK8]V0!5-O+@1S!#/=Z#BBH?H,M #Z+''4UV0RF+U?L?NQGA>?
MZ>D&EGW:^9Z$N0*^7?XDOK3(CAT;'<B;7?A,Z(CPA[P$K3N#6::[/N-[ L^!
M[[K8R^@_T,7RU^KWY8AI<%4<^/7#IO3%1$DV'ZU+2D8"D$' (U$2VP%\$8PO
MDX*3%_J#NXD%-S#N]V^@'P2[CPGN=^ 7^[8 2SF)CEC<CRR(<GO[M3_@]@MI
MPK?MSXR[]G5T+TM5:E?X&QP3A]6"X$GCE_"+Q*9MJ'USY34,\H6+/6A)S:JT
M,#= ->*\[[M(I]UWN^!F%/-WX?N#^GO1%<K+))#\_![BS?PYQB>?O5O&4G?@
M29OX5I8#9-3?AA SVC)/.I"4<>FCJC.=LB\.$F47V='(\WD'@[] TIM6B*4R
MVHI)!1R:Z6>;WS3@J-SA<618M ?X7M*E9P?,9I3,_]GTQJ@PV2D3X--ZUONF
M<>:O)Z>-7>_'=U8$.Y'9B^8[](-WO?<DQ7)3;GY_UWO?KNU)>P<)Y$^4ZH9=
M<G<\J?7@K?<X?P?]YAWNFYHDD%3 (M\$V _"@"0R8\,$;7>5C2Y3NUDE<*G8
MR[$%^PQ/CI\:<,^4+>QU'NR;^CXKGA3: _Z-[K#62@R[P_FNX+24>ZME>\BE
M.SLC$>(A%G+=7<EN!OC^[4]V.QML$M^],F.86-T?-G$&=SZBB8 >\M;&X,=/
MEUMY?<Z_5M >:<,*/WP+7^Z9D#;2WP$IA-?Z)BX\Q>K6VQ9Y/ML4^)J@><H=
M:EL+N[7?WZ2!P6O%>.EF'E%>9(,B[:.W<S?.:[S'_?' 6\)!%-.:GZ_2-N@Q
M[0)P_Y'$"/(WV:"JW,9UC2R?#(G(^A_T2QYD32"+DO$*\-7;I>^J%G?_0+"Q
MO, U$"F5,VQMS2M+ L;&>!(\M#D=ZH5;:R= TI:%6RS!6W)I+_&"Z>[=M4RQ
M,M%T\6Z.P_*)(<L-.92QN/E)9$T%9#+MU=6M3$8Z;O$1_>F3HO$#)-#M 2V^
M=;J)&0B--V0GKE9'##=S\BD>S.7Y^MT^+3%M@:_79D< W!1U"%'T!>4A^,UU
M>VT7C#0])U'5O;,=O<:%%1BK.%#WEU60_]%.ZK]\?(#Q.W:^RE.^]BJ3LKCF
M,XFW2NH"A]\6[;[;@7S*#@CXGG)#TS=-U4"Z,_[^TRRJ!XFE7DD3R#?C)US@
MKR1R7V!H=LZ M[QFP)R^'?OBA0X:^R)38-K%L2M=%MUBBH_*\M\;)<$[? ="
M5:%G\<98CG2\2+E-NOBXI7#1ZNJS.0%W!6DZU!WHVWEOB!2UR_I^-]Z$!*)L
M7X. VV^XNA]=FMQ.PS80J1!C'@F3<D"85N[%^-<-P #0%!?,16%$-IL_@Z;[
M!W21FC9)]-?.MQ_=D3]'V!04PFX=4$4Y]-&KY!E)D(LGHJH]6-U;L)?S:\6F
M@#-K4LPG0UV>Y05IK]/CZ\C+B:7KQ;'%$KE(V:%[Z.HIZPET?2&S%0>\@5V@
M!-,04,AFO71),4/QBH4D?6+Z/LV);Z,*80JE.1DW'\5]&!WN?=_S[K/R=[L5
M=(/I0:/OVD-E?]58X&1ZCAQ\/H?D5,D#4O6SIL';1FYM>@? /R5^X ,>G$>7
M*9"MBCL.UL7$DDG8&E2+V H^C,J_X%_/,HO:-\V,EQF[3<Q0P1=RX,@5N J/
M^>7A]8?834V6'>119VJ>/9.W#BX7B& 7-A)(4!>G\.B2WT/&6U64'Y&=[C;<
M<S9LKW5](O=)H.@QF%]-#$1$>VA))0\%W<#5 ::[U;WU]B]HOOU'='%J;)^4
M&=;,3?B^<6S5UEPM_,ZE61T5XRMU#+%JFL96"CJ(\_BG!,2J]TG^H>^O0]T^
MBMBY5[4,>8$U=E?&^\K576#1+6=46!LN\8<57VFNN>#;<QIZ&>].^#!^!R?_
MVOLJI4*:#RY>1BB"*O/":N6H?'?:;,D:;:EXW>/^LC[I\O[H:!5EE$#[#9?.
M2I[#%6.Y*W/EY:6>MIMS!Z(@WV;WYO ?0W!D*4O\X2%RN5*9DDW.JN!=E>LD
MF42-\+(=<(1D<G3[V3'P4^L@<^\?$\$_6G/N\^9H&]2'1UP*[J&M_E$E?;\L
M$_##GF942V-^",P'<S+W?PSK_;E;CMNJA*SN@XN!C':0R2 .V?.35-7#:P$)
M5P)5 KTEO&^$;RP(GFY(\/TZW4&WG@VM)K+V2!DA=1993+F]AM..!4C0:?+D
M4(;;;-%/VM=XT?D1&8JZGM3OO3YCH(^H$"V>(4A2#&CUF.K<:<UTZH&6A1!A
MT#D? 85WY=5%TBJ3#7"(X*8$&]W=O/6Q,*M4JXZKA9%?C&\DJ591[O<"W&/(
MA)$AB=$T=.#@.A&(>^^K_X(1.=KQNT!<? )?@Q!?62;]<AO)#J>7"4!\ ]]Y
M]W=UG.R_0SJ&!3 &=WKL>U59QKM_$GS8W*6 OT 76RD-^VX\H8\-K8["1L<(
M; TTG!PI-^GOA5_9\_#E8WRL\?P;52$L3@LP>H  6[CCE8K8+Z[W\#$A6T8&
MD=1.Z)8%$JA]"?IAOEPBS5OSI$T?Y#/@KL7X-:G)7LFI'!O#W+4Y5./>I? H
MRYFBF*E(ELL/(TT=7JE)O)!D"76!&<,LFF6" D)=6(.% ",0?^3QMT$Z:NK2
MH%BEKM]EM8R0FA\_;G5+&R;+FA&7 8#@-^*_Z $ MS\P.0 QLP93 (!91 Z
MR::_EOA&+-LHC 9_[QMCS2@AOYNK,CEJ52R<18L<%!##[1AR,Y4O)5YV,RG4
MD%/@*90M[N^&YZ5]@Q0I,P>+%8O8L\)K2\=D<<MT^UUT1L/C"=45_"A*K6M(
M%H;]59S _*?G53T-_8^L\ !UW4(-MDQ\]K[9\2KS\V]IM>*-U!81]N=FY*3W
MF7:G"[W$&+16BY6N\C.>[4C\$KWMM/-%@"6!-LBR2Y>L GU!_U433?_P,3YW
M> -B<)6.75:@Y)-<%/'"[1@.7(8SE<D"T1]U9PEZWE"G/6U4T=:)>GCDMSK.
M %D@=*5?V!+;MS>\B1F>8$/6!BJ(*5\V*<"<5ZAQ5GP+\2,06->EG+%2N_Y]
MW-@OEW;WLXD)<$3&^N#<K5SQVDDM5*\;">2[MX\XTV6>UBLZ7,'\L#BWLBB\
M;Y7J,J=PD'#.LJS&*#12=&JYO>6#OL%[<C-YC*@:H[_=+KF**/I_*4=L_JIA
MY!GS@ZIP7&D$-[E<?.Y@ *8-L)2DIV1U'T!T/S1_-R_ ,*GF(@Y&C;5_Z?$
M'D].?+\L )!E$7(U6O<R8*.[ )B6%7&QQ])]TXVN%:0?7(C5UYN/K[2 N'*"
M/88'3I0ZSVI:G]*R-YY\H,'YZ8CK]_$)NF^#E5?</TAW27D>":0J>T>W[9_^
M1B5C;0%R M?7U\?*JIVU,JW]^,TA>1::(P^O@1C])P0I%\?II 0M$JW"5EX<
MV9N!>&I!/(9'8A=L=O!Q?"$Z_K.>WZ'T!.G3.";UJ :!3\U$\3*"]"D@.JPE
M3/R%OY7VGS!:0]D$N^E]/ _[*:UP^W5(=^W3BQNI"_G/.\'[XO8IWK)?%IDK
MP;T"SBMR0XJ*PVZ7^0&+""/P;8V5YT_[5PV# V+U](>/+>-E[1#%I?6'G\%;
MQ'>VI#.G1$;\3.AK)R,_NT#;2""J31EQR<8^(2DY-MTTC7$BW9PW&Y"NLI>&
M $SRRL4F7D3]:WC7SNA7!0;?PV T799%_TQ>8*!#>+[\;#AP'15,5B-MSR7S
M 2FUN-M-M?09^?>8R$$F] #R!3/],NUP0"M4/QY,&@/ L/J@L>%@'"8.8%L/
M_YA69SHH)AS4$LB!\ITZ>>(X0B&6/)LL>Q#[C&UL/.P%+KTX-J23\O@-"TV4
M\5,0L@)E@?)5];ZZ7IRP(69_:CS=*T-BSZ;G+MW'-33L17G9CC*69Z-NVL<.
MY$0"76CDA'XWALCB55)\U*'IZWVJR\:YA?WE1,9!MSVB8=KB>4@DCO>+@=F:
M='DT'#%#[K?;V_GV%T^H_&-Z7?^)@TX0.[H.4<%FI7AT/LGO7^DA)&R>OT$"
M)=BCT_K3"7R3T%.6$OY^VX'Q@H^^>BDNN0YS/K@F7[Q-U8=ZD-DJ(^Y]NIO(
M;TDT]>+?Q@'96*Z<XQ4)E&H?\ADNM-=?-U]"X] T=0W=R[2TAYI 7(PW#:OG
M,7Q1*$L"1<"_R5 "]H#$^M;L__H'!CD?W&2?[@'KMB,;9YF9IKG,0UO,R->?
MF<E"&VO&B0,P!008GW, J?PQ"I.^89E8\].0U'_.H0.,WTF6^P!MJ2J/D*<,
MR'+>0:*<)K>A':K)L_J]PO+'KP<:YN.DO%FCI]("#N^^;OIHM<R.5G+@<SE-
MB?;:ITO/IJJJI.F!77!/;+G3S2'HX(BU:&@Y Z<ORF'<%UDG@:KVW6J0)P8M
M/:V-65WV9CCFHN[LQE<T(;,F\6E+VQ6%&KABHF#1'D(EW RNG[EB+>@("5PA
MFA,JRC5SY&F$OCRL_W1&]*P&$-/8W^WS(@?:>_X*./6?":_^B8/= -,RX1-:
M%P]N\S=+>WTUFL"R'$0%W@3"S*!,1>;$BM<=U/KW+*=4:]=V*Q\['.>KVXV0
M'J]^-*.'2H/]<U<HDVB$TY,S_;6:38%>$55O:;V+@(@5[&WH$\9O[?Y!@C U
M"A?'T\\X?8DTH4?>AF'L@8A[&$OGD)AMHRN]YE^H&"^I6@1$J\%6QYH+W]2N
MA*#Q875UQ87FH:WG]0T2IM-35T5C1%_4+(HH_U*F9 ("WA_CG@=EE0W>4:41
MJ\L_47[GK8/?EGOW#LBG?Z,+ ,A_'IIVAWY$*>QN,&?(-PT&TUPIT)$[I96?
M"&'$XW K Y[@PC*3'4L]EB?"M)P.??J>M+=VYPL];] P*M6<_HFC7*FIU%EU
M5/W;F]RDG7;LL<((:KR H. T"13@KWIK]TAI5?S=.XL]. +?@&4BRKEZ,F-B
MH=Z/"P#B3['N1E9RP6)D+%X:\H\8S_Q/GN^C>NL-PYZTPJ@KBO=1LR'?V$;L
MBCRF>)I$U"DARA=U59[I%6VIH']8G(,"$-#&*'F+:SAH/_:CS=S35DZN'Z)[
M4^J$'KKK,(R-';UQ V3 2SP*&=NRKUE<WR/>S;6:RFD9UT/.D0$5.3RUG$G@
MH*T@9J+PX%:L.D#B?%;BZ^,\Q+)&A/5&JNLX7VE<:3R ;R=A#[MU13;M- M,
M?@"?Y]H&/3&B,3]ZLX!80OD3LC< 3"\)8)$41C@@U'3SDML@>^Q29]1^-$0>
M-"#5DW]Q;*0O^A5>TF>JS;7E7O=%<>;^\&.)09X),SN4&3*]#H$1J@%E9G("
MRK)VWY<F(-62B$##:P&#D1%R!9?T<,_KZ:4N0,;L$$H)O?ML:58[0\I^%9$?
M^.QM[%GJ&.Y=^_SQ,85^6C7TE2OX!)[-)FGP<SEV4V#UUIS'Z]G0HL>2% ;Q
ML-YP,YNK-;CQ\T4 C8F>@R'?S2Y1R(]A9U%[WB\">)&)TCG_ &OZ+YH8I7H!
MZP+GC\!/\<]BCOJ>:)BZ02]<6TY=2YF&F\Y=Z^ZJO!A[\^J<>XI<P",NG?.G
MFN4?RIM ,\4VW5;$<!*A##4.4ZB3P]/:P6YCNO+ UW6%:ER5@-DG>.*I3ID:
M#DH9,GJ-6[EM&L(1V200<[PIL0_[06*W-)L(0\5@$LC8)>A$KB;KO1L7MAEB
MD"W+,*\_---EB?"X"#FK!4E: !T=B&4_)CVY@W\#\M4?$2HF>?2GT J ;-'J
MFLP5()I")J+Q%TO/8A[DVATM3&\@AK*&QHY1MD^T]>S3T.EBX(-Z$Y^PSZ=N
M(]$Y1SM$FRB.7V@L>?_X98,+F\J$9/_H_VGG2H.:O-9P7!"&HH$"BE!$"I1=
M9%%D#0PWX +$&" P"C0LLFFY;!4(3401!(50$:1:$X$ LJ:R)04,()M4*#L8
M%B6R1R A(60ARPWT3^]T[LQU[CAU[OCCS#??O.]\,]\YS\S[/.<\YVV5 NRZ
M;BTK/)0:_4@,('KY4\4 $--^5O,5>N&81-P">9)2L=.G@//?W"_XY+G/7[C0
M?3$@W(0RWG_(SXSQO,R,]4T10I:M/N]@(P;$H^SKF<XT86"P'%XA._[H>)=_
M_:$5NA@@,S5^Q(0Q2A2<Q0=PQJ),!$A3VY=%6RE8%X;0&G6UPTK#>)T47#KA
M7RY$L:@QE27CG8CQ<B&<EC2XXW#/'.51U@_N^#D/M)>9NQ7MZ+/O\%/Z?W+*
M;!\N7]Z1\G 88[C5.JV#KN*]9/W/"=;)Y<M:AG).="L^L#?;,"_5DO33U^FJ
M9]1OE#_MT68 " ,M%.+,;TGZC.@^I"I./MR@9IILE9Y8Z;!UC<.7Y=1<J?')
MTP0+%,8@&SQLE\_U>-H4@7I1#'C0NQ$IS85 &*#4%0NW8PK['^,12H%Y=J_Y
M]Z+/<*JV'1R!*B\,3+U."R^80L]*GI+9+OC@6T)_G]GW@_81@A@N<7+9O7>,
M+NB[.!^6DVG;FPA;>@), 86A*9N0U,:<]Q/:1J+#C3D+CCVUV3@2FF*'H2[C
MI*;]*_@-N2'58<23AS;7IRE3FEG>P9<J]&G[44FH ?_=='MY[LV^!I]C25;Q
M'1/3"J)*-O-G?E8W21#!Q![M057H9K03HM::0$P!IC_F;@5M]9V>2=Q:$[K5
M%K>]W1.%)]RV]_H+<=E16DUO'J<A-CR0%2U<'48U_1T]<[7N*1%<VIE.J'80
M ^#RMLFBX5@-__")S,/O#)QS3R38*=0;7*@ZX2Z[BNW?4A<HJW8RN8OPM)->
MU3#W5/#+>]"VG*729/H&H896@L%/A%K[ECQ&[)[TF>AZ!OYR6XE+721,U4SM
M-5NQ+E+GD^G\UT+XGI0LV8QBR=N*!!_L XR/5$(^A>8#WB(31M:#61S0+[2Q
MLV;J]53)&*P-1KF_>92Y_PH4IM<5%76O,>"^1\[=W&&0.<HL26=$)!]?[F;&
M.%Q9W)L'OYY4VRU4"=F+=H5+-;:<M]=/,A\B&\:[SX)'AL,BL6^6'4PBOSD5
M)RHB$?KHMX_L&46I<0OI3J,SII<<WFKG\W0@U#B[-D)W3#/6)PX2YN;W<P.3
MB2[@58?E-2OQJ Q0^\M%"7/%%Y+]82]V#LW!:F5W_S"9#7[[+ +R"VDTLFJE
MZNNPM6IM[\+T?>=JOP* %/WQZ%UDA4F!)L/VX%[MA_6_Z[:0H!R\UMI-X>@2
M2/%-L\NF.5=_OLL66='..AZZ00KRNUGDUD\XBM(=(C<01N(C##>51+]Z(H<F
M>W84])NY?& PL'+$CS79@V[;;B2QQ'_RD7'Q=V-C>_@AUM_//,9TF7Q19Z!%
M'+_J&*'6-2O=:"I:%EJ/EPYZPPL@BNX>X16=/WD6RP[$T@Q+4*X1#XTYJ6SD
M<_,+1(DV]I&+<3HZ[^VY?Y33O7IF"Z3;4:4N<"QTD$ZO#%RPV&/YXRX.<,N)
M"Z$N8Y(7,E?GXN><L_ZAXZ/R[0WK&X;KKL/&97GCF]%C)B'3:%P,R^C[??$&
MS9B06L6XG4[;)V:Q<;<([D(<6;Y_'=E]GD(*&EQ9MQ.TQKHR;DX_P_1N$FR&
M+"J>(SWJABL1$7=>E7FI%#K>ZW4'$(;HR6* [%64//?@^&E,T,,4')E,@HH:
M JP6!V(U((G\2W>,1 ,=,6[(']_VO^(O(1.\I-_'$736NM%,FPHU/8O)4\;&
M =[&3\ 9>MD(J$,K('$7# I&_58WJ('_6 7E4RHP?QX\Q<U&(?9:57]6LV4$
M"XCSK,.T"$]")4@%=H^1FTIZ5/O4M,H;C[<;RMVPDR'8:"07YY^/#4_"A4S-
M=E(1=_#+_2(5P2V)YD"* :O0+1"QW2ZL60(32&KDW(*%G]&\[8I]!E*C?8C4
M0N%0E;N[@$<<@VAPE[K.K@)+5V>@#)"3O\[#CG+[7)L4(,IL2PW4)INU 3J5
M=Z#24.A+0/)'.&]?$V<*:B52(84#3TFHU<><R^PV*-4L%B0"KV#9[&*GX.!]
MCT*DBBOU(Z_N-HH"J[PH3+X.V-A=0J#4")3,!+:A3B7T)EK_T/'\4*J^@>3O
MTA!@)7AAW,>D$!^ZVJG'BI_XG7MZZ9?;U.( F>"Y+T_3Z9YB %6]60S NO%*
MQ0!EL')=E&*-U7Q*R61BFD"+B&/UM%B( >^>2F;F>Y8HP7(!)_!4@O$[.MEG
M40@)75Q=%# C^T#<<M"_?4;IAP#$YXS_ZXS+UV[;'RG-B+W8IPNKV?*\-759
M/R ZWP ]X_O#^P=<ERT01:#.6&GTRE7*J1NV&/8]*W]&4W=>>F&I(IF'W8!Z
M_^KLJ1RBW%L'&>F9W_AJU+G>UWU1I##9SYM[^Q"][H%^89,@!M@^8D%$!AF&
MD96NX[3[@O;_E*#'[VC_'/\<_QS_G^*_$UR&U[2&"WT4 X/3?5O9 :&%&3.Y
MSI,AI:I0Z&DQY5]02P,$%     @ ;$"=6,DSQ^T##0  \0X  !0   !C8V-C
M+3(P,C0P-#(Y7V<U+FIP9YU6>SA4:]]^QC@.Q3@FM1%RVA(EY31B(^WLJ51.
M;\TNI)(FE4C,$B&3"#OMR&G4%M*D";%MDQR&R"$D5,Z5\PPU%K-FK6_L:W_?
M]^[W<%WONW_K^6,]Q^MWKW4_]^_&WF)#0&&WLZLSP.%PX$?1 [ !X CP8F(K
M313BHB8A+2$A+BY!D)*2E)8CR,G)$F1E5ZU65%BUFKA:5E9!58&HI*RBHB(G
MK[9&57F-HK**\LHA.+QHC[B$C(2$C/(JV57*_W5@SP%1>B4I/&X#$"/B\$0<
M5@\T <!)X'X/\$?@Q$0Y2DI)RQ!D10O*%( 8#H\7$\>O9"V:C13- W&BA**V
MV4Y)I7U'I38$*YM?2<F3UG$HK579W\G5W7+L7+0,055MC?I:O8WZ!H9&6RVV
M66[?8>7XG9.SRR[7W>X'#A[R\/3R]O7S/QYPXN2I\Q="+H:&70J/N1H;%W\M
M@9Z:]M.M]-L_W\E@Y-^[_TO!@\*B)ZRG9>45SRJK7M35-S1RFII?ON[J[GG3
M^[:O?WAD=&S\XZ?/$Y.\^84O7_F+\-+R"BX<P./^-_XE+J((EYBX.%Y<:@47
M3BQT90%17$+;3%)QYSZIH\%*&\RO2"L[I.25ULKH;-G/53EVKI.@JKMU6(^W
M NUW9/\9L.B_A.S_@/T_KGX@A\>)?AZ>"$A Z,Z@&P#&DPBOD2S3YZC*FPC7
MDO>1UYTZIW_I-GT449'6'&W0[ZIY2NQ5[/ZSN6E).(L%"F*KP3^& <8=#/RT
MRAT#*0_PDT4+&+B!@?75Z@(;6'6J@;:M)[]KZ^<G-QL6"WZ]+?YP<X''^:0L
MT*P+W"(&>*8HH8LK_Z)F57>(/ &.&VVL0DXX92=3?SGB?>DUL7$I(%9%89U?
M] ]6ADQ.<K\2_P:O8L9LM!(AC]JZ/M(=__8+[.KCLR:A*4E9=R@\+?W,O0P@
M;!>F8N ,&=#>]/NWAAO7Q(YDFK\Z/_S*P<E23"LLPWQ[BK2.[KF":,D#%9T'
MD?(PCX9PSA7$I6 *U>Q^="$RD/PS.3 R0-OU:'!'-,G404:*+KPL3&</,8](
M\31CG.(;?VV'OT/V^:[-ZPDZK?^LK)OC-K*=V&]H_62F[_VNM@8@7,.H.8B!
M^'Q:*^6+.VG^2A$T;W'9HY:2?$1<R+ Q#ADAQU?-(;IK34JF)A;^)DRZ',1Z
M&-S47'ZB,TG5L\V>\ZI7:PC?8<"@ P-&)?L:FUAMS<VIS2B@(QY%M?DGK$X?
M"6KHJ?MQ=>V!D./'[ D[=*-V;,75T7K[8Q]E"@R1H^FS(\:>@R^L'A(6MN]]
M;7OOP369V=:7N:&Z!&2+D [YF\*G3>D9S!AHV! #5[^?MMI:Q1Z 6.@ VX_K
M-#Z]X-L8@<R^H\V:M;EX"(+1#]]L$)9$N JS_-).D%9_6;I^<GD'E#T<9_^L
MDB/1]#E?&_=<=SRY" .U*J2QB6H1$8[Y]Z*W/3ND1&-UB=!D.31>B('W3Z&_
MZY3-0>7QR#87Q.2R/!R @25%]A-M@0MRA3VZ^"JS%0/)[1\BV_4+6B;: FM)
MHP&43RB1#DC#C:2O/J3Y;@S,]O^Y\\>2926^/@;BGF,@]O9#J,X! TWYPINB
ME#!PDX30ECIF1$>;?H"*%VH66^"1*)(=!H*H\,9%Q&SNQ6_&C11N*6G81'"Q
M3#6%;SI-+CT]*#Z_E(EV;@P>\SW3N<C*WDP3)1=M,'DH%7UEM[GK]:0:.Z:A
MJ]VDJ$FNE*.7Q6B<KFPZ9+8+9Z.DX3N;P<* 1#$&TKRX%<*DB^QEQTA*&@F'
MVH9Q^,%PK/^HIL0DR;=;:TF_XB?5BNJK-[W5;Q(K-?#/M*(.Q($H^8ET.K>]
MSY1?SDV>.<GEVYYW3#EM,7#0\VNDI!>>[&NX_C(UX?'%)DGIH>$8@T4K8,RU
M1 D6@GUPRV@ AZH2YNA>)5"[BFB6?#AY<:T;BZA4K62S\2-YKJF6K!\K9]_H
M2JHYB S3.FBJW<AYP<F(W=P/UZG\WWP]X2N%$_Q#XSTV?>/=?DD6[^IQZ3^:
M[\+;=$C1/08QP'4B+UE1E3'P]DX(!NZ_L>!>K,R;M%-_0WUZXTCCJ%O/M\<#
M+Q=;/V@]5[?AKKEY]DYQ7\D:GNB[&4'-76$%:'T+4[BI-%?^*2E('CZ=#'OS
M-;GM&)C7@_P<^<E+>(@SEVDIDA7-G&I!-IE\N^MN;S34V,9N1W14_AIQ_AH]
M:BZ+U"P+RH&=C3^3W^:@&GA4]4@I!E;)8F!#,M]1>!VUQP!/\,FQ K5A7T*9
M;8)!TU$Z&",-E4'S@7:J&"AMZ\7 +FHQSYM]"OH7HU'6U!A(O=J'JS0BF;7"
MA^3[4]O\'@57&5]+LJPSNA V@#>*Q*W1(@JU$4U>/5NI1C%,IW%+__U$5+MC
M.N2DB>^Y*5GRF=2?Y,*C*.I\YL>T!AJ>)W6%T3'6^R4S2S<P_-RI_O#W&QNS
M.\=2M_YL.&:\E9SX%1!KQ3'@S'X2BF2TU[(%2ENI0NVX*-M#; !],F0O>K$7
M=U#8/3 > SO<,%#U"@.5+X'03%@##64ODV:<\EM&<F1=@A@(F14O<]9^5XC?
MOGI+*5;4YM2OZXS]@UE#&(#U. G?0@'M Z9>'78;FCXH]%"?!N;(NT@^B#.I
M>!42N,%AC'O_ZB;E;!DCG'4<1 T<:Q_(Y\MP%V>.#A=:!.D%73!-2#<[QO'T
M-UX_\F#DPQ3^VWA&C:SV1,HM+4VO3LHM398FHISI);Q[NHP="ST]<Z=D$VLX
M+,-8H^>J6[@ # 2:MN)3-_MF7GRSW[S^Z(W+R;!![XREP'FR-P61A7WX;@0U
MLY*1B3G(?%WPQ[8Q^ZM?!RJ2W>TUB[]XC+W'P,Q)P45D=4(9<WV$%?JNHZ1Q
MJN)91\](DEF+]?=^SUV>D[9$Y-O$O/Y5?@U4>Z+:.I+K/#)79Z?Z6Q=J\,ZR
M[]CKN5+;6X7&(A+;G>5DQ&R7/NCY>$QB+(HBN@:BZLH=1$3J*PW+A'CZ\0*G
MN%/Z>QRK=LTH]D_JZ(S.1L_G@J%R#?7^X(^BV_8#&]Z8F*UU>P^<QPO=TW=O
MTT"6QHO%[Q<.?T-H/U=PS[>H\9)O2T1^8"CE\=PT[B$\T"##Z^)'"9Q9(^L=
MCCXXN:Q:O%!Z/L[G^GU;CH:V#@&\LS(0;LF5;R##)@X/H3+]6)4#1LSH&7!P
M#8BL$M"%AX1I[+$WM%4K%SP?FI"S6/+X0\A^$0E90CI[^7 DI2CGOV0/RI01
MED"![5)H,PT?2?E;2HB\PN'\32FYCEI*'W99Y\Q^M]IRQ[H+X"X^3>!/Z\]6
M%J94:WPZ<BF<D\@<I4[GR'.T5FE/?&QU,92V)1_2P=]-X5E.WQ:L@]G\#IX@
MXI(P]_BSZ@ZFGMK:B\G;?-?28^9!SGQ;9[A1HAHG3R_*G'2<W4?B0-R]9+IB
M!!4>M^F MX5*OGEAVU&>MU;IB;3:#GJ/ZX[3LV?.GFO@3)'CD"WW8,N=3SHO
MV%H-N+X^S? ,>C@]2FQ0Q$6I.!UFL2JZ'@X]?1IM[>.IX\F(5I9.820:%26M
MF,,)>D84 9D15I.&,L_"5:XTPPB5)VZRG'3%R)HYI\=B!E_5#@U^LI<BOHMI
MD\2G]%52.XT,\,/,M_(H08W*FW ?_E0?FOP=7.)?I;?@.Z_D(9/5X %TIV)J
M-FV)?KE9W7W6&W;A(R(BA=7Q\OSA6]PJW0[4R'-S5:JQEUU;527YS@]#]DEC
M"@37E&=<3KZ)_%L=E/ -3>^P(S=_Y$N\ YSC;_BXO+HFN0GM3G%U5Z;;S\_N
MU-A]EVIK1TV/LA.5\.@>#(BDVD<DU13AIAIF#[G/&G4+&!H4)F18HC?K*+<@
MKC=;5 1DH;=W D4UH+=GN5"@#S4_1#1$\K;%&0.OUYS ]P0NM<(#HSZ#<>P*
MR^3JPP5.<LMQ5WB:>WN"&)7B]?.UA<U&QE$[C7:#LSLYX6CBU(+'" <A,E'5
M^ :R>E@+*M)*?@"BZ]WSD<DWA9TC!EE"1NCMED%^P_L*FF60>N-9J[U2S8,L
MCQNTU1%N\&]%$=["0IKNH[SBR'O?!PTW/RT>N%<9',VT3,,[:^V,>EQ8RVD5
MN\%<IF@B*K)\2IQ%$BEA][5<HR(8<@>X#AS_U!(%7>>+@8.BTFU"1F?R_]3+
ME2]B#W\>9*D)E=N1W%,YR V7?W+!Q>,4.#A9>*@=*2,)RI/_[CW*KN@??:$F
M]PNU[SI*#T#W6I!19^8MZ-]:'+!<C'YS0V &=>[!P$M)D8MJZN$%S'SER?+W
M"^]OG; )&&(FG/V<H_P%7G0Q^FQU=]_D9(RQ<@G_:/F^1-V" L+@)G6KG'^7
M&LF&MBTB@D>=D2@,"W#GW1^9#&^,9S3D/6+4*1UN6->U.W4/1"</WC)I'(JZ
M6WH,RAW\!T* /]F[97=NSG,VMQA5@2UKV4%HE\AIACJS7ML-C%^BG!#8R*C=
M89T/>L^R#ET7H&Y[ H_U_0]02P,$%     @ ;$"=6(B#]1_E"0  1@L  !0
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M;5$("AH]E.FR$CB'T^CZN[IY87_<!J!Q7KA3P>Z_=AS:_PM02P,$%     @
M;$"=6(45KU5?!@  J@@  !0   !C8V-C+3(P,C0P-#(Y7V<W+FIP9ZV3:503
M5Q2 WV0A9$$(A$6M1MEKM<CB@GB(6Z6H'$34N*-1&UPJ!1>$(J.X(*B(6,1Z
MU"A(03@U560Q8@8$B;O%#:)H$A%0%DV"8""3>9VHM1[K#^WIG7?/G+O,O/O=
M^QZLAVI@,V5R\&2 ( A83#X /@03 95",2]2:.2B6]+I-!J=Q6!86')8' Z;
MQ69;];&UL>K#[<-FVSC8<.UX]O;V'&M')P>>DRW/GF?^"4(EOZ'1F70ZDV?%
MMN)]L< *P+4T%T5%G &%BU"Y"*P&?  0.O)&P#M!*&2-%@Q+)HM-)A3;  I"
MI5)H5'/59'03&0<T+MUVL/=X"[NP)0SG:)[/EGW'+5TFG*ZTGU&K=?45Q20Q
M60Z.3GW[N;E[>'X]Q&_$R%&C_<=,G/3=Y*#O@Z>$SYPU6SAG[KRERY;_((Y<
ML7+MNO4;8C?&Q6_=MGU'\LZ4U(S]OV0>R#KXZZ'LG!.YO^7EGRPX4W2VN*2T
M[)SL8E7UI1K%Y2M7;]^Y>^]^7;WR@>9)X].FYI9GSUMU^LY77=VO#3V]9BX$
M4)&_Y9-<7)*+0J-1:0PS%T*)-2=P:?3!WA:VX\,82Z+MG'VV6/(F[#M^NI+I
MXCM#:R^*J64YN/IIW'1FM#=DGP>6])_(WH/]P_4 <*@(.3PJ%PB *3P[U1-\
M2D\%-#(NA;#5>ZL$-H:V:JE/I,SM=-GA^<?BEOFS]AUSI=QL+_ 9=XV3[G^J
M1CX+@J0<"*ZDX"$0E(F)(\,\J4WG589OEY^-C?E=4IDB+K$RGG/7C=Y3'Y_I
ML!OI;EC)-R3&FL($N P"8VIY(<&<:AR&#S?E"C21$%Q4:&_AKF@]ID070Q J
M*]8GO"R)PUK=0I3Z'*.RYK'W?@D&@::.7^1HLA/@TE8)OG\<?P@$59U8:PH$
M3740-,Q$/[1F=0GQ,8W=(@BRQ1!DFL(AR""W2EZ0>#WBU30(]%@!J@\!"840
M6-^$H, #@JP("*+#/K*%]R*T;7N5NX@4"2'L"B6"<X@!T49OM-87@JO$2;(+
M?HA>B@L"B'P)L1 U79KQ (+*M8-^/GB_15V>_O! S]-=ERA!8:T\9;['0V=Y
M[K]J2$ @H,\S'2"<$F^@VD),LV"CF.#>ZI!VA)9"D/=H8=SCT'I<VJ67-\2=
MV=0@CO6OJ&"TE59BJ;U\A=>.P($ZU8['LVN+"Z/.3BC*G^LR.'7L&L0E9LR9
MP[8^>;2T54723%2=Q=>+4 [V@L3*FRKK+=C,ZA$2K+T0N'OH1A$:2>^ZL]*"
MPJ8(PQ !?E!2K3+N0)_?OKTYT#QJ)PANK"8'[4&HZEIS$TE7)0=M+D$;[""(
M:NN:L9GEF?U6<;*;22WH#3)0IB+JA>^RUV+-Y%@:HB!8[4EME1K<%.0>55Y&
MTOG\]@MYP?]<(""J^*4"W#L*=U?I)I'':RD$3*]ZM'E8-[]HDZ2#_^KB0J.\
MMF//A4X%.5W\96\VVK,>@M?V(+$@+"(3_=#%_\*XL"D"=PP@(B6F&@BZ+^[]
M\-S+9YG.0; &-?SH99B /B'QMP407&DI>GU^AVJ%,4A)]F/;_)$FB2K@_-)T
MZWNAG]>I0-20:XS'F0:OQ@NAE7(?W:WN42E^JF\Z-D0H'3M[$I<%#TG0C;L<
MDS%8D^:[];)S>>&3K(XVXP \4NN>IU;UW=AB%%?%9V5VG_=JWR.R]KV6Z19Z
MU-.^9J#?V.$WAV]T#4=7AQK<O9+1E9*=.8J1@<-E6N%.<6F::KI V;8I:IW+
MPM/R6SXC@]C%P0WC+3%/?X\*3%,CZ)HOT-^%X,4#(&B<@[40MO'OWQ]&!9],
M?:W:COX1VQZM*ZJ0H;L3'-7;[Y?[Y_>=_5B[JE]U_^LQ?FM84\?(-+7)UW-&
M7U9O742'H(\W>6W)%A[(@V!#[4?VGPQYPFS3-G1I5%(@ ],E[RGGR?C)J^?Y
M'=45'Q&)^@4[^%%&MXA%<Y,?A6_)^ EQJ8#@\ZO]#+#7$&S'2J7ML=J(BD/B
MK0G]&R7M45;/Y5'*H=B9$2DXYB/,).(6B_WCOM(K^E:HD46%VM+N+H.=+D<1
M_S:_0V*[<M&;?"]UY]BRH\*>IBW3E[BLO<9II&;0$X0?(=>5$PJ5=IJU=>(U
M@6URFK1\>71C2/Q]YJ [V),%0Y<4=_).I EOI)_GB7*:@<4:YJ#-UB7/LE.!
MYR<4*O\"4$L#!!0    ( &Q G5@ T2D+8YP  &^S   4    8V-C8RTR,#(T
M,#0R.5]G."YJ<&?LO'D\U/^[/_P64BA+EJQ3(;)F*]FF",D'6<<2$T*2; EA
MIDA"R%X4V;-D[#MC%T+V[&;L^XQE#+/=T_=WG_,[Y]R?[_=\ON=WG_//?;\\
MKGD,,][SNMZOZWE=S^?U>K^'\HLR#[#>U=;5!FA.T  /J#\ 91LX>^NAN[TC
MX A0!PUE"M $3M#\'K\?3_P>=+2_'^GIZ&CI3M*?//DW8SA]BFH,)T^>8CIU
MFO'WH#YC9F)D_OW+[X/\KW\]04]+2\_(<)*!\9\>E&: [=0)_ D+6II+P DV
M&EHV&DH[ *+.D?YOTZ,!_N]!<X*6COXD W4:3-0W5+)2IT]+2YTT/77&U%>#
MJ*\#=&ST[!=E;YT\9V3'<,F30^Y5;,8I(8W2%D[C08RPO+U7\&E&+N[S/+PB
MET7%KH@K*%Z[KG1#6?.VEK;.'=V[)J9FYA +2RN'AXY.SH]<'GL_\WGNZ^?_
M(N1UZ)NPM^$1<?$)B4G)'SZF9&9EY^3F?<TO*"NOJ*RJKJFM:VUK[^CL^M[=
M,S0\,CHV_FMB$H5>6%Q:7EE=6\?N[NT?X [Q1\>__:(!:&G^9?RI7VQ4OT[\
M7@.&WW[1G/#]_08V.OJ+LB?9;QDQV'F>NR3WZA2'1FQ&:<MI(7EC#*>]UR C
ME[ "2@3[V[6_>?;7' O^+WGVKX[];[\F 69:&NKBT;(!8(!$S(P0 _Y_^_^Z
MK1#]L:XH2.L4>(LE''E.%8SZ?FU[[V#&B>EV5[&C#P?-3R.H(OZ0S'A( >A6
M\?[+.OGD867S##F/DE4NB-6;O57!65'#]A+!@X4F60H0\I8"V-N<:A#DQD!B
M#KH9IN/.7)H\94VFEVKVI "!)DOVRSJS(Y"EG7#P_!*"L?E'&ALIMI*IM+];
M4>9\#O)GHIXE6)*LV+Y. 3!>89TW/GQFPCW$])60V7R_31OHD';S4P+CN%4-
MQR,DL&DKY+/JI&)>8S=U)N*-VYME5M!:8L<OLMDT49P"!&_"QF9O8%+Q(>9X
M;\SR#8A)TK1(53R,V[[K'$OC"__>M* PSMZH]J%>3%F[.=[!=:HOY_@33Y)+
M:$^)28<]WV(4PM&W4!<F28)F(N4O4 \X3A[4N_P4=M[OROB@U/8(V6F> HA/
M#"/GJY'LZ <^[J^L.!9JJD:=(L&'0XU^GN@?B3O7D%MC@3\"-5#A:H]U7W1"
M,YU71SDQ3\,I 'T[AM@!:8>7YRS5+'A/^"5>)MY\=&ZWS]>6C_I1?>1>JU*+
MRAUF/^1=[\,TFVNG'4#OO+G AWT^)FC)I.+1Y/Z-O3L[69V!LE!4>\>+?!T*
M</?.,3H"RW** K3H@.UW>)[HL42G!&5'C:G9C@6HY?VL&"P@7XBU1:# ;VT!
M[%;UE.J9A2B051C/WK//!A*)7<4.]A)#69&M]N!08[E]%[).]9L?7D1W0N.C
M :*<X:Y3!X>1#<,C(RT.X'_,;EU@CH?*DX>IP6 ^]RL59TTPB$4$&L2TUY&:
M3/&^K7SNSA!^SKB;K>?OJ)E-7]W,?9UZ<DC]0Q&"![_3 CJKP!-HAF7J5+8-
MS;T)AG_=X'W]_*?.09PV(UB9Z$'*!L^C9";#T#J3"M"7ZNQ#,- :(E%OA=9H
M)&)_X*/X6Q.ADK>Q$_B^0!VLR@*H(SW*Z@BKTS$7KKP27GG"8.J;NTG2TGL0
MRF;SN0Q!XJ5L<^&]H#O>-BQ3\&@XQL;PEPR*X;,=RIUK/4UYQ+Z'E-Y:YWGU
MY%9J^ _/1 KP6(X":$(O!#I2$1,- _O%])7B!3"&;6G<K\KR_;_=[\V??C61
M(!//F^X$H9W[!O,<-,_@T/ST<1O)20'F<Z'5R9TQUV3X8,.SHGK^9<)E@]*=
M'VEE#N]:OFUC<1IH<FV7V=DYT.M6/&. <TT-3WU6/G#1UWO=8E=?4\N\?:;D
M7^"/\"!]CB%:^^N0=$0IP."U ]3!%@4HKR;&?PPC::]0_W05,N )(;Z5@$\A
MC^\;QBT@CD0\0;@5<O*YVDPJ!-N.YL4R(P!Q/97>/O4EF2?2V<&/^AV2>!C+
MTN_I7,K*C'IU[>,&F 7^-&9R"A66# HEJ[@BF -%B@L]9#)I"1E/-4-!?T":
MB-33$3P6:#,86&\8,<?TS.:%2+/K9VG?TD\Q.ZR![0Z;G#I#35<R&R6O>:;8
M@4/-S3=GQJ>W8[SIVVMQ4'>[MW%Z68&]VXGC\[#R0#'JH1"P;A"[:KT:O!U"
M/M<8R"+:SO7PMO7DH\@O@MLF:U!-/X>.-"YL<2SHK2H?VOJ,5:O[ :3.#6UX
MCB1PFF$/T:(\C0&U#[Q-9ZKT1 0J83L+,V:9G1;TFOQXFC>G[DRK16L%"9Z+
MDKU7UCYL;#,6<P"-Q=7ZAN./S:.O1:3L@'Q(DWEX4 ,'9%FT108OZ=L50W>D
M#.UD.;M&OEIV_V3]/4G$S;7/V/PHC,KY%K6IQJ!X#!^948@@30S:?;8%ZKJ2
ML7'NP1GN]@ W)R=P:[1NM+'AS6+K7Y"Q>;\0B:X)C>?)+H\H0#?QX[&@6>>-
MLT]'7$:74@ERA]#>K*-K 8D</FM: 3HC]!Q&-_][#-('K^HB<H)Q4%+XULK/
M0'U$.AN^Q>&'X-F?CI :;2'QI\)+4I",H]U%_@+%T]?.9 >)2);>.J>O$/$V
MPG(F^L2KD?A?D$YP%0.1FP%G0$J=W&E%GD&PM,,Y;M6>27OE59@W]5U%S_^-
MYL"CUV%"#&XP*'DB'6-F.%F-ZZ^I^TG40Y>C!D[UM&M1$S#+W4%KY>?<+)\/
M=7)]/W_D,;4Z*JZXM^VT\NM8$X>@QD(A>0)465L[V&"#Y=QG.3/]%(K7:I"T
M&AK- K=)G)2;9G:XI./X_;L1]/J@EHLK3[7'G]5)Q%/29_CBYQ_@=<7KY/#@
M!NW&:MPS"A 7!":]<:+"Y-[XWX-)_;^!B5AQ*DJT-88CT!$;YZ?2VGGJHUMN
M/1+9X)6$XWJ?X5]\^<%I4RVZ3R<,@1-W&/*K26G/$+R!8"Q+#+6^W8*S@4[?
MEE;5S+%97>Y9DNR>=+\ E;NE( [#B@C0T'WA;%15?%&R'%$WON)FD[3=&R#P
MS$.I8/]HK7/#MF GT6;BZ6;E\\:8JYF-#JB!S18*<!H2VB""AO/Z8575T\#C
M2T.J_&'ZUT\L/_HLY)_[8&.Q6216:)8N*J[+B5MQ9582 PXG<B]$::+ZZW.5
MUX^=\D1"^[(U _S7+KXK6-AQ##N_$1M=8=H&R:&_(05:+VZ4_CQZJ%$8W'$O
MAS<^*N&;6UWV6&IA;DK3ANE#:AEI'Z#5PLQUG)E?4_RU@]B<C_()#5;5<?'3
M=JQB/G_T1OZU\WF^ME?O::^#+0W87W]RK+N:;_ L%R4UAM+B,'T?X+QY0*V@
M)T@Y<&=#(3W,RKM4R.#%9G+S^.%]ZP(6U+LX04'\J1;O[I--^Z14^'P!N'RN
M<Z=\55"IC@*\EH F,^'<;.?Y;J0/J7RB!^F>X/]T9O0(K!7PT9=UV=(GB\=;
MY\BQX,@'FAQ[8"G#X^PO8?3Z: U1+@7IWFXRF/V#1(B^LQSE&*'UT)'>TN 6
M0\;))"0_T@F*%V/8HB?(Z9Z-S7"E %.V N]>DOG';+)#N9%Q1S,T&U%Y3PWN
M5L)B8+WIU7/-,9/1LU(2FJ,4H#3PCHF\GZMYHKF3TDHWC,MGXQ#VA#G1BL0@
M@98\Z?@(&A>4#M49W]L%.WSW&Q8;D#(@]Q<2Y#;(W.5$4.S6OI%6P,IXZ/^;
M"/=&<L*D A7PH/F N7 P%]$U;Y57,"VUN%) V^,MBZ/1Z/2^Z3W+&."<K00A
M -ZB!Z.#M9#/7\6GK;HVR394RV3A50QK3OC3K$EN!4NA!K E(B7/)1XL8%EP
M#:1J=3!YDJRJ+H\?1&>)5-97X\!AF[XZ=KD7R><SNX_>=CZT[__%8P^<R.+J
M3HA3KR4U(><;D.SJ$GH!F%Z<.L'Y=<.UJ8P:[/TLIT)8X^DP<N!/G)!<VMG5
M?G.D"L+=79&OV^>,QK;EMFAL=II_MN2N"G^2DVJ<KG#\6%9FI:[4N]0G5"S:
M,XIEOOQ3PPU,_*0 '30>X'59&7+$FP:#1@3.FP+$GEV$C]A"29QG @\YX=^#
MJTGU%""G_4A:F9H'(&P4X"E\S5-E4BP3R0]..Q$A]H4E SS_N4D2#\_#'W9"
MSZC"T2KZG*I!& IP#X/[7 2]PRX1$-X:"O%N/0GLPL--?3E7*4")3+/[6Q"]
MNB2>8(FOM7.TRUY#GE6T.*#2ZLJM7/GF/QY6?5]TDF5]IQE;L;61)K%H> ;_
MPOW<8TV#2-/AS9<:N_?7(?ET=[Z\-+!8B@'[W'+HIVE!F(Z1Y?TT4=>;^S1Q
M07C1_*HL'[1+5G(7[*J%($?CG5V'TDH=I@O5QKK.'HB+3GQF?NJSM#QW$RZ*
M%^+O]ROOP)*JZ@Z&>@Z;WAY_RI++",N[FWL)W+SLZ3+1W9C5ZPP/>)ZB:WLX
MR*=^ G^ :;/!!V%26RD NT] H[CAZUG1^J:.RD@#'VN>;?MZV793E"C[[7ON
MDZGWKQ&C<L\X=QXGY2\$>>.*DC4>$0T78EAM6,*4%5R7=>EBKI@W <RE89?$
M#-1==MM(FK1+8&;B#50Z.[Y,PIT7'ZTFHUT5OEVI%W\IW.I4YW($O0.A>^ZU
M%GGOA$?&VW6B*';]%-@%SD1TQG*]+741!(T7B50.NJD_+!W>RM%(PM*.V\O0
M[0XDV5N&*[5Q*[^/^#HT*DQBCXBG ,S/IVQ\RF_D.W&*#P4CA"LC#!'UG/37
MR:?6^*QV;)[T@%GASM#P.9:**,-VWDTNB&[F8Y<\?.(STBUIX2$9?O:2:7I"
MT=VZ;?IXK[+M:=G[G$&:6-JN.1953@QA8:-KH4_H/CQB5JPBN=7\V''74,A:
M9+\ZRMLCPM>:TY+SQ!W.P_C=^7-0&8BZ<B@OYZ7\QN&ZQJT=A:;]^".<TMY]
M:;[35N*1C<-N-BI6QGIFL^)4]E1=;T&-:K3JWZA=$07@Q?>[AZ7QD\>'GTX*
MV.Y76&FV$VRG60Z2+T2;(F8T6V8[$I8O21C051UMRVQW-!:Q553[2LI="M>V
M+(V-CXX<#6>\<0'R#K_7<:A^'2L\.1)[_@&@Y? 8ZE']"H9^")Q>MWAY75[>
M0=(51Y6%?N=(C@/("JQ'$Q_S\+C+R*SLGA$^AXJ(O.P8D/(/]9PW2R&'2YF[
M-M C_XV?A&H<![4N+^ /42_+\2X$ZYR5" 7Z*4YD!(KO0$5D574>OK#%\!QM
MU/TCC E: &56%R?>P _/UX/?IC,&.MHA'E7WIKII&GY2/C=CX:,CP'B5.2^8
M!K&<UNB ^X-4 5.!=:8I"4KC;Z'MJZK/(B>/Z==<)'V$!7)BA)A/>EYZOQ$?
M$GR+'(...7O5,B5)2+I2N7Z7% [?E>ESF?%1SPINL/U1YLQ_^<G,8[XK[L8@
M<%5#6F-:$CB346)E[I<WF?$Z1AXWA\%78SKF<**1W]R(?=:MRJ_G!\[S*[R_
M?@(M20W]EQ"A%\7:L&!$JVP-OY-U>!+H',/I+BIA^ 9QJ@AB6=NLEF]VPBNA
M2WPX[WI-('J[B_/7Z[Y0F<+[[;^;E_Z293N9&F\W W*ZJC0WF:#I2(S)#EZ*
M.Y0".$.W0*_ 92126O5"^XQ[P<87R3$KVGU' ?. 1/+*%1X"X:WL> *\!0*?
MKXB?[LTG]X%+D>$XC?JM0+V%J=.U[_<# K@%N+^ZONI>U'D5!DXJ^K%I\RO.
M0%?TF\MY'R>O]-LN?EV=,$E\&#IUAP^_TYY<UU2:/ZUP_";GZ[1"^?T[+\I5
MV'7)(9P?M3@S/D &P:6@S6J,#BX&8]AA8]W9I(@5YJ4 +\G<ZV2QX6=1ZJVG
MMBY?*Q5XH_?&]SEIH?T/>Y'O SLJD/[1@VHB>P@)NL5# 9PZT.FDZFP<[_31
MRKQH"%D /X=NBLTD0K'O4AA>QSEXHMVLF'DRRL+U>DJ"O]7Y,BUU7JMZ&"MW
MJB_(!:,S#R*RQ2_L=$C(O"8S8)VW0 )+F[[R II&06<E]/RDYN/0+DN>M'*=
MI;<W#8;\UE+P3QLI ,[3'6\*+8-W#$SRNL_,;51541DH4>KBC@CNJ2*W[7Q.
MPDFY@*"2%S];SF)BFL'!Q]R;O47D7VFJ0X&W"O%>\(C3*!"CW_,I2,388A?.
MMSYI&>TNTB;7S,9IQL%C47H$L5NF $]V)E[ )\)P66-D .]J7#<N99\R!F6Y
M_T'>T]_-A]G;NO#26<?VC%/WY-8]@ LF,![8T*1T%.8$=7H/\)7S 3/P5FY!
MV2JL5H2+5<\O&\MUMM:Q7;3.&\='2Z^JY!)[R@I#6LSW8\+!("(4/7!^ US=
M%5,1&0#FPT]Z.V"R-,J,(7K!=-;:(S\%[U3?9K6N.DE(ES,*>6*:,JU0N@ 2
M#&28GPOE[4S'M-VI#YAC>X0+#72%)5_<&C=VZIUHY@ZN6F!36=Q)N&N:<,J0
M 7H'OT,^C4+X04RP*VVIX'"]K\3;>.?YFD"3!2ASE)!CA;GCQ:0EJ1W59?G>
MI\E7*UYE1AGNG"A_PM?T-$/6JD6+P^3?,_''I$\48%&+RN1**M*/Q<6Q5KCT
MB5[R[<@,"F!D"=XW-=N;-J, EQCG<#M4_KU8LT'6O:]#JOU=K'=6,R.('F2_
M/P?/5T4DJY4?^%8-UFS3\_N#BY+?%GG.39>H<$1[A=!/E3)57Z@;SXMW5)HF
M*&0ESR_T&1<E&!^L$X0KW3/U8XVSKYAXIY99E2?BQ]%SFQL*F).IUW<<)]3+
M5N>T(^:BV\+//XSJH*')5%Q.E-K:6L[QOY;UU497K:/]F_#>W:44'8<D>T/A
M.-W+F8A]:*B2.VVKY1G^<J8*+D11]D%">BK<JVP"E.I0&M]E[V@.%9EX!AVW
MT8@00V0J]<DPX+LZH"Q$0X<%0UI\Q)[N:,54:%J;44G-H]S@6X.)R>_A']!(
M&_A\*A1C@6"&_33,([*3<IYN*4#YNJO.R%L#6H[%8"UCY5L><S.$:-CRT&T?
M//9N44]+XML+BZPO(/U8;N:E!MU0G%^H"^*-JQ\%2-E.(QN:;/CIO2N/9NDD
M/!%&,&!;B'+0['K=QPVCP^3/JXC> ;S(#I%+<3/Z,T$%-CXK+'5ZP@TU)V#;
M&P]Z&'PP8+;*Y3T<(_^NAJ2AH\NJRW?2G,><X4($^<E &7-;6"F")2(&_[ J
M;AMI5@<NP3M$>!5+]B9)T$M5)$ [&"80W9O'/EQ4_UF/;_X7FY\T D,*<G=0
M9MJ6'^9I-J#OD1C( %Z"U-6>?R SX8PSQ6KJH+)EW- #7!9Z(85I,:Y/%G*J
M[^VR'#1\)<W^03V7EA0 +\'DZK6.+!W8'$1K2&8Y5V+GPC<=*4!,$K]Z.FW,
M/'_X_:"%#UV]2-^E)9?S!T[>R;<YC+0>.5$? ,Y]\*8$03>0B92RCPQGP5X#
M<]G,^A%08WDH^A"-(;<T%3'W$TZK#=5B#QU_R0J.@K;&!SCN\7$I6NS7^%Q!
M#\I(2TN.&4OEU559.,;*MRD\WF:-'3GY0$W_!;@C_5T3)Y:E&?0&>:*!WC6
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M[2JL?GS],)^ $.)*#'-Z'QTAT5KXJ%"(1Z4D,T(\_)]2UCCP!)*L%4 !CBD
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M//]1ZL4XLVZ^P7'QC??:2\+\/L7!WRS7#Z]5]>7UQ$Y/?)_**:O3Q][HO.Z
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ME\>;=&JYWC6'HY+2CXUC9@>F5%G[87GMBEYKR.<-3Y$=3$B22.^VSNSO1BH
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MGQT8X$'^Q 1>\>9WCJ#>.=B0]&]+9^<'IV$0CXJ'V%F"(1"#HH &>L/VSE-
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M4.2%6^O,YL9-IFODI)2PJ1)[3.?$/P2WTCMQWGW.6<ZW7:,>M^8#,D49$DR
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M)4D$KY-/OM7T+=9PTG<E5.^YRWDN=>^>A#'UEFSEF0TA\L&M/G-QVCF7JK.
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MORVC1E<F<F/("Q?'X]^:>LR,M*UU7HL\IF7E;Y=H/LVG@-SK3S/KO&B!6C/
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M)-.*.V>[\PZICE"=TH:4(2R.&.)YX(>[AF*F9F"T*+6KO#3N<'BVR)VZ,-<
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M_?P4(P-6_U:R0U7<.8=SUT($TUP_>(HF-'0K[9V.,=.T"5%_2!/)>N5 N@G
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M8>=[4, W_3%:IB<Z3K)SP1N!"M[05OH =_+5G3<29V[ME.Y=R(U.'7 I%!R
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M7@W!?(0L:\S>_>\@[#^0E@]&N;B^/K* &J%[!P*'!Y^+S5[V<,EY XN'>9W
M(>?(U37^' F@.=IR+L8V^;I+A$.=O?@\;'95SS+=SD9YI>TCOC@=>\:6T[.T
M^Q:*QVB2 (K(N)6X[;BSG^.HO]4)*4];(%'R.KJH9V3B.>;=_<,,G$G.P(6S
MY^+:(5C!L7;P.4T7V^2I5HFBEB*IJ1);W3YE- 7W<:<_T7OS) 7-_2K/%]$Z
M1KPPNMU68Y;TMJ;6';08>4=H$UMX%?E.(H*;9D2% Z\VUL3E%&E\U'HR,IKF
M2S<7\?A]%DP1^MU)QU5-(>U=E8'Z,[N_CTK"I5;.F<8XE4P[:'@L?WW2:[<.
MMWOT-:R2P+QG8BR%3(/3_"[]VO0T:#O@57QBD\C3#2EJ9FT\'\OR7#2;M=6*
M?NO[C@!%ZVNRW!7^ZE 2H.ZS!.UG<H<SHMH5%S?YQ=^8_3A1=]KWMK)CB)G_
MZ@01?]' C&Z/4_!QBU=_H_6+EZDXG<LV.N.,GLL$UK654YXQ0!#3N(AEAQIG
MHX]M$WE(P)!R#OQBL>QD+B;KO+@=MX7IWN,(MJM1@GQ7A>A>9FC=EU\I'ML\
M!H7ZV=&-2.YA*K>KV#<E/J3$8ZF9L3T?["R&/>IP=/ ?V07$ ,UE[WJMC/T'
M7YMB>%+5F=HS!6:$1N6R!3F$(T\5RG'P>/C)_QLNI0L-/^D]R&>[6)I@K#O
MBYX\W%PHUBEUD-<QJYER1MX\M%9G-0[]A_V$OVQLE:C59K/,MLQP!?;64B86
M/\3FS7JOCY3@KQE&$;XGGPO3%^\Q&'KK&ELJ>!8;W*;;;N!?Z9^)PPIHML9A
MC9"?75LESC5R6]2J<.D9/M941%CN'!^=>JQ<'CNR<ZC?FLKP?A["^,@7HA[\
MO7+H>59U51PN7N,5*PR@^P+I?(=_6#Z^41?A*J\#"2 KM%L5C:P>TQ6AS(H/
M7MN0@)<YR%OD9/UF]X_O:CM+KL['H5RNKR&H^W$7?IE/^MU4$0N::KL %I?U
M6Z_P/OK1^R"S PG=W.<E,MS&<DWFMY(  #9@]C09HC6<_[/:P<#CK@G]ZBWS
M :/Y=_:CUAO"'[>Z4G_B$\@?:L/S/_1!M328VBGU .P22A74)6\J0U^S-V\H
M^>;BWA8%]9,S4 _6T>6,Q'D]X$SH]$:M$PF08']F_.L2(;SR_74--2WOSW+/
MBF>[ZVSD^W.)/;J_B/8Y)OV(K(8]%9/PNJ$P7RO&S>H4L);F3!JYKO/W[\Y=
M>;R6P3)ZN):ZTS?,7^):8SX5>K[E]=FD:5^Q6&]QB]A()X\A-51-6+=:L46L
MTD2PYO.P^*1[W/=Z.2)C/V7+B'\JG-U($*T=$R6:/8^0HV6V?1.>_=H@,>0^
ML"5,1PCC14U=Z]E^P$FHPCE3[6WN#V# F74I':)',BO9R8CBH9WJ G(ULIU-
M ER*$2M/HPB&N =/91-W'C4_>J).RZ6CK6C 2J7>+>CX4G[=:"T+J9Y_[X.0
MD"I?<O>SE"Y\9*E9]89"$M^R8+'SK]J5<;(^M[/^/X;9OQT0/H W<Q(9:]L1
M4V,M8R87.G0E:)O=$3/H(VC2!"VFO>TSJ*7)%#$"Q\K&S:6MPRC08]O4A6;S
MU8$:EUETO"W.L]*OWM,LJNQA.FD)%%GV'9,D_IA/5[^SM?2%O:0*S^*Z%(@,
MD]?MD^NGU2[ND%I-R5'>#C3378&]&5!GPU? 7?YNX>N[BV>EG*,EY)$ &R0W
MGKNJ8O^0?IM!-^;"=7E9S)*%>8%RK2[G)][*3 N3<@.-YB_X,JD*24U#&CF>
MV+=)!_9X-E>,.WPB!;. 3GF]544">#7'Q,FX:%1A<\M\VF#G$0ENX&IY%D;P
M0*1O?E+,_K#V'ZQJ/!HVI^=I6JUGZ"K<TMP]5>!XUE"PN7D<D!!GH#A?S-8O
MQS7Z*RG_-5XQ;/#%4,%T&>.4UZ.'61F,W:[)^O>AK3S606SG KEU6][/0(=:
M'U2!,\PT=S?)*,CK?[.@(C_?Q![UJ'ZL$!]_E'_D##*5CK[,V*RP\L6E/K9K
M6U2732%F_^)\%\]U*WHM#0WCZ[T4?9+FWF8^(4K@L(H*A0^#<X3B^^$T!G5@
M/ODKGU4YWE1\5NK(BR)HD("'=3BK7#_1/6?Z)A/1VZ]>9BL# *  2-X?VY('
MA7&HF#N^0\[J]VM)X'P0A,;)/<W](V8LLHVC4X:+&J<LB"_;AU6LD^>9,[8O
M%4#0(;_A._T"R\:2<&;E[1:>M4@%X=A7&K^Q+X3XF4W3(BQIK/OI6'15H=(S
MS?FKN7_MQK_4&/N+=JJH\O,=0VTY@$$;L>:)8<8RSU:Z;B7.N;[V\0ZZA+O,
M)CC*PA6UWITQQS+[/$$JF!Q0',BY%'#E<&85?+MPGO&LU2._$XT(+T(#XHQ%
M_D2IJ84(XTYCWL4XP@O$K [^07OTB$[NV7I&5QCD+1RS^Q4T,$-EZR)=+E\U
MBLD'J3OHHY<A K_;J-)PM3_5*AD@E%O_5@L)8$+:$Q@Q2:B=#\C[*/ZC":_0
M&)C]D,O[AY([T"]MOI=?[W&/8$<@P^"VW3#816P#:M,2:[YH?L4]!QNF73=T
M>-&W._+9]YN,=L 2=QOE)#(U<Y)Q#A%) NS!,1D"6-#BHZYAJ$QQC[UH&EW)
M&H/->U4B+>^UJR2@8J$Z>+#C@=GT8D$I@7=^ICK0@;NXN.="DHVP:^@*/ND&
M0DY2@\*/@B?FVW/JT*>E:0;SK@S0IDN#*B-R7<3!D7E-E\5KU#^X_$X'[DJ^
M HI+ XVU6^1G_(<+'BR'[?=HX>N1"?9M[H(@MS'Z_+-Z5H[%1,O6F93^'/CV
M2F.9]1J2\?"'\:"R\>&GH>=\'+$X@R=10MT<,;<DA*9O)D0V:U^*C'5RZ0/1
M8MU(0%N4-B[P&PEX%UI^ZCIHQWPYVXJ6VB_EX]-Q1Q'";1)@U)AX?WC7[DO=
MVQ73U;<-7PY%_63.P5KCL3X)R]Z%$5:3^4<I]5]YQX@SR"YBX *$72Y.824W
M&&Z20P*2<-M^_1K([1&0L1Z\8(.S= KBF#)DT8>=E=YCM_OVK5L)!8!"U-39
MCM#1-JP)%9K+AF_S!:\IUOS+YU)_V4PL4>QSJQ$DX)E$=-,EK,3<6I0C]]61
M)U6QM])>T]RS??^2>'&1D1=>$5I9;/R!SK#08%)2KW9"S%SFT^TR@:IG@R9O
M4[7%IERZH1,GY'QWFI:0!OH&IO!"3(JT<;KKJ74<S=H-FJDOO]BT>SJM&"?E
M*:#I3L>)PY3#N'PI6R%TC119>&F4\YO:P:ISXO3G5+@W6;7.>P244_(=\64<
M5D.Z33%.2INRI=$I4_[B V;JT 3-HS#ZI;=83Y[6913N_,A1XJC^JL#V[U-K
M/^JF/SVG/_Y$ JC6"<EC>I:\F!\HV9"2F>T[9K)1$F93O0FLJUNU@*10/E^;
M[=17K9<B#$X'35^0T2!Z)7XT<M[[*RJNTQ@&2URX+&4NT@:X&'E]\^K7-&XM
MW/K.Z'@H9>'%U2"3'5Y*):>AFRHFD+J9O5%KY< M>'ZY+GV6M\WZ^J&E0F+4
M\EMS/5VOHM$?:_@T<!K]U-0/G1U=@L:.><2*Q[Z>=,BO\4.^#.TC&39O>)4@
M&8L7B3]( %F;H_0[W9R'7YQ3+9V\'V*X(LYY;0C<S/>4*^!ZOTR'R>%7NJKB
M@1B=>^@$/9E*?2=HW%RO'B<6>F?=6.^>6*%@O<-$_JH;60D]8/IG[D?^5PTQ
M1 *P/-1;&0/M9<1Q;O'!KGW*M1DFJ?SGP3X>7X[HZ3X?O#-93=G"H30[0%4^
M':Z,4%:4*%4UB,GQFDO%6]$:=."ZO1LX2*ZU(> :8BUNGKJEGP;/A(5\@O*B
M+L=-',0Q.L2;FE[I6'EX4;S-R_MY _=6VQ&B5TFO?Y1:U#10<'=T]CL]'$^[
MOI8#&YKKI%?JET]VM@(W?$(=#SOIXZF<EJ;OQ48*(5873TK^RE$@'D>6IQO$
M=D/H/:R3,\X$2ZF]+X.D,3OF%@B]2'0JE7"_ZJ+PCB,"?-"GR;=P761/')DO
MIGEOZ#!&)5#0N")R973C0NC*I&]K3OEGX:[OOCQ!JM0%,MAK9#"*$B)E],<1
MF) &U,I[)Q&L&D0*@E4YW-.<Z(%B>CM+WI33!21)?NG F^S +J*O(L+\]/P"
M?HYRNV^"<#Y>R[!PHCTZ.WB&G;5R6C2P>\*H5OMY[KI8YE'")N]JI% 6TA),
M^4]_Q^2?-@0YK.92(>56N3@'V,!-&.>(Z J$9HU? @_Q?4^Y-=^D^[@UN_?;
MQ]4K=Z)5ECULT.//:ZF5C'R>J5HB-XLGQ$MVO^]-6[F_,VRVMOEAF*TM886H
M,*\=$.AO@,^%@,MMH-)8!T_RLN.T)DJQ];-;1(Y(7Z*3I>AU@<>,:HH%O,3W
M':^YM)P.F#\-O?@%UA@J/8@1Z!!Q,G]D>,GI&2]-O,9'X:R"^8< 0/F1308N
M9/^^B5?IA["-B*M@UE9RSU+3$>(!+CNT@DOB[%*5Q\DE54<2D*IOJGV"_&+Z
MXG>G*?'77UH'=-Q4*T8%5;M=B -O@.EE[$+''KU,ZZ??V!/02]HKG-3F.G:A
MU>3"E[Z1%8[?.C"YQ\(>_FWA4_@G<=/FO,Q48I.] )@RI!=E=/W=N_T'J8ZZ
M]?#1N.P14.]17"/MPFPHM\R(RF7L[ITTO=$73NMB,B(<'9S7##YK?KK<S,6D
M>CKHG*W)YBS^0A21=IP$<#8*RFX_0/G<V5<R_6AJTU;O5057*;6^2 +,/@:N
M?S(X].V0%XJ$7Q$Y20OU#3[7YF?K+GV0,.A.-(4G_E*9\0&'U_6$2*9?^:!/
M;?)(V5IB)4X_=5(W>^_WJ<0)RU++O] W^*MVSI4"R]Z>R0*US\4KHP3"5')+
MG&3+)QUJ;FZFI)K(&:Q1>]P#@(1;I\=V9[= .!#6'"-*R#R8#4G53_0LT8_J
M9W4<0,C6]F;[G=Y?_DC!Y+Y7IC7=J_\#C%)'8@6A2"JH(&C; !VGNH<W14PL
MMIH%#L-5$JUY5HRI=WY(919IOFKV,3C:AH-]H]J=I-OA]M9/<46N,T[;VK!X
MO.7LG?X-! V68ZE.8OOY<V>KHJ,',TSPM[EC13$IQD%D5NEEG/RGNBI($'*N
M'([2,\:R+.AF3@;,Q09I!AVF?9WA&=RV.7ZAVWUIMRBNP56$6U%CU97B#>,X
M9_8"Y)POO,.*NPF5$GG@Y*QY=[C4:I+8LL.#MKB]813_%D5&@\B:KU.X.U3V
M78FZV).#='\=\$J]2EQW%33S(BJ#.FHOPEK$0:9$<%2*! A6I1BM)$)Z2]D.
M7?&L.")MZP+C>/$"+=HGR+G,M8EKLU:/$ .;\!ZRDW<MOS?S\91!_ZS!KZ3B
M96'BIQY/46[GH%"1<^+/=$\<,$Y%X,C*Z&Q0O)W,=;DNC^'@RBV<]$E>]5TR
M;':4OOWOI98Q%/4KJ!Y:L9-3LQ5QQN&'3[%3ZMN;"EX5)*!'.]<MDG9+2D/?
M.G$RSS-&[HLV6:((,WTP+5"UK+5-,3[A8#49G^5.P8@1WK_H(0'!W#)D4G?#
MYF#S>O12.W71R(A&RZ)QS>+ICE"9X=&?4I\BEMJ:S+@>AW0A6 F)R*<3R&?.
MYE9HV4B\!E1Y#GS:0=,(W1G1&"=9ZASJK4;GQE?WMECTF3X?2]]U:"K'#[HZ
M^2=%MQ^N%YOV).U#7(QHM1L:^%+U:I+* NHRN-M^]EYYE6LHX]@P([EJ$>-X
MG#Y_NJ1L2J^=;\I[>$]'Y LV:1$1!A,=U@]5.8_G&\++9!$*#?L6]G;,O^IX
M4=,=R3)+WNJ4MZ93O[C&'IU9#'7"7<$SU&(WT<&8ZX.-] ZN$JWPU_E6 XUV
M@IG;1PJEU1]RAP?O_5_L_5=44T\<_HT&0>D@TJ1& 46I2N]1D28"@M*%J("
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M959U8NE7U?R-!/;8M;2>/:& ]Q]/J;X[.I5#X"5U3K>K(L8*=*CO_S$B_"0
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MAS$,A@6NS-#;% ,I6'FWT82"E(KK$YW,@5Z!6_J.J=!KVOHG[0![HE4'5,P
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M:F>../O?T;0XM"<=).$(&W68R9'U@UCPKGO;/3A5L(Z7S[OS*C0VJG)/Q]B
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M.#+!$D).^]8GJ4R01 -Z3KE]#$G1;&Y^$;;GE,S.9(SS8GI9(_F>KK)V!.H
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MP-'=J/?.$?]#>HN\-:\6<; ^#6VHR.+0\_2$@5B-DC+B$/HZ:JU67X7R,Z4
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M/^KW8&Y6^)6#/&$ZXGBYUFRY2+0.^7_6J?C_Q_^-P;4[\A]02P$"% ,4
M" !L0)U8Q2#V!/I+ 0!0S0P $0              @ $     8V-C8RTR,#(T
M,#0R.2YH=&U02P$"% ,4    " !L0)U8WY>UMZ4!  "@ P  $0
M    @ $I3 $ 8V-C8RTR,#(T,#0R.2YX<V102P$"% ,4    " !L0)U8">)W
MQ =S   AQP  %               @ ']30$ 8V-C8RTR,#(T,#0R.5]G,2YJ
M<&=02P$"% ,4    " !L0)U8Y\J+%ZA- 0#,I $ %0              @ $V
MP0$ 8V-C8RTR,#(T,#0R.5]G,3 N:G!G4$L! A0#%     @ ;$"=6'DOI\"J
M* $ 7X8! !4              ( !$0\# &-C8V,M,C R-# T,CE?9S$Q+FIP
M9U!+ 0(4 Q0    ( &Q G5A:S+R-""   #MC   5              "  >XW
M! !C8V-C+3(P,C0P-#(Y7V<Q,BYJ<&=02P$"% ,4    " !L0)U8THC,85\M
M   9=P  %               @ $I6 0 8V-C8RTR,#(T,#0R.5]G,BYJ<&=0
M2P$"% ,4    " !L0)U8KC/.NT=N  !;F0  %               @ &ZA00
M8V-C8RTR,#(T,#0R.5]G,RYJ<&=02P$"% ,4    " !L0)U8UN,J.+I,  #;
M=0  %               @ $S] 0 8V-C8RTR,#(T,#0R.5]G-"YJ<&=02P$"
M% ,4    " !L0)U8R3/'[0,-  #Q#@  %               @ $?004 8V-C
M8RTR,#(T,#0R.5]G-2YJ<&=02P$"% ,4    " !L0)U8B(/U'^4)  !&"P
M%               @ %43@4 8V-C8RTR,#(T,#0R.5]G-BYJ<&=02P$"% ,4
M    " !L0)U8A16O55\&  "J"   %               @ %K6 4 8V-C8RTR
M,#(T,#0R.5]G-RYJ<&=02P$"% ,4    " !L0)U8 -$I"V.<  !OLP  %
M            @ '\7@4 8V-C8RTR,#(T,#0R.5]G."YJ<&=02P$"% ,4
M" !L0)U8#1P',?^:  !:L@  %               @ &1^P4 8V-C8RTR,#(T
A,#0R.5]G.2YJ<&=02P4&      X #@"9 P  PI8&

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>cccc-20240429_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cccc-20240429.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-2">0001662579</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-3">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">C4 THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-5">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth information regarding &#x201c;compensation actually paid&#x201d; to our principal executive officer, or PEO, Mr. Hirsch, and to our non-PEO NEOs for each applicable year. The identity of our NEOs other than Mr. Hirsch may vary year-over-year and the identity of which NEOs are included in this table is determined based on those executive officers who were NEOs for the years presented. Compensation actually paid to Mr. Hirsch and our other NEOs is impacted by the fair value of their equity incentive awards, which is calculated in accordance with the provisions of FASB ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. See Note 2 to our audited consolidated financial statements appearing in our 2023 Annual Report for a summary of the assumptions underlying the valuation of equity awards.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;Shareholder return provides the value of common stock as of December 31, 2023, December 31, 2022 and December 31, 2021 assuming $100 was invested in our common stock after the market closed on December 31, 2020.&lt;/span&gt;</ecd:Additional402vDisclosureTextBlock>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-6">&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Table Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;for PEO&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;to PEO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Table Total for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Actually Paid to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-PEO NEOs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shareholder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Return&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Loss &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,790,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,311,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,604,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,945,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,595,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,606,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,509,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,156,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;952,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(79,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,937,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,013,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-7" unitRef="usd">3790099</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-8" unitRef="usd">4311539</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">1604322</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-10" unitRef="usd">1945825</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-11" unitRef="usd">17.05</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-12" unitRef="usd">-128175000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-13" unitRef="usd">2595395</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-14" unitRef="usd">-21606202</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-15" unitRef="usd">3509439</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-16" unitRef="usd">-2156954</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-17" unitRef="usd">17.81</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-3" id="f-18" unitRef="usd">-83892000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-19" unitRef="usd">952200</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-20" unitRef="usd">-79705</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-21" unitRef="usd">3937239</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-22" unitRef="usd">3013310</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-23" unitRef="usd">97.19</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-3" id="f-24" unitRef="usd">-83892000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-25">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;The PEO for each of the periods presented is Mr. Hirsch. The Non-PEO NEOs for 2023 were Dr. Reyno and Dr. Fisher, for 2022 were Dr. Scott Boyle, our Chief Business Officer, and Dr. Fisher and, for 2021 were Lauren White, our then-current Chief Financial Officer, and Dr. Fisher.&lt;/span&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-1" id="f-26">Mr. Hirsch</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-28">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;These amounts are computed in accordance with Item 402(v) of Regulation S-K by deducting and adding the following amounts from the &#x201c;Total&#x201d; column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP):&lt;/span&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Average Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Compensation from Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,790,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,604,322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,595,395&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,509,439&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;952,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,937,239&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments for Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjustments for grant date fair values of equity awards granted in the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,804,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(891,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,624,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,844,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,395,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year-end fair value of unvested equity awards granted in the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,110,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,362,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;356,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,172,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year-over-year difference of year-end fair values for unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(198,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(34,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,018,970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,349,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,356,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(167,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values at vest date for equity awards granted and vested in current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;216,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Difference in fair values between prior year-end fair values and vest date fair values for equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(693,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(113,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,002,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(932,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,324,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Adjustments for Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;521,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24,201,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,666,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,031,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(923,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation Actually Paid (as calculated)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,311,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,945,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,606,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,156,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,013,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-27">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;These amounts are computed in accordance with Item 402(v) of Regulation S-K by deducting and adding the following amounts from the &#x201c;Total&#x201d; column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP):&lt;/span&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Average Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Compensation from Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,790,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,604,322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,595,395&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,509,439&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;952,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,937,239&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments for Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjustments for grant date fair values of equity awards granted in the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,804,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(891,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,624,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,844,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,395,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year-end fair value of unvested equity awards granted in the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,110,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,362,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;356,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,172,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year-over-year difference of year-end fair values for unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(198,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(34,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,018,970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,349,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,356,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(167,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values at vest date for equity awards granted and vested in current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;216,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Difference in fair values between prior year-end fair values and vest date fair values for equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(693,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(113,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,002,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(932,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,324,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Adjustments for Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;521,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24,201,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,666,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,031,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(923,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation Actually Paid (as calculated)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,311,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,945,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,606,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,156,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,013,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-29" unitRef="usd">3790099</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-30" unitRef="usd">1604322</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-31" unitRef="usd">2595395</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-32" unitRef="usd">3509439</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-33" unitRef="usd">952200</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-34" unitRef="usd">3937239</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-4" decimals="0" id="f-35" unitRef="usd">-2804021</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-5" decimals="0" id="f-36" unitRef="usd">-891745</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-37" unitRef="usd">-1624400</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-38" unitRef="usd">-2844379</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-39" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-40" unitRef="usd">-3395354</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-41" unitRef="usd">4110779</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-42" unitRef="usd">1362669</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-43" unitRef="usd">284900</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-44" unitRef="usd">356546</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-45" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-46" unitRef="usd">2172003</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-47" unitRef="usd">-198377</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-17" decimals="0" id="f-48" unitRef="usd">-34088</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-18" decimals="0" id="f-49" unitRef="usd">-18018970</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-19" decimals="0" id="f-50" unitRef="usd">-2349947</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-20" decimals="0" id="f-51" unitRef="usd">-3356456</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-21" decimals="0" id="f-52" unitRef="usd">-167996</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-22" decimals="0" id="f-53" unitRef="usd">106718</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-23" decimals="0" id="f-54" unitRef="usd">17814</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-24" decimals="0" id="f-55" unitRef="usd">158875</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-25" decimals="0" id="f-56" unitRef="usd">104252</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-26" decimals="0" id="f-57" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-27" decimals="0" id="f-58" unitRef="usd">216575</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-28" decimals="0" id="f-59" unitRef="usd">-693659</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-29" decimals="0" id="f-60" unitRef="usd">-113147</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-30" decimals="0" id="f-61" unitRef="usd">-5002002</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-31" decimals="0" id="f-62" unitRef="usd">-932865</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-32" decimals="0" id="f-63" unitRef="usd">2324551</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-33" decimals="0" id="f-64" unitRef="usd">250843</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-34" decimals="0" id="f-65" unitRef="usd">521440</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-35" decimals="0" id="f-66" unitRef="usd">341503</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-36" decimals="0" id="f-67" unitRef="usd">-24201597</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-37" decimals="0" id="f-68" unitRef="usd">-5666393</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-38" decimals="0" id="f-69" unitRef="usd">-1031905</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-39" decimals="0" id="f-70" unitRef="usd">-923929</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-71" unitRef="usd">4311539</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-72" unitRef="usd">1945825</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-73" unitRef="usd">-21606202</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-74" unitRef="usd">-2156954</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-75" unitRef="usd">-79705</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-76" unitRef="usd">3013310</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-78">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="2401" src="cccc-20240429_g10.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-77">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="2401" src="cccc-20240429_g10.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-79">&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="2403" src="cccc-20240429_g11.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
